0.9649519354	matrix metalloproteinase
0.9647068551	portal vein
0.9621351554	bone marrow
0.9604580222	signal transduction
0.9603878938	cyclin d1
0.9601639947	ionizing radiation
0.9597938990	autosomal dominant
0.9592959673	histone deacetylase
0.9587897980	vitamin b6
0.9587123615	quinone oxidoreductase
0.9586838912	amino acids
0.9583584848	benign prostatic hyperplasia
0.9581278219	histone h3
0.9579217292	nadph oxidase
0.9579068885	mesenchymal stem cells
0.9577418998	smooth muscle
0.9571039107	monoclonal antibody
0.9568329368	rheumatoid arthritis
0.9567514933	alkaline phosphatase
0.9566097933	cytochrome p450
0.9559283561	caffeic acid
0.9555275392	fatty acids
0.9555205804	polycyclic aromatic hydrocarbons
0.9553556184	phospholipase a2
0.9553152930	eicosapentaenoic acid
0.9552199848	mass spectrometry
0.9549817817	monoamine oxidase
0.9547948869	neuropathic pain
0.9547266905	valproic acid
0.9543973254	myocardial infarction
0.9541722840	hepatocellular carcinoma
0.9541341426	open reading frame
0.9541259691	monoclonal antibodies
0.9540272809	frontal cortex
0.9538657358	diabetes mellitus
0.9533368690	organic anion transporting polypeptide
0.9532602749	glutathione peroxidase
0.9530593053	retinoic acid
0.9528411666	cerebrospinal fluid
0.9522339499	sciatic nerve
0.9517995242	glomerular filtration rate
0.9517329654	adenylyl cyclase
0.9515774005	skeletal muscle
0.9510423905	allergic rhinitis
0.9509712961	adipose tissue
0.9507520062	adenylate cyclase
0.9504910938	qt interval
0.9503141982	thymidylate synthase
0.9502697049	nicotinic acetylcholine receptor
0.9501664548	aspartate aminotransferase
0.9500095322	naturally occurring
0.9499735901	adverse event
0.9498425071	chronic obstructive pulmonary disease
0.9497708495	body mass index
0.9496874564	lipid peroxidation
0.9495378489	medroxyprogesterone acetate
0.9493428404	heparan sulfate
0.9491655220	tandem mass spectrometry
0.9488956780	polyethylene glycol
0.9488584400	green tea
0.9487763692	inflammatory bowel disease
0.9486414293	reactive oxygen species
0.9482127103	tyrosine hydroxylase
0.9482043940	positron emission tomography
0.9479095538	coronary artery
0.9478342956	gastric emptying
0.9477462968	spinal cord
0.9476885781	voltage clamp
0.9476651860	hypoxia inducible factor
0.9476592670	arachidonic acid
0.9475615398	drinking water
0.9474754529	hydrogen bond
0.9473663084	alternative splicing
0.9470914275	single nucleotide polymorphisms
0.9470252172	hydrogen peroxide
0.9470230465	colorectal cancer
0.9468223835	gel electrophoresis
0.9467144471	heart failure
0.9462861637	prefrontal cortex
0.9462217616	poorly understood
0.9459516986	acute liver failure
0.9458152013	carbon nanotubes
0.9457758102	tyrosine kinase
0.9453838125	bone mineral density
0.9453435041	multidrug resistance
0.9452959967	mesenteric arteries
0.9447728580	propidium iodide
0.9444868166	adverse events
0.9442789180	rhesus monkey
0.9442499106	chromatin immunoprecipitation
0.9440796517	dna damage
0.9440677730	acetic acid
0.9439423983	fluticasone propionate
0.9434269578	liquid chromatography
0.9433285894	bone resorption
0.9432314387	nucleus accumbens
0.9426749597	wound healing
0.9426309296	prostate cancer
0.9423428838	basilar artery
0.9423246023	voltage gated
0.9423188798	vas deferens
0.9421635758	hydrogen bonds
0.9421296888	argininosuccinate synthetase
0.9418806102	cyclic amp
0.9416547814	weight gain
0.9415400123	major depressive disorder
0.9412719700	mm hg
0.9411602950	aryl hydrocarbon receptor
0.9411563868	blood pressure
0.9411007745	site directed mutagenesis
0.9410741202	sulindac sulfide
0.9409531736	hpa axis
0.9408690814	malonyl coa
0.9407934792	surface plasmon resonance
0.9407933322	brugada syndrome
0.9407833263	transforming growth factor
0.9406406313	tumor necrosis factor
0.9406388236	fatty acid
0.9405619690	gap junction
0.9403990680	northern blot
0.9402711069	vascular endothelial growth factor
0.9401965381	superoxide dismutase
0.9401682245	polymerase chain reaction
0.9401598817	small interfering rna
0.9401237299	nerve injury
0.9400981279	steady state
0.9399448171	dihydrofolate reductase
0.9399276963	congestive heart failure
0.9398085837	medicinal chemistry
0.9397349859	epidermal growth factor
0.9395828967	erectile dysfunction
0.9393402447	prostaglandin e2
0.9392082466	luciferase reporter
0.9391044496	middle cerebral artery occlusion
0.9390128724	cysteinyl leukotriene
0.9389931331	unfractionated heparin
0.9389263513	vitamin b12
0.9389249142	triamcinolone acetonide
0.9386079228	carbonic anhydrase
0.9385139237	reverse transcription polymerase chain reaction
0.9382737324	dorsal root ganglion
0.9382442426	western blotting
0.9381993837	left atria
0.9381918638	hmg coa reductase
0.9380667158	phenylalanine hydroxylase
0.9380325094	neurite outgrowth
0.9380101996	endoplasmic reticulum
0.9379593883	splice variants
0.9379540793	insulin sensitivity
0.9379500595	long term
0.9379170982	alanine aminotransferase
0.9378443489	angiotensin converting enzyme
0.9378221722	pertussis toxin
0.9377753022	mesenteric artery
0.9375898839	object recognition
0.9372152810	patch clamp
0.9370790802	oxidative stress
0.9369885259	body weight
0.9366531058	ascorbic acid
0.9365961403	mammary gland
0.9364300357	clinical trials
0.9363650111	pyridoxal phosphate
0.9362967814	mg dl
0.9360984565	golgi apparatus
0.9359810066	polyunsaturated fatty acids
0.9359154814	lymph node
0.9359092661	diabetic retinopathy
0.9359006251	bcr abl
0.9356641002	tranexamic acid
0.9355835923	tricyclic antidepressants
0.9353392727	hydrogen sulfide
0.9351436519	saccharomyces cerevisiae
0.9349177042	methionine adenosyltransferase
0.9348567459	genome wide
0.9347051066	fibroblast growth factor
0.9345825678	bundle branch block
0.9343370129	luteinizing hormone
0.9342022008	folic acid
0.9340063174	glutamic acid
0.9339972056	bile acids
0.9339574242	base pair
0.9338130408	heart rate
0.9336296111	ulcerative colitis
0.9333422141	guinea pigs
0.9331104006	odds ratio
0.9331042944	dissociation constant
0.9330467769	ornithine decarboxylase
0.9326842565	confocal microscopy
0.9322698190	nicotinic acetylcholine receptors
0.9322464109	gallic acid
0.9322054662	insulin resistance
0.9318584606	positive allosteric modulator
0.9318403692	thromboxane a2
0.9316294339	acute myeloid leukemia
0.9315890651	factor xa
0.9315095040	mecasermin rinfabate
0.9313490138	left ventricular
0.9311994258	docosahexaenoic acid
0.9311269927	low density lipoprotein
0.9310051146	western blot
0.9306975140	bronchoalveolar lavage fluid
0.9305347281	guinea pig
0.9304160694	united states
0.9304090161	flow cytometry
0.9302963196	bovine serum albumin
0.9302108355	breast cancer
0.9301705424	ubiquinone oxidoreductase
0.9300593127	strand breaks
0.9300047718	western blots
0.9299196258	platelet aggregation
0.9297325607	escherichia coli
0.9296354338	messenger rna
0.9292163952	epigallocatechin gallate
0.9290587791	ng ml
0.9290032783	nicotinamide adenine dinucleotide
0.9287948075	diastolic blood pressure
0.9284380709	coronary heart disease
0.9283216124	bile acid
0.9282854736	glucose tolerance
0.9279741795	100mg kg
0.9279565879	transcription factor
0.9277471827	rate constants
0.9276855491	cell line
0.9276036635	lactate dehydrogenase
0.9274160733	nucleic acid
0.9273029737	constitutive androstane receptor
0.9272199178	tumor suppressor
0.9271554131	125i icyp
0.9270845752	caenorhabditis elegans
0.9270686963	attention deficit hyperactivity disorder
0.9269681909	mitogen activated protein kinase
0.9265662887	reverse transcriptase polymerase chain reaction
0.9265224674	okadaic acid
0.9264862175	hydrogen bonding
0.9262365895	double blind
0.9260650119	cgp 12177a
0.9260585649	essential oils
0.9258784468	amino acid
0.9256135677	oic acid
0.9255792925	radical scavenging
0.9254345874	p38 mapk
0.9254260826	helicobacter pylori
0.9252913602	glial fibrillary acidic protein
0.9252517432	cyclic adenosine monophosphate
0.9248760364	ethylene glycol
0.9248543986	µg ml
0.9248041883	weight loss
0.9245946896	multiple sclerosis
0.9245938137	bcl xl
0.9244347725	food intake
0.9242779981	cerebral ischemia
0.9241509602	synaptic transmission
0.9240871629	medial prefrontal cortex
0.9239491563	nick end labeling
0.9238457034	cell cycle
0.9236191195	glycemic control
0.9235911232	carboxylic acids
0.9233871314	reverse transcriptase
0.9233568087	rating scale
0.9233303891	tyrosine kinases
0.9232443103	ferulic acid
0.9232085007	public health
0.9231064588	dna methylation
0.9230916878	trna synthetase
0.9230075481	carbon tetrachloride
0.9229619313	nitric oxide
0.9225848933	amyotrophic lateral sclerosis
0.9224903309	angiotensin ii
0.9222984549	cell death
0.9221520272	superior cervical ganglion
0.9221129120	proximal tubules
0.9219592045	sinapic acid
0.9217093621	abdominal aorta
0.9215876527	systolic blood pressure
0.9215107153	dynamic light scattering
0.9214016325	thyroid hormone
0.9213257155	nasal mucosa
0.9211248240	substantia nigra
0.9209457054	ventral tegmental area
0.9208618702	orally bioavailable
0.9207583216	platelet derived growth factor
0.9207543197	white matter
0.9205719138	extracellular signal regulated kinase
0.9205148717	factor viii
0.9205072193	oatp1a 1b
0.9204419465	serine hydroxymethyltransferase
0.9202435015	cell cycle arrest
0.9202180518	acetyl coa carboxylase
0.9200134673	glutamic acid decarboxylase
0.9198571032	ibritumomab tiuxetan
0.9197983454	confidence intervals
0.9197142043	arsenic trioxide
0.9196710692	ribonucleotide reductase
0.9196542153	inducible nitric oxide synthase
0.9196425170	adrenal gland
0.9195821558	niflumic acid
0.9195573746	olmesartan medoxomil
0.9191445360	cigarette smoke
0.9189498239	artemisinic acid
0.9186298550	lipoic acid
0.9186280309	copyright ©
0.9184698824	nitric oxide synthase
0.9183058673	carboxylic acid
0.9181429653	organic anion transporting polypeptides
0.9181377964	ovarian cancer
0.9180692960	short term
0.9180539943	aspidin pb
0.9178989786	mast cell
0.9178620786	proximal tubule
0.9173583512	ischemia reperfusion
0.9173542069	green fluorescent protein
0.9172308862	autosomal recessive
0.9168276364	body weight gain
0.9167221694	atrial natriuretic peptide
0.9165787963	topoisomerase iialpha
0.9164586347	adenosine triphosphate
0.9164566786	electrospray ionization
0.9162811816	amyloid precursor protein
0.9161100701	thiobarbituric acid reactive
0.9160187452	carnitine palmitoyltransferase
0.9157581592	nuclear factor kappab
0.9157097452	chronic myeloid leukemia
0.9156533801	proinflammatory cytokines
0.9156237750	takes place
0.9153540898	progression free survival
0.9153165643	cell lines
0.9151918155	high density lipoprotein
0.9150203365	leydig cell
0.9149831094	sudden death
0.9147325360	circular dichroism
0.9146994307	factor ix
0.9146276870	microg kg
0.9144538836	paw edema
0.9140705426	sialic acid
0.9139639167	glutamine synthetase
0.9139186971	nonsteroidal anti inflammatory drugs
0.9135144362	room temperature
0.9133384199	35s gtpgammas
0.9131492026	advance online publication
0.9129991762	gas chromatography
0.9127325360	choroid plexus
0.9127254651	growth hormone
0.9127167544	memory consolidation
0.9125697238	qtc interval
0.9124100084	dihydroorotate dehydrogenase
0.9122329697	dried blood spots
0.9117969072	salicylic acid
0.9117443940	nitrosative stress
0.9116802560	missense mutations
0.9116507027	muromonab cd3
0.9116044628	nmr spectroscopy
0.9115227306	biliary excretion
0.9112969548	nuclear factor κb
0.9112312918	oleanolic acid
0.9111945254	renal cell carcinoma
0.9108012177	anterior pituitary
0.9107494865	methionine synthase
0.9106448909	ccaat enhancer binding protein
0.9106409796	gastric mucosa
0.9105977237	dentate gyrus
0.9103049765	thymidine incorporation
0.9099316602	structure activity relationships
0.9098537475	dna fragmentation
0.9095532615	lymph nodes
0.9095511794	statistically significant
0.9092105277	flow cytometric
0.9091385300	db db mice
0.9089761082	prostate specific antigen
0.9085224215	cardiac hypertrophy
0.9084551864	negatively charged
0.9084172591	lipid rafts
0.9080686121	electrophoretic mobility
0.9078657086	mitogen activated protein kinases
0.9075448376	ventricular myocytes
0.9071110385	transcription factors
0.9070549629	gram negative
0.9067699168	rna interference
0.9067007694	neutral endopeptidase
0.9066527045	infarct size
0.9066378565	long acting
0.9065421862	50mg kg
0.9062767321	topoisomerase ii
0.9060121967	nicotinic acid
0.9057281760	dna repair
0.9057182248	endometrial cancer
0.9056217051	candesartan cilexetil
0.9055005895	vascular smooth muscle
0.9054560111	penile erection
0.9054250278	mast cells
0.9052586888	life threatening
0.9052120773	nedocromil sodium
0.9050747726	widely distributed
0.9047924128	oral glucose tolerance test
0.9046335305	high fat diet
0.9046242685	amp activated protein kinase
0.9043648127	molecular weight
0.9042660639	healthy volunteers
0.9040531552	lower urinary tract symptoms
0.9039218693	cell viability
0.9038308260	oxidative damage
0.9038052878	ethnopharmacological relevance
0.9035340401	ellagic acid
0.9032793260	imatinib mesylate
0.9032488914	squalene epoxidase
0.9031746313	synaptic plasticity
0.9031675434	heavy chain
0.9031030233	cystic fibrosis
0.9030267484	inhibitory potency
0.9029498177	colon cancer
0.9029238731	freely moving
0.9028828137	splice variant
0.9023470766	nuclear translocation
0.9022503945	estramustine phosphate
0.9021961741	cross linking
0.9020370484	cell cycle progression
0.9019612740	chlorogenic acid
0.9018383035	nonsteroidal antiinflammatory
0.9017359784	arabidopsis thaliana
0.9016474351	nf κb
0.9014969360	pgh synthase
0.9014964491	serine threonine
0.9012155148	lu af21934
0.9010604634	benzoic acid
0.9008575037	neuromuscular junction
0.9007395994	local anesthetics
0.9006714846	intraocular pressure
0.9005095359	aldo keto
0.9004084909	acyl coa
0.9003859582	matrix metalloproteinases
0.9001703204	chinese hamster ovary
0.9001011777	bronchoalveolar lavage
0.8998839819	dose dependently
0.8997529618	renal failure
0.8997234357	udp glucuronosyltransferase
0.8997021578	neurodegenerative diseases
0.8996114440	computed tomography
0.8995029902	parathyroid hormone
0.8994856774	tricyclic antidepressant
0.8992955488	ursolic acid
0.8991181392	kcnq2 q3
0.8990504955	sr 141716a
0.8989999878	cardiovascular risk
0.8988407842	virtual screening
0.8983953842	brush border
0.8982427340	essential oil
0.8981446786	cardiovascular disease
0.8980452323	electron microscopy
0.8977480137	dna polymerase
0.8975757493	gonadotropin releasing hormone
0.8973683403	endocrine disrupting
0.8971336395	nervous systems
0.8969861555	energy balance
0.8968810639	immune responses
0.8968570538	gonadotrophin releasing hormone
0.8968109556	aerial parts
0.8966732925	cyclo oxygenase
0.8965999875	map kinase
0.8963036042	wild type
0.8961773820	ifn gamma
0.8961766112	anti inflammatory
0.8961002805	low molecular weight heparins
0.8960969392	nerve terminals
0.8959338844	blood flow
0.8958546858	working memory
0.8958269017	sprague dawley rats
0.8958014119	tumor growth
0.8957051036	factor xiif
0.8956918740	peptidylarginine deiminase
0.8956116971	serine racemase
0.8954484197	pc12 cells
0.8951359126	allosteric modulators
0.8949873428	tnf α
0.8947435425	long lasting
0.8944910325	insulin secretion
0.8944288143	blood glucose
0.8941775137	tumour necrosis factor
0.8940596368	gastric mucosal
0.8934288966	μg ml
0.8930299324	zinc finger
0.8929646056	risk assessment
0.8929021597	pulmonary fibrosis
0.8927738452	active site
0.8926053243	voltage dependence
0.8921843879	st segment elevation
0.8921453876	liver microsomes
0.8920121382	phenolic acids
0.8918200732	intercellular adhesion molecule
0.8918057629	tnf alpha
0.8917424588	pi3k akt
0.8917172793	norepinephrine transporter
0.8916339164	transient receptor potential
0.8915759659	advanced glycation end products
0.8914885334	half life
0.8912726274	rt pcr
0.8912247571	nmda receptor
0.8911742357	zebrafish embryos
0.8911656975	delayed rectifier
0.8909634961	uvb irradiation
0.8908925685	knockout mice
0.8908029917	aldehyde dehydrogenase
0.8905213131	clinically relevant
0.8904592842	gamma glutamyl
0.8904549649	glur5 kainate
0.8903504080	gamma aminobutyric acid
0.8898844802	null mice
0.8898214674	10mg kg
0.8897988984	inverse agonists
0.8896202048	xenopus laevis oocytes
0.8894269514	airway smooth muscle
0.8892726876	extracellular matrix
0.8892209373	aldehyde oxidase
0.8890192762	mu opioid receptor
0.8887731646	light chain
0.8886593274	hydroxysteroid dehydrogenase
0.8886559326	micrograms kg
0.8886556897	pancreatic cancer
0.8884462048	alanine transaminase
0.8881677114	cognitive enhancers
0.8880040022	consecutive days
0.8879346399	heat shock protein
0.8877639300	cdna library
0.8876257531	phase ii
0.8876133886	lipid metabolism
0.8873546363	linoleic acid
0.8871842534	streptozotocin induced diabetic
0.8870584691	histamine h2 receptor
0.8868734699	nf kappab
0.8868595438	ang ii
0.8866452397	anaplastic thyroid
0.8865765526	glycaemic control
0.8862703139	biologically active
0.8862217626	vesicular monoamine transporter
0.8862210460	thymidine kinase
0.8862033557	transition state
0.8861461776	high throughput screening
0.8860512657	tgf β1
0.8859056956	peroxisome proliferator
0.8855569434	sds page
0.8853997066	gm csf
0.8852769399	radioligand binding
0.8851894099	constitutively active
0.8848799620	interleukin 1beta
0.8846951978	small molecule
0.8845413069	metabotropic glutamate receptors
0.8841392667	drug discovery
0.8841370366	organic cation
0.8840323780	glycogen synthase kinase 3β
0.8837710988	microg bid
0.8837708840	amino acid residues
0.8837128457	antioxidant defense
0.8834054215	free radical
0.8832627244	β catenin
0.8830227265	nr1 nr2a
0.8828414403	white adipose tissue
0.8826001529	serotonin transporter
0.8821067008	beta endorphin
0.8820747756	pulmonary hypertension
0.8820524603	natural product
0.8820521787	gastrointestinal stromal
0.8819900677	animal models
0.8819713538	adrenoceptor subtype
0.8818819741	inverse agonist
0.8818301101	base pairs
0.8818102760	cyclin dependent kinase
0.8816511806	kg bw
0.8816242649	estrogen receptor
0.8814608108	dopamine d1
0.8814348975	sergliflozin etabonate
0.8813810557	cross talk
0.8813723077	organic anions
0.8810150287	mc3t3 e1
0.8810024401	sprague dawley
0.8807939393	er stress
0.8807751588	postprandial hyperglycemia
0.8801124297	enzyme linked immunosorbent assay
0.8800916395	fmol mg
0.8800413065	ko mice
0.8798766676	optic cup
0.8798679749	p450 2a13
0.8795744734	michaelis menten
0.8793874162	binding sites
0.8792389952	androgen receptor
0.8792244445	chloride channel
0.8788917323	udp glucuronosyltransferases
0.8787241270	pituitary gland
0.8786138815	broad spectrum
0.8785140925	adrenergic receptors
0.8781390590	signaling pathways
0.8781036081	steroid hormone
0.8773903020	epidermal growth factor receptor
0.8773584465	dipeptidyl peptidase
0.8773473684	leydig cells
0.8770252920	aggressive behavior
0.8770202692	mechanical allodynia
0.8767768842	electron transfer
0.8767426678	placebo controlled
0.8766807866	special issue entitled
0.8766680917	dim dim
0.8766508658	adrenergic receptor
0.8765323066	adipocyte differentiation
0.8763899402	hyp ·
0.8762245433	negatively regulates
0.8761097556	mineralocorticoid receptor
0.8760477259	transmission electron microscopy
0.8758955847	serine protease
0.8758405670	mass spectrometric
0.8758144890	odds ratios
0.8757092919	alcohol consumption
0.8755562758	tgf beta1
0.8755407557	il 1beta
0.8754155852	glutathione reductase
0.8751974839	basal ganglia
0.8751022184	mg kg
0.8750217687	recent advances
0.8748807087	combination therapy
0.8748351031	diabetic nephropathy
0.8747172194	phase iii trials
0.8747152339	proximal tubular
0.8746050169	structure activity relationship
0.8744910931	sterol regulatory element binding protein
0.8743826060	actin remodeling
0.8742099591	fatty acid synthase
0.8741743376	microg ml
0.8741431699	xenopus laevis
0.8741346702	channel opener
0.8740083178	alpha 2a adrenoceptor
0.8738098365	c57bl 6j
0.8735805058	arginine vasopressin
0.8735768231	tgf β
0.8733204077	cytokine production
0.8732977809	signaling pathway
0.8728986320	inflammatory mediators
0.8728327953	essential hypertension
0.8725563107	nuclear magnetic resonance
0.8724132426	cognitive deficits
0.8722473861	glucose uptake
0.8721843455	partial agonist
0.8719841778	aqueous solution
0.8719194006	selective serotonin reuptake inhibitors
0.8717244644	iib iiia
0.8714059776	physiologically relevant
0.8711542691	solid tumors
0.8710889558	gpiib iiia
0.8710346465	small intestine
0.8710250952	real time polymerase chain reaction
0.8708936527	translation initiation
0.8700917268	blood brain barrier
0.8699179976	glutathione s transferase
0.8699130837	adp ribose
0.8699082854	anticancer agents
0.8698977549	organic anion
0.8698579318	discriminative stimulus
0.8697803919	mixed micelles
0.8697228391	pain relief
0.8694793876	fc gamma
0.8692955648	ig module
0.8690458742	factor vii
0.8688498221	hif 1α
0.8688413811	motor coordination
0.8687751422	qrt pcr
0.8687635566	raas blockade
0.8686582414	major depression
0.8686315696	pulmonary artery
0.8683284018	gp iib iiia
0.8679764400	hif 1alpha
0.8676192046	il 1β
0.8675500321	promyelocytic leukemia
0.8669730828	glutamate decarboxylase
0.8669276208	stem cell
0.8667794500	blood samples
0.8666299364	longer term
0.8663508333	inactivated state
0.8662021009	high performance liquid chromatography
0.8659211790	multidrug resistant
0.8656063096	inversely correlated
0.8653371389	cell adhesion
0.8652846245	⁻ ¹
0.8651877175	adenosine monophosphate
0.8650338659	mda mb 231
0.8649959470	active metabolite
0.8648421767	atherosclerotic lesions
0.8643241011	creatine kinase
0.8643226598	epithelial cells
0.8643149454	apoptotic cell death
0.8641548764	apo ciii
0.8639744137	pressor response
0.8638802181	endothelial dysfunction
0.8638099449	long qt syndrome
0.8631462055	bone mass
0.8628839698	qt syndrome
0.8623441957	cross linked
0.8623280157	glucose homeostasis
0.8622868531	real time pcr
0.8618450783	atypical antipsychotic
0.8613298946	molecular modeling
0.8607584247	potassium channel
0.8606603761	peroxisome proliferator activated receptor
0.8605637404	molecular dynamics simulations
0.8600227357	glucose stimulated insulin secretion
0.8599611557	western blot analysis
0.8598010326	reading frame
0.8597593044	mammary glands
0.8596288864	natriuretic peptide
0.8591960144	releasing hormone
0.8591430456	particle size
0.8590845592	glucose intolerance
0.8588107559	small molecules
0.8583331077	channel blockers
0.8583215287	atypical antipsychotics
0.8582254643	mitochondrial dysfunction
0.8582029057	thromboxane b2
0.8581235238	gsh px
0.8581072123	family members
0.8580877731	pyruvate kinase
0.8580369569	drg neurons
0.8579296353	pancreatic islets
0.8579106477	tumor necrosis factor alpha
0.8578477945	catalytic efficiency
0.8576553212	micromol kg
0.8575784988	tertiary amine
0.8572350388	nerve agents
0.8568364656	myo inositol
0.8567110146	male rats
0.8565108758	ion channels
0.8564927402	nmda receptors
0.8564612746	vascular permeability
0.8564578670	human embryonic kidney
0.8564246001	radix glycyrrhizae
0.8563024004	gsk 3β
0.8560303277	outcome measures
0.8558730310	antioxidant capacity
0.8557518443	osteoblast differentiation
0.8557020702	esi ms
0.8555122494	aqueous extract
0.8555121013	cyclic nucleotide
0.8553340367	tissue engineering
0.8549682173	thioredoxin reductase
0.8548528375	brain derived neurotrophic factor
0.8546365261	inflammatory diseases
0.8544547044	john wiley & sons
0.8544195376	exposed workers
0.8538282040	serine dehydratase
0.8537302833	hepg2 cells
0.8536173577	β ionone
0.8535973102	coronary arteries
0.8535435297	blood vessels
0.8534579841	tumor necrosis factor α
0.8533773857	nuclear factor
0.8532756770	hepatic steatosis
0.8531652337	cell proliferation
0.8528975257	myosin light chain
0.8527923296	linolenic acid
0.8526444132	cross sectional
0.8523896746	beta blockers
0.8523109701	single nucleotide polymorphism
0.8522269552	lipid raft
0.8520856637	excision repair
0.8515096509	water maze
0.8513141882	acquired resistance
0.8511885160	red blood cells
0.8510289010	breast cancer resistance protein
0.8507715436	fish oil
0.8504152359	beta adrenergic
0.8503327323	electrical stimulation
0.8500945258	review summarizes
0.8499880396	pdgf bb
0.8498454775	progenitor cells
0.8498410620	catechol o methyltransferase
0.8497909122	methylenetetrahydrofolate reductase
0.8497090185	alpha 1a adrenoceptor
0.8495057572	binding affinities
0.8494882369	pro inflammatory cytokines
0.8494336366	glucagon secretion
0.8493551248	sodium iodide
0.8493184991	11beta hsd
0.8492432448	allergic asthma
0.8490999274	dietary supplements
0.8490177708	mg bid
0.8489640293	pro inflammatory
0.8489285106	phase iii
0.8489144499	hmg coa
0.8488184210	voltage dependent
0.8487499498	xenopus oocytes
0.8486691042	steroid hormones
0.8484920776	binding site
0.8483992165	coronary artery disease
0.8483544273	dna methyltransferase
0.8483036975	actin rings
0.8482685998	mitochondrial membrane potential
0.8477344683	total cholesterol
0.8476555261	3beta adiol
0.8476542449	sk n sh
0.8473522902	aortic rings
0.8473175557	glucocorticoid receptor
0.8471190641	wistar rats
0.8470452402	targeted therapies
0.8468787384	remain unclear
0.8467625616	calcitonin gene related peptide
0.8467339953	vagal control
0.8467332767	crystal structures
0.8466652919	sertoli cells
0.8465883954	blood coagulation
0.8464098976	ca3 region
0.8463606928	physico chemical
0.8462473175	fluorescence microscopy
0.8462424933	dna topoisomerase ii
0.8461968871	low dose
0.8461766357	plasminogen activator
0.8461582502	topical ocular
0.8458954563	remains unclear
0.8457480550	double strand
0.8455130147	bovine tracheal smooth muscle
0.8455102036	carbetocin metabolite
0.8454832524	drug delivery
0.8453443478	sh sy5y
0.8450898971	type plasminogen activator
0.8446916422	arterial pressure
0.8445882644	fasting glucose
0.8445702076	water soluble
0.8444217550	avoidance task
0.8444115154	silica nanoparticles
0.8443755527	pregnane x receptor
0.8439455330	niemann pick
0.8438832026	positive inotropic effect
0.8436186336	hdl cholesterol
0.8435255564	α glucosidase
0.8434840361	peroxisome proliferator activated receptor gamma
0.8433184760	mucin secretion
0.8431665520	ic50 values
0.8430803856	mir 193a 3p
0.8430578602	ras dva
0.8430228515	low density lipoprotein cholesterol
0.8429581110	aminobutyric acid
0.8428907732	hydroxamic acid
0.8427411075	family member
0.8426761464	clinical trial
0.8426583983	colon carcinoma
0.8426430407	deficient mice
0.8425157750	ubiquitin ligase
0.8420008691	transmembrane domain
0.8419215437	c57bl 6j mice
0.8417996705	nf kb
0.8414507196	transplant recipients
0.8414497438	differentially expressed
0.8411012895	pyramidal neurons
0.8409808080	mek erk
0.8409473648	topo iialpha
0.8407894356	ischemic stroke
0.8407322978	neurodegenerative disorders
0.8405734554	active site gorge
0.8405332284	cardiac output
0.8403617531	conditioned medium
0.8402933936	clinical relevance
0.8401420639	amino acid sequence
0.8399911035	granulosa cells
0.8397498353	disease progression
0.8396680105	rat hepatocytes
0.8396212452	pharmacokinetic pharmacodynamic
0.8395851838	insulin like growth factor
0.8395504955	nh2 terminal
0.8395233427	norepinephrine reuptake
0.8392386500	phasic da
0.8392088558	transiently transfected
0.8386565981	mtt assay
0.8385772643	ethyl acetate
0.8384361050	glp 1r
0.8384140633	breast carcinoma
0.8383939829	diabetic rats
0.8383122810	splice site
0.8380598507	transient transfection
0.8378640314	fxi pka4
0.8375881446	calcium channels
0.8372826278	pharmacokinetic profiles
0.8371248600	confidence interval
0.8369887876	spatial memory
0.8368482816	muscarinic m2
0.8365850308	metal ions
0.8365162170	percutaneous coronary
0.8361956476	lipid lowering
0.8356592366	microarray analysis
0.8355577597	lactic acid
0.8355277920	innate immune
0.8353655123	a549 cells
0.8352736799	drug drug interactions
0.8352408579	risk factors
0.8351119296	17β estradiol
0.8350304990	tissue plasminogen activator
0.8346791131	pro apoptotic
0.8346663144	cell migration
0.8344099372	newly synthesized
0.8343831160	gold nanoparticles
0.8342289855	genetic variation
0.8337343429	transgenic mice
0.8331501305	pgc 1α
0.8329055529	prepulse inhibition
0.8320199178	mg kg body weight
0.8319752582	bone formation
0.8319554724	fasting plasma glucose
0.8318918049	endothelial cells
0.8317364297	previously reported
0.8317192400	dopamine d2 receptor
0.8315167311	adrenoceptor subtypes
0.8309229105	alpha ketoglutarate
0.8308976675	growth factor
0.8307182077	type ii
0.8306333346	inflammatory pain
0.8305485359	progesterone receptor
0.8301025320	metabotropic glutamate
0.8300950347	3t3 l1 adipocytes
0.8299059008	comet assay
0.8298449436	mld stz
0.8297289287	type 2 diabetes mellitus
0.8296690556	aortic endothelial
0.8295042823	lps stimulated
0.8292444421	protective effect
0.8290735633	hypothalamic pituitary adrenal
0.8288828852	human liver microsomes
0.8288393226	response element
0.8287275787	hela cells
0.8283190479	histamine h3 receptor
0.8283086782	class iii
0.8282760755	ifn α2a
0.8280859395	hs crp
0.8280471677	gram positive
0.8279071438	ceftazidime avibactam
0.8278789898	jio gan
0.8278198355	nr1 nr2b
0.8278018772	substrate specificity
0.8276043356	sr bi
0.8275985687	high density lipoprotein cholesterol
0.8275918009	camp response element binding protein
0.8270135822	positively charged
0.8269866215	adrenoceptor antagonist
0.8268936787	cognitive impairment
0.8266272401	cell survival
0.8266074872	crystal structure
0.8265121746	mammary epithelial cells
0.8264638123	homa ir
0.8264633043	ifn γ
0.8263149676	cell types
0.8260664322	mrna abundance
0.8259517440	sphingosine 1 phosphate
0.8259243971	beta lactamase
0.8259030190	canonical wnt signaling
0.8258764154	male wistar rats
0.8257892089	multivariate analysis
0.8255973691	insulin detemir
0.8254915609	multiple myeloma
0.8251443172	dominant negative
0.8249691241	5alpha reductase
0.8249187082	gaba transaminase
0.8246906943	renal tubular
0.8246767344	safety profile
0.8245550408	dissociation constants
0.8245494728	clinical significance
0.8244680748	glutathione s transferases
0.8244299017	molecular docking
0.8244212215	renin angiotensin aldosterone
0.8244148968	high risk
0.8243476904	adverse effects
0.8242813692	tolerability profile
0.8241231663	injected intraperitoneally
0.8240493999	interferon gamma
0.8239432381	micromolar range
0.8239390408	ampa receptor
0.8236174774	aromatase inhibitors
0.8235599664	nonselective cox
0.8235463584	17beta estradiol
0.8234307469	interleukin 1β
0.8230766633	rodent models
0.8230450193	neurological disorders
0.8229890635	molecular mass
0.8226884793	neuronal death
0.8226466900	iron overload
0.8223788640	phosphoinositide 3 kinase
0.8222871339	pg ml
0.8221781686	heme oxygenase
0.8219116802	concentration response curves
0.8216425864	histamine h1
0.8211913820	lipid mediators
0.8211269863	rbl 2h3
0.8209903698	review article
0.8209117160	alcohol dependence
0.8208329955	active ingredient
0.8206149708	chain length
0.8205681557	cdna encoding
0.8204805064	monoamine transporters
0.8204070034	accumulating evidence
0.8200993503	healthy subjects
0.8195982748	endothelium dependent
0.8194208955	nerve growth factor
0.8193043484	colony stimulating factor
0.8192603591	beta lactamases
0.8192435834	drug metabolizing enzymes
0.8189668914	traditional chinese
0.8188327651	female rats
0.8186635776	enzymatically active
0.8183449307	db db
0.8183041459	adhesion molecules
0.8182334890	endothelial cell
0.8178387303	mcf 7
0.8175315047	protein tyrosine phosphatase 1b
0.8171224755	synthetic progestins
0.8169820293	al 4943a
0.8166255175	5mg kg
0.8163478006	betaine homocysteine
0.8162898260	bone turnover
0.8161014466	thyroid cancer
0.8159490291	g1 phase
0.8157706857	voltage gated sodium
0.8157451413	cortical neurons
0.8153720591	hek293 cells
0.8152391002	therapeutic window
0.8152221422	tgf beta
0.8149416956	half maximal
0.8149411789	physicochemical properties
0.8148916930	maximum tolerated
0.8146198851	human bronchial epithelial
0.8145060570	nanomolar range
0.8140047504	anti proliferative
0.8136158423	critical roles
0.8135475110	endothelial nitric oxide synthase
0.8132021813	cerebral cortex
0.8131204149	srebp 1c
0.8128581310	dopamine transporter
0.8127937206	single stranded
0.8125177409	anti diabetic
0.8123470261	brain regions
0.8120870004	gene transcription
0.8118080128	spontaneously hypertensive
0.8115726184	dna adducts
0.8115421502	histamine h1 receptor
0.8114642703	growth plate
0.8112757456	cardiovascular events
0.8112423101	growth factors
0.8108627124	adenosine a2a receptor
0.8106966358	methionine synthase reductase
0.8102292398	freshly isolated
0.8101735463	remained unchanged
0.8101191854	at1 receptor
0.8098671180	methyl ester
0.8098544315	underlying mechanisms
0.8095914136	acute pancreatitis
0.8095546352	late onset
0.8093853093	c2 domain
0.8092497278	guanine nucleotide
0.8092201185	α tocopherol
0.8092081354	kat ii
0.8091931682	alcohol dehydrogenase
0.8091695322	point mutations
0.8091290415	free fatty acids
0.8091017571	high resolution
0.8090773551	long chain fatty
0.8089497735	cerebral ischemic
0.8089460073	dorsal root
0.8087202772	control subjects
0.8086366336	highly conserved
0.8080714000	dna synthesis
0.8076543463	mismatch repair
0.8072639027	atp sensitive potassium
0.8072131363	flt3 itd
0.8071789328	aromatic l amino acid decarboxylase
0.8069674124	autoimmune diseases
0.8068990265	ifn alpha
0.8067742599	metabotropic glutamate receptor
0.8062795793	wnt signaling
0.8060655783	chemical warfare
0.8059287392	firing rate
0.8058624745	ay mice
0.8057880616	hormonal therapy
0.8057293477	high affinity
0.8057195685	nuclear import
0.8056994489	oral bioavailability
0.8056017894	hazard ratio
0.8055735602	retinal ganglion
0.8055023639	metabolic syndrome
0.8054040742	previous studies
0.8050571190	mammalian target of rapamycin
0.8047836394	glucose lowering
0.8047219694	locomotor activity
0.8045487571	dendritic cells
0.8044701193	mda mb
0.8043724838	fusion protein
0.8042609001	neural tube
0.8039254122	remain unknown
0.8037184515	abstract truncated at 250 words
0.8036931291	insulin sensitizing
0.8033242267	dissociation rate
0.8031562038	gastric acid secretion
0.8030792846	binding pocket
0.8029319843	type iii
0.8028542227	large scale
0.8028414912	ser sec
0.8026664692	tumor xenografts
0.8025801198	rapidly absorbed
0.8025638072	benign prostatic
0.8025493538	colony formation
0.8021312631	membrane vesicles
0.8017676351	head and neck
0.8016739891	genes encoding
0.8015789373	structural determinants
0.8014513648	mu opioid receptors
0.8011355668	beta2 adrenergic
0.8010908554	extracellular loop
0.8010164075	plasma renin activity
0.8008109761	gas phase
0.8007751526	advanced breast cancer
0.8005905739	bone loss
0.8003025340	mtorc1 signaling
0.8001805979	met camo
0.8001205559	amiloride sensitive
0.7999201403	cardiovascular diseases
0.7997964265	gamma secretase
0.7996724086	respiratory chain
0.7993056093	breast cancers
0.7988483634	largely unknown
0.7987392277	xenograft models
0.7986667953	anxiety disorders
0.7985790363	cationic amino acid
0.7985628470	current knowledge
0.7985025222	thiazide sensitive
0.7984453992	structurally diverse
0.7983988735	negative regulator
0.7982219945	opioid receptors
0.7981470359	preclinical studies
0.7980484891	myocardial ischemia reperfusion
0.7980153529	responsive element
0.7979518207	histamine h1 receptor antagonists
0.7978809962	end point
0.7977694207	dried blood
0.7973986048	permeability transition
0.7971668925	brush border membrane
0.7970403026	hyp * ·
0.7969627230	dependent manner
0.7968682400	pmol mg
0.7967327786	flanking region
0.7965769159	orders of magnitude
0.7965505247	mmol kg
0.7963506625	cognitive function
0.7963147394	alpha glucosidase
0.7959042366	ternary complex
0.7957442653	conformational change
0.7957061887	organic anion transporter
0.7956931961	alpha tocopherol
0.7953661983	bcl 2
0.7952524623	atrial natriuretic
0.7951768157	completely abolished
0.7951192632	beneficial effect
0.7949388152	alpha 1b adrenoceptors
0.7948940396	insulin granules
0.7946678759	stably expressing
0.7944478656	cancer cell lines
0.7944102890	p38 mitogen activated protein kinase
0.7943134116	aryl hydrocarbon
0.7940948686	reporter gene
0.7940755486	mouse embryonic fibroblasts
0.7940268184	previous reports
0.7940112646	kinetic parameters
0.7938722393	rate constant
0.7938367419	inflammatory cytokines
0.7938108628	protein phosphatase
0.7935176964	trp channels
0.7935030718	advanced glycation end
0.7934094739	α sma
0.7933775984	extracellular signal regulated
0.7931606833	β d glucuronide
0.7930938021	sodium salicylate
0.7930907777	pharmacokinetic profile
0.7930400403	healthy individuals
0.7929920625	remains unknown
0.7928815679	ppar γ
0.7928472606	tgf alpha
0.7927605948	tumor regression
0.7924044105	bronchial epithelial cells
0.7922796203	heterologously expressed
0.7921212590	fructose fed
0.7919201767	crossover study
0.7918575713	tracheal smooth muscle
0.7918438635	long qt
0.7917499232	immune response
0.7916543794	chromaffin cells
0.7912442602	alpha synuclein
0.7910436898	ornithine
0.7909635577	open field
0.7906993494	3t3 l1
0.7905780059	orally administered
0.7904635600	postmenopausal women
0.7902012059	energy homeostasis
0.7900293090	nonselective nsaids
0.7900133738	molar ratio
0.7898133861	liver damage
0.7895824582	fda approved
0.7894654503	structural similarity
0.7892344333	pituitary adrenal axis
0.7891479233	discriminative stimulus effects
0.7886723999	receptor antagonist
0.7885169228	center
0.7884103619	airway epithelial cells
0.7881854460	cyslt1 receptor
0.7880373450	subjective effects
0.7868999743	plant extracts
0.7866789274	cisplatin induced nephrotoxicity
0.7861205910	orally active
0.7858012037	indirect
0.7853042055	protein tyrosine phosphatase
0.7851778861	cell culture
0.7851316552	epidemiological studies
0.7850885655	protective role
0.7850647155	monophosphate dehydrogenase
0.7848785155	meta analysis
0.7844805241	sterol
0.7844709121	cell surface
0.7841067509	drug drug interaction
0.7838786402	squamous cell
0.7836637102	peripheral blood
0.7835031282	inflammasome activation
0.7834324376	neurological
0.7830159109	spontaneously hypertensive rats
0.7828440202	igf 1r
0.7826557783	phosphatidylinositol 3 kinase
0.7824926451	organic anion transport
0.7823041126	cross resistance
0.7822467658	cholinesterase
0.7820617120	lung injury
0.7819778528	myocardial ischemia
0.7819138035	channel blocker
0.7818045135	glycogen synthase
0.7816300436	enhancing
0.7816152754	heat shock
0.7814430284	peripheral blood mononuclear cells
0.7813495327	mild to moderate
0.7809766467	adrenoceptor agonist
0.7807356428	interferon
0.7805756653	competition
0.7803274718	hl60 cells
0.7802766244	unit
0.7802231157	hydroxysteroid dehydrogenase type
0.7800857856	topical
0.7799817140	chloro
0.7797832296	sensitization
0.7796553100	anti angiogenic
0.7794646433	mechanistic
0.7794600311	gamma carboxylase
0.7793924036	imidazoline receptors
0.7791176632	open label
0.7789981016	binding mode
0.7789011584	pge2 production
0.7786486717	cell growth
0.7786290029	task
0.7784290897	marine
0.7784082244	subtype selective
0.7783807385	mortality
0.7783054302	adenine
0.7782506698	dorsal raphe
0.7782080729	rank order
0.7781667750	proline
0.7781122913	nasal
0.7780765684	lactate
0.7779678440	hyperglycemia
0.7777377711	3h paroxetine binding
0.7776908935	binding affinity
0.7776207239	receptor occupancy
0.7776141654	long chain
0.7775701610	glucuronidation
0.7775176692	docking
0.7771336873	single strand
0.7770083461	comparing
0.7767970857	high throughput
0.7767294005	male sprague dawley rats
0.7767088593	profiling
0.7767028418	glp 1
0.7765433011	isomer
0.7762806865	motor
0.7760717352	excess
0.7760430678	estrogenic
0.7758848886	conformational
0.7758775261	amine
0.7758745753	bioactive
0.7758072692	fluorescent
0.7757953267	fatty liver disease
0.7757206706	phenolic compounds
0.7756288610	il 6
0.7754806688	candesartan
0.7752847014	proteasome
0.7751684543	primary endpoint
0.7750944992	average
0.7750472634	pharmacology
0.7750451268	carbohydrate
0.7750395995	methylation
0.7750081132	substantial
0.7749020490	dopamine d3
0.7748597220	receptor subtypes
0.7748271110	metal
0.7747334038	apolipoprotein
0.7746536363	vehicle
0.7745828756	receptor tyrosine kinases
0.7745739472	vp 16
0.7745601713	tissue factor
0.7745150451	butyrylcholinesterase
0.7744080217	sex
0.7743503901	elimination half life
0.7743110055	preclinical
0.7741825819	ion channel
0.7741110205	toxic effects
0.7739605605	mediator
0.7739202211	antihypertensive
0.7738421282	prazosin
0.7737837654	stably transfected
0.7737209428	muscarinic receptor
0.7736685142	structurally related
0.7736084576	adenosine a1
0.7735412309	molecular cloning
0.7735158290	aggressive
0.7735143558	protease
0.7735009552	modifications
0.7734620558	anxiety
0.7733749152	young
0.7733233224	favorable
0.7732492017	succinate
0.7730627053	impaired glucose tolerance
0.7729745628	leukotriene
0.7727279122	sequence identity
0.7725279758	progressive
0.7724295266	treating
0.7722846670	opioid receptor
0.7722779357	healthy controls
0.7722484308	forskolin stimulated
0.7720880680	lc ms ms
0.7720868569	gene expression
0.7720441801	mechanical
0.7720114976	tight binding
0.7719859693	adipocyte
0.7719797400	pharmaceutical
0.7719120697	covalent
0.7719087574	host
0.7718077034	sr b1
0.7715830834	biomarker
0.7714923119	wall
0.7714118821	nitrogen
0.7712610702	spontaneous locomotor activity
0.7711809710	findings suggest
0.7711190571	feeding
0.7710736991	hypothalamic
0.7710384652	hepatotoxicity
0.7709600136	blood pressure and heart rate
0.7709319966	anti apoptotic
0.7707608467	homocysteine
0.7707188305	vasopressin
0.7706410513	chemistry
0.7706362447	atpase
0.7705319283	gnrh ii
0.7705304892	subcutaneous
0.7705071342	mk 801
0.7704651901	immunohistochemistry
0.7704604443	pathological
0.7703632920	ht 29
0.7702665154	neuroendocrine
0.7701735451	homology
0.7701321179	methoxy
0.7700759692	corticotropin releasing
0.7699955152	ethanol consumption
0.7699455193	akt phosphorylation
0.7699175823	secondary
0.7698911614	fish
0.7698819303	workers
0.7696931778	nucleoside transporters
0.7696039329	fasting
0.7695777737	basic
0.7695198685	robust
0.7693333673	alzheimer disease
0.7692847286	efficient
0.7692764914	acetyl coa
0.7690386258	alpha2 adrenoceptor
0.7690341354	surgical
0.7689799426	autophagy
0.7689620579	thiamine
0.7689029665	proliferative
0.7688851472	ach release
0.7688233738	seizures
0.7688168385	dopamine d2
0.7687459334	μg kg
0.7686075709	retinoid
0.7685892173	taking
0.7683443486	highly potent
0.7683084828	oil
0.7681131127	osteoarthritis
0.7678687189	published
0.7677977092	3β diol
0.7677283471	acquired
0.7676793098	rat aorta
0.7676388343	concomitant
0.7676311299	nerve agent
0.7675427511	patients receiving
0.7674934256	chemokine
0.7674748318	μ opioid
0.7674355091	spin
0.7674267305	antitumor activity
0.7674144995	hypoxia
0.7674084664	gel
0.7673943553	adaptive
0.7673882495	carnitine
0.7673053142	quinone
0.7672510887	layer
0.7671986416	parallel
0.7671724373	small interfering
0.7671254664	abdominal
0.7669605960	action potentials
0.7669479997	prominent
0.7667677905	ocular
0.7666148851	ppar gamma
0.7666000772	aromatase
0.7665731130	fibroblast
0.7664939538	arsenic
0.7664838641	transient
0.7664060575	significantly attenuated
0.7661956943	cirrhosis
0.7659463111	alcohol
0.7659073474	lateral
0.7658441974	gender
0.7657990367	sequencing
0.7656787953	suppressing
0.7655935134	constitutive
0.7654903614	paroxetine
0.7652757475	depression
0.7651544978	testosterone
0.7651286816	endothelium derived
0.7649877129	treated rats
0.7649169241	genomic dna
0.7648529101	northern blot analysis
0.7647390434	treatment options
0.7645533294	lithium
0.7643269633	fragment
0.7643067234	metastatic breast cancer
0.7641687705	transgenic
0.7641173770	colitis
0.7640795968	red
0.7640676798	health
0.7639798410	gestation
0.7639334914	quality of life
0.7637738720	urea
0.7637666505	neurotransmitter release
0.7637512176	pi3k akt pathway
0.7637357099	substance
0.7637058618	antidepressant
0.7636822870	congenital
0.7636493813	oxidized
0.7634662555	morphology
0.7633738822	dynamic
0.7633500814	β cell function
0.7632303605	micromolar
0.7630923311	low molecular weight
0.7630907254	pulmonary
0.7630680267	antiproliferative
0.7630323386	principal
0.7630085645	deletion
0.7629908878	aggregation
0.7629074467	sleep
0.7628521024	characteristic
0.7628070587	ns 398
0.7627753838	amyloid
0.7627582742	arthritis
0.7626984287	intravenous
0.7626698344	phospho akt
0.7626595032	estramustine
0.7626185985	hl 60
0.7625893201	trial
0.7625370598	soluble
0.7624649188	fructose
0.7624271974	atherosclerosis
0.7623355961	hydroxy
0.7621796455	glutamine
0.7620878007	global
0.7620578562	urinary
0.7619344707	beta adrenoceptor antagonists
0.7619323953	actin
0.7618618054	rapamycin
0.7618356551	cognitive
0.7618194697	derived neurotrophic factor
0.7618081852	cadmium
0.7617264634	dopaminergic neurons
0.7616936005	bacteria
0.7615926810	coagulation
0.7615888368	temporal
0.7615869071	morphological
0.7615389134	neonatal
0.7614659297	weekly
0.7613827501	phenylalanine
0.7612789347	dementia
0.7612454666	protected by copyright
0.7612076719	structural features
0.7610381146	tsg 6
0.7609753060	ultraviolet
0.7609271782	volatile
0.7609271782	composite
0.7608217590	randomly assigned
0.7607353106	diuretic
0.7606550820	conditioned
0.7606471959	racemic
0.7605466471	adjuvant
0.7605297704	atypical
0.7605290500	inorganic
0.7604996380	longitudinal
0.7604922029	smoking
0.7604506620	methionine
0.7604452229	choline
0.7602624087	protection
0.7600776333	peroxisome proliferator activated receptor alpha
0.7600029729	insulin dependent diabetes
0.7599835747	sample
0.7599505464	neurotoxicity
0.7597198508	inducer
0.7596809197	engineered
0.7596797863	nucleotide sequence
0.7596631866	classical
0.7596574038	strain
0.7596092146	contractile
0.7596034572	morbidity and mortality
0.7596015497	ros production
0.7595455485	microsomes
0.7595298783	excellent
0.7595038933	fold higher
0.7594184264	purification
0.7593414720	amide
0.7593409240	sulindac
0.7592278508	short
0.7591908156	forskolin
0.7591736295	organophosphorus
0.7591033592	adult onset
0.7589704147	biological evaluation
0.7589628410	folding
0.7589303368	oxytocin
0.7589028107	saturation
0.7588162988	thermal
0.7588115407	sulfonylurea
0.7588097378	stage
0.7588037774	partial
0.7587973473	kd values
0.7587206238	diagnosis
0.7586882576	cognitive performance
0.7586717698	gastrointestinal
0.7586690713	nonsteroidal anti inflammatory drug
0.7585591894	aging
0.7585405393	blue
0.7585244657	schizophrenia
0.7584985340	natural
0.7584756531	emission tomography
0.7584367544	perturbation
0.7584111080	cd1 mice
0.7584098338	natural products
0.7583438520	food and drug administration
0.7583069660	mu
0.7583033514	approaches
0.7581713649	isoprenaline
0.7581672995	unsaturated
0.7581467803	small cell lung
0.7580255363	equilibrium
0.7579240663	aldosterone
0.7579036062	genomic
0.7577076353	long term potentiation
0.7577075952	functional role
0.7577021056	mammary
0.7576967199	rofecoxib
0.7576105608	spectroscopy
0.7574131868	progress
0.7573979334	neural
0.7572903019	soy
0.7572056655	acetyl
0.7571049617	middle
0.7570935372	charge
0.7570030879	dna replication
0.7569280888	hydrophobic
0.7569192944	pharmacokinetics
0.7568728126	embryonic
0.7568321475	carotid
0.7568013976	phage
0.7567768737	separation
0.7567539979	tas 102
0.7567392534	tyrosine kinase inhibitor
0.7566646478	anticancer activity
0.7566564296	phospholipase
0.7566498986	oocytes expressing
0.7564925121	zinc
0.7564898908	airway
0.7564121641	hepatocyte
0.7562695936	prior
0.7562363206	type 2 diabetes
0.7562156613	half
0.7562086336	steroid
0.7562004518	amiloride
0.7561952501	baseline
0.7561736970	parental
0.7561458550	arginase
0.7560785012	reuptake inhibitors
0.7560548347	conjugated
0.7560382607	marked
0.7559120883	ampa receptors
0.7559090645	peroxisome proliferator activated
0.7558973397	microarray
0.7558491677	array
0.7556722660	synergistic
0.7556018149	solvent
0.7554016263	prospective
0.7553472629	pigs
0.7553377074	clinical practice
0.7553250613	adsorption
0.7553244645	luciferase
0.7552617988	individuals
0.7551503800	amino terminal
0.7551239884	lead
0.7551237354	pharmacokinetic
0.7550988736	implications
0.7550171821	testicular
0.7550069169	silencing
0.7549638929	cisplatin
0.7549468376	crucial
0.7549223382	adiponectin
0.7548502367	differential
0.7545980826	mrna expressions
0.7545608257	box
0.7545390619	da uptake
0.7545305817	immunoglobulin
0.7544701612	hypercholesterolemia
0.7544701612	thermodynamic
0.7544307071	immunohistochemical
0.7544136929	exercise
0.7543800270	combined
0.7543585605	index
0.7543509801	type ii collagen
0.7543504931	general
0.7542418889	select
0.7541563477	creb phosphorylation
0.7541388433	artificial
0.7541306640	endothelin
0.7541286657	body fat
0.7540429446	serine threonine kinase
0.7539577367	sitagliptin
0.7539184360	peroxisome proliferator activated receptor γ
0.7538386458	ph responsive
0.7537993788	ribosomal protein
0.7536914479	allergic
0.7536806397	lung cancer
0.7536489153	estradiol
0.7535692932	zeta potential
0.7534838951	promoter region
0.7534827044	ec
0.7534741727	predicting
0.7534713569	nmr
0.7533431550	dual
0.7532353300	bde 47
0.7531896149	combining
0.7531668504	information
0.7531096589	delta
0.7530953995	repeated
0.7530716914	higher doses
0.7530568949	cyclic
0.7529856434	improvement
0.7528396446	histone
0.7528359574	arginine
0.7528077965	catalytic subunit
0.7527983253	distal
0.7527955109	crude
0.7526937579	enzymatic
0.7526706808	aluminium
0.7526105558	phosphodiesterase
0.7526027505	linking
0.7526020745	adiponectin levels
0.7525447845	induced neurotoxicity
0.7524822873	neuron
0.7524493271	glucagon
0.7524442708	field
0.7524392307	pharmacodynamic
0.7524229958	imatinib
0.7524078618	fat mass
0.7523979213	mmp 9
0.7522727618	mapping
0.7522459419	imaging
0.7521765435	variations
0.7521652130	green
0.7521645453	arginase ii
0.7521573542	cavity
0.7521353158	mineral
0.7520882789	lung carcinoma
0.7520452197	apo
0.7520297002	immunoprecipitation
0.7520170358	androgen
0.7519812556	mechanisms underlying
0.7518255392	cytokines
0.7517929908	islet
0.7517652586	primary hepatocytes
0.7516993720	circulating
0.7516963704	sulfate
0.7516959232	double
0.7516929360	developmental
0.7510821027	subjective
0.7510462166	additional
0.7509500699	mutagenesis
0.7508902884	oxalate
0.7508311099	complementary
0.7506437541	endocrine
0.7506296569	rna
0.7505903082	ca ii
0.7505863311	neuroprotective effects
0.7505786213	phenyl ring
0.7505524959	chloride
0.7505405862	histamine
0.7504583919	caspase 3
0.7504294874	mobility shift
0.7504095831	acth and corticosterone
0.7503686950	hypothyroidism
0.7503275152	allosteric
0.7502430711	bovine
0.7501866621	previous
0.7501766966	polymer
0.7501649065	ester
0.7501278171	correlation
0.7501051316	mesenteric
0.7500865207	therapeutic targets
0.7500822920	pituitary
0.7500234651	screening
0.7499156103	monitoring
0.7498107209	basolateral
0.7497621716	pai 1
0.7497375221	micelles
0.7496911120	chinese hamster
0.7496547038	predict
0.7496408650	response rate
0.7496173372	myeloid
0.7496040002	arrhythmia
0.7495797892	mesenchymal
0.7494964704	kb
0.7494359065	tau
0.7494076266	obese
0.7493796537	scale
0.7493752689	chinese
0.7493284921	defective
0.7493254845	hedgehog
0.7493149735	steroidal
0.7492283584	ventricular
0.7491469372	liquid
0.7491177196	il 2r
0.7490892450	ethyl
0.7490431169	generally well tolerated
0.7489228255	intraperitoneally
0.7488831608	catalyzed
0.7487267840	ischemia
0.7486954131	cloning
0.7486863460	performance
0.7486695799	chemotherapeutic agents
0.7486263825	spontaneous
0.7485909756	ic50
0.7485334352	surface area
0.7485199113	abundant
0.7485019620	kappa opioid receptors
0.7484641520	replacement
0.7484484921	antinociceptive
0.7484100604	rat cerebral cortex
0.7484037599	severity
0.7484031552	melanoma
0.7483640283	juvenile
0.7483203819	hippocampal slices
0.7483113583	hfd fed
0.7482886937	nature
0.7482639519	conjugates
0.7482532031	point mutation
0.7482436132	bladder
0.7482311167	administered orally
0.7481532954	median
0.7481285773	renal interstitial
0.7479982691	norepinephrine
0.7479425204	x ray crystallography
0.7477760065	short acting
0.7477578138	heterogeneity
0.7477578138	antiinflammatory
0.7477207345	ligand binding
0.7476828147	exendin 4
0.7476659678	alanine
0.7476550841	transcriptional
0.7475785708	hypertension
0.7475463984	fresh
0.7475058206	salt
0.7474616376	week
0.7474572976	predominant
0.7474550849	completely reversed
0.7474496911	reversal
0.7473849113	medical
0.7473664789	leukocyte
0.7472481564	oncology
0.7472360886	cyclooxygenase
0.7471642343	deficits
0.7471126834	linear
0.7470476324	class
0.7470418220	working
0.7469533978	wave
0.7468836150	glucagon like peptide
0.7468094052	ovarian
0.7467573108	tobacco
0.7467573108	radioimmunoassay
0.7466786683	molecular dynamics
0.7466734843	high fat
0.7466052540	celecoxib and rofecoxib
0.7465604610	white
0.7464671613	placental
0.7464583340	β cell mass
0.7464508816	polyclonal
0.7464401438	somatic
0.7464215439	gap
0.7463913133	neuroprotective
0.7463414496	serum testosterone
0.7462945675	hql 79
0.7462738850	heparin
0.7462190317	hepatocytes
0.7461899755	hct 116
0.7461677981	preterm
0.7461397983	amp
0.7459581095	cyp2b6
0.7459248163	mice lacking
0.7458647946	progesterone
0.7458572110	post translational
0.7457755076	leucine
0.7457485225	positron emission
0.7457353621	cortical
0.7456835003	mammalian
0.7456795295	gastric
0.7456646701	diabetic mice
0.7456468648	fluorescence
0.7455941299	adult
0.7455690027	shock
0.7455615220	pregnancy
0.7454445898	nitrate
0.7454019074	reproductive
0.7453855452	thyroid
0.7453336943	adenosine
0.7453055012	disposition
0.7452883059	prostate
0.7452167616	structure based design
0.7451951940	human serum albumin
0.7451426451	hemoglobin
0.7451171144	amyloid β
0.7450922785	fold higher affinity
0.7450747665	learning and memory
0.7450445393	advanced
0.7449967645	plants
0.7449399758	middle cerebral artery
0.7448353731	cannabinoid
0.7448084536	recent studies
0.7447332810	maximal
0.7447094370	occupancy
0.7446869801	biopsy
0.7446742734	serum creatinine
0.7446698879	cytotoxicity
0.7446053665	microdialysis
0.7445516358	utility
0.7445313607	vascular endothelial cells
0.7444068185	human umbilical vein endothelial cells
0.7443781566	experimental
0.7443434377	prenatal
0.7442958221	cortex
0.7442779084	delayed
0.7442667271	plasma membrane
0.7442413072	head
0.7441814584	mood
0.7441541726	foundation
0.7440937722	nmda
0.7440674398	truncated
0.7439743207	equations
0.7439071946	ser
0.7438922697	chromosomal
0.7438664126	clinical efficacy
0.7438304697	phylogenetic
0.7436989430	repair
0.7436978441	psychiatric
0.7436896661	examination
0.7436161308	drug resistance
0.7435325213	benefits
0.7434731107	kinetics
0.7433264816	drug interactions
0.7433117219	distribution
0.7432840247	alkyl
0.7432671947	complete
0.7432587186	common
0.7431673006	scientific
0.7431215935	direct
0.7430658527	kinetic
0.7429771497	tandem
0.7429607204	dopamine d2 receptors
0.7429576671	electrochemical
0.7429304574	inter
0.7429137542	recent findings
0.7428528680	ganglion cell
0.7428415074	microtubule
0.7428301277	hippocampal neurons
0.7427510441	extraction
0.7427346185	ectopic
0.7425972413	tolerability
0.7425916744	future
0.7425872509	nadph
0.7424991388	recent
0.7424578245	lipoprotein
0.7423596687	exchange
0.7422988064	central
0.7422768033	nad
0.7422620950	lipopolysaccharide
0.7422324544	clinical signs
0.7421686322	hospital
0.7421246825	myocardial
0.7420763176	treated animals
0.7420506545	animal
0.7419918473	deleterious effects
0.7419890898	heparin binding
0.7419720775	nadh
0.7419110100	cholinergic
0.7419023977	enhancement
0.7418166255	safety
0.7417490517	extremely
0.7417248297	mapk
0.7417232763	mild
0.7417012891	celecoxib
0.7416807630	interleukin
0.7415208599	pro
0.7414807762	reports
0.7414503536	a1
0.7414287329	cholesterol lowering
0.7414238165	tumour
0.7414106434	programmed
0.7412116295	increasing
0.7411989159	prolonged
0.7411869820	extracellular
0.7411492298	pump
0.7411115644	comparative
0.7410995029	se deficiency
0.7410761473	driven
0.7410587806	uv
0.7410227590	intervention
0.7410044238	completely blocked
0.7409109093	fgf
0.7408931894	adrenal
0.7408133319	calcitonin
0.7408033480	materials
0.7408013330	concentration time curve
0.7407915412	review
0.7407676966	traditional
0.7407097667	eye
0.7406599126	plasticity
0.7406519356	glycogen synthase kinase
0.7406415577	catalytic domain
0.7405004360	aryl
0.7404950143	diverse
0.7404778261	d2 receptor
0.7403967202	enzyme activities
0.7403637565	glutathione
0.7403135256	bone
0.7403046108	immune
0.7402889762	clinical utility
0.7402885223	post
0.7401322077	coa
0.7401079803	biotransformation
0.7400566411	cp
0.7400445317	transfection
0.7398468965	ace inhibitor
0.7398054534	mammals
0.7398032807	approximately
0.7397658966	ec50
0.7397243109	error
0.7395370074	blocking
0.7394772782	lesser extent
0.7394477830	c jun
0.7393735604	barrel
0.7393735604	respiration
0.7393352945	acyl coa synthetase
0.7393225446	electronic
0.7393180819	longer
0.7393017226	incidence
0.7392747955	binding cassette
0.7392444702	ki
0.7392034330	graft
0.7391614558	antioxidant activities
0.7391268317	abt 384
0.7390358429	vital
0.7389713226	salicylate
0.7389607161	entry
0.7389259869	adp
0.7389140081	inclusion
0.7389034944	search
0.7388525378	cell membranes
0.7388479831	flavin
0.7387387797	genetic
0.7387271771	simulations
0.7386997479	dynamics
0.7386118476	alzheimer
0.7384846705	aromatic
0.7384405749	ph
0.7384030405	strategy
0.7383665303	constitutively
0.7383481878	japanese
0.7383352365	calcitonin gene related
0.7381622480	ap
0.7381334381	cholesterol
0.7381273827	rodent
0.7381047692	serum albumin
0.7380673246	alpha 1a adrenoceptors
0.7380405253	targeted
0.7380254153	ketone
0.7378538572	ischemic
0.7378532126	motif
0.7377960196	real time rt pcr
0.7377179847	desensitization
0.7377178030	intracellular calcium
0.7377166206	dosing
0.7376890475	significance
0.7376560219	act
0.7376246279	environmental
0.7375991375	dental
0.7375938959	angiotensin
0.7375685111	bicarbonate
0.7375481625	data suggest
0.7374118310	distinct
0.7373181993	mm
0.7372902946	rank order of potency
0.7372726441	obesity
0.7372703298	electrical
0.7372634500	acetylcholine
0.7372367592	patients undergoing
0.7372346395	organic
0.7371884460	antitumor
0.7371481877	rapid
0.7370865153	procedure
0.7370027956	drug metabolism
0.7368927875	5 meo dmt
0.7368717579	acth
0.7368659076	natriuretic
0.7368195674	clinical benefit
0.7367520114	intake
0.7367183777	women with pcos
0.7366615120	hydroxyl group
0.7366612439	clotting
0.7366218105	fiber
0.7366143642	lavage fluid
0.7365680307	variable
0.7364433119	cortisol
0.7364404929	liver cytosol
0.7364310915	cysteine
0.7363578709	competitive
0.7363392816	gestational diabetes
0.7363314536	output
0.7363314536	inversely
0.7363265940	apple
0.7362949187	fracture
0.7362772750	d3
0.7362732996	threshold
0.7362108090	catechol
0.7362040939	neurotransmitter
0.7361975780	menstrual
0.7361862600	survival
0.7361714878	endpoint
0.7361634337	saline
0.7361435871	km
0.7361413305	early stage
0.7361041353	intercellular adhesion
0.7360167425	quantitative
0.7359907400	renal fibrosis
0.7359427700	formoterol
0.7359247712	dl
0.7359222193	expressions
0.7358709496	kinases
0.7358485165	sulfide
0.7358405810	trained
0.7358252107	focal
0.7357966499	free energy
0.7357703318	female
0.7357561537	spinal
0.7357437527	liver injury
0.7356884100	pancreatic
0.7356664022	sr
0.7356427464	systemic
0.7356156411	src
0.7355067552	dipeptidyl peptidase 4
0.7354900856	familial
0.7353204628	generally
0.7352745690	neuromuscular
0.7352457757	arg
0.7352206702	cultured
0.7351889096	radioligand
0.7351789264	serotonin
0.7350978256	cimetidine
0.7350978256	chondrocytes
0.7350978256	electrophysiological
0.7350794349	polymerization
0.7350771046	ldl
0.7350239319	reference
0.7349954958	macrophage
0.7349621696	egf
0.7349232029	brain natriuretic peptide
0.7348906557	energy
0.7348900434	quantum
0.7348276166	creb
0.7348154448	potassium
0.7348047046	dietary
0.7347672162	il 10
0.7347597722	linkage
0.7347054828	cold
0.7347005033	amino acid transporter
0.7346624543	verapamil
0.7345923818	toxic
0.7345719893	substitution
0.7345437719	physiological role
0.7345298317	tea
0.7345124315	lncap cells
0.7344627559	vegf
0.7344570065	benign
0.7343939428	histamine h1 receptor antagonist
0.7343736986	consensus
0.7343103776	maturation
0.7342969609	male
0.7341930020	antidepressants
0.7341606401	case
0.7341590241	southern
0.7341031491	lung tissue
0.7340488739	hormone receptor positive
0.7340485245	recommended
0.7340428246	computational
0.7340133691	h2o2
0.7339234871	hypertrophic
0.7338974836	lung fibroblasts
0.7338803029	recipients
0.7337375540	nicotine
0.7337312858	wine
0.7337146341	fluoride
0.7336902059	hydrolase
0.7336449120	alternative
0.7335837206	anabolic
0.7334912369	product
0.7334772200	regulators
0.7334764158	technology
0.7334620849	loops
0.7334584393	parkinson
0.7334502802	peripheral blood mononuclear
0.7334300264	nude mice
0.7333985886	plasmin
0.7333480692	stimulating
0.7333321058	disease modifying
0.7333205849	hour
0.7333144166	recombinant human
0.7333100183	attenuate
0.7332742749	solid
0.7332474620	poor
0.7332431144	abt 288
0.7332145606	antibiotic
0.7332059865	rosiglitazone
0.7331941810	rejection
0.7331675434	tcdd
0.7330952568	cyp3a
0.7330875863	sufficient
0.7330705849	cationic
0.7330674171	neurotoxic
0.7330496686	control group
0.7330288815	knockout
0.7329986010	glucose transporter
0.7329905030	d4
0.7329633203	d1
0.7329592550	asthma
0.7329436468	selection
0.7328758882	acetazolamide
0.7328716990	ternary
0.7328461629	fluorouracil
0.7328203841	female mice
0.7327856173	reflection
0.7327681033	gold
0.7327593062	rate limiting
0.7326778392	antigen
0.7325763149	initial
0.7325337808	enzymatically
0.7325008767	sert
0.7324410243	group ii
0.7324196593	methylphenidate
0.7323900434	import
0.7323515972	progestins
0.7323365942	soft
0.7323265427	joint
0.7322492596	radical
0.7322243881	inositol
0.7321838349	g1
0.7321454958	current
0.7320991845	heme oxygenase 1
0.7320742788	physiologically
0.7320359454	medicine
0.7320080388	postprandial
0.7319766401	arginine transport
0.7319705520	pa
0.7319686614	recently approved
0.7319644195	xanthine
0.7319601992	1h pyrazole
0.7319438195	cardiac remodeling
0.7319318287	testosterone to estradiol
0.7319150777	activating
0.7318917053	acetylcholinesterase
0.7318583572	muscarinic
0.7318369663	esophageal
0.7318268443	constant
0.7317990380	research
0.7317716489	met
0.7317425177	neuroblastoma
0.7317048365	platelet
0.7317016308	proteolytic
0.7316938421	morphine
0.7316915152	overexpression
0.7316908895	b1
0.7315868451	lymphocytes
0.7315532650	kappa opioid receptor
0.7315086443	quality
0.7315064557	95 confidence interval
0.7315044194	mass
0.7314977353	ici 182
0.7314938903	ras
0.7314736053	sandwich
0.7314699828	mmp
0.7314592916	her2
0.7314318772	keto
0.7313904196	intraperitoneal
0.7313123780	antiviral
0.7313062469	ms
0.7312505899	ventral
0.7311807808	vesicle
0.7311765092	cation
0.7311555734	mir 663
0.7311364641	clinically
0.7310906845	descending
0.7310885874	antioxidant
0.7310787613	thioredoxin
0.7310671504	biochemical
0.7310401779	sibutramine
0.7310240093	worldwide
0.7309751069	polymorphisms
0.7309442877	flavonoids
0.7309369511	mda
0.7309202152	stem cells
0.7309147976	nf kappab activation
0.7309140694	degeneration
0.7308744869	nitro
0.7308460508	effectiveness
0.7308384928	osteoclasts
0.7308384928	etoposide
0.7307753370	diffusion
0.7307747245	hair
0.7307673521	pde4 inhibitors
0.7307464862	flow
0.7306978619	antipsychotic
0.7306935389	stable
0.7306789698	magnetic
0.7306741971	lps
0.7306337946	pharmacologically
0.7306307744	pair
0.7305929454	national
0.7305298459	fat body
0.7304872955	stat3
0.7304661588	inactivated
0.7304557151	modulators
0.7304353278	finger
0.7304234513	pi3k
0.7304066782	affinities
0.7304005380	interacting
0.7303534031	glucocorticoid
0.7303522024	sigma
0.7303443559	burst
0.7302945880	functionalized
0.7302237921	mobility
0.7301959398	deep
0.7301875974	repeat
0.7301872674	remarkable
0.7301563398	elevated
0.7301375899	representative
0.7301231804	ros generation
0.7301220273	p450
0.7300979003	eukaryotic
0.7300715159	retardation
0.7300412578	evolution
0.7300164352	spatial learning
0.7299736855	canine
0.7299204672	iodine
0.7298829028	visual
0.7298721888	caffeine
0.7297499024	nr2b
0.7297498259	oestrogen
0.7297165220	treated groups
0.7297047805	m2
0.7296465063	transactivation
0.7295916540	metabolizing
0.7294995849	herbal
0.7294946557	correlations
0.7294423764	adenocarcinoma
0.7294044590	testing
0.7293841440	flux
0.7293771362	men
0.7293622938	transition
0.7292656946	hdl
0.7292656432	island
0.7292366807	limitations
0.7291847062	pretreatment
0.7291839572	humans
0.7291837670	respiratory
0.7291763060	kit
0.7290787559	prostacyclin
0.7290305051	thrombin
0.7290092224	immediately
0.7289914664	local
0.7289097276	embryo
0.7288353278	polypeptides
0.7288324408	single
0.7287877736	importantly
0.7287867497	fibroblasts
0.7287791410	capillary
0.7287346137	transformation
0.7287116966	simultaneous
0.7287088058	children
0.7286960508	virus
0.7286947014	postpartum
0.7286780785	simple
0.7286322680	lc
0.7285983012	duration
0.7285832200	gonadotropin
0.7285003413	pg
0.7283943295	moderate
0.7283418579	maintenance
0.7283257095	ampk
0.7282916936	irradiation
0.7282598460	ketoconazole
0.7282589202	structural
0.7282530369	flt3
0.7282389202	gradient
0.7282389202	erythrocyte
0.7282174225	vitamin
0.7282054969	modest
0.7281752252	deliver
0.7281693332	nabumetone
0.7281657291	nicotinamide
0.7281600686	anticancer drug
0.7281358929	matrix
0.7280969192	jnk
0.7280553206	initially
0.7280553206	corticosteroids
0.7280367175	pre
0.7279949574	systolic
0.7279814644	cysteamine
0.7279112777	mao
0.7278989454	ko
0.7278620892	perfusion
0.7278456594	d2
0.7278174175	unique
0.7278127301	zebrafish
0.7277963201	atomic
0.7277635879	herg
0.7277535482	rationale
0.7277216427	grown
0.7276096700	mimic
0.7276077764	add on therapy
0.7275779881	altering
0.7275733227	transcriptional regulation
0.7275622987	integrated
0.7275493444	albumin
0.7275369313	olmesartan
0.7275351180	lipase
0.7275301950	disulfide
0.7274495950	oxidant
0.7274442148	creatinine
0.7274096996	pharmacokinetic and pharmacodynamic
0.7273469787	characterization
0.7273159818	oxysterols
0.7273093412	reductive
0.7272996729	relevant
0.7272131920	adding
0.7271983470	recombinant
0.7271952666	behavioral
0.7271635723	sh sy5y cells
0.7271542918	viability
0.7271476841	atom
0.7271309929	clock
0.7270978969	age
0.7270913722	codon
0.7270572891	embryos
0.7270299093	highly homologous
0.7270125899	ineffective
0.7269455965	neurotrophic
0.7269441685	cyclin
0.7269253170	signalling pathway
0.7268879710	whilst
0.7268758402	von
0.7268703820	reactive
0.7268639375	social
0.7268515196	sildenafil
0.7267914221	ppar
0.7267827245	propranolol
0.7267313941	glial cells
0.7267245127	nmda receptor antagonists
0.7267151767	continuous
0.7266984996	industry
0.7266984996	attack
0.7266984320	apparently
0.7266965992	csf
0.7266947454	recently
0.7266526041	trastuzumab
0.7265433708	metabolizing enzymes
0.7265088776	nephrotoxicity
0.7264941220	d2 dopamine
0.7263957202	inverse
0.7263773149	pcr
0.7263530914	fe
0.7263266904	dams
0.7263016426	heart
0.7262923781	breast tumors
0.7262744600	olfactory
0.7262583650	osteoblast
0.7262436244	safe
0.7262380932	conjugate
0.7262240422	cytotoxic
0.7261407397	vardenafil
0.7261365379	profound
0.7261064707	assembly
0.7260499974	storage
0.7260172945	platelet activation
0.7260035618	hyperplasia
0.7259984898	extended
0.7259187783	adjusted
0.7258697893	fat
0.7258559841	cultures
0.7257922657	fp receptor
0.7257819649	design
0.7257713386	pressor
0.7257644624	chronic heart failure
0.7257585271	beta adrenoceptor
0.7257472731	older
0.7257298746	acinar cells
0.7257133220	epilepsy
0.7257050608	transmembrane
0.7256934761	cytotoxic effect
0.7256785059	se
0.7256708596	potentiation
0.7256681911	antiproliferative effects
0.7256591192	upregulated
0.7256492387	polyamine
0.7256468395	bleeding
0.7256442388	budesonide
0.7256092113	line
0.7255659644	nanoparticles
0.7255581503	human umbilical vein endothelial
0.7255370414	lipoxygenase
0.7255185668	methyl
0.7255117784	tacrine
0.7255003943	pure
0.7254988939	oxidized glutathione
0.7254954611	response curve
0.7254485749	tnf α and il
0.7254458488	scavenging
0.7254451369	ho 1
0.7254049836	silica
0.7253982276	pyruvate
0.7253776998	fas
0.7253505890	lead compound
0.7253147977	simvastatin
0.7253143459	erk
0.7252971326	equal
0.7252835563	states
0.7252777549	neuronal
0.7252536843	ionic
0.7252307085	genetics
0.7252165668	large
0.7251754451	calcitonin receptor
0.7251523025	quantification
0.7251417433	immunoblotting
0.7251417433	crystallographic
0.7250949677	male mice
0.7250368361	type ii diabetes
0.7249993642	bonds
0.7249715890	equivalent
0.7249702000	disrupted
0.7249459093	meta
0.7248739258	finding
0.7248450665	diol
0.7248350097	stages
0.7247501188	state
0.7246625270	gemcitabine
0.7246400934	memory
0.7246400905	start
0.7245864606	e2 related factor 2
0.7245410821	er
0.7245379478	mitiglinide
0.7245074824	enhancer
0.7244942151	catalytic
0.7244858784	estrogens
0.7244500351	prostaglandin
0.7244498324	neutrophils
0.7244416741	modeling
0.7244235170	relative
0.7243595457	gastrointestinal tract
0.7243491809	myosin
0.7243392978	light
0.7243339056	power
0.7242956272	clear
0.7242498601	scanning
0.7242326448	rings
0.7242046270	gnrh
0.7241692234	thiazolidinediones
0.7241636940	element binding protein
0.7241349629	gas
0.7241047109	existing
0.7240981565	yohimbine
0.7240931701	adducts
0.7239925005	smoke
0.7239893336	purpose
0.7238929855	inhibitory activity
0.7238897230	limited
0.7238075221	measure
0.7237557607	grade
0.7237438165	estimated
0.7237345190	hepatic fibrosis
0.7237119114	program
0.7236581215	udp
0.7236330056	cat
0.7236210626	kd
0.7236121355	calcium channel
0.7235999337	controlled
0.7235773463	transplantation
0.7235624475	amitriptyline
0.7235317116	3 methylglutaconic aciduria
0.7235264894	hippocampal
0.7235180342	epigenetic
0.7234786569	experiment
0.7234770364	endothelial function
0.7234660639	dopaminergic
0.7234498324	arsenite
0.7233340087	healing
0.7232986914	bupropion
0.7232897250	cp 778 875
0.7232740203	restriction
0.7232652112	chains
0.7232473463	apoptosis inducing
0.7232000329	examining
0.7232000329	subject
0.7231429659	inhaled
0.7231355865	mrna expression
0.7231285885	particle
0.7231112313	homozygous
0.7230881998	progestin
0.7230578572	ziprasidone
0.7230401857	case control study
0.7230332355	context
0.7230266320	rivastigmine
0.7230058643	bond
0.7229747799	aims
0.7229551884	injuries
0.7229460942	doxorubicin
0.7229250915	neurochemical
0.7229236740	nerve
0.7229086202	serine
0.7228909268	ace inhibitors
0.7228253055	isoproterenol
0.7228229461	cysteine residues
0.7228197359	air
0.7228111392	preparation
0.7228034180	chemical
0.7227900184	white adipose
0.7227807350	benzo
0.7227635859	pr
0.7227628559	literature
0.7227538986	setting
0.7226869900	hepatocellular
0.7226732435	p2y12
0.7226722070	sd
0.7226708596	measuring
0.7226093060	dopamine d4
0.7226075410	telmisartan
0.7226033365	long
0.7225846602	mk
0.7225553104	separate
0.7225356049	order of magnitude
0.7225180975	intrinsic
0.7224903812	heme
0.7224793060	hiv
0.7224776613	tolerance
0.7224607485	interactions
0.7224540706	disrupting
0.7224207509	metabolite
0.7224094707	tube
0.7223973288	hepatoma
0.7222786953	iron
0.7222630391	event
0.7222119930	cl
0.7221901167	panel
0.7221876864	wt
0.7221708763	advantages
0.7221707076	estrogen
0.7221654063	releasing
0.7221631190	square
0.7221631190	prescription
0.7221595974	central nervous
0.7221440432	prevention
0.7221133927	conformation
0.7220983677	mrna level
0.7220895635	irbesartan
0.7220650282	acetaminophen
0.7220427530	incubation
0.7220404321	ketamine
0.7219896452	al
0.7219438247	tumor progression
0.7219157355	flow rate
0.7218995034	recruitment
0.7218916869	hypoxic
0.7218775324	prostatic
0.7218541786	ici 118
0.7218329469	progression
0.7218301036	understanding
0.7217774835	thymidine
0.7217624770	physiology
0.7217020129	pathophysiology
0.7216681598	brown
0.7216597332	oral
0.7216211614	loperamide
0.7215926613	key
0.7215918365	fenofibrate
0.7215521193	higher risk
0.7215377428	catecholamine
0.7215269192	aripiprazole
0.7215083021	inducible
0.7214983549	glibenclamide
0.7214978205	compensatory
0.7214582288	northern
0.7213729020	impulsivity
0.7213577953	chemotherapy
0.7212842989	donepezil
0.7212801041	dna topoisomerase
0.7212589493	migraine
0.7212553472	inhibitory activities
0.7212052791	prolactin
0.7211561988	cotinine
0.7210955624	aldehyde
0.7210752145	tnf
0.7209678623	ache and bche
0.7209150971	agonistic
0.7207647432	alpha 1 adrenoceptor
0.7207229475	ongoing
0.7207105800	cardiomyopathy
0.7206461606	tyramine
0.7206305857	amino acid sequences
0.7205689736	antioxidant status
0.7205573410	voltage
0.7205437910	5 methyl urapidil
0.7205216248	infusion
0.7205013721	akt
0.7203882373	17 beta hsdxi
0.7203775971	immune cell
0.7203681690	losartan
0.7203607433	copyright © 2013 john wiley &
0.7203577038	mucosal
0.7203127174	ultimately
0.7202040255	exenatide
0.7201927316	heat
0.7201918902	elastase
0.7201918902	hemorrhagic
0.7201918902	approval
0.7201918902	organophosphate
0.7201856854	root
0.7201565402	ici
0.7201534316	enriched
0.7201492794	peripheral
0.7201487109	persistent
0.7201286108	regular
0.7201224072	ros
0.7201006922	5 ht2a
0.7200133164	cultured rat hepatocytes
0.7200099485	pharmacologic
0.7200011867	mutation
0.7199956118	reactivation
0.7199592153	hpa
0.7198549941	gaba
0.7198418152	autoimmune
0.7198238152	porcine
0.7198124685	mir
0.7198083630	testes
0.7197868963	helix
0.7197772579	terbutaline
0.7197738440	altered
0.7196870419	arterial
0.7196765405	kainate
0.7195940004	scavenger
0.7195931410	pet
0.7195674596	recombination
0.7195473376	raw 264
0.7194976768	tyrosinase
0.7194427504	citalopram
0.7194227732	network
0.7194217388	etomidate
0.7193860614	e2
0.7193824386	methamphetamine
0.7193282399	halothane
0.7193147563	efflux transporters
0.7193027232	neurotrophic factor
0.7193026504	surface
0.7192804177	classification
0.7192631776	pdgf
0.7192313592	failure
0.7192177258	levodopa
0.7191574047	sumatriptan
0.7191570266	surgery
0.7191154200	encoded
0.7191126423	fenfluramine
0.7190498309	eletriptan
0.7190356494	cb1
0.7189766563	pimozide
0.7189712222	recognition site
0.7189260565	glycine
0.7189238243	remarkably
0.7189048874	endometriosis
0.7189048874	phenotypic
0.7188850917	life
0.7188420995	area
0.7188386201	selenium
0.7188359192	puberty
0.7188248151	supporting
0.7187953776	meperidine
0.7187890318	androgens
0.7187831556	ghrelin
0.7187753629	platelets
0.7187450794	zolmitriptan
0.7187360638	sensor
0.7186696357	chromosome
0.7186650331	hyperactivity
0.7186410103	iii
0.7186246096	simultaneously
0.7185992811	phenyl
0.7185884994	criteria
0.7185391970	sulfasalazine
0.7185375480	genistein
0.7185050716	catecholamines
0.7185039861	headache
0.7185039861	prothrombin
0.7185039861	anesthetized
0.7185039861	flexible
0.7184521577	identifying
0.7184521577	neurodegeneration
0.7184296717	restricted
0.7184239954	therapeutics
0.7184178461	vascular
0.7184018118	protein kinase
0.7183519033	bisoprolol
0.7183374250	3h rs 15385 197
0.7183130960	sequential
0.7183125381	antiepileptic drug
0.7182544813	bioavailability
0.7181374458	target genes
0.7181227522	cell invasion
0.7181083398	signal transducer and activator of transcription
0.7180843740	route
0.7180432023	phorbol
0.7180251064	endocrine therapy
0.7180001115	cases
0.7179107781	nsclc
0.7178716965	ammonia
0.7178316934	isolation
0.7178222338	phenolic
0.7177526827	tamsulosin
0.7176397198	complexity
0.7176397198	rational
0.7176308260	retinol
0.7176225636	triphosphate
0.7176135245	culture
0.7175868441	endometrial
0.7175449016	objective
0.7175380438	atorvastatin
0.7175162359	stop
0.7175049645	calculations
0.7174190893	oncogenic
0.7173720511	mol
0.7173148013	aortic
0.7173078264	osteoporosis
0.7173063833	impaired
0.7172543114	calcineurin
0.7172264131	oxidation
0.7172199227	cyclothiazide
0.7171682259	concentration dependently
0.7171418810	opioids
0.7170978839	carvedilol
0.7170491649	lumiracoxib
0.7170407935	insulin signaling
0.7170047226	hydrophilic
0.7170047226	forced
0.7170047226	asymmetric
0.7170041905	adrenoceptor stimulation
0.7169905103	silymarin
0.7169806875	x ray diffraction
0.7169660187	correlated
0.7169643971	european
0.7169643971	cd4
0.7169201598	trep 132
0.7169125248	cerebral
0.7168565879	offspring
0.7168327982	promoter
0.7168260254	citrus
0.7167933137	growing
0.7167775109	peroxide
0.7167264345	systematic
0.7166958565	atp
0.7166444306	glimepiride
0.7166114283	detectable
0.7165796361	rs 17053
0.7165595485	thyroid cancers
0.7165243117	tyrosine
0.7165222344	hfd
0.7164907274	promising
0.7164689838	recordings
0.7164347398	view
0.7163862110	recurrent
0.7163705958	cluster
0.7163277134	fibrinogen
0.7163251401	n acetylglucosamine
0.7163184777	balance
0.7162823088	ethylene
0.7162682359	parenteral
0.7162469186	typically
0.7162469186	immature
0.7162469186	radioactivity
0.7162416481	oncogene
0.7162046891	fenoterol
0.7162028954	intra
0.7161507887	particles
0.7161225491	poorly
0.7161224003	neuroprotection
0.7161209269	striatal
0.7161183827	melatonin
0.7161039795	imidazole
0.7160600472	pharmacological
0.7160437962	h2
0.7160290732	source
0.7160255274	tryptophan
0.7160144164	consistently
0.7160144164	phentermine
0.7160104070	breast cancer risk
0.7159662521	apomorphine
0.7159294922	initiation
0.7159014648	micro
0.7158911108	l bmaa
0.7158753736	microsomal
0.7158531082	mrna levels
0.7158481972	mature
0.7158203798	aminopeptidase
0.7158162952	previously
0.7158126707	il 8
0.7157717829	nimesulide
0.7157273740	preferential
0.7157119213	tetrahydrofolate
0.7157043362	mtt
0.7156881430	modelling
0.7156840307	erlotinib
0.7156681669	p21
0.7156444787	delivery
0.7156094939	risperidone
0.7156021184	5 ht1b
0.7155861597	neurotoxic effects
0.7155588179	absorption
0.7155524260	histidine
0.7155328789	nucleus
0.7155077417	hf
0.7154000435	excessive
0.7153791853	conversion
0.7153282827	prostaglandins
0.7153065209	responding
0.7152712475	drosophila
0.7152322894	suppressor
0.7152020377	assessment
0.7151893162	external
0.7151836747	maternal
0.7151676267	acute
0.7151649292	gsh
0.7151343944	secretory
0.7150967224	jth 601
0.7150800301	exogenous
0.7150618700	combination
0.7150510209	pharmacodynamics
0.7150450013	phenformin
0.7150138154	arrest
0.7150130501	liver glycogen
0.7150086147	corneal
0.7149987751	lung
0.7149804955	controlled trials
0.7149658139	alters
0.7149387915	methodology
0.7148836685	docetaxel
0.7148825882	troglitazone
0.7148474174	paclitaxel
0.7147094096	safe and effective
0.7146876583	antioxidants
0.7146876583	testis
0.7146740778	establish
0.7146672829	trans
0.7146623469	nuclear factor kappa
0.7146541364	betaine
0.7146535366	polymerase
0.7146343377	resveratrol
0.7146299754	main
0.7146265070	plasma membranes
0.7146134621	opiate
0.7146134621	kidneys
0.7145784249	mouse model
0.7145620983	epithelium
0.7145495126	tricyclic
0.7145335740	cho cells
0.7145051829	antidepressant drugs
0.7145013515	aqueous
0.7144931425	newer
0.7144805785	biotin
0.7144371906	therapeutic doses
0.7144352346	checkpoint
0.7144352346	diacylglycerol
0.7144089940	yeast
0.7143902868	mammary epithelial
0.7143861245	potently inhibits
0.7143791979	method
0.7143675943	da release
0.7143671391	vcam 1
0.7143634919	gestational
0.7143349209	manganese
0.7142723017	studying
0.7141993629	exposures
0.7141993629	visceral
0.7141722255	pioglitazone
0.7140143018	end
0.7140036959	avibactam
0.7139956209	transcripts
0.7139179092	bonding
0.7139058621	dysfunction
0.7138544838	cardiac dysfunction
0.7138418035	mouse hepatocytes
0.7137827254	subclinical
0.7137827254	ifenprodil
0.7137827254	cathepsin
0.7137748002	myeloma cells
0.7137539208	snake
0.7137476552	naproxen
0.7136822353	chronic
0.7136732757	bexarotene
0.7136468691	anastrozole
0.7136397198	accuracy
0.7136397198	discontinuation
0.7136397198	imidazoline
0.7136096049	clonidine
0.7135880569	aberrant
0.7135816997	non small cell lung cancer
0.7135769922	cystine
0.7135455043	phosphatidylserine
0.7135443974	hek 293 cells
0.7134998480	newly
0.7134808087	nuclear accumulation
0.7134192631	dhea
0.7134087947	pathological conditions
0.7133957687	mixture
0.7133390197	antioxidant enzymes
0.7133071211	rasagiline
0.7132908167	heterozygous
0.7132712439	pb
0.7132635123	translation
0.7132521473	catalase
0.7132422450	colonic
0.7132416194	partial agonists
0.7132266445	male and female
0.7132246309	contractions
0.7132213977	heavy
0.7131767806	adipose
0.7131744719	noradrenaline
0.7131408489	nano
0.7131397198	duodenum
0.7131096996	invasion and metastasis
0.7131071835	predictive
0.7131031731	diabetes
0.7131005889	exemestane
0.7130853113	organization
0.7130419636	pregnant
0.7130379736	retinoids
0.7129747637	prednisolone
0.7129747637	clenbuterol
0.7129747637	neuropeptide
0.7129747637	symptom
0.7129560847	il
0.7129517489	utilizing
0.7129503440	database
0.7128695318	procedures
0.7128591960	ir
0.7128393104	areas
0.7128332865	sources
0.7128077785	bis
0.7127363497	analgesia
0.7127363497	dofetilide
0.7127363497	antithrombotic
0.7127363497	hyperthyroidism
0.7127229706	map
0.7127120527	glucocorticoids
0.7126797055	olanzapine
0.7126741442	activin
0.7126183697	adrenaline
0.7124849773	gallium
0.7124758835	nutrition
0.7124746201	rituximab
0.7124519275	glucosamine
0.7124331466	women
0.7123520229	phase
0.7123119991	covalent binding
0.7122637637	nanotube
0.7122361635	subjects
0.7121527748	atropine
0.7121136733	clopidogrel
0.7121086770	fluoxetine
0.7120813831	glutamate
0.7120206202	evidence
0.7120146612	acarbose
0.7120035118	desipramine
0.7119941666	absolute
0.7119665563	cdb 2914
0.7119365109	gentamicin
0.7119295101	dimerization
0.7118034531	neonates
0.7117633277	breast
0.7117580970	hemodynamic
0.7117564344	delta opioid receptor
0.7117470186	larger
0.7117332130	hepg2
0.7117021599	dominant
0.7116904841	bcrp
0.7116873501	immunofluorescence
0.7116393821	investigating
0.7116393821	normalized
0.7116286286	indomethacin
0.7116165202	all rights reserved
0.7115664253	ethanol
0.7115449437	urokinase
0.7115449437	cardioprotective
0.7115332443	mono
0.7115015790	canonical
0.7114641878	atpase activity
0.7114628446	deterioration
0.7114627287	urine
0.7114596220	escitalopram
0.7113927380	a549
0.7113596756	hepatoprotective
0.7113596756	passive
0.7113596756	tadalafil
0.7113559890	thiol
0.7113425486	fda
0.7113319273	dependent protein kinase
0.7113001125	rar
0.7112966651	resolution
0.7112399950	retigabine
0.7112353856	nanoparticle
0.7112178468	diabetic
0.7112042136	potassium channels
0.7111993157	vildagliptin
0.7111969867	identical
0.7111393489	ace
0.7111379074	materials and methods
0.7111348119	plant
0.7111339864	extensive
0.7111301807	integrin
0.7111229682	dopamine
0.7111040855	leukotrienes
0.7111040855	antiarrhythmic
0.7111040617	cardiac
0.7110949851	van
0.7110732914	acidic
0.7110534423	pde4
0.7110132635	lysine
0.7109837001	pulse
0.7109721463	drug candidates
0.7109545545	topiramate
0.7108992236	raf
0.7108900124	a2
0.7108551619	adhd
0.7108444668	genotoxic
0.7108204986	infrared
0.7107766696	elicited
0.7107589351	carboxylase
0.7107479246	thalidomide
0.7107353475	haplotype
0.7107213516	black
0.7106948258	venlafaxine
0.7106514086	fisetin
0.7106231854	g2
0.7105760601	graphene
0.7105639728	labetalol
0.7105627316	binding modes
0.7105575019	bearing
0.7105340186	postoperative
0.7105240146	influences
0.7105240146	essentially
0.7105240146	spectral
0.7105182205	microvascular
0.7105182205	assessing
0.7105182205	surfaces
0.7105142029	pediatric
0.7105142029	successful
0.7105142029	naloxone
0.7105142029	randomised
0.7105109229	concentration response curve
0.7105069115	tunel positive
0.7104781475	nrf2
0.7104600779	colloidal
0.7104415238	pge2
0.7104341287	conjugation
0.7104151570	phosphodiesterase type
0.7103991712	ibuprofen
0.7103940451	kim 1
0.7103893522	mononuclear
0.7103732345	solubility
0.7103732345	eosinophils
0.7103597195	competitive inhibition
0.7103455145	left
0.7103378453	platelet derived growth factor receptor
0.7103185698	intense
0.7103147959	estrous
0.7101293261	lineage
0.7100179207	detailed
0.7099988655	migration and invasion
0.7099727610	proximal
0.7099438902	baicalein
0.7099438902	berberine
0.7099438902	dehydroepiandrosterone
0.7099438902	routine
0.7099194775	epithelial
0.7099110998	negative
0.7098981117	corticosteroid
0.7098708489	defects
0.7098620181	lateral sclerosis
0.7097399564	rs
0.7097251336	nmda receptor antagonist
0.7097251262	hypothalamus
0.7096631748	osteosarcoma
0.7096495855	protein protein interactions
0.7096103452	turnover
0.7095561573	lc ms
0.7094916892	sphingosine
0.7094855321	contrary
0.7094855321	antiplatelet
0.7094775285	bche
0.7094417780	pc
0.7094372475	rolipram
0.7093800930	salbutamol
0.7093138143	spectroscopic
0.7092566898	mucosa
0.7092476876	terfenadine
0.7092320215	hormones
0.7092245743	beta subunit
0.7092229571	adenoma
0.7092229571	dialysis
0.7092229571	clustering
0.7092205245	copper
0.7092140743	regression
0.7092020556	hepatitis
0.7092020556	myeloperoxidase
0.7092020556	quinidine
0.7092020556	tetrahydrobiopterin
0.7091843235	ambrisentan
0.7090752726	selective agonist
0.7090648622	curcumin
0.7090439637	etodolac
0.7090439637	shorter
0.7090376687	inflammatory bowel
0.7089934879	inflammatory responses
0.7089796276	glial
0.7089774899	molecular
0.7088876012	raloxifene
0.7088587481	sodium
0.7088583954	determinant
0.7088287147	ampk activation
0.7087579347	ppar alpha
0.7087335039	electric
0.7086955436	emerging
0.7086800567	ephedrine
0.7086297571	beneficial
0.7085878192	activators
0.7085807275	cis
0.7085671449	variant
0.7085103214	spine
0.7084902787	gamma
0.7084179794	placebo controlled trials
0.7084154413	cytoplasmic
0.7084084947	investigations
0.7084084947	earlier
0.7083486173	leptin
0.7083206617	memantine
0.7082889848	epsilon
0.7082889848	rifampicin
0.7082140486	adhesion molecule
0.7081321315	solid state
0.7081253561	phenelzine
0.7081223522	polyamines
0.7081177725	adjustment
0.7080894293	histological
0.7080491213	retention
0.7080180577	underlying mechanism
0.7080048285	basal
0.7079629574	cigarette
0.7079345657	collagen
0.7079221615	step
0.7078390393	drf 2655
0.7077873360	elimination
0.7077261510	relaxant
0.7077198293	alignment
0.7077014438	macrophages
0.7076645017	attenuation
0.7076415036	murine
0.7075460430	high glucose
0.7074993074	severe
0.7074934384	association
0.7074737192	pindolol
0.7074566073	pyramidal
0.7074396001	cumulative
0.7073996549	investigation
0.7073753795	considerable
0.7073514526	hybrid
0.7073424927	original
0.7073180167	golgi
0.7073062587	renin
0.7072651258	cox 2
0.7071781526	caspase activation
0.7071648791	intron
0.7071531778	jnk and p38
0.7071002461	ketorolac
0.7070673319	material
0.7070110372	branch
0.7070026015	carbon
0.7069817548	temperature
0.7069613744	ion
0.7069194852	diclofenac
0.7069179653	newly developed
0.7069052315	mitochondria
0.7067931177	melamine
0.7067931177	phenoxybenzamine
0.7067917491	lipids
0.7067897653	randomized
0.7067808543	adverse effect
0.7067644699	© 2013
0.7067594414	rna polymerase
0.7067443532	rosuvastatin
0.7066970175	metastatic
0.7066554341	equation
0.7066406594	measurements
0.7066122726	reverse
0.7065990095	cetirizine
0.7065843654	abciximab
0.7065843654	modafinil
0.7065807250	betaxolol
0.7065732412	major
0.7065495700	aggression
0.7065454518	rat stomach
0.7064702153	selectivity
0.7064676239	transfected cells
0.7064603731	nuclear
0.7064102744	botulinum
0.7063125991	carbetocin
0.7063104137	body wt
0.7062630734	beta1
0.7062517390	dasatinib
0.7062403620	exon
0.7062273783	colon cancer cells
0.7062159074	proposed
0.7062005467	multivariate
0.7061743372	lysosomal
0.7061614556	contractile response
0.7061464039	numerous
0.7061422982	experiments
0.7060663844	interplay
0.7060663844	effort
0.7060606411	at1 receptor antagonist
0.7060262869	metformin
0.7060247983	plasminogen
0.7060092870	bosentan
0.7059573990	multiple
0.7058684932	decline
0.7058500002	mglu receptor
0.7058393667	hypothesis
0.7058184098	vehicle treated
0.7057992361	purkinje cells
0.7057285174	statins
0.7056649832	synthesis
0.7056252104	dyslipidemia
0.7056252104	toxicities
0.7056252104	cisapride
0.7056252104	rescue
0.7056077460	mtorc1
0.7055628422	chiral
0.7055215189	phenylephrine
0.7055130761	ceramide
0.7054665563	cdb 4124
0.7054308683	films
0.7054308683	gemfibrozil
0.7054261737	chlorpheniramine
0.7054029808	striatum
0.7053751840	dld 1
0.7053153536	conclusion
0.7053028720	glycation
0.7052334089	commonly
0.7052260541	anterior
0.7052150890	evidence suggests
0.7051994286	antiproliferative effect
0.7051757387	duloxetine
0.7051173446	ciliary
0.7050864492	lipid
0.7050836664	dexamethasone
0.7050632923	age and sex
0.7050471301	thyroid carcinoma
0.7049302451	attempts
0.7049156765	atypical antipsychotic drugs
0.7048906708	improving
0.7048123353	eprosartan
0.7047746514	biphenyl
0.7047555734	bms 690514
0.7047463619	slices
0.7047293163	triglycerides
0.7047254696	postmenopausal
0.7047071365	ponatinib
0.7046884142	physicochemical
0.7046863706	sorafenib
0.7046551480	glycosylated
0.7046391246	interventions
0.7045959394	quercetin
0.7045685163	topo
0.7045387628	abl
0.7045033694	retinoid x receptor
0.7044928790	monkeys
0.7044837252	nicotinic
0.7044216053	cilostazol
0.7044019204	bms 354825
0.7043319429	captopril
0.7042816042	distension
0.7042594038	t1
0.7042088661	intensive
0.7042044067	neurotensin
0.7041879312	similar
0.7041526205	human hepatoma
0.7041418492	focused
0.7041161775	subsequently
0.7040840189	multi
0.7040638566	atrophy
0.7040638566	soybean
0.7040475550	significantly higher
0.7040366814	aimed to investigate
0.7039223855	quetiapine
0.7038933975	preliminary
0.7038112708	car
0.7038091258	tolcapone
0.7037570986	statistical
0.7037247183	da
0.7037145262	valdecoxib
0.7036397684	pde5
0.7036252044	complications
0.7036111061	lps induced
0.7035999769	neuronal damage
0.7035643480	anticancer drugs
0.7034925574	highest dose
0.7034769145	agonistic activity
0.7034436129	versus placebo
0.7034309898	impact
0.7034061055	theoretical
0.7034061055	adequate
0.7033501013	n ethylmaleimide
0.7033409097	docking studies
0.7033366930	glutamate release
0.7033217368	irreversible
0.7033107439	outcome
0.7032811904	ethanol withdrawal
0.7032772381	oocytes
0.7032345496	confocal
0.7032026873	ldh
0.7031882102	ix
0.7031464694	active metabolites
0.7030622762	amorphous
0.7030617843	muscarinic receptors
0.7030323918	controlling
0.7030235778	mutated
0.7029725773	mug
0.7029566073	access
0.7029481725	physostigmine
0.7029481725	retinaldehyde
0.7029481725	sedative
0.7029481725	titration
0.7029377909	elastin
0.7029100304	wb 4101
0.7029014929	omapatrilat
0.7028956247	coa carboxylase
0.7028307541	atomoxetine
0.7027525439	psychomotor
0.7027488709	thiazide
0.7027382365	hazard
0.7026718751	hif
0.7026624506	differences
0.7026498620	e cadherin
0.7026483000	plasma glucose
0.7026060371	poly
0.7025639205	virtual
0.7025633392	reduced glutathione
0.7025381044	probenecid
0.7025007838	theophylline
0.7024172499	allele
0.7023909995	energy metabolism
0.7023819856	coupling
0.7023665650	intracellular
0.7022969970	mathematical
0.7022832356	ms ms
0.7022010791	ach
0.7022005197	clinical outcome
0.7021756074	renal
0.7021359970	catalysis
0.7021359743	scaffolds
0.7021359743	deletions
0.7021053023	liver fibrosis
0.7020810897	apoa
0.7020199048	promoter activity
0.7020113978	significantly lowered
0.7019913148	insulin resistant
0.7019394690	factors
0.7019377956	therapeutic approaches
0.7019372203	forebrain
0.7018281921	characteristics
0.7018176333	dna
0.7017992935	vascular smooth muscle cells
0.7017745597	igf 1
0.7017678755	aminosalicylic acid
0.7017637421	rotation
0.7017637421	metals
0.7016808503	compound
0.7016803063	experimentally
0.7016803063	oregovomab
0.7016679313	editing
0.7015635024	entacapone
0.7015515569	cooperative
0.7015364011	project
0.7015360605	epithelial na
0.7014928790	nausea
0.7014928790	immunomodulatory
0.7014516754	minocycline
0.7014211211	mixed
0.7012492339	combinations
0.7012104000	selectively inhibit
0.7011153256	employing
0.7011153256	predictions
0.7011153256	electrically
0.7010977218	small
0.7010012200	biological
0.7009111882	limit
0.7009001412	c fos
0.7008966837	igf
0.7008891768	diets
0.7008526791	terminal
0.7008373566	coronary
0.7008254728	somatostatin
0.7008069407	luciferase reporter gene
0.7007712616	ns
0.7007351293	mucin
0.7007132338	cataract
0.7006714181	rabbit
0.7006348812	detemir
0.7005723314	glutathione conjugates
0.7005419666	chain acyl
0.7004959349	diazoxide
0.7004959349	toxicological
0.7004959349	proteomic
0.7004904235	sodium channel
0.7004897461	variants
0.7004457270	conventional
0.7004279292	iop
0.7004175878	vemurafenib
0.7003540006	immunohistochemical analysis
0.7003422111	uncoupling
0.7003422111	moclobemide
0.7003422111	reboxetine
0.7002963342	articular
0.7002963342	autoradiography
0.7002919709	aim
0.7002567957	hydroxylase
0.7002521973	volunteers
0.7002008387	ampa
0.7001159403	significantly decreased
0.7001077103	apoptosis induction
0.7000710449	v2
0.7000462880	ag
0.7000351722	cholesterol efflux
0.6999888646	beta2 adrenoceptor
0.6999824508	uvb
0.6999651724	dogs
0.6998837596	procainamide
0.6998831332	intolerance
0.6998705751	background
0.6998460421	peptide
0.6997957695	mutations
0.6997911815	ergotamine
0.6997491965	chromatin
0.6997416361	nr1
0.6995980824	ingestion
0.6995502369	therapeutic approach
0.6995362404	cultured rat
0.6994073894	androstane
0.6993959808	reporter assay
0.6993745746	gut
0.6993638793	mitogen
0.6993474252	localized
0.6992563705	lipid profile
0.6992294729	man
0.6991848331	astrocytes
0.6991777958	sulfonylurea receptor
0.6991604999	ether
0.6991468908	membrane
0.6991463559	epididymal
0.6991463559	proteolysis
0.6991463559	hydralazine
0.6991463559	sepsis
0.6991463559	centrally
0.6991463559	mimicking
0.6991463559	similarities
0.6991274477	blood
0.6991114992	abnormal
0.6990655663	reperfusion injury
0.6990449758	sections
0.6990333355	methyl group
0.6989751603	h1
0.6989082615	participants
0.6988584030	ritonavir
0.6988584030	ritodrine
0.6988584030	flecainide
0.6988306913	tuberculosis
0.6987584012	species differences
0.6987466595	mitochondrial
0.6987026108	transduction
0.6986774432	identification
0.6986695506	greater
0.6986549717	piroxicam
0.6986479300	respective
0.6985966233	β cell dysfunction
0.6985817343	blot analyses
0.6985754367	wnt
0.6985648350	ramelteon
0.6985582637	aspirin
0.6985373149	microglia
0.6985055673	soman
0.6985022041	ml kg
0.6984933313	pranlukast
0.6984682261	topoisomerase
0.6984678302	anion
0.6984495675	cleft
0.6984036473	beginning
0.6982836284	laser
0.6982527882	sms 201 995
0.6982273343	c57bl 6 mice
0.6981066564	pyridoxal
0.6980933953	rhesus
0.6980683991	emission
0.6979967538	at1
0.6979802331	serum
0.6979349916	receptor subtype
0.6979180996	significant improvement
0.6978940643	antifungal
0.6978940643	heterologous
0.6978940643	topically
0.6977842974	iv
0.6977159919	midazolam
0.6976836737	denufosol
0.6976823192	histamine release
0.6976152660	renin angiotensin
0.6976031835	immunity
0.6975086421	probe
0.6974623733	mph
0.6974357004	5 ht1a
0.6974238812	tomato
0.6974023591	triton
0.6973398089	hormone
0.6973279551	hek
0.6972956643	vinblastine
0.6972941434	receptor tyrosine kinase
0.6971772201	warfarin
0.6971717076	impairment
0.6971648059	analyses
0.6971151406	sympathetic
0.6971116381	epidemiological
0.6970756197	minor
0.6970192294	free
0.6969009901	medium
0.6968834931	abt
0.6968827872	alpha1
0.6968305921	sponge
0.6967741383	cytokine
0.6967721871	binding domain
0.6967337806	dr
0.6967026910	follicular
0.6966992628	alpha 1d adrenoceptors
0.6966844989	tone
0.6966632851	3h oxotremorine m
0.6966597978	collagen type
0.6965468624	introduction
0.6965439287	pcr and western blot
0.6965126010	transcriptional activity
0.6964797416	critical
0.6964327196	lu
0.6963395021	5 hydroxytryptamine
0.6963218585	skin
0.6963171074	incretin
0.6963171074	bumetanide
0.6962711299	composition
0.6962637292	ratio
0.6962516692	population
0.6962414050	unlike
0.6961771682	beta blocker
0.6960976995	ca2 + entry
0.6960787998	renal function
0.6960749511	peritoneal
0.6960569486	nilotinib
0.6960558108	clinical pharmacology
0.6960045487	hepatic
0.6959610618	pemetrexed
0.6959560543	contraceptive
0.6959352046	stimuli
0.6958189627	spectrum
0.6957430188	synergy
0.6957079155	adhesion
0.6956496127	nr2a
0.6956479680	beta hsd
0.6956191720	patient
0.6955759947	dosage
0.6955729045	raw
0.6955384498	omega
0.6954373705	management
0.6954205005	drospirenone
0.6954205005	mutational
0.6953776031	comprehensive
0.6953069083	cck
0.6952420243	subtypes
0.6952373352	beneficial effects
0.6952348812	market
0.6952212192	wistar
0.6952179514	multidrug resistance associated protein
0.6952119779	azole
0.6952035162	cox
0.6951950288	sea
0.6951455481	anesthetic
0.6950770535	plp
0.6950074686	presynaptic
0.6949569402	competition binding
0.6949462323	hela
0.6949461780	glucose
0.6949421741	ci
0.6948764778	phosphoinositide
0.6948407426	sensory neurons
0.6948116466	extended release
0.6947267444	monolayer
0.6947200201	clamp
0.6946687802	trp
0.6946066503	neuroinflammation
0.6946066503	neostigmine
0.6946033964	p gp
0.6945772904	cm
0.6945760738	statistically
0.6945746949	fluid
0.6945627823	mouse models
0.6945514512	rat liver
0.6944951529	tamoxifen
0.6944884491	galantamine
0.6944524043	ii
0.6944484458	ad
0.6944348252	pain
0.6943025295	cyp
0.6943004826	di
0.6942479307	disorders
0.6941965418	clinical
0.6941528840	propionic
0.6940875302	finasteride
0.6940797996	treated mice
0.6940549007	sds
0.6940135249	converting enzyme
0.6940088091	unchanged
0.6940067712	solute
0.6939939264	experimental design
0.6939907126	sham
0.6939577098	tramadol
0.6939310416	synthetic
0.6938859621	calcium
0.6938650281	sgc 7901
0.6938411160	alterations
0.6938287325	6 ohda
0.6938107248	danazol
0.6937813614	mepyramine
0.6937813614	evolutionary
0.6937232982	diagnostic
0.6935853918	apoptotic
0.6935792028	evn 50
0.6935619476	short chain
0.6935116116	adverse
0.6934854915	dimethyl
0.6934611028	strand
0.6934076032	disturbances
0.6934076032	phytochemical
0.6934076032	driving
0.6934076032	ultra
0.6932346121	nonsteroidal
0.6932293540	cd3
0.6932228242	reproduction
0.6931824753	airway inflammation
0.6931752953	accumulating
0.6931440648	creatine
0.6931022044	tight
0.6930727023	islet cell
0.6930530745	mcp 1
0.6930516432	diisocyanate
0.6928825326	intestinal
0.6928417006	metabolic pathways
0.6928326024	δ
0.6927500307	metabolic
0.6927415049	forward
0.6926584735	l oddc
0.6926289553	phasic
0.6926263809	response rates
0.6925754444	epigallocatechin
0.6925735651	resting
0.6925710313	lipocalin 2
0.6925288420	result
0.6925224040	physiological processes
0.6925159974	mg
0.6924999579	fibers
0.6924154374	smokers
0.6924080539	seed
0.6923881388	shuttle
0.6923881388	seasonal
0.6923881388	carboxylation
0.6923881388	glargine
0.6923881388	extrinsic
0.6923881388	buspirone
0.6923881388	separately
0.6923881388	cardiomyocyte
0.6923881388	fluvoxamine
0.6923881388	originally
0.6923881388	radicals
0.6923881388	negligible
0.6923881388	bioactivation
0.6923881388	hereditary
0.6923881388	phenobarbital
0.6923881388	stoichiometry
0.6923876979	excluding
0.6923876979	cooperativity
0.6923876979	guided
0.6923690698	carcinomas
0.6923644384	anticancer
0.6923360600	alpha 1a and alpha
0.6923103587	conduction
0.6922934588	making
0.6922597432	water
0.6922463948	treatments
0.6921957449	antiviral activity
0.6921326595	calmodulin
0.6920695080	heterocyclic
0.6920695080	closure
0.6920640692	ebastine
0.6920617958	bodies
0.6920617958	generalized
0.6920213375	organisms
0.6920121933	tissue distribution
0.6919870832	selegiline
0.6919745211	kinase inhibitor
0.6919493372	lox
0.6919398778	cutaneous
0.6917963035	cl l arg
0.6916484485	plasma
0.6915955177	drug release
0.6915324813	all trans retinoic acid
0.6914901859	species
0.6914679423	structurally
0.6914504209	comparisons
0.6914431633	arm
0.6914275074	effective
0.6914213483	mibefradil
0.6913905326	ar
0.6913743938	samples
0.6913667660	significant
0.6913420844	presentation
0.6913089805	sustained
0.6912932923	felodipine
0.6912641372	sec
0.6912336561	gallate
0.6911568425	st
0.6911537451	kinetic analysis
0.6910754008	high mobility
0.6910120865	led
0.6909975031	bile
0.6909703559	protects
0.6909696699	fever
0.6909689239	follicles
0.6909689239	goals
0.6909689239	elacridar
0.6909655880	cns
0.6909580039	ss
0.6908726300	fetal
0.6907428461	phenytoin
0.6906709997	non steroidal anti inflammatory drugs
0.6906648859	high
0.6906498562	alpha 1b
0.6906347364	suppress
0.6906290456	castration
0.6905843642	random
0.6905843642	supply
0.6905340496	c2
0.6904451056	calmodulin dependent
0.6904185212	evaluation
0.6903929687	translocation
0.6903928718	carbonyl
0.6903856515	macaque
0.6903853833	patterns
0.6902629230	specifically
0.6902257927	transport
0.6901125598	dioscin
0.6901125598	fetuses
0.6901125598	deoxy
0.6900222911	corpus
0.6900135055	apical
0.6899878279	cpt
0.6899837247	application
0.6899704722	freshly
0.6899398160	capacity
0.6899182790	pi3k akt signaling
0.6899034164	neuroblastoma cells
0.6898830394	anti
0.6898133029	therapeutic strategy
0.6898056396	prevalence
0.6897646288	selective
0.6897277272	epithelial cell line
0.6896544210	efficacy and tolerability
0.6896516930	weight
0.6896409608	nutritional
0.6896004055	nitrite
0.6896004055	femoral
0.6896004055	neuroleptic
0.6896004055	condensation
0.6895426782	sulfonylureas
0.6895260816	fibrinolysis
0.6894544914	receptor antagonists
0.6894427627	substrates
0.6894229780	fruits
0.6894217012	peak
0.6893787675	discovery
0.6893488222	gst
0.6893472324	ed50
0.6893217723	isolated
0.6892691553	encephalopathy
0.6892691553	helices
0.6892350027	enzymatic activity
0.6892297393	retinopathy
0.6892291677	selective antagonist
0.6891415706	total
0.6891107911	palmitate
0.6891107911	sirolimus
0.6890969500	trophic
0.6890580553	baseline values
0.6890326044	phosphatase
0.6889980631	ions
0.6889757554	regimen
0.6889701299	rats
0.6889643085	cd8
0.6889614446	zone
0.6889209274	sod
0.6888808287	hyaluronan
0.6888789531	opioid
0.6888384857	glycans
0.6888384857	applying
0.6888384857	immunological
0.6888384857	doxycycline
0.6888384857	intermittent
0.6888384857	crystals
0.6888384857	heterogeneous
0.6888384857	keratinocyte
0.6888384857	striking
0.6888384857	live
0.6888384857	edrophonium
0.6888384857	imipramine
0.6888370261	snap 25
0.6887955836	nsaids
0.6887926011	hypermethylation
0.6887926011	concurrent
0.6887891586	rp
0.6887004917	behavioral effects
0.6886078459	cannabinoid receptor
0.6886002120	animals
0.6885494519	issue
0.6885272798	targeting
0.6883340950	acetylcholinesterase inhibitors
0.6882865330	gastrin
0.6882865330	ovariectomized
0.6882865330	arformoterol
0.6882865330	diuretics
0.6882803586	puerarin
0.6882775799	analysis revealed
0.6882251355	apoptosis
0.6882156076	antitumor agents
0.6881702494	cynomolgus
0.6881579235	deprivation
0.6881410618	5 ht1d
0.6881341092	histopathological
0.6880599848	mediate
0.6880480212	liver
0.6880198085	blockers
0.6879926614	frequently
0.6879190923	milk
0.6879190923	face
0.6879155133	ring
0.6878971448	diffuse
0.6878864072	reflex
0.6878719286	cardiovascular
0.6878489710	sulfur
0.6878171793	fit
0.6877814126	5 ht1
0.6877744646	tolbutamide
0.6877744646	disodium
0.6877744646	permanent
0.6877225297	highlight
0.6876754699	arrhythmias
0.6875779310	disrupt
0.6875353178	gh
0.6875017554	complement
0.6875017554	mimetic
0.6875017554	albeit
0.6875017554	schedule
0.6874888439	phospholipid
0.6874888439	depleted
0.6874888439	phases
0.6874789857	polyphenols
0.6874593821	nitro l arginine
0.6874039147	cysteinyl
0.6873956127	sera
0.6873698649	transitions
0.6873206064	circulation
0.6872654679	peroxidase
0.6871908637	5 ht2
0.6871403970	confer
0.6871246776	g protein coupled receptor
0.6869841636	appetite
0.6869749753	conductance
0.6869626856	detection
0.6869351552	igfbp
0.6869288219	inducers
0.6869288219	overweight
0.6869288219	diazepam
0.6869288219	sulfonamide
0.6869288219	pooled
0.6869203943	x ray
0.6869174994	curve
0.6869025157	optimization
0.6868164902	cognition
0.6868164902	lethal
0.6868069362	kcnq2
0.6867829616	raised
0.6867516670	ischemia reperfusion injury
0.6867306711	amino groups
0.6867239609	diesel
0.6867074143	iloprost
0.6866933914	spermine
0.6866867933	insulin
0.6866778311	fos
0.6866233224	calorie
0.6865928706	lymphocyte
0.6865855206	clinically significant
0.6865800568	pressure
0.6865269956	chromatographic
0.6865269956	epicatechin
0.6865218730	nac
0.6864970980	organ
0.6864769455	junctions
0.6864612042	primary
0.6864186539	allosteric site
0.6864087016	np
0.6863634219	cgp
0.6863415110	post transcriptional
0.6862997685	loss
0.6862540382	heart disease
0.6862227128	epinephrine
0.6862227128	specimens
0.6862227128	pesticide
0.6861960927	vegfr
0.6861399987	auc
0.6861320191	cho
0.6860900061	biomarkers
0.6860445694	similarly
0.6859552121	twik 2
0.6859062619	purified
0.6858489939	aid
0.6857462425	complexes
0.6856892800	metabolically
0.6856243378	nf κb activation
0.6856217242	infection
0.6855997612	functional
0.6855896545	dependently inhibited
0.6855817292	superfamily
0.6855777801	epa
0.6855770505	phenylbutazone
0.6855734849	compromised
0.6855734849	subtle
0.6855734849	tension
0.6855734849	chicken
0.6855734849	lovastatin
0.6855734849	nociceptive
0.6855734849	prodrugs
0.6855734849	oocyte
0.6855734849	limits
0.6855734849	inactivating
0.6855734849	homogeneous
0.6855734849	mimics
0.6855734849	fourth
0.6855734849	flurbiprofen
0.6855734849	impairments
0.6855734849	insertion
0.6855734849	export
0.6855734849	glaucoma
0.6855734849	abilities
0.6855734849	multicenter
0.6855643405	wt mice
0.6855381366	pan
0.6854782902	catalpol
0.6854492489	methanol
0.6854492489	distance
0.6854492489	simulation
0.6854492489	ovalbumin
0.6854492489	quantitatively
0.6854492489	chronically
0.6854253380	gp330
0.6854121345	density
0.6854068389	osteoblasts
0.6853884483	pharmacokinetic properties
0.6853202165	immunoreactive
0.6853024629	frame
0.6853012827	angle
0.6852988907	varied
0.6852988907	physiologic
0.6852774873	fast
0.6852676347	buffer
0.6852455260	antisense
0.6852409971	beta 1 adrenoceptor
0.6851784950	metalloproteinase
0.6851637841	glycemic
0.6851478277	reuptake
0.6851394411	stereoselective
0.6851394411	clinicians
0.6851394411	practical
0.6851394411	diarrhoea
0.6850867593	hypoglycemia
0.6850867593	lowest
0.6850749264	differentiation
0.6850656267	therapeutic strategies
0.6850124819	notably
0.6849959192	catalytic site
0.6849748555	rice
0.6849472953	ts
0.6849378489	menadione
0.6849200926	upstream
0.6849200926	sensitized
0.6849120044	op
0.6849104921	low
0.6848685759	potent
0.6848067368	orlistat
0.6847947706	beta amyloid
0.6847425594	muscarinic m2 receptor
0.6847110498	comparison
0.6846987081	il 11
0.6846818429	hne
0.6846746706	ng
0.6846552980	depressed patients
0.6846533620	cholinesterase inhibitors
0.6846084232	equally
0.6845961146	dna damage response
0.6845570628	therapeutic
0.6844745111	protocol
0.6844266764	retinal
0.6844124023	significantly increased
0.6843961511	cytochrome p450 enzymes
0.6843820236	muscle
0.6843804481	glucose metabolism
0.6843584334	studies
0.6843536817	pla
0.6843489141	endogenous
0.6843426089	transfected
0.6843364083	wild type and mutant
0.6843273363	outcomes
0.6843273363	reveals
0.6843014591	functionally
0.6842480244	compounds
0.6842345417	mid
0.6841058911	norepinephrine transporters
0.6841024579	zn
0.6840769011	xenobiotic
0.6840751496	glioblastoma
0.6840321741	change
0.6839990331	relationship
0.6839462376	cardiomyocytes
0.6839280244	cycles
0.6839280244	stimulant
0.6839197839	sons
0.6838791108	taste
0.6838566781	collection
0.6837810008	cyclophosphamide
0.6837577138	lactation
0.6836910213	pyrimidine
0.6836378817	stabilized
0.6836378817	chemokines
0.6836378817	adaptation
0.6836378817	antithrombin
0.6836378817	saturated
0.6836203991	5 ht7
0.6836148055	lp
0.6836143341	steroidogenesis
0.6836083773	velocity
0.6836068078	overlapping
0.6836068078	albino
0.6836068078	glucokinase
0.6836068078	polarization
0.6836068078	dihydroxy
0.6836068078	perturbations
0.6836068078	herbicide
0.6836068078	osmotic
0.6836068078	duodenal
0.6836068078	differently
0.6836068078	reabsorption
0.6835764583	animal model
0.6835147897	uterine
0.6834990331	oxygen
0.6834837996	tryptamine
0.6834780626	herg channels
0.6834557111	vector
0.6834525949	membrane potential
0.6834284840	nf
0.6833868728	medicines
0.6833868728	hypotension
0.6833868728	duplication
0.6833859825	display
0.6833750508	bax
0.6833406857	ga
0.6833268230	acceptor
0.6833268230	fruit
0.6833242361	h9c2
0.6833175066	clinical development
0.6833103422	astemizole
0.6832540522	gnrh receptor
0.6832291001	interpretation
0.6832267101	antipsychotic drugs
0.6832074832	dextromethorphan
0.6831774732	phosphorylase
0.6831668598	tert
0.6831554835	dha
0.6830421619	deficiency
0.6830128816	solution structure
0.6829859545	dye
0.6829620849	clusters
0.6829308000	adult male
0.6829102250	carcinoma
0.6828713622	metoprolol
0.6828713622	proper
0.6828713622	microglial
0.6828713622	discrimination
0.6828713622	blunted
0.6828713622	chemopreventive
0.6828669661	opposite effects
0.6828481590	pec
0.6828308929	stromal cells
0.6827966040	high performance liquid
0.6827406492	na
0.6827400805	t bet
0.6827228955	force
0.6826759788	axis
0.6826686563	pups
0.6826686563	morning
0.6825941161	vectors
0.6825941161	leaf
0.6825941161	hyponatremia
0.6825941161	log
0.6825941161	digestion
0.6825941161	microtubules
0.6825655574	controversial
0.6825655574	vasoconstriction
0.6825280244	substitutions
0.6825280244	continued
0.6825280244	accurate
0.6825280244	impair
0.6825269521	ryanodine
0.6825098760	laboratory
0.6825075720	spermidine
0.6824706337	germ
0.6824706337	episodic
0.6824653232	necrotic
0.6824423553	accelerated
0.6824008442	suramin
0.6823492129	nuclear receptors
0.6823400325	mn
0.6823294588	timolol
0.6823189252	precursors
0.6822918854	flutamide
0.6822918854	leflunomide
0.6822310096	efficacy
0.6821917108	randomly divided into
0.6821671025	exposure
0.6821525910	data
0.6821447774	pesticides
0.6821434688	reactivators
0.6821434688	encapsulated
0.6821434688	acidification
0.6821434688	peroxynitrite
0.6821434688	pyridine
0.6821397907	motility
0.6821171695	mode of action
0.6820983688	structure
0.6820967810	rich
0.6820522585	spleen
0.6820356662	minute
0.6820104812	muller cells
0.6820083189	impairs
0.6820083189	childhood
0.6820083189	slight
0.6820083189	fertility
0.6820083189	airways
0.6820083189	surfactant
0.6820083189	vertebrate
0.6820083189	sertraline
0.6820001319	immunosuppressive
0.6819928734	hs
0.6819866947	synaptic
0.6819749271	addiction
0.6819742326	conversely
0.6819687823	hemorrhage
0.6819647754	transcription
0.6819407434	lens
0.6819407434	cyano
0.6819107577	guidelines
0.6819107577	monomeric
0.6819107577	ameliorates
0.6819107577	sheep
0.6819107577	adenovirus
0.6819107577	etorphine
0.6819107577	peroxisomal
0.6819107577	prolyl
0.6819107577	ligation
0.6819107577	prevalent
0.6819107577	enable
0.6819107577	enrolled
0.6818818238	stroke
0.6818514359	severely
0.6818514359	proapoptotic
0.6818514359	pathophysiological
0.6818065731	palate
0.6817707703	infertility
0.6817707703	counter
0.6817707703	mitotic
0.6817707703	mesolimbic
0.6817636886	bromide
0.6817442174	speed
0.6817255958	gain of function
0.6816963764	lipid accumulation
0.6816371451	premature
0.6815995894	band
0.6815698285	localization
0.6815587561	attenuates
0.6815492980	mechanisms
0.6815374779	leads
0.6815123446	east
0.6815115072	south
0.6814992138	lipid homeostasis
0.6814969826	orphan
0.6814761543	obese women
0.6814437913	immunoreactivity
0.6814272283	ns 49
0.6814128514	trials
0.6814110658	valine
0.6814110658	medullary
0.6814110658	milrinone
0.6814110658	antioxidative
0.6813762619	photoreceptor
0.6813674065	opening
0.6813376707	calpain
0.6813321752	lapatinib
0.6813252005	nuclear receptor
0.6813036834	background and purpose
0.6811773798	clonal
0.6811683704	transporter
0.6811488412	vessel
0.6811488412	solvents
0.6811408114	butyl
0.6810438504	infections
0.6810222973	results
0.6810167237	preincubation
0.6810087936	fixed
0.6810087936	covalently
0.6809731907	hd
0.6809724254	granule
0.6809664872	haplotypes
0.6809605025	acrolein
0.6809395870	effectors
0.6809395870	indole
0.6808454783	late stage
0.6808452568	thymidylate
0.6808406793	lysine residues
0.6808406527	department
0.6807952340	salmeterol
0.6807282433	isolates
0.6807282433	antibiotics
0.6806887684	unfolding
0.6806530076	clot
0.6806474591	aromatase inhibitor
0.6806013528	dobutamine
0.6806013528	ubiquitination
0.6806013528	dilation
0.6806013528	chamber
0.6806013528	optimum
0.6806013528	antagonize
0.6806013528	deduced
0.6806013528	irradiated
0.6806013528	glycerol
0.6805825467	length
0.6805725995	benzyl
0.6805462158	bicalutamide
0.6805462158	eosinophilia
0.6805462158	oxymetazoline
0.6805366249	triad
0.6805183541	study
0.6805058770	ct
0.6804686318	collectively
0.6804503210	findings
0.6804266504	triple
0.6804052279	dopa
0.6804008442	fulvestrant
0.6803770233	based
0.6803615259	gabapentin
0.6803588391	diphenyl
0.6803360729	pka
0.6802860490	early
0.6802853221	phe
0.6802746155	birth
0.6802705047	erk1 2
0.6802141679	myelin
0.6801692254	cytoprotective
0.6801692254	fewer
0.6801661231	mitogenic
0.6801661231	tagged
0.6801627520	polymers
0.6801627520	variables
0.6801624334	derivatives
0.6801540444	adrenergic
0.6801371185	days
0.6801363255	transferrin
0.6801220289	clearance
0.6801196434	b2
0.6801095838	gtp
0.6800986063	murine model
0.6800985628	protective effects
0.6800596271	pharmacokinetic parameters
0.6800265647	copd
0.6799963316	reactive oxygen
0.6799341457	resonance
0.6799296468	l dopa
0.6798411215	subsequent
0.6798250735	energy transfer
0.6797936772	everolimus
0.6797386551	likewise
0.6797362409	adrenoceptor antagonists
0.6797230772	inactivation
0.6797105096	pollutants
0.6797105096	ascending
0.6797105096	dissolved
0.6796461590	in situ hybridization
0.6796356662	en
0.6796138169	native
0.6796079692	korean
0.6795958796	bb
0.6795905362	mice fed
0.6795753200	phentolamine
0.6795753200	agonism
0.6794814978	oxidative
0.6794785255	active
0.6794626112	omeprazole
0.6794624666	cd
0.6794357974	bpa
0.6794217478	onset
0.6794210445	purine
0.6793416399	mutant
0.6793305840	tnf alpha production
0.6793221637	number
0.6792745780	nuclear factor kappa b
0.6792690522	striatal neurons
0.6792394781	fatty
0.6792201829	histology
0.6791936792	serotonergic
0.6791881216	mglu2
0.6791621674	exhibiting
0.6790964115	osteoclast
0.6790860368	chemosensitivity
0.6790676570	mb
0.6790366803	herb
0.6790366803	adulthood
0.6790366803	layers
0.6790366803	saturable
0.6789966242	replacement therapy
0.6789660048	sirt1
0.6789565975	cyp2e1
0.6789489372	ca
0.6788986018	intoxication
0.6788910335	protective
0.6788781364	dihydrotestosterone
0.6788765193	kidney
0.6788744739	caudate
0.6788102245	human umbilical
0.6788079328	gefitinib
0.6787789243	particulate
0.6787789243	evaluating
0.6787789243	normotensive
0.6787756913	sh
0.6787316168	lac
0.6787140362	ulcer
0.6787140362	methylene
0.6786737290	switch
0.6786718677	tumor
0.6786699682	chemoprevention
0.6785714257	hydrogel
0.6785714257	binary
0.6785714257	chemotaxis
0.6785714257	undergoes
0.6785714257	remaining
0.6785714257	predicts
0.6785714257	locally
0.6785714257	adiposity
0.6785714257	preventive
0.6785714257	atenolol
0.6784896368	organophosphorus compounds
0.6784746486	healthy
0.6784684857	tyrosine kinase inhibitors
0.6784620062	alkaloids
0.6784620062	carcinogenic
0.6784620062	partner
0.6784620062	pharmacophore
0.6784481720	gain
0.6784337165	american society for
0.6783210268	mevalonate
0.6783123938	autism
0.6783111864	high dose
0.6782590691	class ii
0.6781781965	panx1
0.6781642734	rhoa
0.6781418023	tunel
0.6781381269	vascular endothelial growth factor receptor
0.6781310812	tubulin
0.6780859879	glass
0.6780791541	venom
0.6780300689	radioresistance
0.6780127849	methotrexate
0.6779838726	pkc
0.6779470892	eosinophil
0.6779442141	cyp1a1
0.6779413240	gal
0.6779337415	3 hydroxy 3 methylglutaryl coenzyme
0.6778868508	hepatic uptake
0.6778782890	twik 1
0.6778322757	lymphatic
0.6778123596	real time quantitative
0.6778064497	pleiotropic
0.6777988114	ne
0.6777819046	ac
0.6777225661	asian
0.6776986238	flavonoid
0.6776986238	presents
0.6776986238	risks
0.6776986238	retained
0.6776986238	concomitantly
0.6776986238	increasingly
0.6776902769	glutamatergic
0.6776839281	donor
0.6776652089	helical
0.6776608606	synovial cells
0.6776390978	modulating
0.6775109292	hplc
0.6774752360	ferric
0.6774702664	brain
0.6774655464	e1
0.6774201170	regulate
0.6773994773	fraction
0.6773590118	egf receptor
0.6773588726	ammonium
0.6773472084	neutral
0.6773165305	activating mutations
0.6772983419	pyrazole
0.6772834105	objectives
0.6772493159	venous
0.6772403001	hsd
0.6772049520	bone marrow derived
0.6771175012	gs
0.6771153117	human hepatocytes
0.6770821109	alkaloid
0.6770791924	nutrient
0.6770715851	biosynthesis
0.6770606120	elicits
0.6770606120	achieving
0.6770606120	prophylaxis
0.6770606120	dark
0.6770606120	architecture
0.6770606120	issues
0.6770483163	wide
0.6770303082	prepulse
0.6770259985	carboxyl
0.6770259981	metastases
0.6770259981	platinum
0.6769516299	elisa
0.6768793251	mycobacterium
0.6768738799	surprisingly
0.6768735239	nonspecific
0.6768735239	indices
0.6768210175	brains
0.6768210175	microparticles
0.6768210175	carcinogens
0.6768089088	5 ht3
0.6767939133	closed
0.6767822905	enrichment
0.6767822905	cilazapril
0.6767434709	prodrug
0.6767405380	cetuximab
0.6767269290	abcg2
0.6766859719	thp
0.6766546752	monoamine
0.6765852249	dose dependent
0.6765811452	column
0.6765632214	ala
0.6765187971	rt
0.6764727026	leu
0.6764400435	p450 enzymes
0.6764248486	furosemide
0.6764088563	diet
0.6763689232	mrp2
0.6762435147	treated group
0.6762287113	recognition
0.6761926984	fluorescein
0.6761885843	theory
0.6761599406	gene therapy
0.6761482867	fumarate
0.6761468067	fine
0.6761132525	cyp2d6
0.6760996212	cycloheximide
0.6760791767	harmaline
0.6760283499	pxr
0.6760166895	ec50 values
0.6760157900	functional characterization
0.6759906019	keratinocytes
0.6759531470	trilostane
0.6759468917	leaving
0.6759468917	coefficient
0.6759177416	elderly
0.6759012173	ml min
0.6758774933	capture
0.6758518198	mr
0.6758510616	freeze
0.6758471490	menthol
0.6758049468	countries
0.6757477789	clomipramine
0.6757268559	glioma cells
0.6757264656	hd patients
0.6756859391	anp
0.6756808520	weakly
0.6756808520	preserved
0.6756808520	experience
0.6756808520	biosynthetic
0.6756808520	inhalation
0.6756808520	intravenously
0.6756644847	markedly reduced
0.6756419878	nos
0.6756069818	irinotecan
0.6755943367	rhythms
0.6755943367	vegetables
0.6755719638	drug
0.6754493732	fp
0.6753315041	sb
0.6752911106	mdma
0.6752753938	supplement
0.6752545335	variation
0.6752395523	anxiolytic
0.6752395523	radiolabeled
0.6752395523	percent
0.6752302389	kat
0.6752205413	prepared
0.6752117630	sar
0.6751275494	streptokinase
0.6751187324	positive
0.6751160153	sequence
0.6750757132	estimates
0.6750757132	ulcers
0.6750663575	ache
0.6750426372	segments
0.6750426372	subcellular
0.6750092180	ventricle
0.6748308306	rat
0.6748058044	death
0.6747948068	nk
0.6747878021	gc
0.6747718283	statin
0.6747525628	intrathecal
0.6747525628	ambenonium
0.6747525628	amiodarone
0.6747237844	isotope
0.6747237844	nerves
0.6747136802	tyr
0.6746863905	proliferating
0.6746519615	reversible
0.6746330159	parp
0.6746284336	pth
0.6745570396	myc
0.6744812537	reconstitution
0.6744787024	experimental approach
0.6744561930	norethisterone
0.6744498884	synthesize
0.6744136221	desaturase
0.6744136221	fatal
0.6743868626	tablets
0.6743868626	chlorpromazine
0.6743868626	accumulated
0.6743486470	dry
0.6743424483	methoxyphenyl
0.6743401263	p300
0.6743147493	hypoglycaemia
0.6743140720	tocopherol
0.6742971963	dose dependent fashion
0.6742970967	undergo
0.6742740695	bw
0.6742691397	excitatory
0.6742532622	prophylactic
0.6741866995	ataxia
0.6741533625	proliferation
0.6741291287	types
0.6740915307	ribavirin
0.6740781502	amylin
0.6740713020	abnormalities
0.6740623743	cu
0.6740575228	placenta
0.6740550788	glyoxylate
0.6740523123	auranofin
0.6740097763	lowering
0.6739898177	generation
0.6739605928	hydrogen
0.6739097615	pge
0.6738901057	rat brain
0.6738553596	pam
0.6738373661	recently discovered
0.6738151678	nuclear localization
0.6738106778	sensitizers
0.6737802844	probes
0.6737136524	carcinogenesis
0.6737136524	malignancies
0.6737061416	ch
0.6736771029	obstructive
0.6736313909	toxicity
0.6736117172	postsynaptic
0.6735986531	pathology
0.6735975678	pk
0.6735767825	calcium dependent
0.6734895601	atm
0.6734668892	anti obesity
0.6734217054	eralpha
0.6733700458	p glycoprotein
0.6733283139	generated
0.6732567576	space
0.6732504695	epidermis
0.6732504695	pyrrolidine
0.6732504695	subchronic
0.6732504695	cannabinoids
0.6732504695	sampling
0.6732504695	phencyclidine
0.6732504695	databases
0.6732504695	pyridinium
0.6732390678	daily
0.6732228805	concern
0.6731949726	physiological functions
0.6731466455	canonical wnt
0.6731450003	kg body weight
0.6731267529	gender specific
0.6730798419	medulla
0.6730550958	anti inflammatory properties
0.6729838980	cyp3a4
0.6729380531	erythrocytes
0.6729313376	p27
0.6729276570	additionally
0.6728289186	viral
0.6727947756	substances
0.6727947756	influx
0.6727906235	cb
0.6727725266	mg daily
0.6727582318	methacrylate
0.6727218811	kappa opioid
0.6726871694	melting
0.6726871694	bilayer
0.6726689439	lysyl
0.6725885664	fragments
0.6725664794	determinants
0.6725565513	standard
0.6725019266	nuclei
0.6724940490	trypsin
0.6724791649	relevance
0.6723219432	rar beta
0.6722076403	pde
0.6722017700	master
0.6722017700	detachment
0.6721664795	beta 2 adrenoceptor
0.6721292099	glucan
0.6721292099	azide
0.6721292099	nocturnal
0.6721207015	medication
0.6721207015	scaffold
0.6721058176	fibrinolytic
0.6720751959	abstract
0.6720703739	induced tachycardia
0.6720300836	therapeutic intervention
0.6719984648	cromolyn
0.6719727288	inflammatory
0.6719716008	devices
0.6719716008	destruction
0.6719373067	dermal
0.6719324184	apixaban
0.6719311359	magnetic resonance
0.6719084390	diphosphate
0.6718995098	cocaine
0.6718069901	gsh levels
0.6717993956	paracetamol
0.6717954898	main outcome
0.6717469400	promotes
0.6717094384	enantiomers
0.6716951735	free medium
0.6716489641	retinoic acid receptor
0.6716283346	lo
0.6716064326	model
0.6715953980	self
0.6715900644	magnesium
0.6715712060	crosstalk
0.6715074510	bp
0.6714843445	epidermal
0.6714563274	trpa1
0.6714184348	sp
0.6713449649	adapalene
0.6713403439	solution
0.6711970881	fas ligand
0.6711342599	bmi
0.6711096792	regions
0.6710949679	modulation
0.6710893386	scores
0.6710209402	inhibitory effects
0.6710092279	strongly suggest
0.6710052331	score
0.6709731105	higher
0.6709647237	sk
0.6709137603	naturally
0.6708815140	diet induced obesity
0.6708725855	9 hydroxyrisperidone
0.6708236453	acetyltransferase
0.6707094384	pore
0.6707084028	antioxidant properties
0.6707067530	models
0.6706958033	caspase 9
0.6706926289	anesthesia
0.6706898273	interestingly
0.6706870075	differential effects
0.6706811346	lower
0.6706533198	bms
0.6706150086	11beta
0.6705799947	reducing
0.6705675078	apoe
0.6705300499	aa
0.6704810998	ca3
0.6704597029	hip
0.6704549763	regulated
0.6704177891	evaluate
0.6703891196	algae
0.6702503580	multifunctional
0.6702503580	ultrasound
0.6702503580	levobunolol
0.6702503580	enoxaparin
0.6702462999	spindle
0.6702389708	gating
0.6701954682	hydroxyzine
0.6701954682	connexin
0.6701954682	hyperammonemia
0.6701954682	injectable
0.6701954682	polymeric
0.6701729049	malignant
0.6701687543	p50
0.6699886826	human lung
0.6699745330	calcium homeostasis
0.6699689370	dna binding
0.6699406296	mifepristone
0.6698977061	signal
0.6698492249	centered
0.6698335662	amprenavir
0.6698319102	code
0.6698319102	filament
0.6698319102	powder
0.6698319102	envelope
0.6698125094	par
0.6697980456	fidelity
0.6697980456	assisted
0.6697956726	reverse transcription
0.6697756061	cross
0.6697431467	haloperidol
0.6696719353	drug interaction
0.6696505057	muscular
0.6696399493	sc
0.6696163882	intact
0.6695878179	strong
0.6695252544	designed and synthesized
0.6694455506	ip
0.6694322322	exact
0.6694265796	executive
0.6694193676	significantly greater
0.6694157601	crystal
0.6693929206	ra
0.6693701732	university
0.6693578675	biological functions
0.6693142660	hr
0.6693129909	gsk 3
0.6693025942	measures
0.6693006458	bdnf
0.6692967294	single doses
0.6692651357	volume of distribution
0.6692156689	target
0.6691647152	subgroup
0.6691647152	hot
0.6691304136	sunitinib
0.6691247948	peg
0.6691183013	oral administration
0.6690990632	indicator
0.6689855454	major metabolite
0.6689462112	lubiprostone
0.6689320681	experimental models
0.6689242079	bbb
0.6689084073	uptake
0.6689065851	braf
0.6688466477	inos induction
0.6688154242	phase iii clinical trials
0.6687859780	highly
0.6687290410	pparγ
0.6686838863	improvements
0.6686822384	interleukin 6
0.6685760590	radix
0.6685356426	human placental
0.6685279981	gip
0.6685235976	pd
0.6685162976	estrogen receptor alpha
0.6684938541	classic
0.6684229865	pi
0.6683720705	u937 cells
0.6683627404	brugada
0.6683256119	cellular
0.6682870658	5 ht6
0.6682583099	olive
0.6682578645	transduced
0.6682578645	resultant
0.6682578645	bulky
0.6682578645	peroxisomes
0.6682578645	prejunctional
0.6682578645	bifunctional
0.6682578645	bioassay
0.6682578645	traffic
0.6682578645	papillary
0.6682578645	notable
0.6682578645	differing
0.6682578645	dihydroergotamine
0.6682578645	gels
0.6682578645	carcinogen
0.6682578645	haemodynamic
0.6682578645	initiating
0.6681955266	disorder
0.6681665415	bevantolol
0.6681288963	dyskinesia
0.6680595163	proinsulin
0.6680138660	methods
0.6680111444	dat
0.6680034386	enzyme
0.6679763012	κ
0.6679638776	tpa
0.6679381259	bmp
0.6679338825	fuel
0.6679338825	pigment
0.6679104189	esters
0.6678968055	officinalis
0.6678900637	pc3
0.6678510077	serotonin reuptake
0.6678052544	covered
0.6677477371	cystathionine
0.6677257447	pseudoephedrine
0.6677119454	growth
0.6677016070	thoracic
0.6676945860	doi
0.6676675211	ova
0.6676627831	dpp 4
0.6676067767	cancer cells
0.6675573372	tata
0.6675539326	angiogenesis
0.6675479535	endothelial
0.6675043105	bartter
0.6674763632	molar
0.6674119114	lesions
0.6673812819	secretase
0.6673524094	meloxicam
0.6672615890	signal transduction pathways
0.6671936270	arabidopsis
0.6671897242	substituted
0.6671747809	nsaid
0.6671636133	presenting
0.6671614766	snap
0.6671318520	folate
0.6671300034	significantly improved
0.6670999235	hca
0.6670839801	simulated
0.6670795898	cos 7 cells
0.6670780120	obese mice
0.6670474790	atherosclerotic
0.6670474790	inside
0.6670164818	finally
0.6670000390	cell cultures
0.6669839185	factor
0.6669411594	ps
0.6668636736	pharmacological profile
0.6668523531	icd
0.6667789769	agonists
0.6666881952	endothelial no synthase
0.6666831863	authors
0.6666140316	e3
0.6665926349	lewis
0.6665675663	trail
0.6665253403	sensitive potassium
0.6664926031	crucial role
0.6664910640	8 oxog
0.6664771342	dose
0.6664389621	net
0.6664373221	g2 m phase
0.6664356500	dex
0.6664324201	downstream
0.6664255864	ppargamma
0.6663515433	modulate
0.6663207007	pkb
0.6662121397	expression pattern
0.6661608785	oxysterol
0.6661608785	lisuride
0.6661608785	submaximal
0.6661257482	extensively studied
0.6661131696	media
0.6660504072	closely related
0.6660491095	rooibos
0.6660354440	amino
0.6660352433	m1
0.6659821813	ob
0.6658872338	predicted
0.6657365392	withdrawal
0.6657335887	individual
0.6657104022	human
0.6655868358	extracts
0.6655825144	thrombocytopenia
0.6655825144	community
0.6655825144	rigid
0.6655755008	limiting step
0.6655720397	fc
0.6655290337	erectile
0.6654444356	gene promoter
0.6654306788	amphetamine
0.6654118844	gstm1
0.6653965331	ef
0.6653040401	interfering rna
0.6652918837	tertiary
0.6652628785	signalling pathways
0.6652425443	hyperhomocysteinemia
0.6652087503	alpha 1 adrenoceptors
0.6651630832	anagliptin
0.6651172877	heparins
0.6650977807	fabry
0.6650975671	silibinin
0.6650830919	overload
0.6650150508	gr
0.6649274831	quinacrine
0.6648956414	population based
0.6648807776	tk
0.6648586423	silent
0.6648377272	app
0.6648347774	reagent
0.6648347774	freshwater
0.6648347774	economic
0.6648347774	naltrexone
0.6648347774	articles
0.6648347774	preeclampsia
0.6648347774	incomplete
0.6648347774	paired
0.6648347774	mesencephalic
0.6648347774	uracil
0.6648347774	sum
0.6648288476	reuptake inhibitor
0.6647420236	cotransporter
0.6645417632	mir 21
0.6645372308	corticosterone
0.6645306634	internal
0.6644664625	asa
0.6644531583	analgesic
0.6644072497	peripheral tissues
0.6643351741	ene
0.6643351741	rauwolscine
0.6643295564	cpa
0.6643069093	survey
0.6643069093	mianserin
0.6643069093	inosine
0.6643069093	hyperinsulinism
0.6643069093	sulfated
0.6643069093	reserpine
0.6643069093	chloroethylclonidine
0.6642986772	late
0.6642938725	deprenyl
0.6642844547	17beta
0.6642714572	cytosolic
0.6642582831	nf kappa b
0.6642278935	solar
0.6642263454	targeted agents
0.6642159616	dimer
0.6642076041	interaction
0.6641771469	pcos
0.6641721589	cruzi
0.6641721589	dodecyl
0.6641721589	discover
0.6641349713	development
0.6641114973	cyp2c19
0.6641114973	th2
0.6641036585	agent
0.6640623631	egfr
0.6640478767	animal studies
0.6640239830	kir6
0.6639831851	hoechst
0.6639831851	canada
0.6639273185	antibodies
0.6639007521	bph
0.6638876278	regulates
0.6638572454	western
0.6638037088	sf
0.6637680623	mek
0.6637289626	h9c2 cells
0.6637133854	module
0.6637057839	idiopathic
0.6636562433	permeability
0.6635841691	rxr
0.6635429169	ophthalmic
0.6635429169	sweet
0.6635429169	follistatin
0.6634841493	fexofenadine
0.6634721913	thiobarbituric acid
0.6634629291	falciparum
0.6634573304	sedentary
0.6634192418	metabolic disorders
0.6634007089	cre
0.6633689241	antioxidant activity
0.6633108749	ceftazidime
0.6633108749	endocytosis
0.6633108389	potential
0.6632223249	lectin
0.6632077457	invasion
0.6631789479	cells expressing
0.6631711904	insight
0.6631111539	min
0.6630404665	insufficiency
0.6630349591	genotyping
0.6629762336	recent evidence
0.6629736915	rhythm
0.6629481149	raft
0.6629466345	tca
0.6629253611	enhances
0.6628693303	injury
0.6628549571	analysis
0.6628069354	phosphorylated
0.6627727982	tgf
0.6626549848	cervical
0.6626057027	sarcoma
0.6626057027	glycoside
0.6626057027	symmetric
0.6626038163	tg
0.6625661759	oatp1b1
0.6625437295	cpg
0.6624734598	activated
0.6624712788	measurement
0.6624652120	m3
0.6624255864	erα
0.6624059836	relation
0.6623306634	overexpressing
0.6622421384	specificity
0.6621900841	assess
0.6621733141	significantly reduced
0.6621330462	fxi
0.6621317052	fibrates
0.6621317052	gelatin
0.6621317052	ankyrin
0.6621317052	nonalcoholic
0.6621059887	lutein
0.6620649394	neuropathy
0.6620491790	fear
0.6620416248	deaminase
0.6618830206	acth secretion
0.6618553637	tyrosine phosphorylation
0.6618421278	potently inhibited
0.6618094976	visible
0.6618094976	septic
0.6618094976	vertebrates
0.6617608671	mcl 1
0.6617049102	beta hydroxysteroid dehydrogenase
0.6616872150	reductase
0.6616142369	molecular mechanisms
0.6615536715	supraoptic
0.6615536715	dilated
0.6615520723	c1
0.6615080029	elongation
0.6615013798	max
0.6614861238	capecitabine
0.6614715285	ifn
0.6614327208	locus
0.6613925481	american
0.6613320660	intracellular camp
0.6613176976	supplements
0.6613134604	trpm8
0.6612705746	a3
0.6612555314	pm
0.6612083691	triclosan
0.6612083691	promethazine
0.6612083691	fractionated
0.6612083691	cohorts
0.6612083691	biophysical
0.6612083691	zileuton
0.6612056728	encapsulation
0.6612056728	glycosylation
0.6612056728	geometry
0.6612056728	molecularly
0.6612056728	podocytes
0.6612056728	note
0.6612056728	analytical
0.6612056728	cholinesterases
0.6612056728	polyplexes
0.6612056728	hydroxyproline
0.6612056728	cysteines
0.6612056728	static
0.6612056728	rebound
0.6612056728	passage
0.6612056728	variance
0.6612056728	endotoxin
0.6612056728	distinctive
0.6612056728	demonstration
0.6612056728	holo
0.6612056728	solubilization
0.6612056728	electrophilic
0.6612056728	prostanoids
0.6612056728	chondrocyte
0.6612056728	insulinotropic
0.6612056728	massive
0.6612056728	barriers
0.6612056728	avoiding
0.6612056728	decision
0.6612047777	flanking
0.6611663335	action potential
0.6611498686	shifts
0.6610799354	transported
0.6610783674	beta 2 adrenergic
0.6610578891	snp
0.6610525908	jak2
0.6610022927	fsh
0.6610021909	parts
0.6610006574	para
0.6609023970	ot
0.6609018089	oxide
0.6608954357	light scattering
0.6608861864	response curves
0.6608801747	human platelets
0.6608661995	sensitivity
0.6608456816	nci
0.6608365859	trigeminal
0.6608182531	additive
0.6607125831	mpp
0.6607066961	caspase
0.6606942106	update
0.6606548116	contact
0.6606359533	mouse
0.6606312231	hand
0.6606287933	pharmaceuticals
0.6606020822	smad
0.6605674567	regulatory
0.6605239748	molecular targets
0.6604504485	ligand
0.6604484449	bi
0.6604484449	configuration
0.6604387058	24h
0.6604303533	5alpha
0.6604092117	manifestations
0.6603940746	val
0.6603488337	cotreatment
0.6603482023	care
0.6602426230	adaptive response
0.6601461147	ml
0.6601271755	nephropathy
0.6600740823	component
0.6600467821	central and peripheral
0.6599505245	caco 2
0.6598789757	modification
0.6598622049	term
0.6598590002	therapeutic agents
0.6598316633	xenografts
0.6598076890	ic
0.6597983801	therapy
0.6597505733	renal injury
0.6597221077	oxidase
0.6597017568	ltb
0.6596817174	cytochrome c release
0.6596716379	domain
0.6596393259	sulfation
0.6596130981	screen
0.6595904665	drugs of abuse
0.6595805739	oxidative stress and apoptosis
0.6595773213	core
0.6595589554	inotropic effects
0.6595180265	© 2013 john wiley & sons
0.6594980485	troponin
0.6594764892	reflected
0.6594375789	ischaemia
0.6594310018	related
0.6593979420	gad
0.6593685568	mc
0.6593140997	niacin
0.6592168787	adjuvant therapy
0.6591200010	tissue damage
0.6590953983	hg
0.6590828886	developing
0.6590674735	oxycodone
0.6590674735	dimemorfan
0.6590608548	voltage activated
0.6590062253	plasma homocysteine
0.6589951425	intraperitoneal injection
0.6589903904	restore
0.6589372644	mediterranean
0.6589288690	affected
0.6588847211	cc
0.6588675809	enantiomer
0.6588525588	muller
0.6588306321	newborn
0.6587287464	l1
0.6586578024	supplementation
0.6586363800	tumor cells
0.6586329196	carnitine transport
0.6586113257	lncap
0.6585980906	intermediate
0.6585938843	hcc
0.6585887026	rhodopsin
0.6585238059	international
0.6585232176	reviewed
0.6585193134	tests
0.6584427998	caspase 8
0.6584392089	hydroxysteroid
0.6583864668	salivary
0.6583542670	verified
0.6581373449	drug development
0.6581221550	span
0.6580976575	duct
0.6580438044	times higher
0.6580265940	angiogenic
0.6580106894	mice
0.6579816060	paw
0.6579031897	cofactor
0.6578750718	staining
0.6578376003	medial
0.6578348717	daily dose
0.6577445114	level
0.6577396920	genetically
0.6577280128	declarative
0.6576942644	molecules
0.6576841365	orientation
0.6576782227	putative
0.6576461874	avoidance
0.6576430114	pim
0.6576247224	aldh2
0.6576132530	acid
0.6575928091	metabolites
0.6575724764	syndrome
0.6575437586	insulin release
0.6575407344	mtx
0.6574969466	acquisition
0.6574923803	patients
0.6574739593	alpha 1b adrenoceptor
0.6574626995	alt
0.6574472420	homa
0.6574216197	alcoholic
0.6573478318	compete
0.6573439290	cort
0.6573103822	olopatadine
0.6573090346	high grade
0.6572723235	anti tumor
0.6572679543	family
0.6572209071	intrinsic activity
0.6571769600	oh dpat
0.6571698586	cys
0.6571277560	drg
0.6571040780	exists
0.6571029953	pravastatin
0.6570615967	second
0.6570438422	ionization
0.6570427571	aromatase activity
0.6570207562	capability
0.6570207562	trace
0.6570207562	antiepileptic
0.6569729019	group
0.6569699536	pyrene
0.6569082136	submitted
0.6568988184	striatal dopamine
0.6568177795	randomized to receive
0.6567839544	requirements
0.6567271550	signaling
0.6566845960	ahr
0.6566545175	stz
0.6566348059	thirty
0.6566045244	roles
0.6565542957	triglyceride
0.6565312587	p2 receptors
0.6564594403	juice
0.6564525390	glyceraldehyde
0.6564525390	hemolytic
0.6564349823	maintaining
0.6564349823	great
0.6564259369	adiol
0.6563990592	respond
0.6563972580	hit
0.6563955153	kda
0.6563005261	results suggest
0.6562525489	volume
0.6562349423	ck
0.6562342342	≤
0.6562294745	biological processes
0.6562252092	ligand binding domain
0.6562017748	mthfr
0.6561958384	tissue
0.6561726175	anions
0.6561281563	functional significance
0.6561241995	gnrh agonists
0.6561064037	nps
0.6560167175	validation
0.6559827211	metabolism
0.6559518941	metabolic pathway
0.6559034991	cyp2c9
0.6558632927	mdr1a
0.6558413318	neutrophil apoptosis
0.6556672703	ab
0.6555976481	fatty acid metabolism
0.6555790446	inhibition constants
0.6555381930	facilitate
0.6554959219	antipsychotics
0.6554632671	success
0.6554632671	estimate
0.6554153551	agents
0.6554141513	vmat
0.6554122223	pregnenolone
0.6554122223	osteopontin
0.6554122223	bilirubin
0.6554122223	abstracts
0.6553660554	h3
0.6553406895	diaphorase
0.6553406895	deamination
0.6553381526	patients taking
0.6553146685	quantitative rt pcr
0.6553051291	once
0.6552800739	acs4
0.6552758506	multicentre
0.6552562210	deviation
0.6552200387	promise
0.6551691675	characterised
0.6551691675	transferases
0.6551676690	p2y
0.6551455788	bridge
0.6551455788	conditioning
0.6551455788	coil
0.6551209624	determining
0.6551072036	third
0.6550898334	cyanopindolol
0.6550868877	cytotoxic effects
0.6550812456	utilized
0.6550808421	mdr1
0.6550797184	low affinity
0.6550787625	inflammasome
0.6550598790	complex iv
0.6550193312	biochemical parameters
0.6550053693	vascular endothelial
0.6549725599	gallamine
0.6549725599	aminoglutethimide
0.6549725599	jejunum
0.6549725599	vibrational
0.6549725599	erythropoietin
0.6549725599	probucol
0.6549725599	mitoxantrone
0.6549725599	fluoro
0.6549725599	phenol
0.6549485980	refractory
0.6549214331	stabilize
0.6549214331	transform
0.6549211835	ribonucleotide
0.6549092561	3beta
0.6548985318	urinary excretion
0.6548920653	plate
0.6548744547	yr
0.6548591450	bay
0.6548473449	iso
0.6547735559	nh2
0.6547096505	malondialdehyde
0.6547025644	ubiquitin
0.6546794073	ki values
0.6546589226	enhanced
0.6546491798	disc
0.6546003625	decade
0.6546003625	episodes
0.6545603267	glur5
0.6545541116	vta
0.6545465650	cml
0.6545280659	transforming growth factor beta
0.6545189184	ligase
0.6545189184	bundle
0.6545027630	h4
0.6545027630	ugt1a1
0.6544190886	hdac
0.6544186276	c4
0.6544014480	vagal
0.6544014480	stranded
0.6543493282	feed
0.6543455330	pghs 2
0.6543350813	times daily
0.6543080218	reviews
0.6542843314	aml
0.6542702540	techniques
0.6542566130	protons
0.6542566130	immunostaining
0.6542566130	caution
0.6542566130	adrenocortical
0.6542566130	sterols
0.6542566130	trifluoperazine
0.6542566130	phenolics
0.6542566130	copy
0.6542566130	bisphosphonates
0.6542566130	virtually
0.6542566130	truncation
0.6542566130	consideration
0.6542566130	alkylation
0.6542566130	thromboembolic
0.6542566130	adrenomedullin
0.6542566130	thiopurine
0.6542566130	limitation
0.6542566130	carcinogenicity
0.6542566130	pollutant
0.6542566130	hypogonadism
0.6542566130	leakage
0.6542566130	levonorgestrel
0.6542566130	transamination
0.6542566130	quinpirole
0.6542477060	feedback
0.6542346038	discriminate
0.6542029559	maps
0.6541538509	potentials
0.6541444473	discovered
0.6541361137	precise
0.6541146221	demethylation
0.6541146221	ganglia
0.6541099940	subtype
0.6539892842	few
0.6539448440	tt
0.6539382864	traumatic
0.6539259868	strictly
0.6539259868	carboxy
0.6539259868	seeking
0.6539259868	pilot
0.6539259868	nanogels
0.6539259868	bulk
0.6539259868	cocktail
0.6539259868	enantioselective
0.6539259868	exogenously
0.6539259868	persistence
0.6539259868	quinones
0.6539259868	designing
0.6539259868	ameliorating
0.6539259868	conditional
0.6539259868	taxane
0.6539259868	rarely
0.6539259868	concurrently
0.6539259868	facilitation
0.6539259868	qualitative
0.6539259868	methacholine
0.6539259868	hypotensive
0.6539259868	causative
0.6538841263	ketotifen
0.6538841263	nomifensine
0.6538841263	intramuscular
0.6538841263	isoflavones
0.6538841263	bicyclic
0.6538841263	fibronectin
0.6538841263	ovulation
0.6538841263	abacavir
0.6538841263	benzofuran
0.6538803062	abrogated
0.6538628841	tetracycline
0.6538420286	obvious
0.6537669160	mt
0.6537039175	cytochrome
0.6536932639	allergens
0.6536932639	manufacturing
0.6536932639	labour
0.6536932639	pulsatile
0.6536932639	antigens
0.6536932639	cleavable
0.6536932639	catalepsy
0.6536932639	procaine
0.6536932639	megalin
0.6536932639	bambuterol
0.6536932639	organophosphates
0.6536932639	monoamines
0.6536803502	minimum
0.6536803502	relief
0.6536555748	expansion
0.6536555748	analyze
0.6536031592	cochrane
0.6535878690	optic
0.6535847483	atp binding cassette
0.6535840776	gaf
0.6535636818	neutrophil
0.6535524474	crh
0.6535458277	faster
0.6535130374	esi
0.6534812186	unlabelled
0.6534626995	mdr
0.6534366194	independent manner
0.6534278510	uterus
0.6534035349	alpha linolenic acid
0.6533938763	bypass
0.6533752544	americans
0.6533744941	mollugin
0.6533744941	rabeprazole
0.6533744941	alprenolol
0.6533589699	gpcr
0.6533525876	outer
0.6533117486	not fully understood
0.6532713050	partly
0.6532521080	6 hydroxydopamine
0.6532488521	michaelis
0.6531964654	ampk activity
0.6531758774	resistin
0.6531758774	lorazepam
0.6531758774	topological
0.6531601679	fold increase
0.6531500534	cancer
0.6531482244	absorbed
0.6531273222	sal
0.6530853873	highest affinity
0.6530820013	challenged
0.6530783689	cerebral artery
0.6529658251	gorge
0.6529586454	gabaergic
0.6529330753	cyp1a2
0.6528940491	n acetylcysteine
0.6528846670	u937
0.6528643113	bone metabolism
0.6527948081	15d pgj2
0.6527300184	sugar
0.6527208315	i2
0.6526273743	rr
0.6526205016	ctnc
0.6526101341	replication
0.6525954292	vulnerability
0.6525946217	nucleoside
0.6525903663	achieved
0.6525574052	neuronal cell death
0.6525455772	µg
0.6524449171	self assembled
0.6524259716	atra
0.6524177348	delay
0.6523621842	carrier
0.6523621842	observation
0.6523495594	ibritumomab
0.6522873423	dabigatran
0.6522515902	tp
0.6522286163	sch
0.6521946180	vesicular
0.6521920704	vitamin k dependent
0.6521595764	atr
0.6521450672	pdgfr
0.6521011021	cleaved caspase 3
0.6520138831	t2dm
0.6519891009	mismatch
0.6519765309	previous study
0.6519222038	ba
0.6518806133	ht
0.6518082988	lh
0.6517896185	bid
0.6517515902	avp
0.6517391032	formulation
0.6516943560	invasive
0.6516711414	pivotal role
0.6516657321	dopamine receptors
0.6516120532	graves
0.6516036876	food
0.6516005883	gcs
0.6515794702	mhc
0.6515603718	bmd
0.6515345415	separated
0.6515224498	cox inhibitors
0.6515086117	intensity
0.6514738756	validated
0.6514711849	summary
0.6514440258	tlr4
0.6514344852	bnp
0.6514148530	ha
0.6513935337	dm
0.6513935337	meth
0.6513886123	facilitated
0.6513789340	open
0.6513395770	deleterious
0.6513395770	coordination
0.6513366722	tachycardia
0.6513306321	dehydratase
0.6512953436	fviii
0.6512733368	highest concentration
0.6511687459	renin inhibitor
0.6511273192	vesicles
0.6510525870	played
0.6510347336	sci
0.6510248045	raman
0.6510226117	full
0.6509742334	tissues
0.6509739581	sur1
0.6509730527	ecg
0.6509619076	monitored
0.6508931231	diaphorase activity
0.6508833097	steroids
0.6508346479	loaded
0.6507704234	ugt
0.6507444263	gonadotrophin
0.6507338795	vii
0.6506863771	mumol
0.6506720930	assessments
0.6506717615	propofol
0.6506717615	frovatriptan
0.6506214714	kinetic analyses
0.6505941277	hippocampus
0.6505496818	eliminated
0.6505393070	bap
0.6504682840	bacterial
0.6504633090	orexin
0.6504630926	conclusions
0.6504310873	ribose
0.6504173711	dioxide
0.6504173711	atopic
0.6504173711	delineate
0.6503691612	anti cancer
0.6503516155	derived
0.6503252609	genotypes
0.6502303487	ticlopidine
0.6501091363	require
0.6501063520	promoted
0.6501063520	transcript
0.6500467399	micellar
0.6500467399	topotecan
0.6500467399	night
0.6500076119	cytochrome c oxidase
0.6499767445	termination
0.6499626783	pah
0.6499319142	residue
0.6499317387	relapsed
0.6499317387	transferred
0.6499246439	monoamine oxidase inhibitors
0.6498717885	sub
0.6498297889	assembled
0.6498297889	spontaneously
0.6497667539	src kinase
0.6497413849	ppi
0.6496126584	colorectal cancer cells
0.6495922197	entecavir
0.6495405728	desirable
0.6495025645	adenosine receptors
0.6494774339	lungs
0.6494715443	lower affinity
0.6494466605	mrna and protein
0.6494360862	vkorc1
0.6494278261	gi
0.6493970235	k1
0.6493926098	controlled trial
0.6492520269	decreased
0.6491707116	page
0.6491689510	dht
0.6491534957	srebp
0.6491380981	lowered
0.6491003834	ru
0.6490968470	crossover
0.6490968470	attachment
0.6490907788	unexpectedly
0.6490405284	guanine
0.6490315011	regression analysis
0.6490205807	tris
0.6489425397	induces apoptosis
0.6489151088	islets
0.6488909321	perform
0.6488720930	maze
0.6488467536	comparable
0.6487997621	upper
0.6487935837	rights
0.6487935837	freely
0.6487911168	ccl4
0.6487047053	peripheral site
0.6486659089	inducing
0.6486290630	low level
0.6485688703	polymorphism
0.6485608060	pancreatitis
0.6485408624	anaplastic
0.6485408624	propensity
0.6485286648	mimicked
0.6485023368	mab
0.6484727991	responses
0.6484662748	aβ
0.6484589398	glucuronide
0.6484510368	pyrophosphate
0.6484201901	glu
0.6483999767	licorice
0.6483456246	streptozotocin
0.6483012303	cleaved
0.6482863987	zeta
0.6482597761	beta adrenoceptor agonists
0.6482155738	warfare
0.6481962962	¹
0.6481614100	oxime
0.6481614100	hydroxylation
0.6481180709	oat3
0.6480672507	obtained
0.6480572184	investigate
0.6480535611	depressed
0.6480300977	anemia
0.6480224933	glp
0.6479707348	biliary
0.6479085021	tm
0.6479001928	alleles
0.6478992204	rats fed
0.6478421478	neoplastic
0.6478220834	transfer
0.6477908447	seizure
0.6477855635	il 2r alpha
0.6477845804	raas
0.6477764885	hybridization
0.6476897838	vascular disease
0.6476748409	° c
0.6476522758	wound
0.6475950535	s adenosylmethionine
0.6475868019	critical role
0.6475461577	carcinoma cells
0.6475254215	selected
0.6475214761	vasculature
0.6475152998	ketoprofen
0.6475021061	methylenedioxymethamphetamine
0.6474889798	anti oxidant
0.6474208188	μmol
0.6474183109	confirmed
0.6474127563	mcl
0.6474072627	concentration range
0.6474057107	isoform
0.6473442395	raldh
0.6473371803	normal
0.6473205503	mpo
0.6472619400	lixisenatide
0.6472105053	allodynia
0.6472105053	dramatic
0.6472105053	detecting
0.6471768011	thyroid tumors
0.6471367156	analogous
0.6471367156	examines
0.6471313788	phenomenon
0.6470732975	xenograft
0.6470630286	interstitial
0.6469654548	cell differentiation
0.6469324633	induction
0.6469313326	consolidation
0.6468999259	depressive
0.6468955671	brl
0.6468712399	nis
0.6468488868	penicillin binding protein
0.6468263512	nick end
0.6467690239	ang
0.6467310270	healthy male
0.6467231060	vi
0.6466852854	diffraction
0.6466698196	citrulline
0.6466641270	intervals
0.6466610838	m5
0.6466570636	retina
0.6466386212	gstp1
0.6464956680	body temperature
0.6464884869	type 1 diabetes
0.6464783360	minimal
0.6464133625	hearing
0.6464133625	calorimetry
0.6463277342	depolarization
0.6463264367	gpx
0.6462960265	odc
0.6462254896	alpha and beta
0.6462160412	protein
0.6461936994	alpha2
0.6461757944	applications
0.6461635707	site
0.6461211295	sensory
0.6461095382	sudden
0.6460848359	type
0.6460458106	agonist
0.6460267656	murine macrophages
0.6460187085	age related
0.6459930213	downregulated
0.6459736041	postnatal
0.6459582814	form
0.6459145325	maintain
0.6458877645	potencies
0.6458865742	encodes
0.6458865742	excitotoxicity
0.6458865742	efforts
0.6457395610	hyp
0.6457117217	p2
0.6457047247	mediates
0.6456561648	cad
0.6456311512	runx2
0.6456291207	dmi
0.6456182748	increased
0.6456101006	methylenetetrahydrofolate
0.6455095673	glands
0.6454675108	proton
0.6454446976	wortmannin
0.6454176226	phosphorylation
0.6453570761	degradation
0.6453291473	cyslt1
0.6453247543	rbl
0.6453151076	arrays
0.6453151076	garlic
0.6452586770	differentially
0.6452513710	clone
0.6452513710	dehydrogenases
0.6451919238	catalytic activity
0.6451755818	bosutinib
0.6451755818	pergolide
0.6451755818	halogenated
0.6451755818	cinobufagin
0.6451755818	groove
0.6451755818	paraquat
0.6451755818	spliced
0.6451755818	recommendations
0.6451755818	defining
0.6451755818	proteoglycan
0.6451755818	phosphotriesterase
0.6451755818	norfenfluramine
0.6451755818	preservation
0.6451755818	plastic
0.6451755818	myelofibrosis
0.6451755818	occupational
0.6451755818	incubations
0.6451755818	hepatotoxic
0.6451755818	hematologic
0.6451755818	lysis
0.6451755818	primate
0.6451755818	quick
0.6451755818	amelioration
0.6451755818	caloric
0.6451755818	thiazolidinedione
0.6451755818	synonymous
0.6451755818	benzodiazepine
0.6451755818	adjunctive
0.6451755818	abnormally
0.6451755818	optical
0.6451755818	pharmacotherapy
0.6451755818	sequestration
0.6451755818	spiperone
0.6451755818	usage
0.6451755818	schizophrenic
0.6451755818	psychostimulant
0.6451755818	reporting
0.6451755818	briefly
0.6451755818	approximate
0.6451755818	vasoconstrictor
0.6451755818	adhesive
0.6451755818	methoxamine
0.6451588934	glomerular
0.6451562227	preference
0.6450979028	dysregulation
0.6450979028	threonine
0.6450951844	lymphocytic
0.6450671433	region
0.6450566158	rate limiting step
0.6450442318	conserved
0.6450203271	potentiated
0.6449852295	deposition
0.6449815628	vmax
0.6449630098	extensively
0.6449565890	past
0.6449444263	version
0.6449444263	chlorophenyl
0.6448913946	innovative
0.6448913946	bepridil
0.6448913946	deficiencies
0.6448913946	dapagliflozin
0.6448913946	disturbance
0.6448913946	ethnic
0.6448913946	glycosaminoglycan
0.6448894931	electrophoresis
0.6448643111	recovery
0.6448097865	down regulated
0.6447850146	maprotiline
0.6447766685	single dose
0.6447078694	pneumoniae
0.6446953689	amplification
0.6446953689	coexpressed
0.6446685953	annexin
0.6446495752	myocytes
0.6446419984	displacement
0.6446419984	advance
0.6446375709	ed
0.6446346377	follicle
0.6445760247	pneumocystis
0.6445749687	β cell
0.6445735400	enos
0.6445575114	leukocytes
0.6445499819	depletion
0.6445449569	challenge
0.6445422311	intravenous administration
0.6445302164	content
0.6444552697	14c
0.6444300296	valuable
0.6443992919	undergoing
0.6443822328	elicit
0.6443822328	similarity
0.6443695354	imiquimod
0.6443695354	terbinafine
0.6443637392	reporter gene assays
0.6443597999	steatosis
0.6443597999	genotyped
0.6443574168	granules
0.6443499814	crp
0.6443456246	sexual
0.6443065328	splicing
0.6443063907	attached
0.6443035132	pmol
0.6442083265	inos expression
0.6441811984	protein synthesis
0.6441764373	acetylation
0.6441573454	ingredient
0.6440779598	pylori
0.6440154618	exploration
0.6439714659	kidney injury
0.6439280767	internalization
0.6438603342	expressed in xenopus oocytes
0.6438110300	closely
0.6437439250	differ
0.6437316157	loop
0.6436898356	mutants
0.6436566581	irs
0.6436088145	weaker
0.6436088145	removed
0.6436088145	underlie
0.6435648272	rectifier
0.6435613249	shmt
0.6435534363	cddp
0.6435032438	blocker
0.6434912792	efficiently
0.6434912548	neurite
0.6434912548	conscious
0.6434456691	rcc
0.6434031161	bk
0.6433471005	temperatures
0.6433097707	carteolol
0.6433097707	cobalamin
0.6432699270	po
0.6432637516	monkey
0.6432517456	aciduria
0.6432437848	documented
0.6431762257	tooth
0.6431762257	dienogest
0.6431685447	improve
0.6431357070	secreted
0.6431349733	ide
0.6431330544	cyp2b6 * 6
0.6430942620	inhibitory
0.6430940923	endogenous opioid
0.6430915408	reactions
0.6430892374	acted
0.6430735143	times more potent
0.6429907482	decitabine
0.6429645400	5ht
0.6429549321	oxidative metabolism
0.6429544419	knockdown
0.6429410200	n terminus
0.6429409640	wogonin
0.6429387859	explanation
0.6429142128	gp
0.6429076931	way
0.6428815996	pairs
0.6428755540	rank
0.6428739812	dog
0.6428650231	pfc
0.6428643187	peptides
0.6428505954	ltp
0.6428400831	kinase inhibitors
0.6428361309	hla
0.6428315208	anticonvulsant activity
0.6427881622	bad
0.6427879617	defect
0.6427740856	elegans
0.6427583732	steps
0.6427583732	analysed
0.6427401854	suppression
0.6426596035	filtration
0.6426345156	microscopy
0.6426097917	guanosine
0.6425833908	methadone
0.6425833908	ethynyl
0.6425833908	nociceptin
0.6425833908	argatroban
0.6425833908	prednisone
0.6425565936	ss rats
0.6425090167	oils
0.6424650914	movement
0.6424581343	anesthetics
0.6424511587	mixtures
0.6424451536	charged
0.6423709244	homologous
0.6423581842	chemicals
0.6423535177	called
0.6423495842	repression
0.6423379047	trna
0.6423240639	dioxin
0.6423062911	comprised
0.6423032716	selective cox 2 inhibitors
0.6422720179	la
0.6422638051	2c
0.6422540582	trpv1
0.6422518060	polypeptide
0.6422464917	induces
0.6421989931	incorporated
0.6421591570	ara
0.6420776300	practice
0.6420730344	abstract truncated at
0.6420520359	insensitive
0.6420491636	symporter
0.6420474946	anticonvulsant
0.6420301199	abcc2
0.6420264072	apparent
0.6419946323	window
0.6419946323	computed
0.6419946323	intercellular
0.6419946323	takes
0.6419518552	minutes
0.6419442324	tumorigenesis
0.6419442324	protecting
0.6419442324	noradrenergic
0.6419442324	supports
0.6419442324	share
0.6419442324	dimeric
0.6419266650	erbeta
0.6418787410	pbmc
0.6418510926	mg once daily
0.6418444507	powerful
0.6418219586	though
0.6418204652	approach
0.6417832498	acute and chronic
0.6417683006	tsh
0.6417645695	strength
0.6417376050	subsets
0.6417376050	squalene
0.6417376050	copies
0.6417334007	antibody
0.6417105481	noted
0.6417082702	atp competitive
0.6416469852	accumulation
0.6416258960	psa
0.6416223213	poisoning
0.6416148291	nacl
0.6415680246	dep
0.6415642046	phospho
0.6415638453	adrenoceptor density
0.6415548385	activate
0.6415479219	sn
0.6414973151	c reactive protein
0.6414958192	liposomes
0.6414059040	apparatus
0.6413985500	then
0.6413974166	label
0.6413947754	mirtazapine
0.6413947754	nonlinear
0.6413947754	internalized
0.6413947754	fragile
0.6413947754	perinatal
0.6413947754	connexin43
0.6413947754	chromium
0.6413947754	drivers
0.6413947754	juglone
0.6413947754	aliphatic
0.6413947754	oligomeric
0.6413947754	replacing
0.6413947754	pharmacogenetic
0.6413418308	stimulates
0.6412745248	stability
0.6412655306	marker
0.6412458056	balb
0.6412174107	bcr
0.6411748120	5mg
0.6411748120	manipulation
0.6411748120	diversity
0.6411462211	scd
0.6411357070	positions
0.6411340242	opposite
0.6411152064	mitochondrial complex
0.6409044289	maximum
0.6408161408	pyrilamine
0.6408161408	carbidopa
0.6408161408	dorzolamide
0.6408161408	rectal
0.6408161408	mexiletine
0.6407055733	scn5a
0.6407017712	atrial
0.6406843969	stabilization
0.6406619206	barrier
0.6406445794	receive
0.6405673777	acute pain
0.6405464212	takeda
0.6405175393	matter
0.6404893228	prolongation
0.6404892668	structure activity relationship studies
0.6404733166	oa
0.6404657279	decrease
0.6404627781	ca1
0.6403510409	wild type mice
0.6403358784	preferentially
0.6403167385	sm
0.6402957015	i1
0.6402783769	periods
0.6402783769	carrying
0.6402736907	isomerase
0.6402122930	ondansetron
0.6401892453	mrna content
0.6401776891	cerebellum
0.6400966872	adrenoceptor blockade
0.6400793771	monotherapy
0.6400445567	dendritic
0.6400445567	morbidity
0.6400229113	immunoblot
0.6400067181	modifying
0.6399980108	develop
0.6399876755	rfrp 3
0.6399521635	oxo
0.6399501848	artemisia
0.6399479621	terminals
0.6399387416	aminotransferase
0.6398739064	glcnac
0.6398682049	cgrp
0.6398572521	cardiolipin
0.6398572521	selenite
0.6398572521	polymerases
0.6398270208	n methyl d aspartate
0.6398152541	prevent
0.6397852938	fgfr
0.6397669353	nc
0.6397486888	related genes
0.6397115300	alpha thrombin
0.6396785714	rheumatoid
0.6396698801	tubules
0.6396682957	detected
0.6396162844	radiation
0.6396002621	electrospray
0.6395890303	analogs
0.6395799412	xa
0.6395668441	17 aag
0.6395565484	carvacrol
0.6395565484	intracerebroventricular
0.6395212404	negatively
0.6395040521	part
0.6394570588	trend
0.6394551608	17β
0.6394352220	tracheal
0.6394152760	distributed
0.6394091751	drugs
0.6394047587	formulations
0.6394047587	potentiates
0.6393541450	trauma
0.6393434375	mv
0.6393119449	features
0.6392752267	livers
0.6392752267	screened
0.6392314881	japan
0.6392313413	tools
0.6391936491	rescued
0.6391854612	clarify
0.6391570653	highlighted
0.6391570653	exploited
0.6391570653	warranted
0.6391570653	proportional
0.6391570653	autocrine
0.6391570653	preferred
0.6391298618	5 htp
0.6391241126	atp competitive inhibitors
0.6390590509	antagonistic
0.6390493723	proteins
0.6390045431	1b 1d
0.6389492226	lv
0.6389076435	erk1
0.6388981119	hematopoietic
0.6388965938	coagulation factor
0.6388889200	tract
0.6388578511	v2 receptor
0.6388346765	ptu
0.6388227275	signalling
0.6388110221	currently
0.6387959834	recurrence
0.6387959834	template
0.6387954301	cbl
0.6387728497	mechanistically
0.6387161686	ni
0.6387110347	gln
0.6386890179	leukemia
0.6386851162	contributions
0.6386732024	rankl
0.6386686249	acetate
0.6385837494	glycoprotein
0.6385556619	aurora
0.6385328188	osteocytes
0.6384729401	small intestinal
0.6384287645	metalloproteinases
0.6384246110	innate
0.6384246110	synuclein
0.6384246110	clinic
0.6384246110	sensitizing
0.6383273920	vp
0.6382762231	stimulation
0.6382727013	gated
0.6382601282	insmed
0.6382291768	question
0.6382265794	overcome
0.6382215260	optimal
0.6382215244	ribosomal
0.6382198805	rat striatum
0.6382120938	egcg
0.6381688332	tubular
0.6381554826	follow up
0.6381240938	cyclosporine
0.6380744310	nachr
0.6380521272	based approaches
0.6380507088	rare
0.6380461008	synthetase
0.6380092774	biology
0.6380075651	appeared
0.6380049859	acyl
0.6378722993	set
0.6378346098	clinical application
0.6377601065	oleic
0.6377601065	mouth
0.6377229727	gla
0.6376786362	rs 15385 197
0.6376528913	b12
0.6376296685	adults
0.6375925410	contributed
0.6375864059	influenced
0.6375829458	uridine
0.6375829458	lifetime
0.6375349856	nucleotides
0.6374755120	atoms
0.6374207231	electrophoretic
0.6374098850	ndga
0.6373682278	atria
0.6373306737	lymphoma
0.6373197999	hct
0.6373008818	breaks
0.6372802925	comt
0.6372774868	micrograms
0.6372685272	chicks
0.6372573197	potently
0.6372460228	range
0.6372161770	2 epimerase
0.6372111230	pyridoxine
0.6372075994	define
0.6371783723	superior
0.6371600295	homeostasis
0.6371558173	osteocalcin
0.6371215684	interesting
0.6371215684	phenotypes
0.6371208499	aldo
0.6370946622	treatment
0.6370667823	overnight
0.6370667823	valacyclovir
0.6370667823	icariin
0.6370667823	biodistribution
0.6370667823	radiotherapy
0.6370403574	synapses
0.6370239053	summarizes
0.6370101569	forms
0.6369567031	slowly
0.6369567031	constitute
0.6369567031	constructed
0.6369567031	moderately
0.6369426776	pathogenic
0.6369426776	allowing
0.6369426776	differed
0.6369426776	displays
0.6369392206	decades
0.6368976423	overexpressed
0.6368890318	foci
0.6368715684	aggregates
0.6368715684	evident
0.6368682414	melanocytes
0.6368682414	extra
0.6368682414	adipogenesis
0.6368682414	greatest
0.6368682414	deleted
0.6368540805	detect
0.6368503475	collected
0.6368433343	based drug design
0.6367985903	monolayers
0.6367772104	converted
0.6367415284	ovariectomy
0.6367415284	amsacrine
0.6367216820	linker
0.6367216820	amines
0.6367036688	redox
0.6366995945	iodo
0.6366970689	galanin
0.6366930036	thr
0.6366872164	group iii
0.6366740026	spectra
0.6366555143	detoxification
0.6366360427	clozapine
0.6366323384	potency and selectivity
0.6366310061	words
0.6366170069	prediction
0.6366024698	bark
0.6366024698	regeneration
0.6366024698	mobilization
0.6366024698	dimers
0.6366024698	biphasic
0.6366024698	possessing
0.6366024698	offers
0.6366024698	neurotransmitters
0.6366024698	trafficking
0.6366024698	created
0.6366024698	slowed
0.6366024698	displaying
0.6366024698	construct
0.6366024698	implying
0.6366024698	asthmatic
0.6366024698	lipophilic
0.6364908766	melanoma cells
0.6364761508	responsiveness
0.6364683041	unclear
0.6364611724	pocket
0.6364425368	so
0.6364227144	coli
0.6363687740	re
0.6363444836	pollution
0.6363089503	exons
0.6363008907	hypertensive patients
0.6362541748	cytoplasm
0.6362378282	points
0.6362288393	raphe
0.6362288393	coadministration
0.6362225978	unrelated
0.6361965717	cohort
0.6361788568	cgmp
0.6361708423	cn
0.6361671308	initiated
0.6361563188	pancreatic β
0.6361518250	chemotherapeutic
0.6361351740	dpp
0.6360704446	akr1c1
0.6360642829	alpha 2 adrenoceptor
0.6360266439	introduced
0.6360259432	present
0.6360227120	distant
0.6360227120	million
0.6360064913	assayed
0.6359580549	resistant
0.6359549018	stronger
0.6359549018	noncompetitive
0.6359549018	reactivity
0.6358988355	block
0.6358917445	gene silencing
0.6358759339	chimeric
0.6358584514	labelled
0.6358584514	substituent
0.6358584514	lost
0.6358584514	infected
0.6357804528	together
0.6357638941	a2a
0.6357619480	count
0.6357505158	recovered
0.6357505158	transformed
0.6357417021	ht29
0.6357350979	attractive
0.6357053184	recruited
0.6357053184	psoriasis
0.6357053184	ameliorated
0.6357053184	diagnosed
0.6357053184	generating
0.6357053184	challenges
0.6357053184	amygdala
0.6357053184	catalyze
0.6357053184	prove
0.6357053184	gave
0.6356963556	coding
0.6356905263	hydrolysis
0.6356868462	antibacterial
0.6356868462	estrone
0.6356868462	carboxylate
0.6356868462	plasmid
0.6356868462	homogenates
0.6356868462	resolved
0.6356650345	monocyte
0.6356316546	patent
0.6356266717	pt
0.6355688240	sgc
0.6354923842	hormonal
0.6354829707	directed
0.6354516549	argininosuccinate
0.6354350267	toxin
0.6354222656	sulphate
0.6354219257	rodents
0.6354219257	concept
0.6354208422	uvb induced
0.6354115932	mediation
0.6354018342	quantified
0.6353848839	characterize
0.6353389649	hcg
0.6353047246	anionic
0.6353047246	tumours
0.6353047246	meal
0.6353047246	yields
0.6352907992	dehydrogenase
0.6352893906	living
0.6352557614	remain
0.6352378646	if
0.6352284429	thin
0.6352109934	cancers
0.6351949536	corticotropin
0.6351949536	endopeptidase
0.6351949536	parathyroid
0.6351893778	location
0.6351849457	assay
0.6351602737	out
0.6351565941	library
0.6351548034	alveolar
0.6351521266	secretion
0.6351011361	chronic pain
0.6350770068	importance
0.6350573243	steroidogenic
0.6350573243	≥
0.6350503681	sgk1
0.6350165739	potency
0.6349834323	camp production
0.6349580527	reuptake inhibition
0.6349277231	α7
0.6349060396	peptidase
0.6348536417	prognosis
0.6348403701	senescence
0.6348158872	sh2
0.6347898982	shift
0.6347739214	ages
0.6347270635	propionate
0.6347217119	lobe
0.6346984304	cdk2
0.6346931915	copolymer
0.6346931915	oximes
0.6346931915	repetitive
0.6346931915	conferred
0.6346884069	bcl
0.6346528569	glioma
0.6346450203	oatp
0.6346254187	paracrine
0.6346254187	protocols
0.6346254187	viable
0.6346254187	describes
0.6346254187	leaves
0.6346254187	3a4
0.6346254187	compartment
0.6346254187	trigger
0.6346254187	optimized
0.6346254187	toxins
0.6346254187	cations
0.6346254187	raises
0.6346254187	inherited
0.6346254187	shifted
0.6345937776	cbs
0.6345901309	extract
0.6345713770	observations
0.6345710787	cs
0.6345699495	abca1
0.6345527609	reperfusion
0.6345512416	plz
0.6345446643	properties
0.6345314022	fragmentation
0.6345230677	antagonized
0.6344904111	reliable
0.6344904111	synergistically
0.6344904111	adjacent
0.6344904111	triggers
0.6344904111	problem
0.6344760667	shp
0.6344328614	cardiac muscle
0.6344227782	pparalpha
0.6344185861	defined
0.6343319829	insulin therapy
0.6343318396	endothelium
0.6342410113	feature
0.6342297449	rating
0.6342149139	candoxatril
0.6341693874	palonosetron
0.6341431644	status
0.6341285457	currents
0.6341081549	transiently
0.6340983386	stiffness
0.6340356791	adduct
0.6340146735	diastolic
0.6340018677	df
0.6339807385	yield
0.6339758263	pretreated
0.6339422050	glucagon like peptide 1
0.6338895278	es
0.6338553846	wiley
0.6338411674	dorsal
0.6338394961	pivotal
0.6338362299	medications
0.6337827814	networks
0.6337780953	ornidazole
0.6337646878	sma
0.6337452174	abc
0.6336645113	relationships
0.6336530678	chemically
0.6336399033	nm
0.6336372410	125i
0.6336156121	aba3
0.6336156121	janus
0.6335907441	rhinitis
0.6335903443	vx
0.6335845910	occlusion
0.6335767911	fact
0.6335642931	nt
0.6335603239	sweroside
0.6335603239	neurotrophin
0.6335603239	reinforcement
0.6335603239	presently
0.6335531979	infarct
0.6335160522	muscles
0.6335075589	8 tetrachlorodibenzo p dioxin
0.6335031726	~
0.6334820055	sperm
0.6334659909	bradykinin
0.6334659909	hydrogels
0.6334659909	termed
0.6334659909	dione
0.6334659909	competitively
0.6334659909	neurones
0.6334623937	vdr
0.6334361965	hydrochlorothiazide
0.6334234185	little
0.6333920437	independently
0.6333872688	synaptosomes
0.6333698787	phosphate
0.6333204412	liver tissue
0.6333106648	cr
0.6333085044	β1
0.6333038088	regional
0.6333038088	promoters
0.6332791254	constants
0.6332697882	proinflammatory
0.6332596050	copolymers
0.6332321573	hcl
0.6332248489	previously published
0.6332150899	vessels
0.6332150899	translational
0.6332118661	glucocorticoid receptors
0.6331838770	elements
0.6331555401	infusions
0.6331527727	extracted
0.6330446930	base
0.6330423219	absent
0.6330000293	added
0.6329188502	1r
0.6329052269	released
0.6328630346	abuse
0.6328426226	reduced
0.6328182374	choice
0.6327783900	6 shogaol
0.6327565423	amplitude
0.6327544988	preclinical and clinical
0.6327194635	property
0.6326891666	cdnas
0.6326778135	syndromes
0.6326041798	anti allergic
0.6325892332	spectrometric
0.6325707759	3β
0.6325695803	implantation
0.6325563143	pi3
0.6325463637	octn2
0.6325460635	eradication
0.6325460635	heroin
0.6325460635	phenothiazines
0.6324853015	enzymes
0.6324709518	molecular markers
0.6324043677	hydroxycholesterol
0.6324043677	shape
0.6324043677	capsaicin
0.6324043677	energies
0.6324043677	anticoagulant
0.6324043677	pool
0.6323915605	donors
0.6323915605	xenobiotics
0.6323915605	antidiabetic
0.6323915605	hearts
0.6323915605	slower
0.6323571930	affecting
0.6323368566	substituents
0.6323299577	physiological
0.6323183656	b6
0.6323150015	curves
0.6322603838	response
0.6322581817	mitragynine
0.6322581817	panitumumab
0.6322581817	roflumilast
0.6322581817	regucalcin
0.6322581817	thermosensitive
0.6322509765	suppressive
0.6322509765	correct
0.6322509765	utilization
0.6322509765	injured
0.6322509765	true
0.6322509765	paradigm
0.6322509765	polymorphic
0.6322509765	sulfonamides
0.6322509765	antinociception
0.6322509765	potentiate
0.6322509765	operated
0.6322509765	changing
0.6322509765	pathologies
0.6322509765	disrupts
0.6322509765	electrode
0.6322509765	prescribed
0.6322509765	easily
0.6322509765	vasodilator
0.6322329471	nanomolar
0.6322146875	pma
0.6321893856	5 ht1f
0.6321703041	confers
0.6321528216	experienced
0.6321402472	medicinal
0.6321336726	pcp
0.6321213182	transferase
0.6321158306	mi
0.6321019987	learning
0.6321019987	occurring
0.6320482379	candidate
0.6320423016	cells
0.6319996886	dihydro
0.6319996886	relapse
0.6319328814	control rats
0.6319137359	sodium channels
0.6319005158	cartilage
0.6318938049	extinction
0.6318902854	specific
0.6318775475	amounts
0.6318484805	doses
0.6318405066	deficit
0.6318361777	oh
0.6318271529	node
0.6318222039	proteasomal
0.6318222039	frequencies
0.6318222039	delivered
0.6318222039	lyase
0.6318081514	adolescence
0.6317546366	focus
0.6317347353	hydrochloride
0.6317169881	thromboxane
0.6317129456	neurotransmission
0.6316902824	consumption
0.6316643752	addition
0.6316318147	behavioural
0.6316268878	modulated
0.6316265772	mat
0.6316084575	consequences
0.6315892892	physical
0.6315892892	positively
0.6315875586	inhibitors
0.6315757146	started
0.6315757146	contractility
0.6315154310	shr
0.6314934788	recognized
0.6314384289	agmatine
0.6314318076	plc
0.6314317670	dissection
0.6314195068	stat
0.6313862466	anti inflammatory effects
0.6313822291	phospholipids
0.6313279636	drug design
0.6313084837	gastric cancer
0.6313078352	perfused
0.6313078352	rabbits
0.6312507498	central nervous system
0.6312338491	androgenic
0.6311734167	ratios
0.6311585623	situ
0.6311313570	profiles
0.6311313242	neurotensin receptor
0.6311192953	activator
0.6310693370	mao b
0.6309718595	reporter assays
0.6309333465	supervillin
0.6309196542	pronounced
0.6308948930	modify
0.6308706098	extent
0.6308451166	ovarian cancer cells
0.6308300211	characterized
0.6308250862	considerably
0.6308250862	discuss
0.6308117841	suspension
0.6307954605	mg kg day
0.6307773849	polysaccharides
0.6307773849	antisecretory
0.6307773849	metallothionein
0.6307773849	progestogens
0.6307773849	glandular
0.6307773849	antiestrogens
0.6307773849	hamsters
0.6307773849	prion
0.6307773849	basiliximab
0.6307773849	quinoline
0.6307773849	repressor
0.6307773849	remikiren
0.6307773849	isometric
0.6307773849	exciting
0.6307731511	decreases
0.6307452174	md
0.6307369809	excluded
0.6307369809	acutely
0.6307284148	sought
0.6306864462	behaviors
0.6306864462	augmented
0.6306848367	vasodilation
0.6306848367	representing
0.6306848367	catabolism
0.6306848367	ameliorate
0.6306848367	moieties
0.6306848367	tightly
0.6306848367	thrombosis
0.6306848367	indications
0.6306848367	designated
0.6306150150	mao inhibitors
0.6306149222	modulator
0.6306103515	efficiency
0.6306069245	igg
0.6306069245	co2
0.6305154453	acute phase
0.6305119932	necrosis
0.6305088518	bronchial
0.6305062071	circadian
0.6305052272	binding
0.6305041597	rac1
0.6304901351	hypersensitivity
0.6304836708	mediating
0.6304721778	fusion
0.6304020605	right
0.6303873143	ppm
0.6303321066	stimulus
0.6303277717	tgf β signaling
0.6302380945	even
0.6302312653	goal
0.6302294482	provide evidence
0.6302284537	availability
0.6302210608	biologically
0.6302186482	galn
0.6302126909	register
0.6302126909	abatacept
0.6302025750	tag
0.6301021339	preventing
0.6300782900	bhmt
0.6300446335	constituents
0.6300446335	indirectly
0.6300339058	mecp2
0.6299194218	constipation
0.6299194218	quaternary
0.6299194218	insomnia
0.6299194218	adolescents
0.6299194218	transit
0.6299023343	bsa
0.6298823525	decreasing
0.6298296103	marimastat
0.6297705579	limiting
0.6297329031	thickness
0.6297329031	suspected
0.6297329031	lesion
0.6297329031	reversibly
0.6297329031	ubiquitous
0.6297329031	formyl
0.6297313420	explained
0.6297253474	pol
0.6296962284	ovary
0.6296900740	mental
0.6296750206	10mg
0.6296182304	protect
0.6296047266	1c
0.6295866876	allopregnanolone
0.6295186239	stimulate
0.6295142649	rapidly
0.6295097186	tomatidine
0.6294994737	snps
0.6294971778	arteries
0.6294940069	gt
0.6294674462	means
0.6294482728	beta and gamma
0.6294354530	plasma concentrations
0.6294328531	casein
0.6294169152	confirm
0.6294161277	mmp 2 and mmp 9
0.6293934988	add
0.6293934988	aspect
0.6293821844	mediated transport
0.6293720122	del
0.6293720122	histochemical
0.6293434636	processing
0.6293224708	null
0.6292227734	decarboxylase
0.6292072649	hf rats
0.6291934508	comet
0.6291763374	diabetic patients
0.6291339700	matched
0.6291339700	successfully
0.6291339700	substantially
0.6291339700	symptomatic
0.6291179471	ache activity
0.6290897442	antioxidant potential
0.6290762510	autophagic
0.6290762510	tabun
0.6290762510	monomer
0.6290762510	subfamily
0.6290461636	previously shown
0.6290410498	infiltration
0.6290410498	cost
0.6290410498	mineralization
0.6290396412	propyl
0.6290396412	osteoclastogenesis
0.6290396412	prostanoid
0.6290396412	sets
0.6290179981	jak
0.6289551225	injections
0.6289522554	pparα
0.6289437384	br
0.6289354903	expressed in chinese hamster ovary
0.6289321428	dg
0.6289069353	α and β
0.6289056463	pdk 1
0.6288979001	protein level
0.6288895559	×
0.6288555182	consecutive
0.6288525340	hydroxamic
0.6288362299	isomers
0.6288362299	reached
0.6288060355	methyltransferase
0.6287958844	infused
0.6287958844	eyes
0.6287905695	6 nitrotryptophan
0.6287741170	identity
0.6287406411	stimulatory
0.6286413568	salts
0.6286306277	pde3
0.6286162830	test
0.6285849358	genotype
0.6285526613	frequent
0.6285387028	elucidate
0.6285192635	ca2 +
0.6284799524	regimens
0.6284755309	fa
0.6284746804	channels
0.6284671309	human embryonic kidney 293
0.6284616857	african
0.6284174840	functioning
0.6284025500	aza
0.6283992247	et
0.6283413544	renal vascular
0.6282667749	defense
0.6282542245	induce
0.6282491728	ablation
0.6282431204	significantly suppressed
0.6282214303	aspartate
0.6282098208	ota
0.6281965615	regulation
0.6281961106	whole cell patch clamp
0.6281754611	fall
0.6280873311	nmol
0.6280861602	channel
0.6280591369	malonyl
0.6280479184	sil
0.6280258864	domains
0.6280245562	negative breast cancer
0.6279971778	remodeling
0.6279846677	damage
0.6279237116	spironolactone
0.6279237116	exocytosis
0.6279237116	summarize
0.6279237116	chemotactic
0.6279237116	processed
0.6279237116	determines
0.6279237116	burden
0.6279237116	elusive
0.6279237116	assumed
0.6279237116	provoked
0.6279237116	excreted
0.6279237116	impacts
0.6279237116	converts
0.6279237116	leukemic
0.6279237116	clarified
0.6279237116	coated
0.6279237116	encode
0.6279237116	named
0.6279237116	stabilizes
0.6279237116	backbone
0.6279237116	subcutaneously
0.6279237116	catalyses
0.6279237116	accepted
0.6279237116	accumulate
0.6279237116	obstruction
0.6279237116	autoreceptor
0.6279237116	tonic
0.6279237116	cytosine
0.6279237116	retrieval
0.6279048936	99m
0.6278785522	pre treatment
0.6278772383	pe
0.6278433664	knock out mice
0.6278226190	non hodgkin
0.6277982379	alter
0.6277779470	ucp 3 mrna
0.6277752411	proved
0.6277633966	early phase
0.6277449336	converting
0.6277448183	almost
0.6277345226	significantly lower
0.6276904070	su11248
0.6276904070	c6
0.6276884868	2b
0.6276787314	values
0.6276675838	pharmacological effects
0.6276658447	pq
0.6276443082	pca
0.6276427612	rpe
0.6275932155	tc
0.6275411957	inhibiting
0.6275096246	scattering
0.6274875329	actions
0.6274816301	employed
0.6274366665	size
0.6274343068	segment
0.6274033827	residues
0.6273160887	intestine
0.6273124020	numbers
0.6273048104	offer
0.6273048104	readily
0.6272862979	strontium
0.6272862979	dutasteride
0.6272650352	hc
0.6272382427	clc
0.6272352577	injection
0.6271821747	month
0.6271806666	calculated
0.6271748339	wk
0.6271666009	bind
0.6271656102	dmt
0.6271172396	sites
0.6271113001	reflect
0.6270930024	cox 1
0.6270707124	gapdh
0.6270676183	pancreas
0.6270460512	suppresses
0.6270453138	3t3 l1 cells
0.6270195298	hydroxyl
0.6269760184	fungal
0.6269760184	partners
0.6269760184	plaque
0.6269760184	excitation
0.6269126608	highest
0.6269034251	dependence
0.6268795768	mo
0.6268712349	chem
0.6268349724	nizatidine
0.6268349724	biochemistry
0.6268349724	pharmacogenetics
0.6268349724	tetracyclines
0.6267726547	effector
0.6267726547	integrity
0.6267726547	dramatically
0.6267359312	ikk
0.6267155877	cancer progression
0.6266733223	blockade
0.6265793354	s6
0.6265668380	opinion
0.6265425062	pa2
0.6265018604	galactose
0.6264816142	hours
0.6264520735	xenopus
0.6264446335	interface
0.6264416873	spots
0.6264416873	associate
0.6264416873	pass
0.6264340420	disease
0.6264195949	training
0.6263704078	bs
0.6263644640	acts
0.6263160887	triggered
0.6263104348	sem
0.6262529478	prevents
0.6262285718	cell membrane
0.6262251264	ganglion cells
0.6261928775	glutamate transporter
0.6261185682	presented
0.6261129543	pai
0.6260833579	human liver
0.6260633562	strategies
0.6260312653	randomly
0.6259945756	inhibition
0.6259943449	chain
0.6259528800	advantage
0.6258562785	take
0.6258459533	site directed
0.6257960512	preparations
0.6257510767	electron
0.6257448819	terminal half
0.6257357457	il 18
0.6257064419	possesses
0.6257064419	varying
0.6256784475	monophosphate
0.6256513326	neurodegenerative
0.6256513326	cytosol
0.6256359231	agonists and antagonists
0.6256340360	gavage
0.6256340360	citrate
0.6256340360	displaced
0.6256340360	thio
0.6255974262	sizes
0.6255974262	problems
0.6255974262	consumed
0.6255974262	latency
0.6255974262	counterparts
0.6255974262	pools
0.6255927675	hamster
0.6255400426	clinically important
0.6254923372	insulin receptor
0.6254141611	anthocyanidins
0.6254065538	p38
0.6253990791	p38 mitogen activated protein
0.6253822291	makes
0.6253702385	vegf release
0.6253555796	glomerular filtration
0.6252931714	imidapril
0.6252931714	microinjection
0.6252901293	orally
0.6252744424	diminished
0.6252734354	exclusively
0.6252243859	hba1c
0.6251978962	gad65
0.6251964808	youth
0.6251816630	promote
0.6251684040	h1 receptor
0.6251065243	exert
0.6250756908	des
0.6250662264	cholesterol biosynthesis
0.6250440062	molecular target
0.6250358873	sv
0.6250166155	gly
0.6250005703	nhe3
0.6249997655	contractions of rat
0.6249972701	transforming
0.6249729941	metastasis
0.6249374268	stress
0.6249333931	pvn
0.6248590443	anti metastatic
0.6247960512	fractions
0.6247950487	cse
0.6247684324	chop
0.6247566576	epr
0.6247488795	⁻
0.6247315821	complex
0.6247189207	lactamase
0.6246513326	knowledge
0.6246212414	hypertrophy
0.6245907094	target gene
0.6245772112	based chemotherapy
0.6245617957	aorta
0.6245464935	lasting
0.6245335929	measured
0.6245114767	slow
0.6245100869	pki
0.6244620536	reward
0.6244290658	close
0.6244180982	firing
0.6244114359	deoxyuridine
0.6244049640	alpha 1a
0.6243993479	hyperglycaemia
0.6243990960	benefit
0.6243952727	riboflavin
0.6243891656	analogue
0.6243826133	crf
0.6243780511	pon1
0.6243639287	ability
0.6243068484	balb c mice
0.6243037706	pathway
0.6242931853	mptp
0.6242714515	cam
0.6242698374	rho
0.6242169746	starting
0.6241994003	molecule
0.6241978813	positivity
0.6241636469	iu
0.6241343215	tiuxetan
0.6240943506	responsive
0.6240878118	u
0.6240748325	y
0.6240633471	1h
0.6240631872	rac
0.6240334020	jurkat
0.6239726129	radioactive
0.6239651763	ω
0.6239651763	environments
0.6239651763	acetylated
0.6239651763	carrageenan
0.6239651763	leukaemia
0.6239651763	residual
0.6239651763	load
0.6239651763	fused
0.6239651763	hydroxylated
0.6239651763	bromo
0.6239269322	adenylate
0.6239065538	acting
0.6238904169	bound
0.6238881231	work
0.6238778694	strains
0.6238645435	origin
0.6238143544	gtpgammas
0.6237459664	micromol l
0.6237388719	flip
0.6237332401	beta2
0.6237315319	emt
0.6237250667	oxidoreductase
0.6236965755	enhancers
0.6236965755	outgrowth
0.6236772317	conivaptan
0.6236349739	phosphatidylinositol
0.6235231910	causing
0.6234997041	genome
0.6234336627	mate
0.6233986744	clinical studies
0.6233937945	protected
0.6233607968	placebo
0.6233357030	expression
0.6232988994	kinetic properties
0.6232713225	months
0.6232552486	clones
0.6231996050	labeling
0.6231816630	demonstrates
0.6231735038	g csf
0.6231691252	hek293
0.6231504532	glut3
0.6231479410	gliclazide
0.6231438894	agt
0.6231017919	encoding
0.6230898269	azilsartan
0.6230380279	deficient
0.6230328208	broad
0.6230054420	requirement
0.6229482928	emax
0.6229390640	maintained
0.6229334699	1alpha
0.6229316630	typical
0.6229054924	aged
0.6228230507	pig
0.6227500411	unaffected
0.6227361913	cell
0.6227283532	5 methoxytryptamine
0.6227037742	mini
0.6227037742	lysozyme
0.6227037742	mechanically
0.6227037742	sign
0.6227037742	carboxylesterase
0.6227037742	rutin
0.6227037742	atosiban
0.6227037742	persons
0.6227037742	phagocytosis
0.6227037742	nutrients
0.6227037742	cholestatic
0.6227037742	organotypic
0.6227037742	performing
0.6227037742	atrazine
0.6227037742	formaldehyde
0.6227037742	establishing
0.6227037742	tunable
0.6227037742	quantitation
0.6227037742	coumarins
0.6227037742	phenols
0.6227037742	stathmin
0.6227037742	concepts
0.6227037742	stratified
0.6227037742	osteoblastic
0.6227037742	transcribed
0.6227037742	methazolamide
0.6227037742	supernatants
0.6227037742	probed
0.6227037742	parathion
0.6227037742	carefully
0.6227037742	biogenic
0.6227037742	electrodes
0.6226623125	reporter
0.6226422906	frequency
0.6225873821	neurons
0.6225859462	identify
0.6225494366	foxo1
0.6225451207	γ
0.6225307171	isozyme
0.6225017097	penicillin
0.6224926803	weak
0.6224858399	augmentation
0.6224858399	quantify
0.6224311942	stimulated
0.6224212522	sequences
0.6224079800	primarily
0.6223913001	luminal
0.6223913001	seeds
0.6223913001	coactivator
0.6223913001	glycoproteins
0.6223913001	phytochemicals
0.6223913001	contaminants
0.6223913001	erythroid
0.6223913001	phosphatases
0.6223913001	epitope
0.6223835101	cup
0.6223743572	antagonism
0.6223581082	efficacious
0.6223564486	caucasian
0.6222753546	beta3
0.6222753546	detergent
0.6222753546	lipoproteins
0.6222753546	orthosteric
0.6222753546	stroma
0.6222753546	operation
0.6222753546	aldehydes
0.6222575341	exerted
0.6222575341	involve
0.6222481774	loading
0.6222481774	families
0.6222375385	yet
0.6222057501	puma
0.6222029426	glycogen
0.6220987570	receiving
0.6220815127	transporting polypeptide
0.6220422578	protein and mrna
0.6220024959	ccl
0.6219828539	enhance
0.6219707264	platform
0.6219638366	abcb1
0.6219626167	concentration
0.6219451876	autonomic
0.6219451876	cyclosporin
0.6219451876	α1
0.6219451876	5a
0.6219451876	dicarboxylate
0.6219451876	heterodimers
0.6219451876	polar
0.6219451876	malate
0.6219451876	alpha2a
0.6219451876	deoxycytidine
0.6219349854	implication
0.6219336622	ho
0.6219282225	catalysed
0.6219222331	reaction
0.6218837004	excitability
0.6218837004	modeled
0.6218837004	bands
0.6218837004	valsartan
0.6218837004	polysaccharide
0.6218837004	weaning
0.6218837004	sensitizes
0.6218837004	localize
0.6218837004	electrostatic
0.6218837004	raise
0.6218837004	reason
0.6218837004	liability
0.6218837004	remission
0.6218837004	comprising
0.6218837004	acyltransferase
0.6218837004	facilitates
0.6218837004	reach
0.6218837004	probable
0.6218837004	locations
0.6218837004	dosed
0.6218837004	wash
0.6218837004	arise
0.6218837004	dosages
0.6218460873	ma
0.6218441903	cftr
0.6218441903	ass
0.6218148329	cycling
0.6218058826	x
0.6217811307	pattern
0.6217637199	studies demonstrated
0.6217583424	producing
0.6217283532	5 ht1c
0.6217179916	yielded
0.6216591119	trap
0.6216458940	slope
0.6216432007	3t3
0.6216432007	stably
0.6216344752	tsa
0.6216033401	tranylcypromine
0.6216033401	1b1
0.6216033401	plaques
0.6215459701	glut
0.6214966344	components
0.6214683466	completed
0.6214680325	cardiotoxicity
0.6214272728	heterologously
0.6213601314	markedly
0.6213481774	sensing
0.6213319958	chemerin
0.6213319958	urothelial
0.6213319958	nadolol
0.6213319958	nanocrystals
0.6213319958	stresses
0.6213319958	thieno
0.6213319958	dimethylarginine
0.6213319958	grafts
0.6213319958	oxandrolone
0.6212325173	bde
0.6212229455	nuclear factor of activated t cells
0.6211107825	glycolate
0.6211107825	spermatozoa
0.6211107825	amezinium
0.6211107825	cilomilast
0.6211107825	baicalin
0.6211005914	reversed
0.6210753444	cb2
0.6210728454	hh
0.6210697824	sun
0.6210495304	synovial
0.6210477723	icam 1
0.6210122293	pra
0.6208748711	nav1
0.6208653780	first
0.6208600470	expected
0.6208544176	chaperone
0.6208544176	precipitation
0.6208544176	homolog
0.6208544176	enables
0.6208544176	transcriptionally
0.6208544176	lipogenesis
0.6208544176	elevations
0.6208544176	microenvironment
0.6208544176	giving
0.6208544176	reflecting
0.6208544176	stabilizing
0.6208544176	presumed
0.6208544176	parasite
0.6208544176	neurotoxin
0.6208544176	immobilized
0.6208544176	postulated
0.6208544176	indication
0.6208544176	machinery
0.6208544176	midbrain
0.6208544176	sufficiently
0.6208544176	paraoxon
0.6208544176	reasons
0.6208544176	fundamental
0.6208544176	systematically
0.6208544176	framework
0.6208544176	cognate
0.6208544176	explaining
0.6208544176	undetectable
0.6208544176	malignancy
0.6208544176	carry
0.6208544176	ketanserin
0.6208544176	repolarization
0.6208544176	gradually
0.6208544176	raising
0.6208544176	confirming
0.6208301783	β
0.6208236254	changed
0.6208091318	lactose
0.6208045212	lactic
0.6207473438	much
0.6206904107	completely
0.6206642920	clorgyline
0.6206642920	reductases
0.6206642920	exchanger
0.6206642920	esterified
0.6206642920	autoreceptors
0.6206642920	naïve
0.6206642920	cure
0.6206642920	vomiting
0.6206385931	2a13
0.6206183405	2r
0.6206009451	positron
0.6205700194	gene regulation
0.6205220500	kinase
0.6204825392	discussed
0.6204808448	support
0.6204784420	conclude
0.6204641182	calnexin
0.6204641182	pepsin
0.6204641182	resolving
0.6204641182	dyes
0.6204641182	retains
0.6204641182	sulfamates
0.6204641182	exploratory
0.6204641182	determinations
0.6204641182	ivermectin
0.6204641182	steatohepatitis
0.6204641182	supportive
0.6204641182	gastroduodenal
0.6204641182	silicon
0.6204641182	algal
0.6204641182	compromise
0.6204641182	p15
0.6204641182	cinnamaldehyde
0.6204641182	dysregulated
0.6204641182	clotrimazole
0.6204641182	mutagenicity
0.6204641182	biotinylated
0.6204641182	methiothepin
0.6204641182	normalization
0.6204641182	safer
0.6204641182	deptor
0.6204641182	functionalization
0.6204641182	histopathology
0.6204641182	optimizing
0.6204641182	yellow
0.6204641182	tethered
0.6204641182	biogenesis
0.6204641182	polyphenol
0.6204641182	nandrolone
0.6204641182	obtaining
0.6204641182	lisinopril
0.6204641182	antiserum
0.6204641182	younger
0.6204641182	aspartoacylase
0.6204641182	qualitatively
0.6204641182	packing
0.6204641182	methylmalonic
0.6204641182	immunocytochemistry
0.6204641182	restoring
0.6204641182	purinergic
0.6204641182	graded
0.6204641182	kinetically
0.6204641182	introducing
0.6204641182	substitute
0.6204641182	mazindol
0.6204641182	amrinone
0.6204641182	damaging
0.6204641182	neutralization
0.6204583821	classified
0.6204321437	human ether
0.6204317322	c57bl
0.6204275450	tazarotene
0.6203883458	low and high
0.6203301006	adrenoceptors
0.6202510767	approved
0.6202158426	evoked
0.6202001816	antagonistic activity
0.6201900023	units
0.6201645959	antiandrogen
0.6201645959	clarithromycin
0.6201645959	epoxide
0.6201645959	esterase
0.6201645959	caspases
0.6201645959	transgene
0.6201645959	thioridazine
0.6201065315	place
0.6201052560	μ
0.6200912553	fluvastatin
0.6200912553	acetone
0.6200912553	silver
0.6200912553	aquaporin
0.6200912553	disubstituted
0.6200912553	diazinon
0.6200912553	removing
0.6200912553	enalkiren
0.6200912553	corneas
0.6200912553	taxanes
0.6200912553	griseofulvin
0.6200912553	sedation
0.6200912553	micrornas
0.6200912553	azoles
0.6200912553	benzodiazepines
0.6200912553	precipitated
0.6200836654	proliferation and differentiation
0.6200762737	control
0.6200508557	crc
0.6200444770	fpg
0.6200354602	us
0.6200318313	biotinylation
0.6200149689	4h
0.6199997778	stomach
0.6199740373	protein expressions
0.6199614361	tio2
0.6199457416	gabaa
0.6199310493	ezetimibe
0.6199020034	analogues
0.6198964230	includes
0.6198744856	itd
0.6198402317	methods and results
0.6198335827	reveal
0.6197576575	c ebpβ
0.6197540070	remains poorly
0.6197005813	tr
0.6196982886	human breast
0.6196894702	lsd
0.6196698111	relaxation
0.6196526840	attenuated
0.6196413215	order of potency
0.6196259552	underwent
0.6196259552	cascade
0.6195852241	formation
0.6195788082	weeks
0.6195777181	igf i
0.6195568587	ecstasy
0.6195084230	fu
0.6195081859	slightly
0.6195051482	opn
0.6194746525	labeled
0.6194533867	limb
0.6194471516	pten
0.6193839278	sensitive
0.6193543228	p65
0.6193343457	ptz
0.6193177405	correlates
0.6193095174	film
0.6193095174	recycling
0.6193051444	colorectal
0.6192905107	reduction
0.6192817064	twitch
0.6192817064	mglur1
0.6192817064	relatives
0.6192817064	carbamate
0.6192689968	asct2
0.6192492581	strikingly
0.6192230584	substrate
0.6191682618	adrenoceptor
0.6191391743	amph
0.6190856513	contents
0.6190621480	influence
0.6190205278	provide
0.6189911938	edema
0.6189907911	function
0.6189412107	ca2
0.6189387302	som230
0.6189069367	p selectin
0.6188784515	oestrogen receptor
0.6188666996	and neck squamous
0.6188653287	precursor
0.6188355596	nqo1
0.6188130900	uk
0.6188014615	gfp
0.6187865577	mglu5
0.6187492954	remains
0.6187341442	bleomycin
0.6187341442	isoleucine
0.6187341442	died
0.6186763328	nervous system
0.6186533600	octopamine
0.6186533600	antofine
0.6186533600	ecto
0.6186331872	ozone
0.6186331872	depth
0.6186331872	alternatives
0.6186135608	adr
0.6185608504	taken
0.6185494778	alpha 2c
0.6185215211	positive and negative
0.6185144058	human tumor cell lines
0.6185096213	cpp
0.6185023301	hct116
0.6184949580	erbb2
0.6184679100	dissociation
0.6184675040	gw572016
0.6184478967	hematological
0.6184478967	damaged
0.6184478967	highlighting
0.6184478967	hyperlipidemia
0.6184478967	reflects
0.6184478967	cascades
0.6184478967	revealing
0.6184478967	dihydropyridine
0.6184478967	attenuating
0.6184478967	widespread
0.6184478967	corrected
0.6184478967	possessed
0.6184478967	unexpected
0.6184478967	slowing
0.6184478967	extend
0.6184478967	constitutes
0.6184403202	tnfalpha
0.6184210195	affects
0.6183874462	proven
0.6183801477	exist
0.6183245715	asparagine
0.6183245715	kcat
0.6183198985	rate
0.6183160927	shows
0.6182558455	pfos
0.6182310961	cleavage
0.6182283532	5 ht4
0.6182118523	such
0.6181773123	excretion
0.6181580703	tumor cell lines
0.6181502854	ee
0.6181172613	requiring
0.6181172613	cytoskeleton
0.6181172613	cholestasis
0.6181172613	intermediates
0.6181172613	biologic
0.6181172613	2d6
0.6181172613	modulatory
0.6181172613	enabled
0.6181172613	naive
0.6181172613	promotion
0.6181172613	laboratories
0.6181172613	actively
0.6181172613	reconstituted
0.6181172613	lacks
0.6181172613	functionality
0.6181172613	putrescine
0.6181172613	constituent
0.6181172613	therapeutically
0.6181172613	behaviour
0.6181172613	sensors
0.6181172613	highlights
0.6181172613	myocardium
0.6181172613	proteases
0.6181172613	alleviate
0.6181172613	subgroups
0.6181104283	beta cell function
0.6181041652	alpha
0.6179937239	sarin
0.6179937239	users
0.6179937239	diameter
0.6179937239	carboxamide
0.6179937239	epithelia
0.6179937239	motifs
0.6179937239	commercial
0.6179937239	ovine
0.6179937239	methylated
0.6179937239	compartments
0.6179842405	dopamine d4 receptor
0.6179503336	tbars
0.6179424392	potential targets
0.6179205675	supported
0.6179079187	parental cells
0.6178925815	reinforcing
0.6178160108	mesylate
0.6177911781	subunits
0.6176762956	ars
0.6176610574	dpph
0.6176211537	colq
0.6175607885	characterisation
0.6175489481	lqt3
0.6175443391	moiety
0.6175339804	steroid receptor
0.6175000069	pharmacological properties
0.6174995550	aag
0.6174497248	isoenzymes
0.6174477774	markers
0.6174353981	rates
0.6173924227	modified
0.6173676056	utr
0.6173676056	btx
0.6173105509	solutions
0.6172994460	camp
0.6172785950	society
0.6172573624	ossification
0.6172573624	endochondral
0.6172573624	macular
0.6172418625	determined
0.6172183337	salicylates
0.6171715435	stretch
0.6171209559	oat
0.6170972371	inactive
0.6170801283	injected
0.6170641713	rewarding
0.6170499463	dpd
0.6170436377	candidates
0.6169848535	percutaneous
0.6169848535	penile
0.6169848535	coadministered
0.6169848535	blots
0.6169704588	b5
0.6169571141	bioactivity
0.6169571141	concerns
0.6169571141	instability
0.6169571141	antiapoptotic
0.6169571141	surrounding
0.6169571141	hyperalgesia
0.6169571141	constructs
0.6169571141	larvae
0.6169571141	addressed
0.6169571141	responded
0.6169571141	dissociated
0.6169571141	extension
0.6169571141	conformations
0.6169571141	heteromeric
0.6169571141	incorporating
0.6169571141	stained
0.6169571141	prognostic
0.6169571141	lumen
0.6169002964	treatment option
0.6168420075	·
0.6168066935	attention
0.6167976247	bolus
0.6167976247	tetrahydro
0.6167724637	cerebellar
0.6167724637	sulpiride
0.6167724637	triacylglycerol
0.6167424614	needed
0.6167424092	glur
0.6167389121	ibd
0.6167356686	rat and human
0.6167191733	hydrocarbons
0.6166703539	therapies
0.6166355502	1β
0.6166325623	performed
0.6166179538	times
0.6166132903	mtc
0.6165888228	ginger
0.6165079906	inhibitory concentration
0.6165030202	rsv
0.6164256309	locomotor
0.6164066928	link
0.6163886070	er negative
0.6163251793	pomc
0.6162761809	beta end
0.6162621667	tool
0.6162254632	b raf
0.6162014615	dhpg
0.6161893038	pyridostigmine
0.6161893038	repaglinide
0.6161893038	lycopene
0.6161875047	associations
0.6161249880	ht2b
0.6161111476	ptx
0.6161026773	lfa 1
0.6160337438	hoat4
0.6160065462	supplemented
0.6159943288	penetration
0.6159943288	diarrhea
0.6159943288	roots
0.6159901804	migration
0.6159864532	pathways
0.6159787947	five
0.6159550708	nucleotide
0.6159477110	improved
0.6159368660	glycan
0.6159368660	p75
0.6159043808	xl
0.6158160973	neuronal survival
0.6158130357	blocked
0.6158052586	analog
0.6157671739	subunit
0.6157416930	synthase
0.6157210404	perhaps
0.6156881628	t
0.6156816935	adipocytes
0.6156594076	lpa
0.6156302633	partially
0.6156295843	produce
0.6156152385	mineralocorticoid
0.6155817936	α
0.6155241217	address
0.6154787574	cx43
0.6154397140	europe
0.6154121399	acs
0.6153854705	cdna
0.6153184414	report
0.6153102381	membranes
0.6152804460	outward
0.6152770723	junction
0.6152685520	difficult
0.6152432887	spatial
0.6152068875	scope
0.6152005195	b cell lymphoma
0.6151889589	retinoic acid receptors
0.6151815441	symptoms
0.6151668060	aflatoxin
0.6151668060	mum
0.6151355003	tomudex
0.6151343483	controls
0.6150429848	ka
0.6150318645	aliskiren
0.6149822595	lacking
0.6149781244	smaller
0.6149724325	fold
0.6149408170	abolished
0.6149248284	efficacy and safety
0.6148641680	antagonists
0.6148597716	old
0.6148448220	fibrosis
0.6148252086	cyt
0.6148163505	colon
0.6148130357	affect
0.6146963731	april
0.6146882725	th1
0.6146476641	pc12
0.6146383514	undertaken
0.6146079832	transmission
0.6145887742	fed
0.6145711479	dt
0.6145675391	degrees
0.6145578289	mechanistic studies
0.6145287016	mor
0.6145192411	positive breast cancer
0.6145105743	pcl
0.6145094788	ret
0.6145049124	generate
0.6144581313	medline
0.6144414678	microg
0.6144197667	twenty
0.6144030222	tf
0.6144017383	previous findings
0.6143223324	assays
0.6143000010	phd
0.6142896701	gpx1
0.6142819644	differs
0.6142609098	upregulation
0.6142556464	tablet
0.6142556464	responders
0.6142508517	monocytes
0.6142268932	downregulation
0.6141902456	∼
0.6141545372	week old
0.6141134079	fashion
0.6141027702	erk phosphorylation
0.6140992364	ethanol induced
0.6140902354	portal
0.6140771973	occur
0.6140555867	ig
0.6140237610	neck
0.6139318466	membrane bound
0.6139160108	object
0.6139056486	mediated contractions
0.6138088594	daf
0.6138038125	metabolized
0.6137893745	central role
0.6137166436	receptor
0.6137085126	ast
0.6136841972	±
0.6136722618	structures
0.6136710336	possess
0.6136295904	carbonic anhydrase inhibitors
0.6136106209	glial cell
0.6135910899	john
0.6135837680	occurred
0.6135833150	phex
0.6135776323	usa
0.6135260094	biological activities
0.6134781244	allowed
0.6134164395	mrnas
0.6133926289	carriers
0.6132807477	res
0.6132681610	cpe
0.6130828466	enac
0.6130712058	manner
0.6130571039	environment
0.6130270103	sdf
0.6129991030	epac
0.6129644735	agreement
0.6129483167	nachrs
0.6129226315	il 2
0.6128187498	purkinje
0.6128113746	dc
0.6128077148	ht2c
0.6127738311	c3
0.6127165189	position
0.6127071577	gd
0.6126966812	gmp
0.6126814494	dec
0.6126661889	conducted
0.6126648040	oat1
0.6126195930	dependent and independent
0.6126004219	cox 1 and cox 2
0.6125809832	caco 2 cells
0.6125753008	proteasome inhibitor
0.6124867650	syn
0.6124867650	beta1ar
0.6124867650	unity
0.6124499766	emerged
0.6124446463	action
0.6124313465	teta
0.6123947488	prevented
0.6123224465	reverses
0.6123224465	piperidine
0.6123224465	imply
0.6123224465	wounds
0.6123224465	relaxations
0.6123224465	drop
0.6123224465	coefficients
0.6123224465	coating
0.6123224465	utero
0.6123224465	repressed
0.6123224465	complication
0.6123224465	overexpress
0.6123224465	occupied
0.6123224465	yielding
0.6123224465	ileum
0.6123224465	1a1
0.6123224465	entered
0.6123224465	monomers
0.6123224465	anticoagulation
0.6123224465	chosen
0.6123224465	dextran
0.6123224465	marketed
0.6123224465	insecticides
0.6123224465	situations
0.6123224465	fate
0.6123224465	overlap
0.6123224465	excitotoxic
0.6123224465	hyperglycemic
0.6123224465	abolishes
0.6123224465	unusual
0.6123224465	bath
0.6123224465	chaperones
0.6122639370	t pa
0.6122598918	understood
0.6122052213	fgf 7
0.6121230394	protease inhibitors
0.6121052299	beta2ar
0.6120663621	promoting
0.6120494223	disruption
0.6120428051	ccr5
0.6120315266	administered
0.6120102929	name
0.6120016999	nonselective
0.6119758143	glucose oxidation
0.6119464802	cell mass
0.6119445637	located
0.6119307837	twice daily
0.6118623226	li
0.6117737347	kg
0.6117227170	inhibit
0.6117212664	antioxidant and anti inflammatory
0.6116500010	pnd
0.6116375420	classes
0.6116088114	de novo
0.6115667121	hypertensive
0.6115649064	remained
0.6115564527	fold lower
0.6115497269	females
0.6115472755	exhibits
0.6115412544	four
0.6114828862	ep
0.6114557850	linked
0.6114144946	structural and functional
0.6114026085	cloned
0.6113973266	µm
0.6113867680	penicillin binding
0.6113811872	surge
0.6113591850	populations
0.6113480695	signs
0.6112600414	induced apoptosis
0.6112107085	upa
0.6111528791	once weekly
0.6111528180	activation
0.6111403679	applied
0.6111090035	events
0.6111057725	4b
0.6110941927	inflammation
0.6110850729	beta 2 adrenoceptor density
0.6110503564	brief
0.6109957946	axl
0.6109925410	antagonist
0.6109504167	receptors
0.6109405387	risk
0.6109332845	etoh
0.6109243786	deferasirox
0.6109243786	hypospadias
0.6109243786	biochemically
0.6109243786	buprenorphine
0.6109243786	proteoglycans
0.6109243786	extravasation
0.6109243786	brexpiprazole
0.6109243786	versatile
0.6109243786	droplet
0.6109243786	deoxyglucose
0.6109243786	retrospective
0.6109243786	mesalamine
0.6109243786	swim
0.6109243786	dimethocaine
0.6109243786	cerivastatin
0.6109243786	zuclopenthixol
0.6109243786	polyp
0.6109243786	mimosine
0.6109243786	stopped
0.6109212058	exposed
0.6109151731	cd1
0.6108805415	hk
0.6108724296	assessed
0.6108563204	dehp
0.6108563204	bm
0.6108539671	mglu
0.6108395616	asp
0.6108148870	l cystine
0.6108003336	alp
0.6107906552	demonstrate
0.6107846106	weeks of age
0.6107837731	tas
0.6107807132	bone mineral
0.6107747849	directly
0.6107716631	talampanel
0.6107626518	whether
0.6107151171	adult rat
0.6106778445	μm
0.6106758955	patch
0.6106535491	glucoside
0.6106195691	epo
0.6106090035	targets
0.6105494223	interact
0.6105472755	activates
0.6105205545	chk1
0.6105205545	akr1b10
0.6105133213	systems
0.6103557188	discussion
0.6103442353	colchicine
0.6102772460	humanized
0.6102604165	years
0.6102453336	acs1
0.6102041345	tail
0.6101983907	tested
0.6101820265	susceptible
0.6101124397	stromal
0.6101102903	antitussive
0.6100232161	largely
0.6100003865	cannabis
0.6100003865	apigenin
0.6099739856	beta 2 adrenoceptors
0.6099537477	jaceosidin
0.6099537477	alendronate
0.6099537477	huperzine
0.6099515482	1b
0.6099435385	bsep
0.6099129056	post injection
0.6099127823	ea
0.6098973189	qd
0.6098922987	xct
0.6098922987	chelator
0.6098922987	nondiabetic
0.6098922987	antihistamines
0.6098922987	glycolytic
0.6098922987	inappropriate
0.6098922987	communication
0.6098922987	salvage
0.6098922987	killing
0.6098922987	cancerous
0.6098922987	skeleton
0.6098922987	saponins
0.6098487913	hz
0.6098249206	tpo
0.6098146215	p22
0.6097777191	nmj
0.6097777191	dopac
0.6097759675	important
0.6096955334	parameters
0.6096513310	apelin
0.6096319123	males
0.6096271593	day
0.6095950791	cycle
0.6095904463	underlying
0.6095805006	binding assay
0.6095512800	production
0.6095444427	suggested
0.6095268191	behavior
0.6094899543	inhibitory effect
0.6094628997	appropriate
0.6094455666	flibanserin
0.6093969222	c terminal
0.6093948318	gray
0.6093948318	antidiuretic
0.6093707916	ciii
0.6093555770	sct
0.6093334284	keap1
0.6092905437	ato
0.6092790488	gdnf
0.6092247564	safety and efficacy
0.6092037905	gfr
0.6091869279	structured
0.6091158465	engineering
0.6090670290	human butyrylcholinesterase
0.6090628066	condition
0.6090191702	huvec
0.6089995629	three dimensional
0.6089543986	jun
0.6089268191	products
0.6088690472	reduce
0.6088659211	stem
0.6088440300	normetanephrine
0.6088264165	human embryonic kidney 293 cells
0.6087153598	interference
0.6086738572	direct interaction
0.6086511639	cy
0.6086455251	organs
0.6086455251	greatly
0.6086352898	border
0.6086319123	predominantly
0.6086183622	isozymes
0.6085837918	μg
0.6085339476	1α
0.6085317961	therapeutic potential
0.6085057678	breast cancer cell lines
0.6084814398	incorporation
0.6084200284	susceptibility
0.6083717868	lxr
0.6083200812	formed
0.6083168157	explain
0.6083161833	avoid
0.6083161833	plexus
0.6083059234	lyso
0.6081854572	involvement
0.6081815655	occurs
0.6081534207	unknown
0.6081525376	knockout rats
0.6081433854	express
0.6081045683	lorcaserin
0.6081045683	voluntary
0.6081045683	trabecular
0.6081045683	standardized
0.6080993176	os
0.6080882710	pi3k inhibitor
0.6080283298	nash
0.6080141249	administrated
0.6080141249	thrombus
0.6080141249	allergen
0.6080141249	propeptide
0.6080141249	kynurenine
0.6080141249	palmitoyl
0.6080141249	generates
0.6080141249	quinazoline
0.6079789093	suppressed
0.6079694630	ptdser
0.6078617006	serotonin reuptake inhibitors
0.6078584191	ex vivo
0.6078095945	given
0.6077685056	canagliflozin
0.6077646651	calves
0.6077646651	biopterin
0.6076963309	brs
0.6076848109	elucidated
0.6076848109	concluded
0.6075696242	monoamine transporter
0.6075648037	required
0.6075567973	4a
0.6075508253	arsenic exposure
0.6075489538	release
0.6075208318	bd
0.6075187618	oatp2b1
0.6075187618	mrp1
0.6075187618	oatp1b3
0.6074928813	pgh
0.6074786669	schild
0.6074768724	mig6
0.6074768724	rxralpha
0.6074732908	triglyceride levels
0.6074003710	pahs
0.6073883938	kinetic studies
0.6073339337	restored
0.6073231787	raw264
0.6073013223	derivative
0.6072935140	lower concentrations
0.6072861019	rock
0.6072253540	ssris
0.6072037905	cvd
0.6071645590	synthesized
0.6069845047	va
0.6069435433	novel
0.6068790512	s1
0.6068445289	3a
0.6067990511	processes
0.6067120784	1a
0.6066848109	providing
0.6066451671	transaminase
0.6066319123	recorded
0.6065803272	expressing
0.6065630360	resistance
0.6065122055	rb
0.6065014311	phthalate
0.6065014311	holoenzyme
0.6065014311	locomotion
0.6065014311	overflow
0.6064554356	nafld
0.6064432587	az
0.6063704132	expressed
0.6063605189	v600e
0.6063487132	5 ht
0.6063000751	huvecs
0.6062775245	strongly
0.6062120155	p16
0.6062120155	betamethasone
0.6062085631	affinity
0.6061636147	ssri
0.6061393560	epi
0.6061108477	macrocyclic
0.6061108477	irreversibly
0.6061108477	nortriptyline
0.6061108477	shared
0.6061108477	measurable
0.6061108477	antiestrogen
0.6061108477	semi
0.6061108477	augments
0.6061108477	damages
0.6061108477	spanning
0.6061108477	exclusion
0.6061108477	astrocyte
0.6061108477	progressed
0.6061108477	isoflavone
0.6061108477	ultrastructural
0.6061108477	metabolize
0.6061108477	input
0.6061108477	volumes
0.6061108477	paralleled
0.6061108477	routes
0.6061108477	constriction
0.6061108477	parameter
0.6061108477	collagenase
0.6061108477	epileptic
0.6061108477	hypothesize
0.6061108477	probability
0.6061108477	illustrate
0.6061108477	shares
0.6061108477	accelerate
0.6061108477	shaped
0.6061108477	mapped
0.6061108477	ways
0.6061108477	delays
0.6061108477	largest
0.6061108477	asymptomatic
0.6061108477	implanted
0.6061108477	principle
0.6061108477	synthesizing
0.6061108477	uncertain
0.6061108477	antiangiogenic
0.6061108477	narrow
0.6061108477	bases
0.6061108477	sized
0.6061108477	washout
0.6061108477	unaltered
0.6061108477	solved
0.6061067559	ro
0.6060597271	variability
0.6059386005	ideal
0.6059347043	rather
0.6059224674	what
0.6058864245	up regulated
0.6058792513	tzd
0.6058622001	transporters
0.6058195163	n
0.6057481175	cip1
0.6057382962	hcy
0.6057265755	mechanism
0.6056831855	shown
0.6056476654	hsp90
0.6054790067	ngf
0.6054320554	mf
0.6054158735	provided
0.6054117811	ovx
0.6053500690	tpp
0.6053206663	rad51
0.6053206663	stat1
0.6053206663	rnas
0.6053048696	av
0.6052892357	kinase activity
0.6052531629	diseases
0.6052355453	versus
0.6052291650	chf
0.6050868870	o2
0.6050722992	markedly suppressed
0.6050581947	cos
0.6050244137	negatively correlated with
0.6049774269	results in increased
0.6049660563	mouse and human
0.6049231670	groups
0.6049155829	differentiated
0.6049155829	forming
0.6049004518	emphasis
0.6049004518	granulocyte
0.6048931516	si
0.6048383654	hpf
0.6048333964	ncam
0.6047836477	ws
0.6047574770	efflux
0.6047480350	k562
0.6047443555	hm74a
0.6047127823	msc
0.6047118895	2s
0.6046898050	hinokitiol
0.6046834798	exp
0.6046830518	dp
0.6046773224	mapk pathway
0.6046498091	tdcpp
0.6045533134	extrusion
0.6045533134	immobility
0.6045533134	repeats
0.6045533134	4β
0.6045533134	collecting
0.6045533134	amides
0.6045139706	lung epithelial cells
0.6044931645	replace
0.6044842539	cancer risk
0.6044706589	hu
0.6044434575	activated protein kinase
0.6044334400	blocks
0.6043954587	dif 3
0.6043358262	adjusting
0.6043358262	dihydrofolate
0.6043358262	nanotubes
0.6042940643	mediators
0.6042707316	mediated apoptosis
0.6042496531	achieve
0.6042480221	2h
0.6042365243	3h
0.6041079776	functions
0.6040780054	observed
0.6040081260	cultured human
0.6039418886	united
0.6038402763	pgi
0.6038116341	turn
0.6038043696	december
0.6037909536	thc
0.6037576888	mdd
0.6037383553	ym
0.6037219378	boron
0.6036632659	resulting
0.6036482297	chronic inflammatory
0.6036029793	male subjects
0.6035961103	de
0.6035832653	depend
0.6035831925	untreated
0.6035809131	alkaline
0.6035246397	regulator
0.6034948633	hl60
0.6034723528	profile
0.6034574263	these
0.6034426098	gm
0.6034000290	randomly divided
0.6033964272	fmol mg protein
0.6033804611	superoxide
0.6033732214	ligands
0.6033303047	low nanomolar
0.6032647910	reported
0.6030932954	developed
0.6030658480	buche
0.6029949203	nmdar
0.6029735279	cinv
0.6029430055	chronic lymphocytic
0.6029369356	qt
0.6029215643	period
0.6029177319	mehg
0.6029022945	tumors
0.6028953284	ia
0.6028887909	k3
0.6028351268	higher concentrations
0.6028263392	l
0.6028219750	ssat
0.6028079038	dose range
0.6027866906	gastrodin
0.6027866906	fenpropimorph
0.6027866906	gastroprotective
0.6027866906	metoclopramide
0.6027866906	pelargonidin
0.6027866906	melanocortin
0.6027866906	anandamide
0.6027866906	pars
0.6027866906	primer
0.6027866906	rhodamine
0.6027859608	lys
0.6027805150	hsp
0.6027125131	radiation induced
0.6027092557	people
0.6027044191	do
0.6025982801	kappa
0.6025741582	universal
0.6025715837	fshβ
0.6025715837	n2
0.6025660072	isoflurane
0.6025660072	α2
0.6025660072	quantities
0.6025660072	branched
0.6025660072	expanded
0.6025660072	permeable
0.6025660072	proximity
0.6025608454	nh
0.6024958574	cyslt
0.6024440333	hsa
0.6024361200	pcb
0.6024088655	adh
0.6023902825	leydig
0.6023612479	crystallography
0.6023612479	returned
0.6023476430	contraction
0.6023129890	2a
0.6022535864	concentrations
0.6022288271	pancreatic beta cells
0.6022224262	photoaffinity
0.6022224262	miglustat
0.6021872526	star
0.6021470730	heparan
0.6021468686	erg
0.6021468686	nadp
0.6021468686	opc
0.6021382621	culture medium
0.6021219339	evaluated
0.6020062998	body
0.6020017846	genetic variants
0.6019511057	mean
0.6019503360	frap
0.6018840563	pla2
0.6018489039	dose related
0.6018243065	p53
0.6018219910	none
0.6018188335	cortisol levels
0.6017236430	npy
0.6017007285	galanthamine
0.6017007285	parkinsonian
0.6017007285	assignment
0.6017007285	surgically
0.6017007285	developments
0.6017007285	conservation
0.6017007285	beclomethasone
0.6016866576	contained
0.6016577139	new
0.6016076888	cll
0.6015832653	final
0.6015580310	her
0.6015580238	sdh
0.6015580238	gfap
0.6015545811	interval
0.6015462986	ld
0.6015291362	process
0.6014326029	t3
0.6013781516	deficient cells
0.6013754435	plga
0.6013556832	independent
0.6012555082	aromatic hydrocarbons
0.6011833337	three
0.6011509399	dgk
0.6011396457	hmg
0.6011383862	pl
0.6011222950	produces
0.6011222950	propose
0.6011173474	mtor
0.6010329294	coenzyme
0.6009997926	hnet
0.6009784860	ofq
0.6009448716	tnfα
0.6009321447	14 3 3epsilon
0.6009156740	mpa
0.6008214328	go
0.6008055882	inflammatory response
0.6007825211	expression and activity
0.6006632197	regulating
0.6006462650	chromatography
0.6006386237	lpl
0.6006337852	predictor
0.6006123861	microm
0.6006066206	cbp
0.6005609917	rp1
0.6005147669	ppg
0.6004891327	alk
0.6004711280	dihydroorotate
0.6004076854	dependent
0.6004039673	vsmc
0.6004039673	dss
0.6004039673	ogtt
0.6004016035	sur
0.6003752153	hlm
0.6003166726	hoat1
0.6003077708	counts
0.6002602322	bioactive compounds
0.6002130396	kcl
0.6001592804	overall
0.6001357312	fmlp
0.6000483621	paper
0.6000483621	option
0.6000062448	csa
0.5999955679	art
0.5999501474	experimental data
0.5999434668	r
0.5999033116	pdc
0.5998218823	activities
0.5998017959	improves
0.5998017959	explored
0.5997842329	chloroform
0.5997842329	selenocysteine
0.5996483071	oct
0.5996390325	full length
0.5996316211	angiotensin ii type 1 receptor
0.5996183717	ghr
0.5995992902	11c
0.5995922721	technique
0.5995115239	mtrr
0.5994840237	oxldl
0.5994108454	sa
0.5993314091	dhp
0.5992742676	snail
0.5992486923	series
0.5992149789	example
0.5992123268	bcl2
0.5991931116	active sites
0.5991601667	cd44
0.5991601667	h2ax
0.5991601667	ep1
0.5991390036	icam
0.5991262860	cushing
0.5991262860	sp1
0.5990631149	qsar
0.5990547785	effectively
0.5990532712	synthesized and evaluated
0.5990363296	suggest
0.5989802829	january
0.5989802829	nr2c
0.5989802829	gtpase
0.5989701201	o
0.5989519318	hp
0.5989337605	ptp1b
0.5989337605	pak1
0.5989197255	examined
0.5989165986	parent
0.5989137524	pte
0.5988514963	adenosine receptor
0.5988377064	designed
0.5988229565	development and progression
0.5988114748	spr
0.5988062733	wky
0.5988062733	fitc
0.5987823472	point
0.5987820636	inos
0.5987196789	bio
0.5987155258	pf
0.5986896126	atc
0.5986643044	lfa
0.5986339925	human and rat
0.5986043841	clinical evidence
0.5985600134	apoptotic pathway
0.5985212660	requires
0.5984961675	fully
0.5984860338	each
0.5984462615	dopamine neurons
0.5984444238	increase
0.5984402565	mcf 7 cells
0.5984283442	optimize
0.5984283442	associates
0.5984283442	fails
0.5984283442	pithed
0.5984283442	details
0.5984189250	hl
0.5984093270	diethylcarbamazine
0.5984079366	p450s
0.5983934671	ncct
0.5983898682	recently reported
0.5983732509	a1c
0.5983615801	beta
0.5983597845	inhibitor
0.5983312372	cabozantinib
0.5983184803	alpha 2 adrenoceptors
0.5983152281	next
0.5982788609	edta
0.5982788609	impdh
0.5981808033	sweat
0.5981808033	glutaredoxin
0.5981808033	torpor
0.5981800157	obtain
0.5981317585	± 0
0.5980587509	ginsenoside
0.5980155807	therapeutic index
0.5979965244	beta adrenergic receptors
0.5979958654	colony
0.5979646152	many
0.5979509399	tft
0.5979451283	proportion
0.5979329974	mrna
0.5979071434	synergistic effect
0.5978825550	regarding
0.5978764509	2 nonenal
0.5978544258	matrigel
0.5978523965	create
0.5978523965	monitor
0.5978523965	breakdown
0.5978256054	catalyzes
0.5978256054	demonstrating
0.5977988958	complexed
0.5977827442	receptor agonist
0.5976879327	exerts
0.5976836406	rvt
0.5976578340	studied
0.5976482934	enprofylline
0.5976482934	transcriptome
0.5976482934	probing
0.5975297576	isoforms
0.5975294379	caused
0.5975212660	signals
0.5975097170	pps
0.5975031946	chow
0.5974781654	v1a
0.5974710942	degree
0.5974514161	mechanism of action
0.5973752702	top
0.5973208629	gb
0.5973164687	ten
0.5972699321	degenerate
0.5972699321	dexmedetomidine
0.5972603547	infants
0.5972340220	cows
0.5972266991	hdl c
0.5972144859	seven
0.5972070241	abundance
0.5972038559	instead
0.5971706710	cla
0.5970178392	phosphoribosyltransferase
0.5969908888	functional characteristics
0.5969449082	established
0.5969097133	incubated
0.5969005401	knock down
0.5968994952	nnos
0.5968549808	trx1
0.5967263754	the
0.5967152559	upon
0.5966942014	involved
0.5966763579	fret
0.5966003607	basis
0.5965866252	transmission electron
0.5965758031	katp
0.5965728825	increases
0.5965490743	cancer therapy
0.5965269996	oestradiol
0.5965269996	carbamazepine
0.5965269996	direction
0.5965048636	mci
0.5964673423	involves
0.5964291306	response element binding protein
0.5964138797	granulosa
0.5964070842	bafilomycin
0.5964070842	galangin
0.5964070842	echocardiography
0.5964070842	methimazole
0.5964070842	ginseng
0.5964070842	questionnaire
0.5963760497	most
0.5963757106	inr
0.5963652209	down regulation
0.5962862404	this article reviews
0.5962117578	mediated
0.5962108454	nr
0.5961854924	serious
0.5961424781	modulates
0.5960989133	bc
0.5960964022	ntr
0.5960617091	produced
0.5959950724	sdz
0.5959862761	crbn
0.5959607588	once daily
0.5959433623	dox
0.5959214507	again
0.5959166854	icyp
0.5959079029	brs 3
0.5958877632	gene encoding
0.5958719075	rise
0.5958464055	cas
0.5958352993	esmolol
0.5957137524	lev
0.5957094213	gssg
0.5956960272	electrolyte
0.5956960272	nitrendipine
0.5956960272	distinguish
0.5956960272	consequent
0.5956960272	repress
0.5956960272	opportunity
0.5956960272	helpful
0.5956960272	opportunities
0.5956960272	mannose
0.5956960272	industrial
0.5956960272	represented
0.5956960272	osteogenic
0.5956960272	inherent
0.5956960272	drive
0.5956960272	mutagenic
0.5956960272	gained
0.5956960272	ordered
0.5956960272	discusses
0.5956960272	overproduction
0.5956960272	individually
0.5956960272	dispersion
0.5956960272	eukaryotes
0.5956960272	ortho
0.5956960272	trough
0.5956960272	potentiating
0.5956960272	antifolate
0.5956960272	gluconeogenesis
0.5956960272	contaminated
0.5956960272	sacrificed
0.5956960272	alkylating
0.5956960272	enkephalin
0.5956960272	intramolecular
0.5956960272	sulfhydryl
0.5956960272	harmful
0.5956960272	preadipocytes
0.5956960272	sulfamate
0.5956960272	amylase
0.5956960272	30min
0.5956960272	validate
0.5956960272	toxicant
0.5956960272	ortholog
0.5956960272	embedded
0.5956960272	critically
0.5956960272	ingested
0.5956960272	offered
0.5956960272	broadly
0.5956960272	modestly
0.5956960272	vary
0.5956960272	prone
0.5956960272	fractures
0.5956960272	traditionally
0.5956960272	primers
0.5956960272	applicable
0.5956960272	aminoacylation
0.5956960272	inserted
0.5956960272	lean
0.5956960272	48h
0.5956960272	corresponded
0.5956960272	transmitter
0.5956960272	neuroleptics
0.5956960272	monoaminergic
0.5956960272	counterpart
0.5956960272	divalent
0.5956960272	comprises
0.5956960272	isoenzyme
0.5956960272	suited
0.5956960272	solely
0.5956960272	tumorigenic
0.5956960272	sensation
0.5956960272	hemodynamics
0.5956960272	maximally
0.5956960272	harboring
0.5956644946	potent and selective
0.5956137106	this
0.5955596369	genistin
0.5955498825	pghs
0.5955359689	liver and kidney
0.5955264181	included
0.5955129558	zns
0.5954673423	represents
0.5954331808	possibly
0.5953966237	psd
0.5953949429	nine
0.5953691911	until
0.5953472130	ptp
0.5953472130	vt
0.5953472130	cag
0.5953472130	vldl
0.5953472130	thf
0.5953422921	genes
0.5953353189	ucp
0.5953271651	chip
0.5953213055	pfoa
0.5953213055	prl
0.5952833631	exhibited
0.5952128585	essential
0.5951880191	annexin v
0.5951509267	pcsk9
0.5951417954	htr
0.5951317987	lines
0.5950251607	lactamases
0.5950251607	glycaemic
0.5950077954	mmi
0.5949900844	compared
0.5949841920	amoxapine
0.5949841920	tasks
0.5949841920	24r
0.5949841920	hyperoside
0.5949841920	lacked
0.5949841920	crystalline
0.5949841920	distributions
0.5949841920	chelators
0.5949841920	fertilization
0.5949841920	resins
0.5949841920	seedlings
0.5949841920	immortalized
0.5949841920	strongest
0.5949841920	atherogenic
0.5949841920	beats
0.5949841920	oxygenation
0.5949841920	raclopride
0.5949841920	plots
0.5949682930	mode
0.5949672130	shell
0.5949161847	kainate receptors
0.5948656550	sirna
0.5948652625	received
0.5948576528	hydroxyphenyl
0.5948307570	hypertensive rats
0.5947884395	hypothesized
0.5947854634	epratuzumab
0.5947631958	bipolar
0.5947631958	analyse
0.5947631958	nitroprusside
0.5947041907	95 ci
0.5946926662	findings demonstrate
0.5946886192	oxa
0.5946512600	at1r
0.5946438172	selective antagonists
0.5946146192	normally
0.5945964205	ae
0.5945836151	glucose dependent
0.5945351839	dopamine receptor
0.5944517555	convertase
0.5943782986	aif
0.5942137150	in
0.5942081637	stalk
0.5942081637	potato
0.5942081637	hyperphagia
0.5942081637	chlorpyrifos
0.5942081637	prohormone
0.5942081637	neurobehavioral
0.5941730511	carried out
0.5941699353	beta adrenoceptors
0.5941696733	surrogate
0.5941675934	zd1694
0.5941647669	aii
0.5941639722	purified recombinant
0.5941635525	emotional
0.5941635525	excised
0.5941635525	sequenced
0.5941635525	guanidine
0.5941635525	scopolamine
0.5941635525	extreme
0.5941635525	mesangial
0.5941635525	primates
0.5941635525	questions
0.5941635525	integral
0.5941635525	homologue
0.5941635525	physically
0.5941635525	degrading
0.5941635525	polarized
0.5941635525	unstable
0.5941635525	degraded
0.5941635525	hyperinsulinemia
0.5941635525	patches
0.5941635525	toxicology
0.5941635525	synthetases
0.5941635525	ranges
0.5941635525	lipolysis
0.5941635525	accessible
0.5941635525	inadequate
0.5941635525	fatigue
0.5941635525	hydrophobicity
0.5941635525	creating
0.5941635525	ultimate
0.5941635525	microscopic
0.5941635525	facilitating
0.5941635525	identifies
0.5941635525	aggrecan
0.5941635525	sparing
0.5941635525	challenging
0.5941635525	decarboxylation
0.5941635525	progressively
0.5941635525	secrete
0.5941635525	eventually
0.5941635525	favor
0.5941635525	thymus
0.5941635525	counteracted
0.5941635525	recording
0.5941635525	links
0.5941635525	killed
0.5941635525	varies
0.5941635525	paradigms
0.5941635525	pseudo
0.5941635525	nifedipine
0.5941635525	confirms
0.5941635525	amplified
0.5941635525	splenocytes
0.5941635525	connected
0.5941635525	menopausal
0.5941635525	signature
0.5941635525	proteomics
0.5941635525	insult
0.5941635525	lysosomes
0.5940957984	receptor agonists
0.5940669619	hmc
0.5940429645	widely
0.5940258986	maximal response
0.5940249524	frd
0.5940152850	resorption
0.5939877428	c
0.5939679026	8 oh dpat
0.5939300406	hva
0.5938960646	alteration
0.5938909195	induce apoptosis
0.5938592558	apocynin
0.5938219031	®
0.5937469959	data demonstrate
0.5936809198	g
0.5936594803	niemann
0.5936226639	highly selective
0.5935809352	wy
0.5935638999	consistent
0.5935032278	alternatively
0.5935032278	correspondingly
0.5934665058	cancer cell line
0.5934269781	mmc
0.5934269781	dvs
0.5933709856	acids
0.5933444190	free fatty acid
0.5931874693	akrs
0.5931643010	good
0.5931578493	f2
0.5930914994	p
0.5930826507	endothelin 1
0.5930796052	endpoints
0.5930788609	gdm
0.5930788609	fad
0.5930761997	studies demonstrate
0.5930636177	gossypol
0.5930636177	eplerenone
0.5930636177	anthocyanins
0.5930636177	conotoxin
0.5930636177	carboxylesterases
0.5930636177	dabrafenib
0.5930636177	chalcones
0.5930636177	wogonoside
0.5930629865	mda mb 231 cells
0.5930434671	ptsd
0.5930434671	aldh
0.5930369711	labor
0.5930369711	folds
0.5930369711	erosion
0.5929803966	fasn
0.5929319896	potent antitumor
0.5929050173	element
0.5929041209	immunocytochemical
0.5929023012	er β
0.5928626580	considering
0.5928134911	mechanism based
0.5927884395	showing
0.5927352077	gist
0.5927338915	selectively
0.5926953329	cyp2c8
0.5926953329	cd25
0.5926695411	binds
0.5926658606	akt1
0.5926187435	design and methods
0.5925746667	corresponding
0.5925737182	hache
0.5925710043	lid
0.5924809198	h
0.5924396818	pkd
0.5924256208	exhibit
0.5923354893	tic
0.5922818846	mcpp
0.5922818846	ol
0.5922472850	kvlqt1
0.5922472850	pge1
0.5922032061	results demonstrate
0.5921966237	bal
0.5921966237	dhfr
0.5921747065	order
0.5921712494	ep3
0.5921662634	k
0.5921397773	shrna
0.5921375241	glutamyl
0.5921359913	mg2 +
0.5921255512	cav 1
0.5921234717	cardiovascular effects
0.5921015043	asm
0.5920770491	threefold
0.5920366334	co
0.5919792017	biosensor
0.5919792017	microgram
0.5919723896	ce
0.5919161888	s1p
0.5918710736	arbs
0.5918546581	erβ
0.5918546581	mets
0.5918396066	scf
0.5918077954	cec
0.5917965108	mpfc
0.5917963685	implicated
0.5917873769	plasma glucose levels
0.5917623871	w
0.5917284723	investigated
0.5917119647	fold greater
0.5917055402	mcao
0.5917055402	faah
0.5916963004	fxo
0.5916963004	pap
0.5916963004	mgmt
0.5916963004	afm
0.5916329853	activity
0.5915914405	phenotype
0.5915300027	photons
0.5913825932	considered
0.5913631438	bak
0.5912386273	mcp
0.5912216974	determine
0.5911773253	muc2
0.5911705182	analyzed
0.5911531033	vmat2
0.5911029589	mas
0.5910656444	explore
0.5910566893	further
0.5909890469	identified
0.5909195842	almotriptan
0.5909195842	allopurinol
0.5908793383	microtubule associated protein
0.5908654232	nucleotide binding
0.5906872448	de pointes
0.5906532417	mcf7
0.5906016433	5 ht2c
0.5905633536	about
0.5905487370	significantly
0.5904903830	fxr
0.5904480837	gjic
0.5904170007	cell morphology
0.5904148791	myeloid leukemia
0.5903366083	platelet function
0.5902871635	ctl
0.5902871635	trh
0.5902871635	mri
0.5902871635	gra
0.5902488014	dried
0.5902469962	ctx
0.5902321907	cv
0.5901261627	potentially
0.5901260692	stat5
0.5901101208	mcf
0.5901089598	off
0.5900965291	ay
0.5896878637	tof
0.5896280859	hnscc
0.5896280859	tlr
0.5896141253	under
0.5895920935	time
0.5895647498	mmhg
0.5895624548	effects
0.5895349330	d
0.5894742827	smo
0.5893264277	high fat diet induced
0.5892607269	ki 67
0.5892537701	n6
0.5892481440	saline treated
0.5892319404	pathogenesis
0.5892045682	n terminal
0.5890953321	research design and
0.5890464482	fv
0.5890131916	effect
0.5890101836	pc3 cells
0.5890002462	embryonic fibroblasts
0.5889902918	raralpha
0.5889702608	glioma cell
0.5889245450	suggests
0.5888803558	outside
0.5888776267	ephrina5
0.5887899140	following
0.5887385932	gene
0.5887147557	gdh
0.5887129572	as
0.5886991145	sirtuins
0.5885927096	ly
0.5885432405	whole body
0.5884760413	microl
0.5884695978	cells in culture
0.5884210218	lack
0.5883440086	administration
0.5882071565	appearance
0.5881354782	nedocromil
0.5881354782	polyethylene
0.5881354782	blockage
0.5881354782	nitrosative
0.5881354782	predictors
0.5881017571	first pass
0.5880999448	cdc2
0.5879149565	chromaffin
0.5878706758	inhibits
0.5877972134	demonstrated
0.5877760321	m
0.5877169838	nir
0.5877169838	aicar
0.5876830491	exception
0.5875702638	some
0.5875655456	liposomal
0.5875655456	globulin
0.5875655456	microspheres
0.5875655456	11β
0.5875655456	pulses
0.5875655456	grape
0.5875655456	primed
0.5875494800	side chain
0.5875460664	zearalenone
0.5875460664	legumain
0.5875460664	nonadrenergic
0.5875460664	arachidonate
0.5875438715	member
0.5874876511	believed
0.5873269589	levels
0.5873202817	cassette
0.5873195714	col1a1
0.5873195714	sv2a
0.5873167274	removal
0.5872756558	fibrillary
0.5872756558	basilar
0.5872756558	intraocular
0.5872756558	reserved
0.5872756558	verify
0.5871711653	breast cancer cells
0.5871396876	sur2a
0.5871378870	taa
0.5871378870	gaa
0.5871378870	pnpo
0.5870958318	bfgf
0.5870333307	sgc 7901 cells
0.5869955197	suitable
0.5869292719	compare
0.5868100333	options
0.5867977128	l glutamate
0.5867647121	oc
0.5867524799	nkcc1
0.5867429507	divided
0.5865553832	tumor tissue
0.5864876511	assigned
0.5864465140	hiv 1
0.5864344491	xc
0.5864249317	transducer
0.5864249317	recessive
0.5864019266	th17
0.5863137486	lmwh
0.5862446235	cos 1 cells
0.5862162431	ige
0.5862026204	dck
0.5861928207	mec
0.5861464694	beta cell
0.5860624881	tx
0.5860624881	fdh
0.5860003026	play
0.5859804153	apl
0.5859804153	als
0.5859732400	fl
0.5859378442	uc
0.5858789112	alpha4
0.5858789112	acne
0.5858789112	liraglutide
0.5858789112	ethnicity
0.5858789112	6a
0.5858789112	stressed
0.5858789112	rightward
0.5858420371	possible
0.5858097325	eight
0.5857480243	era
0.5856570249	licofelone
0.5856415317	atp sensitive
0.5856283953	endo
0.5855413180	tss
0.5855413180	mrp
0.5854720110	acute coronary
0.5854686490	nhl
0.5854686490	lpo
0.5854073879	gyrus
0.5853864526	adcc
0.5853864526	mtd
0.5853741725	neither
0.5853536664	histamine h3
0.5853442688	transplant
0.5852518867	arb
0.5851877428	no
0.5850320619	revealed
0.5849172574	fcs
0.5848535032	portion
0.5848507522	don
0.5848128026	conformer
0.5848128026	proteinase
0.5848128026	photo
0.5847378763	missense
0.5846691828	participation
0.5846691828	squamous
0.5846664841	active form
0.5845867960	ranging
0.5845798530	play important roles
0.5845725852	cdk1
0.5845500591	pp
0.5844733854	wood
0.5844733854	imidazo
0.5844733854	perforin
0.5844733854	matriptase
0.5844686490	pmn
0.5844686490	lt
0.5843921741	glut2
0.5843921741	s100a4
0.5843921741	ep2
0.5843816543	microbial
0.5843816543	loci
0.5843816543	fluids
0.5843816543	wet
0.5843816543	pathologic
0.5843816543	reagents
0.5843816543	chemoresistance
0.5843816543	androstenedione
0.5843816543	claimed
0.5843816543	homologues
0.5843816543	suffer
0.5843816543	doxazosin
0.5843816543	alpha2b
0.5843816543	inactivates
0.5843816543	exclusive
0.5843816543	benzene
0.5843816543	phenomena
0.5843816543	hyperthermia
0.5843816543	dynamin
0.5843816543	transepithelial
0.5843816543	splenic
0.5842686346	induced liver injury
0.5842118471	pghs 1
0.5841752123	tem
0.5841650072	concerning
0.5841303934	ica
0.5840216071	physiological concentrations
0.5840045735	asic
0.5840045735	vhl
0.5840045735	ntd
0.5839490004	reduces
0.5838149912	treated
0.5838048058	inotropic
0.5837697202	way 100635
0.5837223153	all
0.5837212039	deacetylase
0.5837044485	litchi
0.5836579068	progenitor
0.5836433753	α2a
0.5836044750	significant differences
0.5835527707	_
0.5835527707	supplemental
0.5835389188	dma
0.5835096780	skeletal
0.5835081119	ubiquinone
0.5835081119	deiminase
0.5834849301	beyond
0.5834680459	aminomethyl
0.5834655554	vsmcs
0.5834300307	niddm
0.5833531621	hrv
0.5832797874	whole
0.5832278925	tbi
0.5832278925	socs
0.5831831200	hdc
0.5831780439	does
0.5831254446	induced
0.5828567445	down
0.5828546201	represent
0.5828542840	gland
0.5828537923	2b6
0.5828535032	dentate
0.5828535032	discriminative
0.5828257655	kgf
0.5828030588	1s
0.5827991691	sirnas
0.5827991691	twofold
0.5827957395	dhps
0.5827707124	highly specific
0.5826344254	second messengers
0.5825259845	gpcrs
0.5825212022	fifty
0.5824351703	low density
0.5823701774	beag
0.5823592553	asc
0.5823529548	drd2
0.5822937804	omega 3
0.5822406002	ldl c
0.5822119536	bmp 7
0.5821744395	fusion proteins
0.5821455326	commercially available
0.5820798277	hmp
0.5820798277	cask
0.5820798277	gdc
0.5820558264	hepg2 cell
0.5820520191	drinking
0.5820420356	csee
0.5820420356	dota
0.5820420356	dad
0.5820394716	leading
0.5820101756	involving
0.5820061427	tubule
0.5820052905	ascribed
0.5820052905	vulnerable
0.5820052905	regarded
0.5819956519	3p
0.5819510945	prostaglandin synthesis
0.5819376940	dfdc
0.5819005447	neuro
0.5818920061	c myc
0.5817622013	ecm
0.5817030206	gag
0.5816097304	pcna
0.5815862260	conditions
0.5815133695	cellular energy
0.5814686096	neoadjuvant
0.5814686096	sulfonate
0.5814686096	lactating
0.5814686096	wake
0.5814686096	hik1
0.5814686096	depolarizing
0.5814686096	abundantly
0.5814686096	capillaries
0.5814686096	docked
0.5814686096	hrrm2
0.5814686096	consuming
0.5814686096	lever
0.5814686096	satiety
0.5814686096	images
0.5814686096	mimetics
0.5814686096	reorganization
0.5814686096	coregulator
0.5814686096	pyrazolo
0.5814686096	fibrin
0.5814686096	pentasaccharide
0.5814686096	impairing
0.5814686096	diflunisal
0.5814686096	thromboembolism
0.5814686096	theta
0.5814686096	benzamide
0.5814686096	entering
0.5814686096	fluorinated
0.5814686096	reasonable
0.5814686096	tendency
0.5814686096	alcohols
0.5814686096	contralateral
0.5814686096	cornea
0.5814686096	prolong
0.5814685388	using
0.5814110669	growth inhibition
0.5813380193	lowers
0.5813380193	2b7
0.5813380193	endometrium
0.5813380193	histaminergic
0.5813380193	conferring
0.5813380193	chemoattractant
0.5813380193	upregulate
0.5813380193	synapse
0.5813380193	thrombotic
0.5813380193	oncogenes
0.5813380193	totally
0.5813380193	synthases
0.5813380193	alternate
0.5813380193	controversy
0.5813380193	movements
0.5813380193	codeine
0.5813380193	alpha1a
0.5813380193	antimicrobial
0.5813380193	evidences
0.5813380193	fungi
0.5813380193	anticipated
0.5813380193	remove
0.5813380193	synergism
0.5813380193	virgin
0.5813380193	tetrazolium
0.5813380193	deprived
0.5813380193	7a
0.5813380193	specificities
0.5813380193	lethality
0.5813380193	overt
0.5813380193	soil
0.5813380193	nisoxetine
0.5813380193	fibrotic
0.5813380193	taurocholate
0.5813380193	peripherally
0.5813380193	expand
0.5813380193	drives
0.5813380193	feasible
0.5813380193	playing
0.5813380193	methyltransferases
0.5813380193	outflow
0.5813380193	counteract
0.5813380193	histones
0.5813380193	inactivate
0.5813380193	declined
0.5813380193	situation
0.5813380193	osteoporotic
0.5813380193	persisted
0.5813380193	edible
0.5813380193	anthracycline
0.5813380193	trachea
0.5813380193	anchored
0.5813380193	nitrotyrosine
0.5813380193	elevating
0.5813380193	ensure
0.5813380193	aggregate
0.5813380193	translated
0.5813380193	house
0.5813380193	progestogen
0.5813380193	augment
0.5813380193	exacerbated
0.5813380193	notion
0.5813380193	adjustments
0.5813380193	dioxygenase
0.5813380193	neovascularization
0.5813380193	marginally
0.5813380193	disturbed
0.5813380193	lifespan
0.5813380193	polyps
0.5813380193	surprising
0.5813380193	implicate
0.5813380193	entities
0.5813380193	contacts
0.5813380193	acceptable
0.5813380193	unidentified
0.5813380193	initiate
0.5813380193	searched
0.5813380193	oligosaccharides
0.5813380193	pyridyl
0.5813380193	implicating
0.5813380193	eliminate
0.5812700531	er α
0.5812658955	ih
0.5812527543	prb
0.5812263591	iib
0.5811627916	b
0.5811353279	weeks of treatment
0.5811351886	h5
0.5809467134	z
0.5809129042	six
0.5808990532	ltc4
0.5808926244	mglur
0.5808777000	d3 receptors
0.5808171407	elisidepsin
0.5808171407	butein
0.5807823879	lymph
0.5807559888	mut
0.5807484264	galpha
0.5807484264	cxcr4
0.5807484264	jbp485
0.5807284780	et al
0.5805998515	5 aminosalicylic acid
0.5805880779	ftidc
0.5805880779	ssao
0.5805618180	ins
0.5805184451	receptor blockade
0.5804906440	tpm
0.5804906440	tsl
0.5804906440	hsya
0.5804906440	coc
0.5804906440	ncx
0.5804906440	orf
0.5804288679	efs
0.5804194871	well tolerated
0.5804050007	ge
0.5803994198	v
0.5803896278	rhs
0.5803773877	consists
0.5803773877	knock
0.5803773877	ranged
0.5803246558	contrast
0.5802808883	after
0.5802753642	5b
0.5802235036	p gp and bcrp
0.5801794706	cell apoptosis
0.5801614643	antipsychotic agents
0.5801570216	rrm1
0.5801490004	displayed
0.5800909084	mitochondrial glutathione
0.5800688115	circular
0.5800490071	several
0.5799711473	positive control
0.5799709105	orders
0.5799529440	lipopolysaccharide induced
0.5798087044	ht2a
0.5797914642	experimental animals
0.5797523877	transporting
0.5797471498	digoxin
0.5797004031	hence
0.5796843970	hoat3
0.5796766468	adverse drug
0.5796039807	previously demonstrated
0.5795598808	bnct
0.5795598808	cdo
0.5795598808	apd
0.5795598808	spect
0.5795598808	bbm
0.5795598808	mct
0.5795598808	gac
0.5795506950	cyp2b6 activity
0.5795147362	selectin
0.5795089796	oht
0.5795089796	rage
0.5795089796	fak
0.5795089796	gtk
0.5795089796	onoo
0.5795089796	pns
0.5795089796	bh
0.5794997516	a
0.5794916663	dadle
0.5794916663	cnt
0.5794862867	include
0.5794747858	another
0.5794629811	occurrence
0.5794559133	bromfenac
0.5794550278	correlate
0.5794346104	hi
0.5793495259	a4
0.5792729432	significantly elevated
0.5791449809	examine
0.5791194794	sfn
0.5790888842	dbh
0.5790566697	il 4
0.5790108942	j
0.5789904590	pkmζ
0.5789904590	cyp51
0.5789628809	per
0.5789608093	inhibited
0.5789502200	lispro
0.5789446406	consequently
0.5789340122	structure and function
0.5788797665	airway smooth
0.5788773877	overview
0.5788384113	palmitoyltransferase
0.5788384113	cystic
0.5788346143	behaved
0.5788346143	myelogenous
0.5788346143	glucuronosyltransferases
0.5788346143	room
0.5788120674	gamt
0.5788120674	paf
0.5788120674	bpde
0.5788120674	vpa
0.5788120674	dem
0.5787336235	herein
0.5786086447	messenger
0.5785688787	target tissues
0.5785282021	melanomas
0.5785282021	filaments
0.5785282021	evoke
0.5785282021	secreting
0.5785282021	operate
0.5785282021	neuroinflammatory
0.5785282021	bioscavenger
0.5785282021	paraventricular
0.5785282021	instillation
0.5785282021	antiport
0.5785282021	accomplished
0.5785282021	doxepin
0.5785282021	anticoagulants
0.5785282021	enlargement
0.5785282021	cotransport
0.5785282021	oscillations
0.5785282021	entrance
0.5785282021	continuously
0.5785282021	kindling
0.5785282021	citrin
0.5785282021	aerobic
0.5785282021	phosphatidylcholine
0.5785282021	recognizes
0.5785282021	redistribution
0.5785282021	considerations
0.5785282021	opposing
0.5785282021	flexibility
0.5785282021	diethyl
0.5785282021	rule
0.5785282021	neuropsychiatric
0.5785282021	schedules
0.5785282021	liquids
0.5785282021	catechin
0.5785282021	reaching
0.5785282021	insecticide
0.5785282021	contaminant
0.5785282021	chelating
0.5785282021	quiescent
0.5785282021	silenced
0.5785282021	starvation
0.5785282021	equipotent
0.5785282021	alleviated
0.5785282021	standards
0.5785282021	holds
0.5785282021	hypoglycemic
0.5785282021	emulsion
0.5785282021	player
0.5785282021	alleviating
0.5785282021	programs
0.5785282021	sensitivities
0.5785282021	trends
0.5785282021	hallmark
0.5785282021	hold
0.5785282021	junctional
0.5785282021	formalin
0.5785282021	rendered
0.5785282021	stored
0.5785282021	definition
0.5785282021	possibilities
0.5785282021	catalyzing
0.5785282021	perspectives
0.5785282021	defence
0.5785282021	hydroperoxide
0.5785282021	timing
0.5785282021	axons
0.5785282021	evaluates
0.5785282021	balanced
0.5785282021	perivascular
0.5785282021	favourable
0.5785282021	discrete
0.5785282021	cytoskeletal
0.5785282021	homogenate
0.5785282021	inability
0.5785282021	1g
0.5785282021	malaria
0.5785282021	observe
0.5785282021	attracted
0.5785282021	antagonised
0.5785282021	patents
0.5785282021	bronchodilator
0.5785282021	monthly
0.5785282021	adapted
0.5785282021	preferring
0.5785282021	connection
0.5785282021	insect
0.5785282021	monocytic
0.5785282021	homomeric
0.5785282021	dissociate
0.5785282021	cough
0.5785282021	dysmenorrhea
0.5785282021	convenient
0.5785282021	dispersed
0.5785282021	afferent
0.5785282021	libraries
0.5785282021	strips
0.5785282021	neuropeptides
0.5785282021	cofactors
0.5785282021	shortened
0.5785282021	interindividual
0.5785282021	proteinuria
0.5785282021	acceleration
0.5785282021	imbalance
0.5785282021	elevate
0.5785282021	translate
0.5785282021	principally
0.5785282021	simply
0.5785282021	exceeded
0.5785282021	stereoisomer
0.5785282021	radioligands
0.5785205339	one
0.5784673511	ht1b
0.5783402249	hill
0.5783294327	artery
0.5783163445	dynamics simulations
0.5782041989	stable disease
0.5781257565	induced cell death
0.5780944317	performance liquid chromatography
0.5779972184	coverage
0.5779943989	ta
0.5779943989	pdr
0.5779175667	kinase domain
0.5778894489	just
0.5778796440	biological activity
0.5777422438	org
0.5776801761	long term treatment
0.5776725960	expert
0.5776719571	acinar
0.5775630101	cyclase
0.5774933824	mao inhibitor
0.5774634876	expression and function
0.5774264675	tat
0.5773699692	structure based
0.5773286107	hmgb1
0.5773166733	public
0.5773166733	acidosis
0.5773166733	bioavailable
0.5773166733	participated
0.5772461894	pnu
0.5772112995	among
0.5770551427	ai
0.5769487255	l arginine
0.5769261844	sah
0.5769261844	aprt
0.5769261844	pufa
0.5768821043	sulfone
0.5767021080	am
0.5766817555	e
0.5765834087	yl
0.5765496347	impdh1
0.5765496347	tgfβ
0.5765033478	q
0.5764868895	showed
0.5764859331	difference
0.5764330904	members
0.5764278311	rnase
0.5764278311	c2c12
0.5762850594	advances
0.5762814086	plays
0.5762727951	smedds
0.5762727951	ri
0.5762727951	mep
0.5762727951	odn
0.5762727951	ido
0.5762721143	racemase
0.5761428998	→
0.5760625653	significantly inhibited
0.5760512367	over
0.5760489009	epithelial cell
0.5759942842	4 thiadiazole
0.5758120631	u pa
0.5758071726	2p
0.5757708121	bun
0.5757708121	eeg
0.5757708121	hts
0.5757708121	ffa
0.5757653237	alefacept
0.5757653237	monocarboxylate
0.5756412811	significant difference
0.5756311424	dim
0.5754955368	t4
0.5754509976	lactam
0.5754509976	restraint
0.5754509976	chickens
0.5754250715	ctp
0.5752978442	sstr
0.5752720918	prolidase
0.5752720918	halogen
0.5752720918	immunosuppression
0.5752720918	bridges
0.5752229290	gk
0.5751771289	throughout
0.5750946278	atp dependent
0.5750773992	24 hours
0.5750616282	carried
0.5750519403	enzyme activity
0.5750442533	experimental model
0.5750415448	in pithed rats
0.5750409908	disease causing
0.5750226214	coupled
0.5749293298	potential role
0.5749057735	bso
0.5749057735	luts
0.5747911551	glucose and insulin
0.5747618167	selectively inhibited
0.5747078764	hydroxymethyl
0.5746245456	d2r
0.5746245456	bh4
0.5744919606	scc
0.5743681539	nvp
0.5742089717	pdgfra
0.5740505411	glutamate receptor
0.5739709105	ketoglutarate
0.5739358975	apob
0.5737984609	pfs
0.5737984609	dbp
0.5737747815	th
0.5737242547	srf
0.5737242547	adma
0.5737242547	psma
0.5737242547	mif
0.5737177887	gitelman
0.5736440886	insights
0.5735733554	hba
0.5735616282	understand
0.5734059296	indicating
0.5733577066	mapks
0.5733546173	puma g
0.5733419845	more
0.5733127114	por
0.5732712315	determination
0.5732459795	cap
0.5730383609	possibility
0.5730164627	cg
0.5729712813	data obtained
0.5728895663	gstt1
0.5728895663	glun2b
0.5728895663	hm74
0.5728895663	altogether
0.5726769691	gsk
0.5726542484	only
0.5726377663	tolerated
0.5725983654	patients with relapsed
0.5725553697	the general population
0.5725198849	human prostate
0.5725092823	bha
0.5725092823	gsis
0.5725092823	akr
0.5725092823	pal
0.5722664070	hsp70
0.5722545967	dose dependently inhibited
0.5722382317	dphd
0.5722382317	tam
0.5722382317	mva
0.5722382317	edl
0.5722315399	tpi
0.5722315399	rai
0.5722310521	octn1
0.5722302125	cadherin
0.5721897970	downstream signaling
0.5721370149	both
0.5721106624	sam
0.5721036165	transgenic mouse
0.5720655795	tumor tissues
0.5720283126	therapeutic efficacy
0.5720078487	lags
0.5720078487	mpg
0.5720078487	rko
0.5720002165	5 fu
0.5718976055	dif
0.5718488801	antioxidant and anti
0.5718424889	second messenger
0.5718343971	ono
0.5717492902	molybdenum
0.5717492902	alpha7
0.5717492902	alpha2c
0.5717492902	≈
0.5716876705	pyrimidinone
0.5716876705	hydroxyflutamide
0.5716876705	weights
0.5716876705	monohydroxytamoxifen
0.5716876705	ranitidine
0.5716876705	thiazole
0.5716876705	fission
0.5716876705	phospholamban
0.5716876705	chick
0.5716876705	bones
0.5716876705	desensitized
0.5716876705	glucuronides
0.5716876705	hgsta4
0.5716876705	200mg
0.5716876705	mothers
0.5716876705	pressures
0.5716876705	poisons
0.5716876705	sirtuin
0.5716876705	p53r2
0.5716876705	hippocampi
0.5716876705	autonomous
0.5716876705	testolactone
0.5716876705	character
0.5716876705	insoluble
0.5716876705	favors
0.5716876705	fractional
0.5716849802	splice
0.5715827183	targeted therapy
0.5715094018	nbup
0.5714311034	lesser
0.5713995244	completely inhibited
0.5713686022	stress response
0.5713382679	jak3
0.5712372141	bowel
0.5712324796	cerevisiae
0.5712324796	regard
0.5710846288	β cells
0.5710674518	vitiligo
0.5710674518	react
0.5710674518	overdose
0.5710674518	dilevalol
0.5709964701	1beta
0.5709923623	n acetyl
0.5709768238	matrices
0.5709768238	adenomas
0.5709768238	maleate
0.5709768238	luteolin
0.5709768238	transcytosis
0.5708061971	p75ntr
0.5708033529	bup
0.5707660335	c terminal domain
0.5707428459	avt
0.5707428459	hifu
0.5707297452	here
0.5707223939	prefrontal
0.5707146893	glr3
0.5707036253	aspects
0.5706111570	styrene
0.5705733072	hb
0.5705555204	special
0.5705201514	accordingly
0.5704446887	r2
0.5704362655	v1
0.5704308765	responder
0.5704308765	dendrimers
0.5704289785	cholesterol metabolism
0.5704156093	lead compounds
0.5703959379	plk
0.5703467675	h1 receptor antagonist
0.5703031103	msh
0.5703031103	rti
0.5703020493	ds
0.5702907756	pao
0.5702566761	trifluoromethyl
0.5702164015	vitamin e
0.5701436922	rgc
0.5701436922	dmn
0.5701436922	bapta
0.5701436922	igt
0.5701436922	hrpc
0.5701436922	mam
0.5701432633	gene transfer
0.5701418931	two
0.5701295169	terms
0.5700244925	beta 1 adrenoceptors
0.5699617728	rec
0.5698292931	calu
0.5697322289	eds
0.5696608451	before
0.5696240851	proof
0.5696240851	coexpression
0.5695962744	tlr7
0.5695962744	p2x3
0.5695930336	emptying
0.5695718634	besides
0.5695551822	cxcr7
0.5694528999	certain
0.5694354027	concentration dependent
0.5694087504	rdx
0.5694087504	fvii
0.5694087504	glt
0.5693909979	single agent
0.5693166215	upar
0.5693066022	ppt
0.5692730530	pgp
0.5692324194	markedly inhibited
0.5691987494	subset
0.5690662151	t2d
0.5690511763	glucosidase
0.5690430397	absence
0.5690306299	ecs
0.5689794717	mutant mice
0.5689258241	dietary exposure
0.5689074739	hex
0.5688884869	type 2 diabetic
0.5687279148	2α
0.5687279148	levocabastine
0.5687279148	hypomethylation
0.5687279148	plot
0.5686900581	eps
0.5686516802	propidium
0.5686051881	receptor subunits
0.5685867008	tak
0.5685804962	hek 293
0.5685657633	aox
0.5685657633	hsc
0.5685500758	naag
0.5685500758	af
0.5685473610	polyunsaturated
0.5684638461	tgif
0.5683618008	nevertheless
0.5683069738	luc
0.5681515065	dcbn
0.5680940817	rat model
0.5679891414	world
0.5679597335	his
0.5679079558	f
0.5678019042	hek cells
0.5677369810	mek1
0.5677179367	like
0.5676786025	cd11a
0.5676786025	ugt1a
0.5676786025	h295r
0.5676786025	cyp3a5
0.5676203088	phip
0.5675783730	least
0.5675383070	trkb
0.5674751668	pbmcs
0.5673439428	contribute
0.5672951452	available
0.5672847851	noradrenaline release
0.5672238309	phenserine
0.5670631366	5h
0.5670141931	cyclooxygenase 2
0.5669719338	ugts
0.5669278702	temsirolimus
0.5669278702	parkinsonism
0.5668701573	triamcinolone
0.5668701573	cessation
0.5668232196	bok
0.5668183500	bip
0.5667939063	bont
0.5667713485	despite
0.5667375221	hep
0.5667049337	alcohol dependent
0.5666264319	abeta
0.5666264319	gad67
0.5666160119	i
0.5665835119	history
0.5665126222	rnai
0.5665126222	tdp
0.5664744197	hql
0.5663871424	findsite
0.5663791014	mglu3
0.5663519377	s
0.5663221158	mmol
0.5662681102	pin1
0.5662489164	endogenous ligand
0.5661736851	tamibarotene
0.5661358908	fluticasone
0.5658314339	a go go related gene
0.5658093801	c jun n terminal kinase
0.5657908661	rela
0.5657834195	ly294002
0.5657400383	thyroid hormone receptor
0.5656798245	appears
0.5656678168	nor
0.5655063047	biological effects
0.5654748646	synthesis and structure activity
0.5654400202	7kc
0.5654400202	voglibose
0.5654400202	lacz
0.5654387388	last
0.5653257660	elevation
0.5653125121	pd98059
0.5653125121	cav1
0.5652759719	tub
0.5652177684	glut4
0.5651256483	observations suggest
0.5651245882	various
0.5650965937	results confirm
0.5650734980	tb
0.5650587855	indeed
0.5650151589	hent1
0.5649382081	entire
0.5648274573	a 381393
0.5647163552	mac
0.5646875577	hv
0.5646875577	spd
0.5646875577	ddi
0.5646875577	eb
0.5646875577	cpf
0.5646875577	cbdp
0.5646875577	bat
0.5646875577	sfo
0.5646875577	dbs
0.5646730650	contributing
0.5645718827	adomet
0.5645387425	tki
0.5645014439	cyps
0.5645014439	mmps
0.5643589418	il 5
0.5643445388	mps
0.5641985951	1l
0.5641560869	4f2hc
0.5641240500	mdl
0.5641240500	skf
0.5641240500	dmbt
0.5641240500	win
0.5641240500	bmy
0.5641233009	pdk
0.5640851173	percentage
0.5640345343	human organic anion
0.5639365461	treated cells
0.5639082345	suggesting
0.5637784562	attributable
0.5637501026	gsk3β
0.5635921579	odds
0.5635921579	adenylyl
0.5635700599	rharg
0.5635669361	induced cytotoxicity
0.5635392922	estrogen receptor beta
0.5633998407	myeloma
0.5633125487	anti inflammatory action
0.5633077530	evn
0.5632357700	hal
0.5631960386	failed
0.5631600633	tba
0.5631600633	rvlm
0.5631600633	neca
0.5631600633	emiq
0.5631600633	eta
0.5631600633	hrsv
0.5631600633	hcec
0.5631600633	mdck
0.5631000695	blotting
0.5630997457	gyki
0.5629613541	dfbp
0.5629415733	insulin stimulated
0.5628311675	ain
0.5628311675	dldh
0.5628066838	che
0.5627785902	h1 receptor antagonists
0.5626775600	nitrosylation
0.5626775600	fluphenazine
0.5626775600	hyperinsulinemic
0.5626775600	adsorbed
0.5626775600	preconditioning
0.5626775600	bacterium
0.5626775600	nickel
0.5626775600	resembles
0.5626775600	thalamus
0.5626775600	liposome
0.5626775600	loxapine
0.5626775600	centers
0.5626775600	washing
0.5626775600	melperone
0.5626775600	combine
0.5626775600	diphenhydramine
0.5626775600	delaying
0.5626775600	chymotrypsin
0.5626775600	enter
0.5626775600	mitosis
0.5626775600	manifestation
0.5626775600	reproduced
0.5626775600	insufficient
0.5626775600	preceding
0.5626775600	characterizing
0.5626775600	uncharged
0.5626775600	pyridin
0.5626775600	peel
0.5626775600	multitargeted
0.5626775600	turned
0.5626775600	configurations
0.5626775600	2c19
0.5626775600	pyrrolo
0.5626775600	indicators
0.5626775600	rearrangements
0.5626775600	covariates
0.5626775600	allograft
0.5626775600	littermates
0.5626775600	oligomerization
0.5626775600	worsening
0.5626775600	afforded
0.5626775600	prototype
0.5626775600	decay
0.5626775600	aversive
0.5626775600	dichloro
0.5626775600	cortices
0.5626775600	anchorage
0.5626775600	modifies
0.5626775600	etiology
0.5626775600	cleared
0.5626775600	axonal
0.5626775600	woman
0.5626775600	pathogens
0.5626775600	illness
0.5626775600	signatures
0.5626775600	melanin
0.5626775600	accurately
0.5626775600	desired
0.5626775600	examinations
0.5626775600	unmodified
0.5626775600	emergent
0.5626775600	colocalized
0.5626775600	heterodimer
0.5626775600	cefadroxil
0.5626775600	myometrial
0.5626775600	hydroxyurea
0.5626775600	untranslated
0.5626775600	antineoplastic
0.5626775600	triggering
0.5626775600	gross
0.5626775600	infantile
0.5626775600	enalapril
0.5626775600	insults
0.5626775600	dutp
0.5626775600	mentioned
0.5626775600	nematode
0.5626775600	allelic
0.5626775600	replicated
0.5626775600	checked
0.5626775600	embryogenesis
0.5626775600	ends
0.5626775600	multimeric
0.5626775600	kind
0.5626775600	completion
0.5626775600	stimulants
0.5626775600	prerequisite
0.5626775600	resection
0.5626775600	competing
0.5626775600	resembling
0.5626775600	electrophysiology
0.5626775600	rivaroxaban
0.5626775600	diethylstilbestrol
0.5626775600	granisetron
0.5626775600	convert
0.5626775600	depots
0.5626775600	retain
0.5626775600	nanocomposites
0.5626775600	incompletely
0.5626775600	phosphoprotein
0.5626775600	glycosides
0.5626775600	lanosterol
0.5626775600	hydrolyze
0.5626775600	guide
0.5626775600	lysates
0.5626775600	foods
0.5626775600	6h
0.5626775600	dizziness
0.5626775600	intranasal
0.5626775600	judged
0.5626775600	chronotropic
0.5626775600	sporadic
0.5626775600	salmon
0.5626775600	reversing
0.5626775600	settings
0.5626775600	shunt
0.5626775600	prosurvival
0.5626775600	coordinated
0.5626775600	buffered
0.5626775600	propargyl
0.5626775600	prototypical
0.5626775600	compliance
0.5626775600	fermentation
0.5626775600	leftward
0.5626775600	natriuresis
0.5626775600	immobilization
0.5626775600	modality
0.5626775600	detrimental
0.5626775600	operative
0.5626691752	magnitude
0.5626121014	at
0.5626049182	vegf expression
0.5625467263	modes
0.5625432536	membrane proteins
0.5625377746	rfrp
0.5624853215	evidenced
0.5624681803	zn2 +
0.5622546369	mrna and protein levels
0.5622140900	hole
0.5622140900	knee
0.5621787693	infarction
0.5621571243	neuropathic
0.5621118616	vein
0.5620639315	during
0.5620541894	parent compound
0.5620476242	interacts
0.5620317289	uses
0.5619161014	significantly diminished
0.5619035713	fmo3
0.5619035713	taar1
0.5618855985	commercially
0.5618738704	cds
0.5616514340	timp
0.5616488334	ie
0.5616456693	wb
0.5616171546	f3
0.5615924819	binding protein
0.5615102345	treatment groups
0.5613559049	intracellular reactive oxygen species
0.5613072272	cardiac function
0.5611616632	side chains
0.5611492811	p4
0.5611051206	fasting plasma
0.5610097301	survivors
0.5609567885	including
0.5608625130	vas
0.5608538743	they
0.5607854442	lavage
0.5607117705	treat
0.5607084642	markedly increased
0.5605853701	gpr55
0.5604701573	threatening
0.5604701573	unfractionated
0.5604701573	sciatic
0.5604630184	related factor 2
0.5604100326	primary cortical
0.5603615086	lbl
0.5603615086	soce
0.5603615086	nfa
0.5603382900	spi
0.5602728968	moving
0.5602372132	eag
0.5602354347	pegylated
0.5602222098	around
0.5601679382	phs
0.5601461791	inward
0.5601414783	since
0.5600939660	rat heart
0.5600507754	tandem mass
0.5600327205	s nitrosation
0.5599920232	protein levels
0.5599211487	computer
0.5598729724	presumably
0.5598680410	sclerosis
0.5597969997	boc
0.5597251839	gram
0.5597111603	sms
0.5596900346	h3r
0.5595659371	respect
0.5595591872	musk
0.5594489437	examples
0.5594489437	hydration
0.5594489437	7βohc
0.5594489437	addictive
0.5594489437	psychostimulants
0.5594489437	dipeptide
0.5594334636	human cancer cell lines
0.5592921178	inhibitory action
0.5590772372	tolvaptan
0.5590695355	spontaneous locomotor
0.5588697204	consequence
0.5588304053	participate
0.5588282537	vascular function
0.5586568717	an
0.5586404753	consisting
0.5586159358	intracellular ca
0.5584924983	significantly enhanced
0.5584260916	lowering effect
0.5583420374	needs
0.5583420374	288
0.5583012174	™
0.5583012174	p95erbb2
0.5583012174	equivalents
0.5582901209	high cholesterol
0.5582201661	phox
0.5581948793	ly117018
0.5581173928	follow
0.5579346931	pox
0.5578936607	contribution
0.5578569959	studies suggest
0.5577260516	physiological conditions
0.5576789112	interfere
0.5576417019	article
0.5576119707	parabens
0.5576119707	covering
0.5576119707	stores
0.5576119707	antiallodynic
0.5576119707	calycopterin
0.5576119707	sulfite
0.5576119707	betagamma
0.5576119707	meet
0.5576119707	chitosan
0.5576119707	thiazol
0.5576119707	tracer
0.5576119707	fractionation
0.5576119707	sessions
0.5576119707	catalytically
0.5576119707	errors
0.5576119707	monophasic
0.5576119707	antiandrogenic
0.5576119707	flushing
0.5576119707	inflamed
0.5576119707	calpastatin
0.5576119707	2cl
0.5576119707	parasites
0.5576119707	arousal
0.5576119707	acylcarnitine
0.5576119707	partitioning
0.5576119707	translocated
0.5576119707	transplanted
0.5576119707	triazol
0.5576119707	fabrication
0.5576119707	tertile
0.5576119707	priming
0.5576119707	toloxatone
0.5576119707	malformations
0.5576119707	4e
0.5576119707	concerted
0.5576119707	perspective
0.5574428242	dcs
0.5573995804	mouse brain
0.5573917118	mdckii
0.5572492950	txb2
0.5571861627	because
0.5571062302	peptidylarginine
0.5570571260	imidacloprid
0.5570571260	p42
0.5570571260	dissolution
0.5570571260	masses
0.5570571260	sensitizer
0.5570571260	epoxy
0.5570571260	grow
0.5570571260	constricted
0.5570571260	darunavir
0.5570571260	p185erbb2
0.5570553978	ckd
0.5570553978	fsap
0.5570553978	mw
0.5570553978	acc
0.5569466401	ltd
0.5569416066	entitled
0.5569363723	plasminogen activator inhibitor
0.5568448280	limbs
0.5568339293	vegfr2
0.5568198940	dimensional
0.5567673166	erk1 2 phosphorylation
0.5566986946	cav
0.5566332036	mc3t3
0.5566332036	menten
0.5566270680	cdb
0.5564942703	db
0.5563969240	significantly affected
0.5563104960	prostatic hyperplasia
0.5562933750	fmol
0.5562887731	polycyclic
0.5562866925	iodide
0.5562866925	replaced
0.5562609390	degrees c
0.5561543365	frontal
0.5561501160	throughput
0.5561501160	reticulum
0.5561022372	sepracor
0.5559850234	normal subjects
0.5559304040	very
0.5559211684	cf
0.5559211684	tfp
0.5559211684	amd
0.5559211684	ik
0.5558539671	camkii
0.5557332344	las
0.5557001748	fatty liver
0.5557000334	nude
0.5557000334	pregnane
0.5556749545	depends
0.5556555456	aadc
0.5556450118	cii
0.5555867954	pod
0.5555486974	depending
0.5555055317	lbd
0.5555000447	ε
0.5554793302	cpla2
0.5554668823	b1r
0.5554603455	nonsteroidal anti inflammatory
0.5554579573	role played by
0.5554164461	nox
0.5552916878	estrogenic activity
0.5552299120	horn
0.5552299120	hexane
0.5552299120	dizocilpine
0.5552299120	switching
0.5552299120	frutescens
0.5552299120	thermogenesis
0.5552299120	build
0.5552299120	encountered
0.5552299120	mucus
0.5552299120	purposes
0.5552299120	originate
0.5552299120	organelles
0.5552299120	warrants
0.5552299120	costs
0.5552299120	amlodipine
0.5552299120	cranial
0.5552299120	conjunctivitis
0.5552299120	solubilized
0.5552299120	noncoding
0.5552299120	unambiguously
0.5552299120	renders
0.5552299120	osteoprotegerin
0.5552299120	endocannabinoid
0.5552299120	pyrrole
0.5552299120	calreticulin
0.5552299120	accompanying
0.5552299120	impulsive
0.5552299120	enrollment
0.5552299120	correspond
0.5552299120	prolongs
0.5552299120	acetaldehyde
0.5552299120	oriented
0.5552299120	fetus
0.5552299120	supposed
0.5552299120	built
0.5552299120	implies
0.5552299120	clonogenic
0.5552299120	portions
0.5552299120	intoxicated
0.5552299120	melanogenesis
0.5552299120	ethers
0.5552299120	noticeable
0.5552299120	represses
0.5552299120	termini
0.5552299120	instances
0.5552299120	chemotherapeutics
0.5552299120	hypertriglyceridemia
0.5552299120	inhibitions
0.5552299120	sympathomimetic
0.5552299120	electrophiles
0.5552299120	allergy
0.5552299120	speculated
0.5552299120	exaggerated
0.5552299120	nociception
0.5552299120	harbor
0.5552299120	lengths
0.5552299120	desogestrel
0.5552299120	1a9
0.5552299120	interacted
0.5552299120	stereochemistry
0.5552299120	ingredients
0.5552299120	competent
0.5552299120	alkylated
0.5552299120	granted
0.5552299120	procollagen
0.5552299120	histologically
0.5552299120	reciprocal
0.5552299120	corresponds
0.5552299120	accessibility
0.5552299120	cavernosum
0.5552299120	increment
0.5552299120	euglycemic
0.5552299120	densities
0.5552299120	stereoisomers
0.5552299120	resemble
0.5552299120	prominently
0.5552299120	displace
0.5552299120	accelerating
0.5552299120	assumption
0.5552299120	ago
0.5552299120	photoreceptors
0.5552299120	biofilms
0.5552299120	meiotic
0.5552299120	episode
0.5552299120	rifamycin
0.5552299120	11r
0.5552299120	advent
0.5552299120	losses
0.5552299120	biopsies
0.5552299120	spinning
0.5552299120	scarce
0.5552299120	gonad
0.5552299120	neutralizing
0.5552299120	α4β2
0.5552299120	predictable
0.5552299120	oligomers
0.5552299120	inert
0.5552299120	carprofen
0.5552299120	bezafibrate
0.5552299120	subpopulation
0.5552299120	heavily
0.5552299120	phosphates
0.5552299120	occupy
0.5552299120	reinforcers
0.5552299120	alpha1b
0.5552299120	wildtype
0.5552299120	neurotoxins
0.5552299120	asked
0.5552299120	dimethoxy
0.5552299120	homeostatic
0.5552299120	plates
0.5552299120	expenditure
0.5552299120	gate
0.5552299120	pulp
0.5552299120	dependency
0.5552299120	cirrhotic
0.5552299120	walled
0.5552299120	oligonucleotide
0.5552299120	hindered
0.5552299120	ovaries
0.5552299120	accumulates
0.5552299120	mesothelioma
0.5552299120	2c9
0.5552299120	2b1
0.5552299120	cleaving
0.5552299120	₂
0.5552299120	utilize
0.5552299120	ascites
0.5552299120	dilatation
0.5552299120	arises
0.5552299120	nonpeptide
0.5552299120	difficulties
0.5552299120	licensed
0.5552299120	trophoblast
0.5552299120	evolutionarily
0.5552299120	attempted
0.5552299120	encouraging
0.5552299120	hits
0.5552299120	participating
0.5552299120	phosphodiesterases
0.5552299120	adopts
0.5552299120	uniform
0.5552299120	transmural
0.5552299120	depleting
0.5552299120	failing
0.5552299120	rendering
0.5552299120	sotalol
0.5552299120	deactivation
0.5552299120	catabolic
0.5552299120	fluoropyrimidine
0.5552299120	valid
0.5552299120	pumps
0.5552299120	ionotropic
0.5552299120	render
0.5552299120	continue
0.5552299120	declines
0.5552299120	homodimer
0.5552299120	homogeneity
0.5552299120	extends
0.5552299120	sequentially
0.5552299120	erg3
0.5552299120	accessory
0.5552299120	epitopes
0.5552299120	genotoxicity
0.5552299120	lysate
0.5552299120	steric
0.5552299120	investigates
0.5552299120	hitherto
0.5552299120	myristate
0.5552299120	disappearance
0.5552130270	gq
0.5552130270	scatchard
0.5552130270	du145
0.5552130270	u50
0.5552130270	hacat
0.5552130270	t47d
0.5550399200	serve
0.5550357252	aea
0.5550357252	pn
0.5550055845	vav1
0.5549945472	non
0.5549015330	shed
0.5548522450	ac3174
0.5548522450	nfκb
0.5548522450	china
0.5548522450	cxcl8
0.5547972497	rat kidney
0.5547685463	growth inhibitory
0.5545259180	hete
0.5545259180	gg
0.5545040523	mmr
0.5545040523	ggqld
0.5545040523	ltc
0.5545040523	etm
0.5545011138	binding assays
0.5544796420	rargamma
0.5544796420	nox4
0.5544796420	hsd2
0.5544004406	il 13
0.5543953002	rems
0.5542269644	gp130
0.5541968096	sert binding
0.5540438845	mtmr13
0.5540419930	later
0.5540399200	interfering
0.5539719085	serves
0.5538058768	site specific
0.5537597888	∞
0.5537502666	dfp
0.5536351878	potential therapeutic
0.5535794182	pcbs
0.5535333806	nick
0.5534858585	served
0.5534782209	betaar
0.5534601479	adult mice
0.5534238727	by
0.5534088916	protein expression
0.5534046670	use
0.5533493666	thus
0.5532974690	breast cancer cell line
0.5532799145	3alpha
0.5532233522	mirnas
0.5531232889	ari
0.5531232889	bsc
0.5531232889	gfj
0.5531232889	lta
0.5531232889	em
0.5531232889	pic
0.5530877280	ex
0.5529934108	how
0.5529474656	glp 2
0.5529416066	indicative
0.5529371259	bdl
0.5529371259	blg
0.5529345835	ubr2
0.5529345835	danshen
0.5529345835	igf2r
0.5529345835	b3lyp
0.5529345835	ugt1a9
0.5529345835	october
0.5529345835	mat2a
0.5527131029	reductions
0.5526226378	ca2 + channels
0.5524730758	cyp3a activity
0.5524203301	acetic
0.5523843618	complex formation
0.5521924220	twelve
0.5521332058	g protein coupled receptors
0.5521057946	d mph
0.5519871396	antiproliferative activity
0.5518501062	pias1
0.5517834753	tnap
0.5517803888	oatps
0.5517662241	mtap
0.5517367311	ligand dependent
0.5517046860	other
0.5516923775	delta1
0.5515418850	lhrh
0.5515418850	tdi
0.5514859150	beta 1 and beta 2
0.5514685062	ptgfr
0.5514685062	dhe
0.5514339034	mwcnt
0.5514249964	direct evidence
0.5513441150	macroglobulin
0.5513441150	teratogenic
0.5513441150	diurnal
0.5513441150	hydrolytic
0.5513441150	neonate
0.5513441150	prolonging
0.5513441150	wasting
0.5513441150	flick
0.5513441150	ethephon
0.5513441150	slippage
0.5513441150	sphingomyelinase
0.5513441150	ischaemic
0.5513441150	ropivacaine
0.5513441150	angiographic
0.5513441150	cefotaxime
0.5513441150	deacetylation
0.5513441150	solvation
0.5513441150	sulphated
0.5513441150	cromoglycate
0.5513441150	imidazol
0.5513441150	quipazine
0.5513441150	excipients
0.5513441150	lamellar
0.5513441150	remodelling
0.5513441150	distances
0.5513441150	indol
0.5513441150	ritanserin
0.5513441150	unliganded
0.5513441150	grapes
0.5513441150	ine
0.5513441150	methyltetrahydrofolate
0.5513441150	letrozole
0.5513441150	thresholds
0.5513441150	aminoglycoside
0.5513441150	filgrastim
0.5513441150	suggestive
0.5513441150	lining
0.5513441150	marginal
0.5513441150	deaths
0.5512685373	300 microg kg
0.5512430212	c677t
0.5512430212	akr1b1
0.5511438743	mmol l
0.5510392796	role
0.5508821017	lastly
0.5508350670	date
0.5508204469	pgis
0.5508204469	pots
0.5508204469	glast
0.5507600006	ppars
0.5507598041	therefore
0.5507426648	p aminohippurate
0.5506888952	studies revealed
0.5506762949	epc
0.5506762949	dft
0.5506762949	mdh
0.5506762949	mic
0.5506762949	bza
0.5506762949	ria
0.5506572083	1a2
0.5506572083	medaka
0.5506572083	emesis
0.5506572083	rimonabant
0.5506572083	p38mapk
0.5504616068	mg twice daily
0.5504609973	cmax
0.5504587819	positive correlation
0.5503770860	hmi
0.5503770860	sl
0.5502938258	rv
0.5502742061	blind
0.5502628428	wev
0.5502628428	lpv
0.5501537163	hydrocarbon
0.5501386432	near infrared
0.5500482232	p2y12 receptor
0.5500360120	serotonin receptors
0.5500191133	meanwhile
0.5500111390	key enzyme
0.5500034295	for
0.5499765737	oxygenase
0.5499666840	real
0.5498110117	3h paroxetine
0.5497493488	binding proteins
0.5496475028	active compounds
0.5496263173	trka
0.5494668330	blood levels
0.5494521723	iκb
0.5494521723	mp2
0.5494521723	pde3a
0.5494521723	iks
0.5494153920	while
0.5493504561	pp2a
0.5492742061	contributes
0.5492171222	116
0.5491664357	raldh2
0.5491422048	arf
0.5488869642	induced hepatotoxicity
0.5487832823	signal regulated kinase
0.5487629061	no significant difference
0.5486901483	stress induced
0.5486174771	when
0.5484397940	particularly
0.5484286481	fold decrease
0.5484058522	nbp
0.5484058522	dca
0.5484058522	ddah
0.5483879716	oral glucose
0.5481965353	129
0.5481168580	ctni
0.5480590434	fab
0.5480576576	strong evidence
0.5480325173	shp 1
0.5479653161	chemical structures
0.5478968577	kw
0.5478968577	stm
0.5478968577	mip
0.5478433529	key role
0.5478323090	namely
0.5478029260	moreover
0.5477966467	β1ar
0.5477559756	cpr
0.5476507743	gbs
0.5476507743	alad
0.5476507743	pbp
0.5476507743	bdz
0.5475989875	based assays
0.5475818246	er alpha
0.5475738268	accompanied
0.5475650983	px
0.5475001805	mcs
0.5474512359	jurkat t
0.5474432638	fev
0.5473771346	affinity and selectivity
0.5473353084	kainate receptor
0.5472662781	changes
0.5472653261	5 lox
0.5472615999	autosomal
0.5472552888	s100p
0.5472403057	coat
0.5472403057	₅
0.5472403057	har
0.5472246204	actinomycin d
0.5471953496	anti oxidative
0.5471770628	smooth muscle cells
0.5470765737	marrow
0.5469829864	me
0.5468950748	protein and mrna levels
0.5468646329	nitric oxide production
0.5467876848	catenin
0.5466848723	furthermore
0.5465809509	right ventricular
0.5464769261	intravenous injection
0.5464202630	attributed
0.5463673013	mms
0.5463548192	responsible
0.5463286472	smad4
0.5463079368	mefs
0.5462641435	h3 receptor
0.5460892046	ldh x
0.5460866437	× 10
0.5460528410	on
0.5459818683	f344
0.5459434645	rat hippocampus
0.5458876023	2alpha
0.5456894866	rats received
0.5456496271	alpha 2b
0.5454354798	there
0.5452808157	fidarestat
0.5452808157	nucleosomes
0.5452740498	related compounds
0.5449697215	composed
0.5449623208	pbs
0.5449255032	metabotropic
0.5448066507	across
0.5447779351	132
0.5447624822	kr
0.5447185509	meg
0.5446890737	cord
0.5446598595	79
0.5445110477	similar potency
0.5444630909	brain tissue
0.5444085325	srbp
0.5444085325	heterozygotes
0.5443257410	2 neu
0.5442932512	zol
0.5442495189	cb1 receptor
0.5441386557	alimta
0.5441187538	gga
0.5441187538	gf
0.5441187538	adm
0.5441187538	lrp
0.5441187538	nodat
0.5440182550	timp 1
0.5439620527	glycol
0.5439497396	pparbeta
0.5438936928	arginase activity
0.5437829007	carboxylic
0.5436717669	isa
0.5436498894	g2 m
0.5434949869	confidence
0.5434681120	molecular structure
0.5431988452	nqo2
0.5431895516	future studies
0.5431203360	different
0.5430290871	thought
0.5429249205	account
0.5429176445	vs
0.5429036439	kappab
0.5428746384	100μm
0.5428472361	who
0.5428338419	nfatc1
0.5428263311	high density
0.5427289274	within
0.5427023384	human brain
0.5426326423	wild
0.5425717599	eu
0.5425717599	iaa
0.5425717599	qe
0.5425717599	bcm
0.5425717599	ghis
0.5425717599	pdb
0.5425717599	ggt
0.5425717599	pse
0.5423252521	independent mechanism
0.5422956838	dr5
0.5422036556	600
0.5422030495	bps
0.5422030495	f1
0.5422030495	u0126
0.5421340647	lymphocytic leukemia
0.5420602927	drd3
0.5418799454	spectrometry
0.5417795056	give
0.5417783978	one carbon metabolism
0.5417197423	gy
0.5415801144	sry
0.5415630056	results reveal
0.5414375692	ap 1
0.5414003842	fpr2
0.5414003842	insl3
0.5414003842	pde10a
0.5413052502	peroxisome
0.5412991308	ganglion
0.5412844484	findings support
0.5410610926	to
0.5410586045	sixty
0.5410005615	mat1a
0.5409689598	therapeutic target
0.5409484833	mt1
0.5409484833	mt2
0.5409362800	monw
0.5409362800	dmf
0.5408757889	ouabain
0.5407483811	thereafter
0.5407112496	smooth
0.5406873996	5 ht2b
0.5406360422	dmas
0.5406265880	cbr1
0.5406265880	y1
0.5406265880	erbb3
0.5406265880	mgadp
0.5405404704	l citrulline
0.5405114234	mdm2
0.5405114234	cdk4
0.5403301128	plasminogen activator inhibitor 1
0.5399006077	strongly inhibited
0.5398993173	monoclonal
0.5398551506	steady
0.5396130427	dephosphorylated
0.5396130427	p110α
0.5396130427	cholangiocyte
0.5396130427	17alpha
0.5396130427	formate
0.5396130427	p14arf
0.5396130427	pentagastrin
0.5396130427	maleimide
0.5396130427	carbinolamine
0.5396130427	alfentanil
0.5396130427	limonene
0.5396130427	euthyroid
0.5396130427	ergosterol
0.5395853319	deltakpq
0.5395853319	svct1
0.5395853319	nlrp3
0.5395584510	regulatory subunit
0.5394139845	tbhq
0.5394139845	antihistamine
0.5393585448	irs 1
0.5393077843	pick1
0.5393077843	akr1c3
0.5391830996	although
0.5391567519	isolated rat
0.5391498554	pc2
0.5389230153	median follow up
0.5388876982	prp
0.5387683399	fr
0.5386829145	aldh1b1
0.5386829145	δnp63
0.5386354798	we
0.5384981282	apart
0.5382153908	allow
0.5381738252	molecular mechanism
0.5381712253	terminus
0.5380623020	coa reductase
0.5379090406	usually
0.5378814918	first line
0.5378778279	insight into
0.5378451967	second generation
0.5378296256	itx
0.5378296256	spacrcan
0.5377805982	transcript levels
0.5376241186	msh2
0.5376241186	rev1
0.5375189968	100g
0.5375189968	adamantyl
0.5374735750	it
0.5374697065	control diet
0.5373012959	near
0.5372497670	presence
0.5371858852	seminal
0.5371858852	aspartic
0.5370692330	mcd
0.5370386399	others
0.5366658774	caspase 1
0.5365056811	protein kinases
0.5364443207	spla2
0.5364358852	nitrosation
0.5364358852	messengers
0.5363850042	mda levels
0.5363263060	mediated transactivation
0.5361557865	analysis showed
0.5360029354	through
0.5359732670	zr
0.5359598041	our
0.5359444531	e selectin
0.5356706144	hvdr
0.5356527655	eg
0.5356165341	urb597
0.5356165341	par4
0.5356165341	cd74
0.5356165341	pim1
0.5356165341	smad1
0.5356165341	jak1
0.5356165341	ag490
0.5356165341	ephb4
0.5356165341	hsd1
0.5356165341	glun1
0.5356165341	way100635
0.5355104652	living cells
0.5354355221	make
0.5352905542	ile
0.5352482259	bt
0.5352482259	osi
0.5352360253	prevention and treatment
0.5351830063	l arg
0.5351783791	6r
0.5351783791	mglurs
0.5345074500	glucose tolerance test
0.5344661790	er positive
0.5344015437	resulted
0.5343187512	any
0.5342767926	first line therapy
0.5342616993	hdn
0.5340701153	rev
0.5339831056	generation of reactive oxygen species
0.5339065687	receptor mediated
0.5337778363	glut 4
0.5337222550	5 ht2a and 5 ht2c
0.5336890316	higher affinity
0.5336478231	lycopenoic
0.5333785210	10μm
0.5333785210	srage
0.5333785210	machr
0.5333430611	multidrug
0.5332692185	oxotremorine
0.5332692185	aminohippurate
0.5332429034	mammalian brain
0.5332385318	κb
0.5331875382	gsts
0.5331502173	follows
0.5331323955	c57bl 6
0.5330126619	trprs
0.5330126619	erk2
0.5329228163	from
0.5329149512	related disorders
0.5328200627	bearing mice
0.5328100580	twice
0.5327938457	mitogen activated
0.5327811917	bisphenol a
0.5327488608	markedly decreased
0.5326644707	low doses
0.5325214657	cyclin dependent
0.5324959836	better
0.5324507252	egf induced
0.5322846336	also
0.5321400310	phorbol 12
0.5321133451	fold selectivity
0.5317933553	analyses revealed
0.5317562973	orl1
0.5317562973	ld50
0.5317562973	rcts
0.5317296549	d 1997
0.5317141067	ntds
0.5316942984	micromol
0.5316644037	hai
0.5316152374	β oxidation
0.5314667158	dose response
0.5314136092	neuronal activity
0.5313174282	useful
0.5313146893	regulated genes
0.5312900583	1μm
0.5312774423	pgd2
0.5312692905	recently identified
0.5312596117	transplant patients
0.5312352704	gpr35
0.5312352704	jzl184
0.5310823772	pag
0.5310366308	2d
0.5310270622	forty
0.5309042861	ucp 3
0.5307650783	ogd
0.5307650783	apj
0.5307650783	ope
0.5307650783	cnf
0.5307650783	tes
0.5306411264	former
0.5305233746	induced toxicity
0.5304826733	delta opioid
0.5304050691	dnmt1
0.5303647278	l cysteine
0.5301904460	95
0.5301440810	hsc70
0.5301440810	β3
0.5301401136	neuronal injury
0.5301259694	lpa1
0.5301259694	fmo1
0.5301259694	ccl2
0.5301259694	cgp12177
0.5301181835	human gastric
0.5299648869	rctr1
0.5298305476	1997
0.5298148868	fph
0.5297483339	iontophoresis
0.5297483339	mantle
0.5297483339	erection
0.5297483339	ulcerative
0.5297483339	opener
0.5297483339	cytometric
0.5297483339	etabonate
0.5297436598	far
0.5296003714	a special issue entitled
0.5295384791	ep4
0.5295384791	lyn
0.5295384791	sucampo
0.5295384791	stim1
0.5295384791	pitx3
0.5295384791	t2
0.5295384791	n1
0.5295384791	p2y1
0.5295384791	min6
0.5295384791	atp8a1
0.5294760855	smad2
0.5294760855	fischer
0.5294760855	nr2d
0.5294760855	paeoniflorin
0.5294760855	pompe
0.5294760855	march
0.5294760855	mancozeb
0.5294760855	azd2171
0.5294760855	lat3
0.5294760855	at2
0.5294760855	ugt2b10
0.5294760855	su5416
0.5294760855	lrp4
0.5294760855	heparg
0.5294094849	hbv
0.5293717815	paqr3
0.5293717815	wnt6
0.5293618961	tac
0.5293218303	imt
0.5292296297	300
0.5292018729	structure based drug
0.5290814772	nadh dependent
0.5289585465	pim 1
0.5288108235	d galn
0.5286633944	gaf b
0.5285983441	drug target
0.5284304347	dose dependently increased
0.5283945692	higher dose
0.5283265342	vmat 1
0.5283248422	synthesis and biological
0.5282832979	cb1 receptors
0.5282391666	inflammatory cytokine
0.5282291667	conformational changes
0.5281881793	interferes
0.5281619030	having
0.5280022155	virexx
0.5280022155	pocl
0.5280022155	michael
0.5280022155	s9
0.5280022155	ly395153
0.5280022155	biochem
0.5280022155	swiss
0.5277483071	mechanisms involved
0.5275934036	dismutase
0.5275101550	become
0.5272972273	nahs
0.5272644519	anti inflammatory activities
0.5272480154	beta4gal
0.5272480154	metabolizers
0.5272235625	mekk2
0.5272235625	cyp2b4
0.5272013335	peroxidation
0.5271590630	top2
0.5268195762	attempt
0.5267737347	hsert
0.5265816672	actinomycin
0.5264116429	s2
0.5263830996	however
0.5262603089	mg ml
0.5260979134	anxa1
0.5260979134	sur2b
0.5259574235	hormone levels
0.5259481884	scd 1
0.5259353180	sd rats
0.5259341021	muc1
0.5259341021	semet
0.5258779075	chinese hamster ovary cells
0.5258208154	ers
0.5258208154	bmax
0.5257407861	vmh
0.5257407861	dedtc
0.5257386915	mk2
0.5257205942	adrenoceptor agonists
0.5256347545	pthrp
0.5256347545	atf4
0.5255886978	reading
0.5253982807	aqp5
0.5253982807	nk1
0.5252506562	end products
0.5251660832	mediated efflux
0.5251647666	p2x
0.5250659074	inhibitory avoidance
0.5250632994	eleven
0.5249956156	hematopoietic cells
0.5249597183	improved survival
0.5248554208	binding characteristics
0.5248553902	dependently
0.5247504272	self assembly
0.5246224937	receptor blocker
0.5246056951	errα
0.5246056951	ptps
0.5243813870	sod1
0.5240656367	5 meo
0.5240032983	chlorogenic
0.5240032983	nodes
0.5240032983	35s
0.5240032983	compensate
0.5240032983	emergence
0.5240032983	immunodeficiency
0.5235365820	cloned human
0.5234603576	selected compounds
0.5233304665	azd6140
0.5232752462	stat3 signaling
0.5232602815	drug administration
0.5232368028	phte
0.5232019831	fpps
0.5231888390	cyp19a1
0.5231888390	adhs
0.5231888390	rhbg
0.5231888390	ltd4
0.5231888390	lrrk2
0.5231437145	trx
0.5231437145	iκbα
0.5231175460	control animals
0.5230410092	mouse liver
0.5230327705	bmp 2
0.5229983192	especially
0.5229865671	igg1
0.5229564915	&
0.5228488401	he
0.5228262073	smad7
0.5228262073	mg132
0.5228262073	ccl3
0.5228262073	nb2
0.5228262073	acsl4
0.5228262073	nox2
0.5228262073	cdcl2
0.5228262073	jnk1
0.5228262073	nifs
0.5228262073	v3
0.5228191672	myo
0.5227859087	small cell lung cancer
0.5227382588	250
0.5221840386	ops
0.5221840386	pufas
0.5220927649	pis
0.5220424241	zero
0.5219859440	chemical structure
0.5218853238	nh3
0.5218853238	angii
0.5217535310	patients with type 2 diabetes mellitus
0.5217486411	t lymphocytes
0.5217282143	less
0.5216839371	49
0.5215898582	unlikely
0.5215074574	mechanisms of action
0.5214849799	150 mg
0.5214269083	key enzymes
0.5213272038	sinapic
0.5213272038	feasibility
0.5213272038	restoration
0.5213272038	acetonide
0.5213272038	medroxyprogesterone
0.5213272038	hydroxyvitamin
0.5212078513	thd
0.5211471464	pyk2
0.5210850865	experimental conditions
0.5210671832	384
0.5209573586	dermatitis
0.5209573586	oleanolic
0.5209573586	luteinizing
0.5209573586	elucidation
0.5209573586	sole
0.5209573586	thaliana
0.5209294724	sglt2
0.5208942018	im
0.5207320009	d816v
0.5207179454	human recombinant
0.5206698725	mg day
0.5206262088	seems
0.5205531908	serms
0.5205531908	ffas
0.5202446247	fviia
0.5202446247	u46619
0.5202407983	rafts
0.5202407983	ursolic
0.5202367718	significantly prolonged
0.5202278337	phgpx
0.5200673820	67
0.5200389242	pancreatic β cell
0.5199797764	continues
0.5199797764	estimation
0.5199355817	6 nc
0.5198090686	glucuronidation activity
0.5197907119	clearly
0.5195440694	cerebrospinal
0.5195431793	aimed
0.5194964582	d2 antagonist
0.5194784644	ca2 + currents
0.5193998907	chat
0.5192836960	human colon cancer cells
0.5192736123	ifngamma
0.5192736123	c5
0.5192386212	accounting
0.5192386212	publication
0.5192386212	online
0.5191991655	smad3
0.5191991655	asic3
0.5191912021	acetic acid induced
0.5190827748	kca3
0.5190827748	trpml1
0.5190827748	kv7
0.5190827748	raig1
0.5190827748	pkcδ
0.5190827748	viia
0.5190827748	gsta1
0.5190827748	wb4101
0.5190827748	cd2
0.5190827748	m6p
0.5190827748	ephb1
0.5190827748	ent1
0.5190385622	cyclo
0.5190297377	75
0.5190108386	sb224289
0.5190021395	ikr
0.5190021395	h460
0.5190021395	ecl2
0.5190021395	caucasians
0.5190021395	i3a
0.5189141317	signal transducer
0.5189100309	197
0.5188897038	linoleic
0.5188297557	iddm
0.5187383974	up regulation
0.5186900609	zinc binding
0.5186867719	azd1656
0.5186867719	phd2
0.5186867719	gw660511x
0.5186867719	h146
0.5186867719	cyp11a1
0.5186867719	raldh1
0.5186867719	ly541850
0.5186867719	cd40
0.5186867719	kcc1
0.5186867719	biol
0.5186867719	fer
0.5186867719	pkcα
0.5186867719	rad9
0.5186867719	ulva
0.5186867719	mtmr2
0.5186867719	gsk1292263
0.5186867719	mrp3
0.5186867719	cyp2d
0.5186867719	g6pc2
0.5186867719	fam36a
0.5186867719	myd88
0.5186867719	glyt2
0.5186867719	ramp1
0.5186867719	torpedo
0.5186116270	sf 1
0.5185556151	150
0.5185202982	expressed in cos
0.5184599764	benzoic
0.5183883103	non steroidal anti inflammatory
0.5182458604	mc2r
0.5182458604	sb203580
0.5182458604	pams
0.5182458604	tzds
0.5181378913	ki =
0.5180439403	induced contraction
0.5179863426	variety
0.5178554105	amongst
0.5178296480	nd
0.5175434721	hcox
0.5174618832	fragment based
0.5174386212	deferens
0.5173999303	tlr8
0.5173999303	cat1
0.5173999303	pat1
0.5173999303	kcnk1
0.5173999303	clfn
0.5173999303	tmem106b
0.5173892601	except
0.5173607728	erk activation
0.5173464642	201
0.5173433618	treg
0.5172711258	oct1
0.5172711258	kars
0.5172711258	kies
0.5172711258	ebs
0.5172711258	pha1
0.5171837650	cytotoxic activity
0.5171617863	brdu
0.5171617863	pgs
0.5171053182	47
0.5170726701	cyclin e
0.5169408208	achr
0.5169408208	d6d
0.5169408208	npc1l1
0.5169408208	top1
0.5169408208	lc3
0.5168625213	endorphin
0.5168625213	glucuronosyltransferase
0.5168625213	consisted
0.5168625213	100mg
0.5168625213	brush
0.5168204674	determined by measuring
0.5166742621	piperazinyl
0.5166322254	adss
0.5165942745	34
0.5165614145	1000
0.5165162401	brbk1
0.5164726408	focusing
0.5164726408	belongs
0.5164726408	eicosapentaenoic
0.5163881865	case control
0.5163738039	chemically induced
0.5162500213	likelihood
0.5162500213	tegmental
0.5162500213	depended
0.5162078687	pyridoxal 5
0.5159726408	valproic
0.5159532790	value
0.5158625213	pgc
0.5158441621	120
0.5158000213	dinucleotide
0.5158000213	ionizing
0.5158000213	participates
0.5158000213	belonging
0.5158000213	compatible
0.5157624352	2013
0.5156995024	spions
0.5156995024	gnrhr
0.5155439355	primary cultured
0.5155163074	help
0.5155000213	50mg
0.5154017600	normal weight
0.5153834505	results support
0.5153782421	free survival
0.5153598044	trpc6
0.5153598044	bdzs
0.5152232983	29
0.5152082252	gfs
0.5152017308	92
0.5151523494	its
0.5151418090	80
0.5151403849	id
0.5149537563	84
0.5147955932	sodium dependent
0.5147291783	dependent mechanism
0.5146573375	pc 3 cells
0.5146143290	regulatory proteins
0.5146098657	dose dependently reduced
0.5146051240	vivo
0.5145019041	made
0.5144357953	*
0.5144180882	87
0.5143770116	pde4b
0.5143681845	irf5
0.5143681845	cnn1
0.5143681845	lta4
0.5141281862	with
0.5140453620	human breast cancer cells
0.5137851553	fgfs
0.5137851553	hbf
0.5137172661	nscs
0.5137127176	82
0.5136072665	apoptotic cells
0.5135070885	1d
0.5133063992	adenocarcinoma cells
0.5132835621	src1
0.5132835621	lysrs
0.5132835621	ip3
0.5132789691	highly sensitive
0.5130629160	whereas
0.5130092312	high level
0.5130059898	regulatory element
0.5129799816	referred
0.5129799816	linolenic
0.5129195153	06
0.5129083649	100
0.5127782003	102
0.5126546403	sori
0.5124709300	partially inhibited
0.5124178760	24 hour
0.5123705926	par 1
0.5121447415	structural basis
0.5120968011	potent anti inflammatory
0.5120556373	necessary
0.5119776323	glutamic
0.5117936897	without
0.5117932808	proximal tubule cells
0.5117551390	ta1
0.5117551390	tcf7l2
0.5116685653	stat5b
0.5113287938	calcium release
0.5111887372	mostly
0.5111887372	became
0.5111371356	necrotic cell
0.5110655402	control mice
0.5109887128	118
0.5108230222	h2s
0.5107535626	24
0.5105979628	plasma cholesterol
0.5105978760	pog
0.5105605851	year
0.5105428498	onto
0.5105402042	dicaffeoylquinic
0.5105117147	08
0.5104354861	followed
0.5103340165	d fenfluramine
0.5102339598	72
0.5101091437	2005
0.5100126701	treated patients
0.5099620806	09
0.5098540105	slc2a4
0.5098540105	s100a12
0.5098540105	gw433908
0.5098540105	foxo3a
0.5098540105	gstm3
0.5098540105	rhob
0.5098540105	k18
0.5098540105	ntp
0.5097714985	experimental evidence
0.5097480132	fdurd
0.5097365908	caffeic
0.5097048793	afb1
0.5096645420	indicate
0.5095554010	2012
0.5093628936	76
0.5093336669	described
0.5093306589	89
0.5093306589	86
0.5091267808	drug therapy
0.5090420055	tissues examined
0.5089878327	arg290
0.5089878327	do3a
0.5089878327	med31
0.5089585475	sup sup
0.5089116534	luciferase activity
0.5087566883	3 hydroxy 3 methylglutaryl
0.5087384645	reported previously
0.5087209017	182
0.5086528987	immediate
0.5086528987	becomes
0.5086528987	800
0.5086528987	hundred
0.5082839617	find
0.5082125341	toll like
0.5082109938	grip1
0.5081757826	mj33
0.5081757826	cramb816
0.5081757826	cip2a
0.5081757826	sqstm1
0.5081757826	rdh12
0.5081757826	cyp2j2
0.5081757826	hdac3
0.5081757826	rg1
0.5081557067	dm2
0.5081557067	dsc3
0.5081557067	tig1
0.5081557067	cd16
0.5080502058	90
0.5080060464	insights into
0.5078756492	2010
0.5077809309	serotonin receptor
0.5077091354	30
0.5076726868	cause
0.5076231876	oxm
0.5076231876	dmap1
0.5076231876	icam2
0.5076231876	tak1
0.5076231876	pi3kgamma
0.5076231876	ikappab
0.5076231876	clpp
0.5076075521	il 6 production
0.5075681615	devoid
0.5074792236	those
0.5073803948	photons s
0.5071213991	site of action
0.5071180020	tomography
0.5071180020	accumbens
0.5070470396	intact cells
0.5069997177	37
0.5068758799	likely
0.5066315555	along
0.5065260579	between
0.5065236723	pbdes
0.5063985803	their
0.5061823695	h2o
0.5061727655	low micromolar
0.5061197755	48
0.5060964230	99
0.5060041681	110
0.5059796098	subjected
0.5058000679	hif1α
0.5057667826	thereby
0.5056310208	own
0.5056310208	done
0.5055382051	vitamin d receptor
0.5055314640	during pregnancy
0.5054796098	°
0.5054762319	72 hours
0.5054664972	must
0.5053821306	camp levels
0.5052458093	top2a
0.5050912525	nmol l
0.5050805549	adh5
0.5050805549	qr2
0.5049953993	capable
0.5048920753	emax =
0.5048731301	mitochondrial function
0.5048713634	780
0.5048713634	212
0.5048713634	otherwise
0.5048713634	180
0.5048713634	consider
0.5047849484	ugt2a2
0.5047849484	cdk9
0.5047849484	svmps
0.5047796098	carbonic
0.5047416073	dags
0.5047416073	leurs
0.5047379443	pmol l
0.5047110223	containing
0.5046470690	knock out
0.5043607942	400 mg
0.5043523784	brain gaba
0.5043025145	aged mice
0.5042629327	nfkappab
0.5042371092	31
0.5042163419	rinm5f
0.5042075320	camp response element
0.5041215314	lxrα
0.5040040436	ppardelta
0.5040040436	fgf23
0.5039265797	primary cultures
0.5036864450	pept2
0.5036741384	differential scanning
0.5036624734	28
0.5035748843	but
0.5034696025	71
0.5034232971	551
0.5034232971	quite
0.5032951287	whom
0.5032509548	arachidonic
0.5031403395	interest
0.5031231350	side effects
0.5030942346	mmp 2
0.5030708888	epidermal cells
0.5028726456	still
0.5027277695	160
0.5025306696	h115w
0.5025306696	dgkgamma
0.5025114250	drug transporters
0.5024782542	20
0.5022491394	drug metabolizing
0.5021425470	positive inotropic
0.5019393650	indicated
0.5019125927	beta agonists
0.5017509548	majority
0.5016935014	07
0.5015457225	particular
0.5014793246	significantly reduce
0.5013321147	gtpgammas binding
0.5011454988	140
0.5010452729	retinoic
0.5009862859	chronic ethanol
0.5007970353	45
0.5006072855	describe
0.5005860925	known
0.5004173010	fty720
0.5004128701	agonist activity
0.5003840237	ppm1a
0.5003431147	hup a
0.5001329427	up
0.5000978219	daily administration
0.5000417493	similar results
0.4999734317	why
0.4998630130	500
0.4997715003	002
0.4995938607	real time
0.4994244892	93
0.4993477960	ones
0.4993303401	year old
0.4993028900	d2 receptors
0.4992826023	airway epithelial
0.4992606148	57
0.4992606148	94
0.4990452729	nervous
0.4990120329	adenosine a2a
0.4989855867	cos cells
0.4989386562	400
0.4988609764	81
0.4988609764	78
0.4987503012	ache inhibition
0.4984519098	13
0.4982924369	cloz
0.4981677989	of
0.4981370974	tissue samples
0.4981328771	cell loss
0.4980657835	indicates
0.4979074064	marked decrease
0.4978573889	200 mg
0.4978449533	below
0.4978446233	25 dihydroxyvitamin
0.4978344656	not
0.4976939696	130
0.4976774659	neonatal rat
0.4975207918	allows
0.4974392154	greater than
0.4973884474	prostate cancer cells
0.4973512683	already
0.4970946239	00
0.4970170007	results obtained
0.4969194773	well documented
0.4967379647	69
0.4966777688	relative to placebo
0.4966760652	30 mg kg
0.4966740390	91
0.4966648854	regulatory element binding protein
0.4966606148	005
0.4966406361	inhibitory concentrations
0.4966345241	c5a
0.4966345241	alpl
0.4966345241	ac1
0.4966345241	map2
0.4966038505	selective cox 2 inhibitor
0.4965745533	003
0.4965725564	51
0.4965347924	nearly
0.4965347924	85
0.4964965010	higher potency
0.4963294183	brain injury
0.4963272815	58
0.4960399441	107
0.4959924519	never
0.4959924519	whereby
0.4959084111	inner
0.4957670156	asmase
0.4952072521	system
0.4949990270	15
0.4949578046	found
0.4949416922	66
0.4949281274	increased significantly
0.4947788121	61
0.4947444824	molecular pathways
0.4946086101	combined treatment
0.4944418686	54
0.4944220903	used
0.4944036537	re uptake
0.4941769895	hl 60 cells
0.4940904647	500 mg
0.4940709666	retn
0.4940079576	52
0.4939474593	side
0.4938903937	toward
0.4935856647	+
0.4934439755	40
0.4931864795	04
0.4931354408	us fda
0.4930648169	0001
0.4929818170	provides
0.4929506357	detail
0.4929506357	always
0.4928636676	alkaline phosphatase activity
0.4928512189	73
0.4927671900	highly effective
0.4927214574	mrna and protein expression
0.4927179170	88
0.4926586905	17
0.4926461048	inos mrna
0.4926247299	18
0.4924704756	vegfr 3
0.4922942227	kidney disease
0.4922340021	substrate binding
0.4920298989	16
0.4919867283	associated
0.4918469594	50
0.4918387755	14
0.4918306169	sch b
0.4918157491	seen
0.4917199059	caspase 3 activation
0.4916699806	2004
0.4916663244	once daily dosing
0.4916487169	=
0.4913281717	101
0.4911348116	inducible nitric oxide
0.4910531523	0
0.4909938268	59
0.4909002820	12
0.4908185204	now
0.4906285114	liver cancer
0.4906147586	77
0.4906079872	previously identified
0.4903631240	caco 2 cell
0.4903232908	relatively
0.4902912648	fgf 10
0.4902613953	155
0.4902538328	25
0.4901775332	than
0.4901598865	gene family
0.4901465614	stimulated cyclic amp
0.4900761942	53
0.4898309543	105
0.4898284619	2003
0.4896399918	suffering from
0.4896286044	fifth
0.4896236701	43
0.4896099251	against
0.4895756197	000
0.4895732324	enos activity
0.4894981585	without affecting
0.4894394894	39
0.4893674113	a dose dependent manner
0.4893168991	801
0.4893040617	above
0.4890768289	11
0.4886982442	62
0.4885852533	10
0.4885225161	cellular functions
0.4885033810	mumol l
0.4884726181	5 lipoxygenase
0.4884115181	immune cells
0.4883147805	398
0.4880224648	125
0.4880081520	55
0.4878646830	21
0.4878358539	63
0.4877811677	83
0.4877785516	123
0.4877557445	basal levels
0.4876149108	every
0.4874220850	membrane protein
0.4872900435	seemed
0.4872553054	98
0.4872450162	74
0.4872187076	showed significant
0.4871399030	latter
0.4871032126	60
0.4870305877	2000
0.4870305877	450
0.4870305877	112
0.4869197046	probably
0.4868055894	decreased significantly
0.4867826988	3d
0.4867353543	131
0.4867230829	68
0.4864787288	mechanism underlying
0.4863981334	97
0.4863452175	show
0.4862959746	ng g
0.4862313316	third generation
0.4861651039	96
0.4860676818	inside out
0.4859906596	56
0.4857427885	nadph oxidase activity
0.4857184561	g gap
0.4852581263	alone
0.4852301658	l methionine
0.4851384173	angiotensin ii type
0.4850717211	where
0.4849613227	mediated endocytosis
0.4849224771	65
0.4848618404	ph dependent
0.4848610621	glutathione levels
0.4847270383	need
0.4845143703	5
0.4844394933	hepatic lipid
0.4842649120	dopamine release
0.4842064385	1038
0.4842064385	etc
0.4842064385	becoming
0.4842064385	too
0.4842064385	back
0.4841717222	2007
0.4840804589	2008
0.4840350321	amino acid transport
0.4840000675	hepatoma cells
0.4837029164	protein kinase c
0.4837027734	so called
0.4835598815	42
0.4832846977	significant correlation
0.4832195717	35
0.4830403515	44
0.4828537618	hepatic glucose
0.4828320499	antagonist ici
0.4826860583	seem
0.4825158716	itself
0.4822254925	70
0.4822050803	46
0.4821721966	cellular responses
0.4820510438	self administration
0.4820299456	64
0.4818942293	600 mg
0.4818826440	33
0.4814682692	annexin 1
0.4811592178	therapeutic agent
0.4809448083	38
0.4808666392	potent compound
0.4805656383	frequency dependent
0.4805042557	23
0.4803408970	ache inhibitors
0.4802058645	beta 2 adrenoceptor mediated
0.4801590876	compared with placebo
0.4800607491	selective inhibitors
0.4800016803	whose
0.4799578062	41
0.4799573185	acid derivatives
0.4799472064	subjects received
0.4799410363	ganglion neurons
0.4797847606	264
0.4797634671	19
0.4796044928	27
0.4795355825	26
0.4795143302	often
0.4794576704	008
0.4794576704	700
0.4794576704	122
0.4794576704	enough
0.4794576704	themselves
0.4794149517	well
0.4794110062	cannot
0.4793830161	8
0.4792465546	22
0.4791349623	x linked
0.4791084495	2
0.4790769278	towards
0.4789976078	32
0.4789753067	02
0.4788989045	patients received
0.4788984319	patients with schizophrenia
0.4784164537	akt signaling
0.4783647591	200
0.4781598358	area under
0.4778730890	20 mg kg
0.4778231890	binding of 125i
0.4777817610	3
0.4776110464	9
0.4775773849	mammalian cells
0.4775167556	ability to inhibit
0.4773137582	into
0.4772766888	compared with vehicle
0.4772580995	1999
0.4766602006	single nucleotide
0.4765920796	chronic myelogenous
0.4765818953	vitamin c
0.4765060594	6
0.4763081307	alpha methyl
0.4761160551	receptor binding
0.4760332505	d3 receptor
0.4759340707	best
0.4758553463	phosphorylation of akt
0.4757182270	cell free
0.4754297770	pharmacological characterization
0.4753578599	1
0.4751863963	113
0.4751252673	divided into three groups
0.4751235271	cd4 + t cells
0.4750245571	05
0.4747426899	selective agonists
0.4747315970	induced platelet aggregation
0.4746431977	235
0.4745255823	non small cell lung
0.4741724463	03
0.4739352956	so far
0.4738849944	case study
0.4738567704	5 lo
0.4737087717	pcr analysis
0.4735426709	231
0.4734880651	synergistic effects
0.4731617510	438
0.4731617510	208
0.4731447192	higher concentration
0.4729804039	contain
0.4728565221	oxytocin receptor
0.4726945049	sub 2 sub
0.4722976588	36
0.4721891208	drug resistant
0.4721034983	7
0.4720720897	cancer cell proliferation
0.4718990760	contains
0.4718334506	glucose 6 phosphate
0.4717281873	cells stably expressing
0.4716121400	appear
0.4715892864	344
0.4715892864	took
0.4715892864	gives
0.4715892864	formerly
0.4715892864	behind
0.4714210494	conscious rats
0.4713626317	growth factor receptor
0.4711445671	based assay
0.4707949195	mouse bone
0.4705356503	nan
0.4704665302	phosphodiesterase 5
0.4699838124	240
0.4698215391	vegf receptor
0.4697914243	postnatal day
0.4694990547	differ significantly
0.4693411731	kept
0.4692714425	2002
0.4692670895	receptor ligand
0.4691567785	physical activity
0.4689515817	this article
0.4686473985	correlation between
0.4683302627	advanced glycation
0.4682350566	293
0.4681745192	mainly
0.4679274872	due
0.4679001658	cox inhibitor
0.4677916486	350
0.4677916486	006
0.4677916486	004
0.4677916486	151
0.4677916486	429
0.4677916486	114
0.4677916486	entirely
0.4677156911	3 methylglutaconic
0.4676754006	chikusetsusaponin
0.4674790251	5 asa
0.4674626314	via
0.4670819893	either
0.4670345505	synthesized compounds
0.4670317149	assay showed
0.4668896640	il 1
0.4666301742	course
0.4666269519	mu opioid
0.4665851392	breast cancer cell
0.4663040976	4
0.4662592631	2d nmr
0.4661462298	177
0.4660655137	present findings
0.4660179958	side effect profile
0.4657990077	glucose stimulated insulin
0.4657196006	agonist binding
0.4656007753	1998
0.4655435251	001
0.4652315250	5 fluorouracil
0.4649325924	2001
0.4647151553	amphetamine induced
0.4646432098	cloned alpha
0.4644786107	focuses on
0.4644503045	plasma insulin
0.4641731474	mitogen activated protein
0.4640975209	serum insulin
0.4638225637	il 12
0.4637866101	10 mg kg
0.4637587709	camp signaling
0.4635134364	486
0.4635083734	scavenging activity
0.4631818162	192
0.4631318589	mmp 1
0.4631236874	or
0.4630744129	dose dependent manner
0.4629871216	approximately 20
0.4627880547	cholesterol levels
0.4627048800	glutamate receptors
0.4626709997	mice exhibited
0.4625273414	106
0.4624616737	389
0.4622537661	interleukin 2
0.4622410412	2011
0.4622010499	amount
0.4619823219	will
0.4619261280	hormone receptor
0.4617066952	binding domains
0.4615892265	would
0.4614683450	330
0.4612939685	small molecule inhibitors
0.4610593253	alpha beta
0.4610295638	gene mutations
0.4609004251	108
0.4608180094	igfbp 2
0.4608088809	30 min
0.4600275407	signal pathway
0.4600100540	dependent pathway
0.4597047592	taken together
0.4596201321	dose and time dependent manner
0.4596150373	phase iii clinical
0.4596004339	assays showed
0.4595892265	causes
0.4594541685	100 microm
0.4593852206	vascular smooth
0.4591750549	approximately 50
0.4591030884	the present study
0.4590078496	patients with type 2 diabetes
0.4588048717	tissue specific
0.4586422194	positively correlated
0.4586324665	breast cancer patients
0.4585071419	should
0.4583499238	260
0.4583499238	124
0.4583407523	sup
0.4582094188	them
0.4580888278	phase ii clinical
0.4579411044	atp binding
0.4578892863	might
0.4578244026	age dependent
0.4575855828	type 2 diabetic patients
0.4575071419	01
0.4575015900	antagonist binding
0.4574381168	phosphorylation of p38
0.4571080962	irreversible inhibitor
0.4569674709	studies showed
0.4567518155	human breast cancer
0.4566609118	being
0.4566196752	plus
0.4564206706	expressed genes
0.4563416922	same
0.4563150537	rapid onset
0.4559458405	121
0.4559161112	glp 1 receptor
0.4554264613	vitamin k
0.4553787365	erk1 2 activation
0.4550735148	human cancers
0.4550066362	104
0.4550066362	placed
0.4550066362	643
0.4550066362	135
0.4550066362	375
0.4550066362	710
0.4550066362	167
0.4550066362	somewhat
0.4549711308	and
0.4549274125	cisplatin induced
0.4547052939	prostaglandin e
0.4542766471	mediated metabolism
0.4539411086	time points
0.4537272139	all trans
0.4537057315	akt pathway
0.4536805029	c terminus
0.4535168755	divided into
0.4534986568	159
0.4534986568	435
0.4534986568	220
0.4531573628	duration of action
0.4527365619	875
0.4526489550	glucose levels
0.4524909653	week old mice
0.4524323116	insulin levels
0.4523811354	cell signaling
0.4522329405	vesicular monoamine
0.4521238808	able
0.4521016020	concentration and time dependent
0.4518169556	serum glucose
0.4515836976	676
0.4515836976	bottom
0.4515836976	239
0.4515836976	2009
0.4515836976	926
0.4515836976	210
0.4515836976	205
0.4515836976	606
0.4513600559	greater than or equal to
0.4513235383	liver specific
0.4512940257	213
0.4512940257	117
0.4512940257	134
0.4512940257	1995
0.4512940257	187
0.4512444191	a lesser extent
0.4509981925	expressing cells
0.4504053513	data support
0.4501906497	mitochondrial membrane
0.4498924916	transcriptional activation
0.4497307456	462
0.4497307456	211
0.4496229977	anti inflammatory drugs
0.4493681318	inc
0.4492902407	related diseases
0.4492453576	ca2 + channel
0.4491198078	d serine
0.4490331884	can
0.4486004200	human whole blood
0.4481789399	activity relationship studies
0.4481331472	fold higher than
0.4478987253	human skin
0.4478771004	1 piperazinyl
0.4476326827	111
0.4472337258	expressed in chinese hamster
0.4468011637	did
0.4467632133	5 alpha reductase
0.4467282755	high sensitivity
0.4466484124	1996
0.4466484124	290
0.4466259289	these findings suggest
0.4465790971	g protein coupled
0.4464801142	binding profile
0.4462590486	had
0.4462590486	could
0.4461093516	sequence analysis
0.4461016798	these results suggest
0.4460642622	cyclooxygenase 1
0.4457447295	are
0.4456992750	is
0.4453249896	anti inflammatory effect
0.4453182423	respectively
0.4452954799	30 minutes
0.4448166454	concentration dependent manner
0.4448056845	4 hne
0.4447019308	l cpa induced
0.4446394341	activation of ampk
0.4445690553	5 ht1b receptors
0.4445364982	specific inhibitors
0.4445205181	most common adverse
0.4443741496	lung cancer cells
0.4443159456	glucose concentrations
0.4439414543	oxidative stress related
0.4439016559	may
0.4438704078	induced currents
0.4436546230	three dimensional structure
0.4435930728	ic50 =
0.4435161188	specific antibodies
0.4430914542	cox 2 expression
0.4430751051	been
0.4430751051	which
0.4430751051	have
0.4430161871	high affinity binding
0.4430044960	cholinergic activity
0.4425645258	ligand based
0.4424067626	selective cyclooxygenase 2
0.4422538524	bcl 2 family
0.4422399490	cancer cell
0.4420751051	has
0.4417695495	was
0.4417695495	were
0.4417536338	il 2 receptor
0.4413581879	related proteins
0.4406418124	glucose production
0.4406210121	motor activity
0.4405084012	thp 1 cells
0.4404162653	designed to evaluate
0.4403334631	l carnitine
0.4402874710	blood spots
0.4402446504	skeletal muscle cells
0.4401119458	25 hydroxyvitamin d
0.4401073062	tumor cell
0.4399478620	give rise to
0.4397695495	be
0.4396551531	that
0.4393009981	liver cells
0.4391049850	receptor activation
0.4390007294	100 mg kg
0.4388248510	cck 8
0.4386750478	14 days
0.4384921381	adrenoceptor mediated
0.4382321441	pi3 k
0.4380494876	estrogen receptors
0.4379441950	nf κb signaling
0.4379242683	down regulates
0.4377935702	parp 1
0.4377431172	mononuclear cells
0.4376774820	target gene expression
0.4376375947	4 hydroxyphenyl
0.4373230238	activation of nrf2
0.4370536154	in vitro
0.4368297703	acetylcholine receptors
0.4367907436	to calculate
0.4367784507	isoprenaline induced
0.4367373549	5 ht2c receptor
0.4364707231	effectively inhibited
0.4362402666	limiting enzyme
0.4360206934	good agreement
0.4358584322	nsclc cells
0.4355691219	leukemia cells
0.4355070110	high potency
0.4353807600	mol l
0.4353039824	cell number
0.4350983249	ache inhibitor
0.4344238249	results showed
0.4342960606	accounts for
0.4341891500	increased incidence
0.4341325690	channel activity
0.4338079077	protein interactions
0.4337239536	in vivo
0.4336840073	receptor type
0.4335792565	related protein
0.4334621663	cells express
0.4333950236	cultured cells
0.4333667921	commonly used
0.4333534170	alpha 2a
0.4331647136	cyclic adenosine
0.4325699648	stress related
0.4325039888	mg dose
0.4324214376	receptor antagonism
0.4319864382	l proline
0.4319051002	human serum
0.4318428153	induced seizures
0.4313841138	risk factor
0.4313177214	medical treatment
0.4311922315	low concentrations
0.4308163632	a go go
0.4307564725	whole blood
0.4306573193	x ray crystal structure of
0.4306405455	mantle cell
0.4303550007	target of rapamycin
0.4302334644	human insulin
0.4300855324	human breast cancer cell
0.4300634284	knockdown cells
0.4299277216	chronic myeloid
0.4298172534	clinical response
0.4295059345	rate limiting enzyme
0.4291591997	widely used
0.4290751799	showed higher
0.4281864771	cell type
0.4281227766	liver failure
0.4281037124	protection against
0.4280933066	diabetes induced
0.4278922265	compared with controls
0.4277157470	balb c
0.4276054140	positively correlated with
0.4275800832	l mph
0.4274840034	significant reductions
0.4273853802	brain membranes
0.4269866361	well established
0.4269638893	cross talk between
0.4269198363	tended to
0.4269118707	vitamin d
0.4262560930	a concentration dependent manner
0.4258009430	exhibited potent
0.4257972703	fed mice
0.4256294575	knowledge about
0.4252251752	serve as
0.4252006488	cancer patients treated
0.4247049064	oral doses
0.4246770873	selective estrogen
0.4246199076	induced oxidative stress
0.4244145148	ii gnrh
0.4243826293	enzyme inhibitor
0.4243795472	increased apoptosis
0.4243607285	chemical properties
0.4243353905	mediated signaling
0.4243294886	ho 1 expression
0.4240728277	delta 5
0.4237421987	owing to
0.4228730825	g feed
0.4226451357	enzyme inhibitors
0.4225636690	m2 receptor
0.4224594241	previous work
0.4223642529	human blood
0.4221980403	normal levels
0.4219697136	* 1 *
0.4214786385	cox 2 selective
0.4213277167	binding studies
0.4212572682	well defined
0.4210448753	l glutamine
0.4210412051	l name
0.4207495072	d1 receptor
0.4207316690	l phenylalanine
0.4207266442	results suggested
0.4204673735	the last decade
0.4204575955	extracellular signal
0.4204567664	enzyme inhibition
0.4204356618	calcium binding
0.4200379203	21 days
0.4198925712	antioxidant enzyme
0.4198439040	postmenopausal women with
0.4192383363	two dimensional
0.4190978356	designed to investigate
0.4188646532	d4 receptor
0.4187626028	4 yl
0.4182884334	analysis demonstrated
0.4181641873	multiple dose
0.4180505913	cell carcinomas
0.4178711351	adult brain
0.4177952883	steroid receptors
0.4177633828	dhea s
0.4177609230	hypoxia inducible
0.4176274644	raldh 1
0.4174776888	early stages
0.4172070729	mg kg per day
0.4171831006	human lung cancer
0.4171672789	human subjects
0.4170858317	significantly up regulated
0.4170578948	recent data
0.4164636241	play important
0.4164427079	human macrophages
0.4157606180	expression patterns
0.4151729684	unable to
0.4149338898	dependent apoptosis
0.4149330821	ar antagonist
0.4144314902	anti inflammatory activity
0.4143396822	histamine induced
0.4141614704	aldosterone induced
0.4137148817	n demethylation
0.4132177197	depressive disorder
0.4131560014	hormone dependent
0.4130714236	nf l
0.4129909780	resistant cells
0.4127930534	shown to possess
0.4127460563	induced pain
0.4123967133	vasopressin induced
0.4123604309	dependent fashion
0.4122511983	reductase activity
0.4120382965	cox 2 inhibitor
0.4119382555	serotonin reuptake inhibitor
0.4118985273	repeated administration
0.4117110026	transduction pathways
0.4115636881	human neuroblastoma
0.4112834726	belong to
0.4110837555	coupled receptor
0.4108077868	increased plasma
0.4107891589	human platelet
0.4107742062	c kit
0.4106685826	angiotensin ii type 1
0.4104773613	high concentration
0.4101238514	drug targets
0.4097172044	receptor stimulation
0.4096804762	l cpa
0.4095433868	times greater
0.4094734714	us food and drug administration
0.4094242938	nicotine induced
0.4093757268	inflammatory disease
0.4093244277	loss of function
0.4092109846	human kidney
0.4089203289	down regulate
0.4086065543	subjected to
0.4085205100	lung cells
0.4084364627	contributor to
0.4083209734	recent years
0.4081241817	ec50 =
0.4076691895	ranged from
0.4076534218	insulin igf
0.4076148129	experiments revealed
0.4076077646	beta cells
0.4074229682	guanosine 5
0.4071294380	these results demonstrate
0.4070096757	n terminal domain
0.4069454189	positive cells
0.4067889354	arsenic induced
0.4063807547	the mainstay
0.4063689602	muscle cells
0.4063632559	risk patients
0.4063043184	most abundant
0.4062817098	responsible for
0.4056505571	compounds showed
0.4052374357	fe s
0.4052075490	induced oxidative
0.4050941022	receptor phosphorylation
0.4048697510	protein coupled receptor
0.4048252673	cancer patients
0.4047815951	serum concentrations
0.4046722770	did not alter
0.4045932437	increased sensitivity
0.4045025647	c abl
0.4044094387	induced nephrotoxicity
0.4043960560	et 1
0.4043295375	dependent inactivation
0.4038879206	renin angiotensin system
0.4037290685	arterial blood
0.4036491148	neuronal cells
0.4032732866	glucose stimulated
0.4030167498	rat cerebral
0.4029003812	selective beta
0.4026013159	regulatory element binding
0.4022682191	decreased plasma
0.4021391528	did not differ
0.4020634416	accounted for
0.4020232303	protects against
0.4020131037	caspase 3 activity
0.4016829593	human colon cancer
0.4015517720	stress conditions
0.4014594836	recent study
0.4014260706	link between
0.4012187211	glucocorticoid induced
0.4011240951	gnrh r
0.4010971449	human peripheral blood
0.4010708790	cox 1 cox 2
0.4009586015	negative effect
0.4008533027	t cell
0.4007596332	gene expression analysis
0.4006706124	hif 1
0.4005368849	these observations suggest
0.4003719889	human nasal
0.3997355658	relevant concentrations
0.3997180363	x ray crystal
0.3996927588	basal plasma
0.3995881506	5 ht3 receptors
0.3990885937	camp dependent
0.3987413237	selective serotonin
0.3982845049	2 yl
0.3982286860	testosterone levels
0.3981566434	differences between
0.3981021337	≤ 0
0.3977070573	chronic exposure
0.3976401566	onset of action
0.3972815624	light induced
0.3972577967	chloride cotransporter
0.3971872186	derived growth factor receptor
0.3971284237	insulin induced
0.3969707383	these data suggest
0.3967626901	positive allosteric
0.3966730319	neuroprotective effect
0.3965934169	important implications
0.3962148873	recently shown
0.3960514875	significantly correlated
0.3957090260	nmda induced
0.3956863130	4 chlorophenyl
0.3955322233	cellular uptake
0.3955138954	500 mg kg
0.3954109844	mitochondria mediated
0.3946808407	the other hand
0.3945994808	10 ⁻
0.3944529259	5 ht2 receptors
0.3944213411	drug binding
0.3944121288	n methyl
0.3943024218	cellular proliferation
0.3942995714	subunit expression
0.3940785226	cardiac sodium
0.3939985688	oh bde
0.3939364587	phosphodiesterase 4
0.3939075075	± 4
0.3933685893	an open label
0.3932565569	allosteric modulator
0.3931619903	human heart
0.3930538678	selective inhibitor
0.3928437465	the concentration response
0.3928189759	cells overexpressing
0.3924456046	most frequent
0.3922944778	tyrosine phosphatase
0.3920988882	reminiscent of
0.3920652003	role in modulating
0.3918949762	stimulatory effect
0.3916521415	second line
0.3914045175	isolated compounds
0.3914038496	high doses
0.3913681466	at 37 degrees
0.3909662701	male rat
0.3909402703	did not affect
0.3908673111	elevated plasma
0.3908571498	impaired glucose
0.3907097107	study demonstrates
0.3904693171	μmol l
0.3903488708	antinociceptive effects
0.3902251520	clinically useful
0.3901679842	exhibited significant
0.3901528564	safety data
0.3899542795	25 dihydroxyvitamin d
0.3896436076	cox 2 selectivity
0.3893217046	depended on
0.3892272055	further investigation
0.3892125758	currently in phase
0.3891118833	k atpase
0.3889133827	per se
0.3885804401	fold more potent
0.3885112461	dependent signaling
0.3884625495	lower dose
0.3882638076	human cancer
0.3879617660	times higher than
0.3878620963	ci = 0
0.3874919113	functional properties
0.3873363538	5 ht2 receptor
0.3870343790	advantages over
0.3869302682	mediated responses
0.3865044498	uv b
0.3862291781	study group
0.3861087757	high performance
0.3859815825	k + channels
0.3859491661	protein aggregation
0.3857010014	urinary tract
0.3855792116	cox 2 inhibitors
0.3852078644	c met
0.3851518933	into account
0.3850649980	100 mg
0.3850534949	almost completely
0.3847279724	experimental results
0.3845352070	this paper
0.3839591412	k + channel
0.3839227723	novel object
0.3838020499	kinase signaling
0.3835731975	tested compounds
0.3834722946	alpha 1d
0.3831680235	interplay between
0.3829355038	tolerance test
0.3828622145	signaling proteins
0.3826138974	4 methylenedioxymethamphetamine
0.3821721925	rather than
0.3819663246	human bronchial
0.3818030471	gene polymorphisms
0.3817885124	raf 1
0.3814963896	plasma renin
0.3813403523	stimulation induced
0.3808707871	metastatic breast
0.3806580457	atp sensitive k
0.3806221877	potential mechanism
0.3804739411	induced obesity
0.3802948072	receptor expression
0.3799796695	mechanisms of resistance
0.3798772391	most potent
0.3796202436	human epidermal
0.3795885817	non steroidal
0.3794585021	oxidase inhibitor
0.3789120384	therapeutic concentrations
0.3788211916	plasma levels
0.3780460554	depends on
0.3778829874	antidepressant like
0.3776638019	120 mg
0.3776590717	do not
0.3773412981	inhibition studies
0.3769257008	25 hydroxyvitamin
0.3768861386	human colorectal
0.3768213042	randomly assigned to
0.3767195324	even though
0.3766777684	randomized controlled
0.3759515354	reductase inhibitor
0.3756929892	factor 1alpha
0.3753667896	ang ii induced
0.3753368223	prostate specific
0.3751645689	results provide
0.3750724337	reduced significantly
0.3745249471	plasma concentration
0.3744184991	target proteins
0.3736565709	group than in
0.3734077256	therapeutic drugs
0.3730154442	thp 1
0.3728994332	signaling molecules
0.3727520327	serves as
0.3727267110	exhibited high
0.3726948521	induced apoptotic
0.3725265508	receptor gene
0.3722864766	at least as effective
0.3721676347	receptor ligands
0.3720872801	this study examines
0.3720684028	most common
0.3719867022	receptor function
0.3719402370	cytochrome c
0.3719316414	binding of 3h
0.3714329754	an important role
0.3711639316	important role
0.3711438997	body mass
0.3710968398	8 oxo
0.3709198587	18 kda
0.3706788037	dependent enzyme
0.3702353037	activated protein kinases
0.3702096278	very low
0.3701272244	smad 3
0.3690763874	in most cases
0.3688654960	40 mg kg
0.3687954419	induced acute
0.3684935898	oxidase inhibitors
0.3684180899	the present investigation
0.3682201685	selective cyclooxygenase
0.3681184860	irrespective of
0.3676309174	protein content
0.3674083250	alpha mrna
0.3670943674	chronic obstructive
0.3665894459	dose and time dependent
0.3665894339	hyp *
0.3663027740	response element binding
0.3658834969	ii activity
0.3658548035	1 and cox 2
0.3658234721	mg min
0.3658046797	accompanied by
0.3657969858	pr b
0.3655878071	twenty four
0.3655813398	wide range of
0.3655740166	induction of apoptosis
0.3650340361	o β d
0.3648942150	dehydrogenase activity
0.3647918565	nf κb pathway
0.3643255532	specific activity
0.3642238669	direct binding
0.3641908018	for further development
0.3637584711	functional roles
0.3635244799	differential expression
0.3634467880	compared to wt
0.3633200343	whole cell
0.3628215236	intracellular signaling
0.3627358090	5 ht1a receptors
0.3625234066	5 mg kg
0.3622857679	oral dose
0.3622826212	type 1
0.3622586702	previously described
0.3622312409	high selectivity
0.3614141863	erk 1 2
0.3613679700	p less than 0
0.3613105844	receptor mrna
0.3610931902	competitive inhibitors
0.3608481123	hi 6
0.3603514021	receptor signaling
0.3603136071	insulin like growth factor 1
0.3602026716	human cancer cells
0.3600260269	focusing on
0.3598135199	to date
0.3598061287	side effect
0.3597854860	100 nm
0.3592346544	κb pathway
0.3590071379	r and s
0.3588243848	currently in clinical
0.3588017462	studies performed
0.3586425801	300 microm
0.3585939333	48 hours
0.3583669810	direct effect
0.3581739251	matrix metalloproteinase 2
0.3581033369	15 mg kg
0.3580304916	13 acetate
0.3578049130	mediated inhibition
0.3574949513	therapeutic effect
0.3574782408	cd4 + t
0.3574028023	these results support
0.3571141229	cpt 1
0.3568895408	dose and time
0.3568867536	structure function
0.3567963088	aimed at
0.3566032500	control levels
0.3565075103	alpha adrenoceptor
0.3563651185	effective in reducing
0.3562803274	these data demonstrate
0.3562551011	basal activity
0.3562481334	human colorectal cancer
0.3562312241	3 yl
0.3561079276	key roles
0.3557573106	depending on
0.3556487174	compared with control
0.3556181906	molecular basis for
0.3556072996	km =
0.3544494978	serotonin 5 ht
0.3543322550	these results provide
0.3543165704	trail induced
0.3541857795	carcinoma cell
0.3541541107	vegfr 2
0.3539368165	daily living
0.3538834566	shown to decrease
0.3538713378	treatment of hypertension
0.3538407596	inflammatory effects
0.3537269114	relationship between
0.3535110117	clinical activity
0.3534338091	demonstrated efficacy
0.3534168904	antigen induced
0.3533799019	phospholipase c
0.3527269612	greater extent
0.3526507760	regulatory protein
0.3526494736	affinity state
0.3526393029	the substantia
0.3525204177	compared to controls
0.3521141438	treatment of obesity
0.3519742801	expression levels
0.3519567857	methyl 4
0.3518916026	l serine
0.3518416362	clinically used
0.3515939881	shown to inhibit
0.3514511047	better understand
0.3509674508	48 h
0.3508706586	ht2a receptor
0.3507165138	r = 0
0.3504041442	related peptide
0.3502591914	non canonical
0.3501869204	study shows
0.3501511112	co expressing
0.3500485480	p = 0
0.3497843514	troponin c
0.3497726621	studies provide
0.3495054234	hypothalamic pituitary
0.3493388450	5 ht2c receptors
0.3492539840	apolipoprotein e
0.3490799116	design and synthesis of
0.3489903891	the presence and absence
0.3489170539	findings provide
0.3489019671	to determine
0.3488044851	10 microm
0.3486968140	group showed
0.3485545797	binding properties
0.3483956246	significantly inhibit
0.3481996508	served as
0.3479375882	increased serum
0.3479338522	these observations
0.3477424697	contribute to
0.3477040023	cyclo oxygenase 2
0.3476977847	cells transfected with
0.3472387657	diet induced
0.3472262568	protein coupled receptors
0.3471341267	blood cells
0.3467748255	non diabetic
0.3467384612	approximately 100
0.3465275464	belongs to
0.3465024333	cell activation
0.3465022159	to treat
0.3464989434	neuronal cell
0.3464799900	time and dose dependent
0.3463808232	expression profiling
0.3463770388	time course
0.3462033995	the present study aimed
0.3461563295	ed50 =
0.3460490398	significant effects
0.3458290754	pituitary adrenal
0.3457566227	account for
0.3457212516	this review
0.3456272165	dependent kinase
0.3453996424	300 mg
0.3453235424	to investigate
0.3452392229	n methyl d aspartate receptors
0.3451254217	data showed
0.3446240887	acetylcholine receptor
0.3446029233	mrna expression levels
0.3443889249	24 weeks
0.3443231110	k + current
0.3440615191	in vitro and in vivo
0.3439396110	10 fold
0.3434413122	not significantly affect
0.3434305807	term exposure
0.3433307739	obtained from
0.3433264226	compared to control
0.3423614289	induced injury
0.3417397901	active compound
0.3415809483	potential clinical
0.3410665113	similar effects
0.3405802285	transcriptional level
0.3403730668	synthase activity
0.3402318669	human prostate cancer
0.3400527865	no significant differences
0.3395961257	dependent enzymes
0.3393268723	acute liver
0.3391694725	does not
0.3391650493	sensitive sodium
0.3390758832	anion transporter
0.3390683093	led to
0.3390374684	40 week old
0.3388003972	did not correlate
0.3386110004	thought to
0.3384059217	gstp1 1
0.3383155190	chronic administration
0.3382059294	100 μm
0.3378805387	an autosomal recessive
0.3375784819	did not change
0.3374061842	insulin concentrations
0.3373065509	regulated kinase
0.3370008419	attributed to
0.3368902613	shown to exhibit
0.3367149348	14 3 3
0.3366615771	consistent with
0.3365512859	disease activity
0.3363934187	100 fold
0.3363714932	human ovarian
0.3358977334	well known
0.3356854421	p creb
0.3354987758	phosphate dehydrogenase
0.3354547597	72 h
0.3353700575	pharmacological treatment
0.3353090477	4 oxo
0.3353053755	inhibitory effect on
0.3352901659	systemic administration
0.3351445532	na +
0.3350293517	in addition
0.3346738291	cox 2 mrna
0.3345983281	appears to
0.3345792909	bcl 2 expression
0.3344558903	the current study
0.3343669643	multidrug resistance associated
0.3341942000	data provide
0.3339380360	fluorescent protein
0.3338260155	mpp +
0.3337626216	specific ligand
0.3337510051	l alanine
0.3335557754	clinical data
0.3335350822	intestinal epithelial
0.3334771809	c fos expression
0.3333101242	induced cardiac
0.3331750293	h2o2 induced
0.3331407413	effects of morphine
0.3330605229	s disease
0.3328352488	elevated levels
0.3328249003	a dose dependent increase
0.3326288581	oxidative stress induced
0.3322941044	pre treated
0.3321022441	human tissues
0.3320642697	significantly lower than
0.3310716126	12 months
0.3308993374	serum levels
0.3303715048	expression profile
0.3303237339	highly expressed
0.3303115130	differs from
0.3301867877	d amphetamine
0.3301020838	previously observed
0.3299091570	resulted in
0.3299066081	de novo synthesis
0.3296988750	metabolic effects
0.3296904968	cells exhibited
0.3291552692	significant change
0.3289354753	clinical study
0.3285260309	functional studies
0.3284138433	ph 7
0.3282645564	tissues including
0.3281325608	polymerase chain
0.3278877243	significantly affect
0.3277443845	study suggests
0.3275517986	mediated pathways
0.3275356208	existence of
0.3274485110	3h 5 ht
0.3270369124	experiments showed
0.3268018252	platelet derived
0.3267719369	glutamate induced
0.3265178001	interferes with
0.3264354108	time point
0.3260131643	injury in rats
0.3260082257	serum free
0.3259218450	adhesion molecule 1
0.3257478175	75 mg
0.3257010282	japanese patients
0.3255651004	receptor affinity
0.3253826666	hydroxy 3
0.3252575733	human plasma
0.3249443261	a time and
0.3248869751	chemotherapy induced
0.3248273538	pancreatic beta
0.3247882209	first generation
0.3247559784	relation between
0.3246958849	n methyl d aspartate receptor
0.3243783377	fed rats
0.3242866536	results revealed
0.3239858378	micro m
0.3238479831	related enzymes
0.3238432365	these findings demonstrate
0.3237933119	ranging from 0
0.3236167360	± 5
0.3236067708	leading to
0.3232189257	based design
0.3231861979	surface expression
0.3230338520	control values
0.3230269388	time and concentration
0.3230136624	moderate affinity
0.3229939828	human tumors
0.3229150148	37 degrees c
0.3228811555	renal cell
0.3228461426	a high fat diet
0.3226963545	associations between
0.3224692197	positive correlation between
0.3224384342	long term effects
0.3224343467	control cells
0.3222106881	significantly increase
0.3221572631	± 1
0.3218809358	inhibitory activity against
0.3218598933	12 weeks
0.3216664814	patients with severe
0.3216303176	the aerial
0.3215147115	20 mg
0.3214755985	200 mg kg
0.3213574034	interaction between
0.3210738213	intracellular accumulation
0.3209579677	pulmonary disease
0.3209178127	information about
0.3208884615	fat diet
0.3207141259	agonist induced
0.3204435176	high concentrations
0.3204030536	results indicate
0.3203423105	the blood brain barrier
0.3199436623	synthesis and biological evaluation of
0.3199361581	functional activity
0.3198202290	fully understood
0.3198049850	moderate affinity for
0.3196007823	glucose concentration
0.3195984496	important roles
0.3193277508	showed similar
0.3192266522	findings indicate
0.3188023290	histamine release from
0.3187895855	acid secretion
0.3185570443	non competitive
0.3185353216	drug transporter
0.3185045712	gastric acid
0.3182723625	study revealed
0.3181202513	systolic blood
0.3180552511	whole cell patch
0.3178825300	focused on
0.3178036421	long term use
0.3176624241	significantly higher than
0.3176533477	expression level
0.3176395823	inotropic effect
0.3175365568	directed against
0.3173538833	these data support
0.3172010380	cell derived
0.3171948809	chronic treatment
0.3168417653	pathways involved
0.3168398319	determine if
0.3167768605	regulated gene
0.3167397479	28 days
0.3164572504	protein protein
0.3163586491	inducing factor
0.3163284424	according to
0.3162678566	increased risk
0.3162549723	80 mg
0.3162177306	mediated mechanism
0.3161982058	phosphate dependent
0.3159787191	related adverse
0.3159318338	ii trials
0.3157539974	structural basis for
0.3154201538	effective treatment
0.3153243803	triphosphate binding
0.3151628614	did not
0.3149830236	potent anti
0.3149141136	cell based
0.3147875325	24 h
0.3147235073	cell specific
0.3144258368	factor x
0.3138489886	treatment decreased
0.3137593494	cell function
0.3135428544	mice showed
0.3134284097	50 mg kg
0.3132806329	increased intracellular
0.3130616608	ranging from
0.3125927150	study suggested
0.3125156910	15 min
0.3122979166	specific binding
0.3119409801	normal control
0.3119271163	mg protein
0.3117137682	inflammatory cells
0.3116663615	at least partly
0.3115926899	acid induced
0.3113595689	major depressive
0.3113559148	tumor necrosis
0.3113101001	potent inhibitors
0.3113082568	morphological changes
0.3105762700	competitive inhibitor
0.3104729412	emerged as
0.3103481517	compared with
0.3102137120	induced diabetic rats
0.3101849631	currently available
0.3099355241	at least in part
0.3099104558	compatible with
0.3098554032	oral glucose tolerance
0.3093338003	results highlight
0.3093146689	compared with normal
0.3092265404	compound 1
0.3091224123	mechanism involved
0.3091011576	more potent
0.3090829125	antioxidant effects
0.3089755938	play important roles in
0.3085408093	rat hippocampal
0.3079807516	results demonstrated
0.3079631251	16 mg kg
0.3078232704	significant decrease
0.3075085457	liver disease
0.3074154129	whole brain
0.3073975294	normal range
0.3073618973	fold lower than
0.3073464836	transporter expression
0.3072262108	reductase inhibitors
0.3071565470	mmp 3
0.3070730614	present study
0.3069552545	shown to induce
0.3068854270	contributes to
0.3067945082	these findings support
0.3066459388	potential target
0.3065529608	hormone receptors
0.3061884461	25 mg kg
0.3061735567	vitamin b
0.3061640844	at least
0.3061070001	to assess
0.3058153114	+ 0
0.3057521459	an update
0.3057243730	cross over
0.3054831073	uptake inhibitors
0.3054288034	enzyme linked
0.3052156297	ec 4
0.3052035471	oxidase activity
0.3051920255	patients with mild
0.3049537364	important implications for
0.3048374554	receptor alpha
0.3046329034	this study
0.3044624054	showed high
0.3039511797	acid synthase
0.3039385351	adrenergic agonist
0.3037654645	examine whether
0.3033379174	anti inflammatory drug
0.3028363735	induced cell
0.3026833402	referred to as
0.3026636368	primary human
0.3024223542	3 keto
0.3023864116	regardless of
0.3023217646	= 0
0.3023095970	modeling studies
0.3022275628	failed to
0.3019815471	no detectable
0.3018086310	early stages of
0.3017393082	replaced by
0.3015133729	classified into
0.3014940911	leukotriene receptor
0.3014320953	an attractive
0.3013880366	5 yl
0.3011736864	receptor kinase
0.3011453322	human airway
0.3008984178	not well understood
0.3008367923	non selective
0.3008168727	diastolic blood
0.3006098483	human renal
0.3004662483	synthase inhibitor
0.3003152682	dna binding activity
0.3000040629	expression profiles
0.2999482279	expression analysis
0.2998596568	capable of
0.2998571008	approximately 10
0.2997586607	levels increased
0.2993912949	the surface of
0.2993048945	hours after
0.2992189830	treatment increased
0.2991949604	non invasive
0.2991880042	cell lymphoma
0.2991507516	at high concentrations
0.2989060860	coronary heart
0.2988784504	normal cells
0.2986043605	bovine serum
0.2985220066	reduced plasma
0.2985204388	receptor blockers
0.2983828490	the growth of
0.2983239148	dependently reduced
0.2981050370	well characterized
0.2979205672	old male
0.2977787423	a wide variety of
0.2976976139	coupled receptors
0.2975254713	c src
0.2974528542	therapeutic effects
0.2972937525	mediated pathway
0.2971764882	patients with advanced
0.2970102179	study demonstrated
0.2969210388	after oral administration
0.2968251180	full agonist
0.2968124567	in vivo and in vitro
0.2968055272	protein kinase b
0.2965745627	progression free
0.2959388180	8 fold
0.2958332595	these data provide
0.2958035368	10 and 20
0.2955667203	lower incidence of
0.2953108975	p 0
0.2952887090	activated t cells
0.2947900154	streptozotocin induced
0.2947257088	much higher
0.2947141696	acidic protein
0.2946653451	c jun n terminal
0.2942021965	to evaluate
0.2939148121	o linked
0.2932210543	attributable to
0.2931768062	cd8 +
0.2929498445	androstane receptor
0.2929371175	specific inhibitor
0.2925092054	malignant cells
0.2921814694	the presence or absence
0.2920832099	a potential therapeutic target
0.2917236098	60 min
0.2916248200	cell lung cancer
0.2914590087	phosphatase activity
0.2912470401	study showed
0.2911767018	induced hepatic
0.2911083833	stimulated human
0.2909600434	selective cox 2
0.2908586676	compared with wild type
0.2907881354	does not require
0.2907284076	receptor family
0.2905288651	protein tyrosine
0.2904977910	one or more
0.2904499637	interacts with
0.2904137026	belonging to
0.2903912949	the transcription of
0.2902479065	kg day
0.2900944264	less potent
0.2897925800	controlled study
0.2895400950	ph 6
0.2895137167	stimulated camp
0.2893912949	the age of
0.2892633715	these findings
0.2890529087	s phase
0.2890085172	extracted from
0.2887638623	immediately after
0.2887584361	il 3
0.2887444593	in vivo microdialysis
0.2887227638	incorporated into
0.2885154327	protected against
0.2883912949	the decrease of
0.2882012344	beta hydroxysteroid
0.2878433214	cell carcinoma
0.2875902265	in order to
0.2875581492	fold greater than
0.2875542939	d aspartate
0.2874518718	the survival of
0.2873912949	the interactions of
0.2873912949	the process of
0.2870309712	serious adverse
0.2868127131	regarded as
0.2867791890	before and after
0.2864448663	the time of
0.2862728938	induced renal
0.2861224270	interfere with
0.2859615029	defense against
0.2855912949	the type of
0.2855784270	mice treated
0.2855507805	significant inhibition
0.2854518718	and migration of
0.2853972207	leads to
0.2850764297	time and concentration dependent
0.2850748851	ligand induced
0.2850121478	the rate limiting enzyme
0.2848453123	kidney 293 cells
0.2846896522	approximately 30
0.2843912949	the affinities of
0.2841227481	human cardiac
0.2837418180	able to
0.2837330970	these results suggested
0.2836826411	the design and
0.2835143718	in vitro and in
0.2834812309	lower than
0.2834175264	to examine
0.2830823148	in conjunction with
0.2829646845	abstract 1
0.2826826411	the affinity and
0.2826538267	receptor gene expression
0.2824974521	d glucose
0.2824706235	acts as
0.2823912949	the response of
0.2823501957	significant effect
0.2823201285	min 1
0.2819776831	nad +
0.2817525039	immune system
0.2815531513	compared to vehicle
0.2812018718	the reaction of
0.2810908905	6 months
0.2810652444	activator inhibitor
0.2807689206	l type
0.2806875500	human colon
0.2799505301	subunit gene
0.2799217529	more pronounced
0.2798460758	drug levels
0.2796738119	no obvious
0.2794529023	co administered
0.2793912949	the study of
0.2793339423	50 mg
0.2791555924	k ras
0.2791113525	cox 2 inhibition
0.2789778646	vegf d
0.2787755586	induced endothelial
0.2787615337	3 hydroxy 5
0.2787228362	kappab activation
0.2785912949	the selectivity of
0.2785140330	behaved as
0.2782871671	30 days
0.2781412949	the density of
0.2780498439	alone and in combination
0.2780408702	insulin dependent
0.2779124014	in accordance with
0.2778350352	daily dosing
0.2774175080	accounting for
0.2772217997	to compare
0.2771264120	chloro 2
0.2768902974	n =
0.2765042464	well understood
0.2763412949	the size of
0.2762643718	of mice with
0.2762160110	x 10
0.2761210510	clinical effects
0.2760110908	due to
0.2759844425	mediated effects
0.2758860727	± 6
0.2758090944	association between
0.2754957737	potent inhibition
0.2750644266	kinase akt
0.2750536385	4 methoxy
0.2749742194	antiplatelet effects of
0.2748263734	cancer treatment
0.2746909806	data indicate
0.2746090222	relatively low
0.2742860249	broad range of
0.2741706022	to obtain
0.2736612614	more effective
0.2736282234	5 ht1a receptor
0.2735733179	less than
0.2733484103	interleukin 1
0.2732056963	angiotensin ii receptor
0.2731361969	role in regulating
0.2727645451	did not modify
0.2727083073	stimulating factor
0.2726836737	present review
0.2726143404	n acetyl d
0.2724108543	to understand
0.2723430732	na + k +
0.2722813404	no synthase
0.2721582859	embryonic kidney
0.2719495339	as well as
0.2716193733	correlated with
0.2715473396	overall survival
0.2712350449	a group of
0.2711750827	correlations between
0.2710853648	h prazosin
0.2707438689	investigated whether
0.2706171334	the selective 5
0.2706105658	17 beta
0.2705806325	based on
0.2702437303	a greater extent
0.2702310922	to explore
0.2700344566	continues to
0.2698123817	nonsteroidal anti
0.2694691312	class of compounds
0.2693412949	the performance of
0.2693191801	in xenopus oocytes
0.2692886163	with and without
0.2685408727	the generation of reactive oxygen
0.2685215902	depend on
0.2684833030	day old
0.2683412949	the synthesis and
0.2683179433	in part to
0.2681412949	the field of
0.2680462842	cells showed
0.2678077604	a total of
0.2677306379	n and c
0.2676269207	in spite of
0.2674914570	the potency and
0.2673067362	devoid of
0.2672288641	compared to
0.2666309319	in order to investigate
0.2665693795	the absence and presence of
0.2661412949	the viability of
0.2655922418	basolateral membrane
0.2652887595	cat 1
0.2652643718	the outcome of
0.2650627774	90 min
0.2649657977	involved in
0.2639470985	type 2
0.2639098989	these findings provide
0.2632643718	and apoptosis of
0.2631858112	time dependent manner
0.2626557319	current study
0.2625570159	10 mg
0.2624071115	stimulated insulin secretion
0.2623312484	beta 1
0.2622643718	a study of
0.2620738720	complex i
0.2620507825	showed significantly
0.2620218950	increased blood
0.2620206546	after surgery
0.2619384577	structure activity
0.2617165394	examined whether
0.2616118630	of cells in
0.2614520743	10 mm
0.2612866405	before and during
0.2606631346	thereby reducing
0.2599831246	antagonist activity
0.2597689815	tubule cells
0.2596857916	required for
0.2595423317	terminal kinase
0.2593978861	g kg
0.2587360639	stably transfected with
0.2581833330	time and dose dependent manner
0.2580589244	to create
0.2580139595	t cells
0.2577802433	important roles in
0.2577623740	those of other
0.2574236903	dependently increased
0.2572113611	treatment of alzheimer
0.2571501814	most frequently
0.2571379050	shown to play
0.2571065882	used to treat
0.2570376454	more efficient
0.2568195556	an important
0.2563917868	30 microm
0.2560916110	induced caspase
0.2556895755	mg kg i
0.2554840635	the feasibility of
0.2554694652	activating factor
0.2554213984	t1 2
0.2553816361	t cell activation
0.2553263731	firing activity
0.2553059526	brain natriuretic
0.2551903840	key roles in
0.2551387756	still unknown
0.2549453894	the proliferation and
0.2549004654	per min
0.2548348570	activated protein
0.2547855357	20 min
0.2547088025	the functions of
0.2546158728	and differentiation of
0.2544079120	n acetyl l
0.2540126583	hydroxy 5
0.2537030746	in situ
0.2536900004	glucose 6
0.2533713636	shed light on
0.2533517872	regulated kinase 1
0.2533126843	an essential role
0.2529955567	potential anti
0.2529376474	mean age
0.2525930267	possible role
0.2524550475	composed of
0.2523773877	cox 1 cox
0.2523587472	consisting of
0.2522485126	high levels of
0.2521231716	iii trials
0.2520170771	intracellular reactive
0.2517994809	after sci
0.2517853256	cholinergic system
0.2517156538	small molecule inhibitors of
0.2514837026	high levels
0.2514265085	act as
0.2514114640	isolated from
0.2513497630	catalysed by
0.2513348061	the same
0.2513044288	g protein
0.2511934588	compensate for
0.2507960602	25 mg
0.2507476905	release of cytochrome c
0.2507032972	ectopic expression of
0.2505595221	more efficiently
0.2504523183	non peptide
0.2501382651	induced ca
0.2501338177	of mrna for
0.2499903444	the food and
0.2496805049	and tolerability of
0.2495634857	did not inhibit
0.2485406749	determine whether
0.2485234629	1 yl
0.2482301815	under investigation
0.2475539934	this study demonstrates
0.2474788922	resulting from
0.2474651472	t type
0.2467267210	receptor genes
0.2463612170	derived from
0.2459833804	the efficacy and
0.2458372362	aimed to
0.2458348929	10 μm
0.2454915822	normal human
0.2453955912	receptor dependent
0.2453920674	the basolateral membrane
0.2452609069	requirement for
0.2450693386	ca i
0.2450288060	in vivo and in
0.2449604692	treatment option for
0.2448920850	in part by
0.2448166763	urinary excretion of
0.2445582360	significant increases in
0.2444610768	most effective
0.2443583031	lower urinary
0.2440630129	3 mg kg
0.2437048747	a time and dose dependent manner
0.2434078367	levels decreased
0.2432982747	low levels of
0.2432938220	more potently
0.2428581041	inhibition of acetylcholinesterase
0.2427899513	dopamine d
0.2425367125	50 microm
0.2424166753	to determine whether
0.2416843358	able to induce
0.2416663028	lower levels
0.2412805477	specific expression
0.2411687665	phase 2
0.2411206264	incorporation into
0.2409558388	higher levels of
0.2406851253	as low as
0.2406624580	cos 1
0.2405301036	to achieve
0.2403526852	chronic treatment with
0.2399953509	protein 1
0.2398957717	+ prazosin
0.2396718469	of rats with
0.2395247245	binding activity
0.2393013290	significant decreases
0.2390320132	anti il
0.2388423438	orexin a
0.2385949349	intravenous injection of
0.2384630528	protein binding
0.2377470652	such as
0.2375722728	selective 5 ht
0.2371441808	iii clinical trials
0.2370941143	expression of mrna
0.2370643737	known about
0.2369348152	5 ht3 receptor
0.2367507227	the culture medium
0.2364820402	supported by
0.2364285444	g proteins
0.2363404794	to identify
0.2361524116	contributing to
0.2356553978	shed light
0.2355376535	human alpha
0.2353692451	t cell proliferation
0.2352882973	treatment of chronic
0.2351810882	acid residues
0.2351718686	potent inhibitor of
0.2350946985	no production
0.2350151601	a double blind
0.2345701576	with respect to
0.2344339622	pc 3
0.2342891950	decreased serum
0.2337630649	0 mg kg
0.2335292279	injury induced
0.2331147334	damage induced
0.2328462608	alpha reductase
0.2327610205	evaluate whether
0.2326667816	alone or in combination
0.2325814615	and safety of
0.2324789583	100 nmol
0.2324130396	10 and 20 mg
0.2322117666	recombinant b
0.2321374472	specific gene
0.2320221325	microtubule associated
0.2317689751	per day
0.2314890525	activated receptor
0.2312790320	protect against
0.2312560237	this finding
0.2311573215	the active site
0.2311356850	circulating levels of
0.2309293582	4 weeks
0.2308206690	inhibition of 3h
0.2306445196	receptor selective
0.2305513808	ii receptor
0.2303511220	human beta
0.2302024157	kd =
0.2299364731	after adjusting for
0.2298500314	difference between
0.2296809187	further evaluation
0.2292275634	well studied
0.2290541548	introduced into
0.2287290071	mg twice
0.2285200297	in postmenopausal women
0.2284475914	relationships between
0.2283681291	risk factor for
0.2282618066	complexed with
0.2281090770	methyl 5
0.2277925228	the gastrointestinal tract
0.2275957591	classified as
0.2274098948	followed by
0.2273861087	does not affect
0.2272542197	higher levels
0.2270724437	with or without
0.2266482449	growth factor receptors
0.2266082156	effects of
0.2261586459	hydroxy 2
0.2258486604	the molecular basis
0.2255209328	less effective
0.2249887378	± 3
0.2245392903	stimulatory effect of
0.2245260638	receptor beta
0.2243160978	mao a
0.2243114719	used clinically
0.2243022956	associated with
0.2242834069	indicative of
0.2238018059	differences among
0.2235037874	resulted in increased
0.2234390346	human cells
0.2233361707	characterized by
0.2232849389	catalyzed by
0.2231133988	kg per
0.2225978651	any significant
0.2222094986	inhibitory effects on
0.2221450784	7 hydroxy
0.2220426633	100 μg
0.2218017414	an alternative
0.2215176340	role of
0.2215041371	in contrast
0.2214689413	15 mg
0.2213991879	alpha 2
0.2212314678	glucose induced
0.2209150392	nuclear translocation of
0.2204732052	rats pretreated with
0.2203724975	firing activity of
0.2194280765	therapeutic agent for
0.2190474024	kg per day
0.2186643011	focus on
0.2185643063	synthase 1
0.2184237782	ec 1
0.2183812635	to generate
0.2181452757	allosteric modulator of
0.2179666628	significant decrease in
0.2179567670	b domain
0.2177857515	closely related to
0.2176321842	rats treated
0.2175022000	ec 3
0.2170574844	alone and in
0.2169855165	significant decreases in
0.2169155089	used to measure
0.2168418485	40 mg
0.2165242290	na k
0.2164645342	one carbon
0.2162775990	ca v
0.2159284186	oral administration of
0.2159280197	this work
0.2155357955	exposed to
0.2154035965	as monotherapy
0.2146082156	inhibition of
0.2144203910	induced increases in
0.2144173124	much less
0.2143857276	study evaluated
0.2143834602	no significant effect
0.2142646770	interactions between
0.2141306825	activator of transcription
0.2139246516	transporter gene
0.2138185435	rats exposed to
0.2136882753	higher than
0.2135749977	crystal structures of
0.2135357262	damage response
0.2131415716	released from
0.2130818322	proteins involved
0.2129443164	enzymes involved
0.2129281554	the safety and
0.2129116580	ca2 + i
0.2126056119	treatment of inflammatory
0.2120568797	acid reactive
0.2115547735	did not produce
0.2114188285	1 mg kg
0.2112730760	the control group
0.2111861718	ii induced
0.2111788848	expression of genes
0.2111016083	4 hydroxy
0.2109664428	patients treated with
0.2107279951	dose dependent increase in
0.2105526403	not clear
0.2105057145	8 weeks
0.2104492574	7 days
0.2104290779	the hypothalamic pituitary adrenal
0.2103670520	by high performance liquid chromatography
0.2103618995	across species
0.2100026406	s syndrome
0.2098316879	to analyse
0.2098259531	ic50 value
0.2096469165	patients with chronic
0.2093375387	2 pam
0.2091411953	the nucleus accumbens
0.2091394941	3 fold
0.2091004727	selective inhibition
0.2090813243	the objective of
0.2089781102	s lymphoma
0.2089778876	significantly induced
0.2089775309	methyl 1
0.2084587920	expression in human
0.2082505406	patients with acute
0.2081230936	increasing concentrations of
0.2079600276	to avoid
0.2079486015	phenyl 1
0.2074130753	ic50 values for
0.2073947912	essential for
0.2072994353	to monitor
0.2072983062	precursor protein
0.2072392597	competitive inhibitors of
0.2071318494	an animal model
0.2070781704	300 microg
0.2069904811	cox 2 protein
0.2068768684	b cell
0.2067873467	believed to
0.2058726481	to verify
0.2056988186	to address
0.2056215999	treated with
0.2054726775	ectopic expression
0.2050742159	fos expression
0.2049797951	much lower
0.2047944683	5 ht1b receptor
0.2046600008	human serotonin
0.2045719197	impact on
0.2045117057	n acetyl beta
0.2044271209	receptor positive
0.2041018793	ki = 0
0.2040209243	significantly less
0.2039302461	inhibition of cox 1
0.2036116390	a variety of
0.2034632795	at ph 7
0.2032153532	significant reduction
0.2031897228	potent inhibitors of
0.2030613016	influenced by
0.2029297588	4 fold
0.2029210757	these drugs
0.2029116712	6 phosphate dehydrogenase
0.2027321844	significant reductions in
0.2024055363	compared to wild type
0.2022986983	some cases
0.2022826010	induced neuronal
0.2022317440	patients with
0.2022188766	but not
0.2021413083	prior to
0.2019639214	induced dna damage
0.2015695681	5 ht release
0.2012144725	mg kg per
0.2009397086	half life of
0.2007527378	participate in
0.2007309855	non neuronal
0.2006903101	* 2
0.2004536761	apoptosis induced by
0.2004179629	drug induced
0.2003103354	the presence of
0.2001942766	binding protein 1
0.2000538196	non steroidal anti
0.1998227315	one patient
0.1995585266	100 mm
0.1995180654	explained by
0.1994670767	sk n
0.1994241886	mice treated with
0.1993498726	human dopamine
0.1991337648	inhibition of platelet
0.1990943941	recently described
0.1990467546	for detecting
0.1988565097	cos 7
0.1988239958	repeated administration of
0.1986831005	did not exhibit
0.1984729086	ic50 = 0
0.1984500812	dose dependent inhibition of
0.1983665724	the same extent
0.1982951652	treatment of diabetes
0.1982714496	emphasis on
0.1980710837	associated antigen
0.1980382200	very important
0.1979613748	human tumor
0.1979409173	to detect
0.1978923083	most commonly
0.1978872689	2 fold
0.1977327110	shown to
0.1977153716	brain levels
0.1977050296	by measuring
0.1976638398	caused by
0.1975484107	binding to
0.1973053455	only slightly
0.1971974372	28 day
0.1971626953	the first time
0.1971257163	new insights into
0.1971000168	t allele
0.1970795473	incubated with
0.1969918855	this issue
0.1967184372	approximately 4
0.1961548820	receptor activity
0.1959660443	effects on
0.1955691103	proteins involved in
0.1955472085	a significant decrease
0.1954560134	co administration
0.1952444891	exposure to
0.1950170718	more effective than
0.1947647378	lead to
0.1947550275	acted as
0.1947283917	vs 0
0.1944739196	chronic heart
0.1944144586	293 cells
0.1943622864	fold increase in
0.1941295045	induced by
0.1940493459	consisted of
0.1938086875	seem to
0.1937046968	vulnerable to
0.1934632089	in wild type mice
0.1932751908	effect of
0.1929990303	intraperitoneal injection of
0.1929928196	methyl 2
0.1929735557	did not prevent
0.1926223224	inhibition of cox 2
0.1926056583	blocked by
0.1926014978	1 methyl 4
0.1925574007	treatment of acute
0.1925054192	after adjustment for
0.1923079088	most promising
0.1922016565	phosphatidylinositol 3
0.1920980139	an extended
0.1919054208	ability to
0.1918858856	similar to
0.1918592749	induced pulmonary
0.1917533884	treatment of breast
0.1917332908	no difference
0.1917130510	in silico
0.1913199787	retinoid x
0.1907437510	an effective
0.1907433389	factor 1
0.1906426587	participates in
0.1906244403	to optimize
0.1903079582	exon 1
0.1902550477	30 nm
0.1899174178	in humans
0.1897378318	promising new
0.1895912210	0 mm
0.1895683215	induced phosphorylation of
0.1893642107	c peptide
0.1893122527	three times
0.1892503720	decreased expression of
0.1891978797	to elucidate
0.1891419898	more potent than
0.1890293071	modulated by
0.1890048755	peptidase 4
0.1888727258	structural changes
0.1885696843	cells in vitro
0.1884507913	oxygenase 1
0.1883051281	5 mg
0.1882884762	functional roles of
0.1882689961	this hypothesis
0.1878292306	to measure
0.1877779577	used in combination
0.1874433311	amino 2
0.1872335559	clinical use
0.1872218895	amino 3
0.1867533255	most likely
0.1866426869	intracellular accumulation of
0.1865993007	interact with
0.1864822214	most important
0.1864819701	x =
0.1864056234	inhibition of human
0.1863864379	extracellular levels of
0.1863382490	p dioxin
0.1862625615	a conformational change
0.1862042066	beneficial effects on
0.1861526270	therapeutic target for
0.1853707040	no effect on
0.1853607601	induced increase in
0.1852879404	x kg
0.1852269047	a high throughput
0.1850450093	an attempt to
0.1848039128	inotropic effects of
0.1847851443	significant reduction in
0.1845267912	the aerial parts
0.1843309967	these results indicate
0.1842791917	time dependent
0.1840512739	increased cell
0.1840501247	for 15 days
0.1840196504	17 alpha
0.1838418362	activation of caspase
0.1835979841	beta 2
0.1835869535	incubation with
0.1835564421	this effect
0.1834260146	inhibitory effects of
0.1833921175	bind to
0.1833481581	presented here
0.1832561845	ascribed to
0.1832428760	most importantly
0.1831640293	activation of
0.1830492847	to quantify
0.1823214766	1 microm
0.1822922924	high affinity for
0.1822682676	30 mg
0.1822408546	increased expression of
0.1817360462	20 microm
0.1816768164	restoration of
0.1816591522	at position
0.1815963574	kinase dependent
0.1815452954	these findings indicate
0.1814394491	in bronchoalveolar lavage
0.1814351219	the hypothalamic pituitary
0.1814205882	identification of
0.1812845545	cells from oxidative
0.1811325222	more effectively
0.1809658243	serum levels of
0.1809582910	selective over
0.1808120961	structure of human
0.1807282175	in comparison to
0.1805713447	prepared from
0.1805289416	frequently used
0.1804794975	faster than
0.1804089378	effect on
0.1802820173	fold more
0.1802425918	expression profiles of
0.1800306462	type b
0.1800278318	2 carboxylic acid
0.1795139587	apart from
0.1794494152	fold increased
0.1790974895	anti inflammatory effect of
0.1787652968	up regulation of
0.1786906166	related to
0.1784888581	superior to
0.1784691297	most active
0.1784570963	activation of nuclear factor
0.1781782290	options for
0.1780933227	h nmr
0.1780290795	chronic exposure to
0.1779363382	suitable for
0.1779136741	phase 1
0.1777256600	± 2
0.1776859180	line therapy for
0.1776265824	the entire
0.1776187945	disruption of
0.1775374240	unaffected by
0.1774569106	did not influence
0.1773975549	in 3t3 l1 adipocytes
0.1772091531	the dopamine d2 receptor
0.1771659852	significantly higher in
0.1770976413	for use in
0.1767089915	these results
0.1764461901	selective alpha
0.1763084955	an effort to
0.1762954388	effects of chronic
0.1762901303	transporter 2
0.1760867374	intravenous administration of
0.1760504077	like growth factor
0.1759904012	7 fold
0.1759230367	values of 0
0.1759008561	mimicked by
0.1758215939	a significant increase
0.1756905788	based upon
0.1755029788	inhibitor of human
0.1754304218	induced inflammatory
0.1754158461	these data
0.1753429674	this phenomenon
0.1753117560	kinase 2
0.1752874635	9 fold
0.1748981182	the ventral tegmental area
0.1748834837	factor alpha
0.1747138663	determined using
0.1746716956	implicated in
0.1746029208	these differences
0.1745910235	correlates with
0.1745353462	these agents
0.1743969666	alpha 1
0.1742974810	pretreatment with
0.1742006278	new series
0.1741796349	receptor 1
0.1739563786	by high performance liquid
0.1735776616	children with
0.1735558987	healthy control
0.1734662932	each group
0.1732463667	these data indicate
0.1730789691	in rat brain
0.1730065800	expression of
0.1728108353	methoxy 2
0.1727812095	a time and dose dependent
0.1727435768	genes involved
0.1725620239	in terms of
0.1724769017	cells exposed to
0.1724581887	transcriptional activation of
0.1724222400	against oxidative stress
0.1723062618	transporter 1
0.1723001180	higher affinity for
0.1722915807	acid metabolism
0.1722675682	significantly correlated with
0.1722514148	receptor subunit
0.1720026676	group b
0.1719181891	20 nm
0.1718905800	as follows
0.1718260063	women with
0.1718049363	4 mg kg
0.1717985830	coadministered with
0.1717938925	20 fold
0.1717937365	mediated by
0.1717755386	resulted in significant
0.1714884043	5 fold
0.1713486755	in recent years
0.1712996018	induces apoptosis in
0.1712722464	evidence indicates
0.1708966165	apoptosis in human
0.1707581207	time curve
0.1706818920	mean arterial
0.1706486499	elucidation of
0.1700930244	a significant reduction
0.1693848975	1 week
0.1693092687	abolished by
0.1692734257	10 mg kg day
0.1692078226	in xenopus laevis oocytes
0.1690243220	type 1 receptor
0.1689847521	kinase 1
0.1689198140	hydroxyl group of
0.1688378159	the rate limiting step
0.1687969126	these compounds
0.1686913056	kg 1
0.1686596718	induced diabetic
0.1684220284	structural features of
0.1683789562	cysteine s
0.1682970511	methyl 3
0.1682691018	terminal domain of
0.1682591028	5 ht receptors
0.1681094901	characterization of
0.1679687445	did not induce
0.1679323571	new insights
0.1678934066	low levels
0.1678045195	under conditions
0.1674977277	returned to
0.1674822649	role in
0.1674653490	activity toward
0.1673676275	disease associated
0.1672893498	activity in vitro
0.1668463045	different types of
0.1667722578	24 h after
0.1666903254	receptors in rat
0.1666436909	crystal structure of
0.1664623690	affinities for
0.1663667414	treatment of asthma
0.1662043752	pre treatment with
0.1661777557	in guinea pig
0.1660839277	p =
0.1659237336	increase in plasma
0.1658274389	a wide range of
0.1657727402	treatment of human
0.1656626472	increased levels of
0.1655178445	at 37 degrees c
0.1655012289	cell death through
0.1654865034	in mammalian cells
0.1654495137	determined by
0.1654454611	selective inhibition of
0.1652897096	100 microg
0.1652775005	by site directed mutagenesis
0.1650719855	mice exposed to
0.1648194441	at baseline
0.1647941872	the alpha 1a adrenoceptor
0.1645600093	no effect
0.1645388172	high affinity binding of
0.1645322144	fails to
0.1643925418	dna binding activity of
0.1643360212	25 microm
0.1642358901	the purpose of
0.1641969925	in chinese hamster ovary cells
0.1640016080	measured using
0.1639326691	four groups
0.1639005323	increased risk of
0.1636773501	mrna expression in
0.1634071997	associates with
0.1633057337	transfected into
0.1631010481	mg d
0.1628455168	with ki values
0.1627280290	a high affinity
0.1627176474	approximately 5
0.1625417068	pharmacological characterization of
0.1625351426	balance between
0.1624337497	a dominant negative
0.1623556173	these effects
0.1622033198	determined whether
0.1621406705	respond to
0.1621067518	direct inhibition of
0.1619351827	an additional
0.1618905670	divided into three
0.1618307536	regulated by
0.1617613278	this property
0.1616582634	an extremely
0.1616449013	japanese patients with
0.1612394598	along with
0.1611558393	resulting in
0.1611293012	10 min
0.1611074705	rapid onset of
0.1610754107	systemic administration of
0.1609420209	report here
0.1602448969	develop new
0.1601962431	an overview
0.1601029199	nuclear localization of
0.1599994523	the present study examined
0.1598473838	appear to
0.1597771408	highly expressed in
0.1596936747	two isoforms
0.1595534008	selectivity against
0.1594942959	encoded by
0.1594932131	each patient
0.1594931616	type i
0.1590355815	significant increase in
0.1587391840	acid binding
0.1586494812	in summary
0.1585255710	the guinea pig
0.1584142326	decreased cell
0.1582133951	95 ci =
0.1579797182	further support
0.1579473876	domain containing
0.1579208352	larger than
0.1578902321	5 methyl
0.1578761838	specific binding of
0.1578501159	susceptibility to
0.1577451053	proof of
0.1577360119	anti inflammatory effects of
0.1574901433	associate with
0.1574607234	cell death induced by
0.1571782753	30 fold
0.1571773540	relative to
0.1571488778	response to
0.1571026435	a selective cox 2 inhibitor
0.1570443234	effective against
0.1568614767	chronic administration of
0.1567904299	pharmacological profile of
0.1566609373	modulation of
0.1566551694	genes involved in
0.1566476953	binding sites for
0.1566045357	mrna expression of
0.1565019881	consists of
0.1565004634	minutes after
0.1564248788	high selectivity for
0.1563709976	analysis indicated
0.1563454417	model system
0.1563410385	2 weeks
0.1562954279	seemed to
0.1562745312	extracellular levels
0.1561917076	days after
0.1561503704	in vitro models
0.1561264586	an essential
0.1558541576	present results
0.1558419425	metalloproteinase 2
0.1556568928	the wild type
0.1556518797	acid receptors
0.1556479900	cancer cells in vitro
0.1556431467	a major role
0.1555405856	altered expression of
0.1553556093	large number of
0.1553367519	estimation of
0.1552542348	the present review
0.1551237480	genes related to
0.1550331859	rats treated with
0.1550100464	cytotoxicity against
0.1549865874	elevated levels of
0.1549380018	plasma levels of
0.1548727490	inhibited tumor
0.1548634205	an in vitro model
0.1548164514	the present studies
0.1545850876	assessed using
0.1545369920	the epidermal growth factor receptor
0.1545289102	activity in vivo
0.1542364016	induced inhibition of
0.1540778108	to clarify
0.1540775387	arteries from
0.1537167697	at steady state
0.1535406897	group 1
0.1534019312	kinase 1 2
0.1533416539	no longer
0.1527312346	1 adrenoceptor antagonist
0.1525721830	cell cycle arrest in
0.1525379978	explanation for
0.1525090232	caused by mutations
0.1524325631	linked to
0.1524245692	inhibition of tumor
0.1523121986	8 mg kg
0.1521772390	used to assess
0.1520358725	lipid accumulation in
0.1518672178	the molecular mechanism
0.1517887770	the normal range
0.1517535407	recognized as
0.1516361918	reversed by
0.1516250059	tool for
0.1515655913	synthase 2
0.1514594148	the past
0.1513993821	an increase in
0.1513288744	approximately 1
0.1512873856	high doses of
0.1511189292	at positions
0.1511085049	induced vascular
0.1510621228	the molecular mechanisms
0.1508692542	5 ht2a receptor
0.1508631362	dependent protein
0.1508123024	appeared to
0.1507770711	anti inflammatory activity of
0.1505505903	involved in cell
0.1503717974	5 ht receptor
0.1503453867	observed between
0.1503359122	differences in
0.1502011495	plasma concentrations of
0.1501985333	enzyme responsible for
0.1501698634	thus far
0.1500412974	likelihood of
0.1499968341	more than
0.1498162678	inhibited by
0.1497720717	more recently
0.1496912402	result from
0.1495723668	stimulus effects of
0.1494796165	doses of 0
0.1493422392	uptake into
0.1493269813	pathways involved in
0.1492183799	rank order of
0.1491771735	a dose dependent
0.1489813026	to delineate
0.1489794357	patients treated
0.1488923289	combination therapy with
0.1488879700	induced liver
0.1488700176	no significant
0.1488459350	the dorsal raphe
0.1486236716	supplemented with
0.1486180420	proved to
0.1485741880	the parent compound
0.1484541946	growth in vivo
0.1483222325	the plasma membrane
0.1482619875	induced apoptosis in
0.1482432619	the results showed
0.1481452881	pivotal role in
0.1481407335	serotonin 5
0.1481158759	with regard to
0.1479401226	complex 1
0.1478104807	to define
0.1477989600	localized to
0.1477895223	recovery from
0.1477015532	antagonized by
0.1476465232	the presence or absence of
0.1471064478	these same
0.1470323380	by inhibiting
0.1468718554	the norepinephrine transporter
0.1468676740	attempt to
0.1468217290	a significant role
0.1467995456	in chinese hamster ovary
0.1467342745	lower levels of
0.1466876792	a small molecule
0.1465176262	the frontal cortex
0.1464998936	in human umbilical vein endothelial cells
0.1463390227	the glucocorticoid receptor
0.1462428880	regulation of
0.1462421305	n = 11
0.1461791806	as evidenced by
0.1461665318	a high fat
0.1461428406	10 nm
0.1460477716	system y
0.1457957018	mediated induction of
0.1456697760	a single
0.1456079999	like behavior
0.1455692103	receptor gamma
0.1455204800	not affected
0.1453966687	the present work
0.1448942319	min before
0.1447172891	members of
0.1447145026	the endoplasmic reticulum
0.1446289681	delivery system
0.1445356708	no synthesis
0.1443152356	the present study investigated
0.1442723426	studied using
0.1442380979	ki values of
0.1442374267	eliminated by
0.1441355249	60 mg
0.1440457183	occurred at
0.1440370534	act through
0.1438540437	to better understand
0.1436864303	currently used
0.1436488113	as effective as
0.1436453668	adverse effects of
0.1435429274	evaluated whether
0.1434517532	prevented by
0.1433959817	ros generation and
0.1433236630	independently associated with
0.1432298690	in guinea pigs
0.1431703393	the small intestine
0.1431380213	inflammatory activities
0.1430903104	an important role in
0.1430858056	produced by
0.1430668363	in mice
0.1430038208	n = 8
0.1430012139	evaluated using
0.1429463725	the context of
0.1429098089	contributed to
0.1429066153	rescued by
0.1427735625	mg kg b
0.1427584411	5 microm
0.1427063146	a cell based
0.1426454613	ii inhibitors
0.1425038349	to predict
0.1424599219	in vitro studies
0.1423849696	the androgen receptor
0.1422336298	gene expression in
0.1420742603	to produce
0.1420450468	the sole
0.1418150717	resulted from
0.1417982668	the renin angiotensin system
0.1417185023	significant difference in
0.1417153756	b radiation
0.1416707304	these enzymes
0.1413467611	treatment of parkinson
0.1413272955	release from
0.1412381494	h post
0.1410033494	apparent k
0.1409252626	potent inhibition of
0.1409146103	the cell cycle
0.1408271612	a key role
0.1406897740	95 ci 0
0.1405375786	the cerebral cortex
0.1405218028	the dentate gyrus
0.1404439270	treatment with
0.1404040616	metabolic effects of
0.1403835049	therapeutic use
0.1403346856	oxidative stress in
0.1402205568	performed using
0.1401963329	in hippocampal slices
0.1398624906	structure activity relationships of
0.1397086140	both cell lines
0.1396542332	did not differ between
0.1396475407	2 mg kg
0.1396338754	insulin like
0.1394258470	observations indicate
0.1393711056	affinity for
0.1393691073	protective effects of
0.1393310453	+ 14
0.1390602856	5 mm
0.1389727504	1 mm
0.1388770450	significant inhibition of
0.1388613429	a series of
0.1388309291	group 2
0.1385937064	a concentration dependent
0.1385832717	glucagon like
0.1385470350	but rather
0.1385275900	replaced with
0.1384391554	both groups
0.1383902696	low affinity for
0.1381244040	further studies
0.1380883893	treatment of breast cancer
0.1380657085	6 weeks
0.1380032215	the pro apoptotic
0.1379467398	11 beta
0.1379406981	the prefrontal cortex
0.1378648227	about 20
0.1377285506	triggered by
0.1377060754	study aimed to
0.1375904611	structure activity relationship of
0.1373028620	amino 1
0.1372300483	to determine if
0.1372013693	low concentrations of
0.1371772434	currently under
0.1371053482	possible mechanisms
0.1370783898	more severe
0.1369860044	specific activity of
0.1369519632	the high affinity
0.1369355101	three groups
0.1367699209	cell cycle arrest and
0.1367663561	high degree of
0.1366138383	induced increase of
0.1366102332	located at
0.1365849317	for example
0.1364396824	important role of
0.1364067691	in vitro experiments
0.1363120978	95 ci 1
0.1363038621	a comprehensive
0.1362927718	two groups
0.1361820816	= 8
0.1358989967	l amino acid
0.1358775766	the substantia nigra
0.1357689518	high concentrations of
0.1355829825	cardiovascular system
0.1355334540	confirmed by
0.1355157997	co administration of
0.1355040285	primary cultures of
0.1354688081	five patients
0.1354139919	the spinal cord
0.1353166304	interfering with
0.1352212602	to develop
0.1351141373	3 months
0.1351102085	access to
0.1350059744	+ 2
0.1349684037	9 + 0
0.1349642052	iontophoresis of
0.1349424676	the aim of
0.1347044421	9 ±
0.1346564347	associated proteins
0.1343837224	aspects of
0.1343832722	these cells
0.1342241684	submitted to
0.1341045966	two distinct
0.1340720896	+ 1
0.1339680706	or saline
0.1339674565	significant increase of
0.1339557951	down regulation of
0.1337808763	significantly lower in
0.1337384434	needed to
0.1336936779	to characterize
0.1335961710	recognized by
0.1334293045	sensitivity to
0.1334255287	acute administration of
0.1333983475	in conclusion
0.1332869900	oral doses of
0.1331775658	induced decrease in
0.1331565399	a large number
0.1331111984	the proximal tubule
0.1330963151	mg l
0.1330673600	by decreasing
0.1329864944	in rats
0.1329541006	12 week
0.1329483282	purified from
0.1329467619	to overcome
0.1328780330	from baseline
0.1328771181	mediated inhibition of
0.1328518525	distinct from
0.1328113796	increasing concentrations
0.1327223979	weeks after
0.1326291937	correlate with
0.1325933584	4 phenyl
0.1324986086	carried out using
0.1323987668	in vitro assay
0.1323519211	brain levels of
0.1323016341	activity in human
0.1322475013	a potential role
0.1321673603	to prevent
0.1321388847	6 nm
0.1321238124	assigned to
0.1320861464	an amino acid
0.1320687674	* 6
0.1319173393	susceptible to
0.1318842895	+ 7
0.1318442470	8 nm
0.1317629694	+ 8
0.1315044837	by liquid chromatography
0.1314832047	the basis of
0.1312676156	both in vitro and in vivo
0.1310405624	all patients
0.1309507972	affected by
0.1308794593	an average
0.1308647936	activity relationships
0.1307967278	to improve
0.1307209217	broad spectrum of
0.1306326882	2 amino 1
0.1305854797	= 12
0.1305551884	the hypothesis
0.1303655927	does not appear to
0.1302631864	accounted for by
0.1301742869	did not reduce
0.1301219925	in combination with
0.1300626923	significant effect on
0.1300107103	equal to
0.1299386547	this process
0.1298880213	adrenoceptor selective
0.1298171020	more susceptible to
0.1296385461	= 9
0.1293368297	oral dose of
0.1292864998	new targets
0.1291321865	the ability of
0.1290821259	measured by
0.1290752536	direct effects of
0.1290440697	+ 3
0.1289889398	genotyped for
0.1289284774	all three
0.1288811418	to promote
0.1288347179	to form
0.1288108510	inhibitory effect of
0.1288012264	d glucuronide
0.1286851720	treatment of advanced
0.1285715638	two main
0.1285429290	2 chloro
0.1284972301	induced production of
0.1284677486	provide new
0.1283459682	considered as
0.1282189508	apoptotic cell
0.1281209513	a selective beta
0.1279521007	* 4
0.1279388113	+ 6
0.1277526678	induced reduction in
0.1277366940	experiments using
0.1276162970	to establish
0.1275379661	implications for
0.1274848028	reductions in
0.1274043604	a broad spectrum
0.1273575288	the catalytic site
0.1273449372	by western blot analysis
0.1272107215	different classes
0.1270903246	an increased risk
0.1270732598	ic50 value of
0.1270337490	a panel of
0.1268899419	2 and mmp 9
0.1266510954	approximately 2
0.1265945500	close to
0.1265498949	the enzyme
0.1265218742	the serotonin transporter
0.1260628725	binding site of
0.1258675535	to test whether
0.1258654076	significantly different from
0.1257769976	studies show
0.1257354695	about 50
0.1256623495	sufficient to
0.1256560164	little effect on
0.1256536321	majority of
0.1252916187	+ 4
0.1252567356	converted to
0.1251267736	no evidence
0.1250466379	4 months
0.1249589203	potential use
0.1249515015	induced expression of
0.1248375423	pharmacological inhibition of
0.1248223009	protein 3
0.1247916447	relatively high
0.1247234666	prevention and treatment of
0.1246739781	mg kg p
0.1244440057	bound to
0.1244163000	conformational change in
0.1243410124	in drinking water
0.1243234021	a risk factor
0.1241720393	this result
0.1239220999	low doses of
0.1237456871	a pivotal role
0.1237148487	mean =
0.1235937686	these receptors
0.1234581245	subsets of
0.1234563584	not significantly different
0.1234252687	7 microm
0.1233923132	elicited by
0.1230522474	increased phosphorylation of
0.1229006836	unrelated to
0.1227814233	9 mg
0.1227349409	receptor α
0.1226832576	a monoclonal antibody
0.1226238040	as indicated by
0.1225383483	x receptor
0.1224057386	removal of
0.1222250308	expressed in
0.1222228452	roles for
0.1222157056	resistance to
0.1221859886	evoked by
0.1221113675	the results obtained
0.1221081021	mediated via
0.1220749983	mice resulted in
0.1220263719	3 microm
0.1220042372	expression in
0.1219654199	approximately 3
0.1219561570	selectivity for
0.1219541761	mice than in
0.1217409500	activity of
0.1215134283	an ic50 value of
0.1214275865	receptor tyrosine
0.1213624312	significant effects on
0.1212788164	= 1
0.1212435886	the brain
0.1212207275	active against
0.1211502315	m cell cycle
0.1211204997	the transcription factor
0.1209622419	erk 1
0.1208495693	to estimate
0.1208098611	interaction with
0.1208042162	i o
0.1207767539	transcriptional regulation of
0.1207277365	induction of
0.1207027687	an indirect
0.1206926722	activation of nuclear
0.1206562177	+ 9
0.1205921030	concentration of 10
0.1204489793	3 hydroxy
0.1203744012	liver x
0.1202607242	response induced by
0.1201504051	positive cells in
0.1201272252	enzymes involved in
0.1199935201	4 week
0.1196784407	this report
0.1194657320	significant differences in
0.1194076218	the dopamine transporter
0.1194009239	the drug
0.1193790310	pretreated with
0.1190796761	kappa b
0.1190693296	less potent than
0.1189811569	at ph
0.1189664914	6 phosphate
0.1189274166	the positive inotropic
0.1189203166	= 7
0.1189100184	n = 12
0.1188907861	8 days
0.1187406572	this pathway
0.1186900711	in nude mice
0.1186647453	interacting with
0.1185598399	the authors
0.1185367884	45 mg
0.1184804614	to perform
0.1184567696	by western blot
0.1184191964	synthesized and evaluated for
0.1183257856	a new class of
0.1181144450	mediated activation of
0.1180350227	in conscious rats
0.1179899062	in clinical practice
0.1178830220	mediated through
0.1178777054	in breast cancer cells
0.1178019461	an allosteric
0.1177420575	as first line
0.1176909049	5 μm
0.1176875706	binding of
0.1176291072	the results suggest
0.1175730246	as expected
0.1174103645	cessation of
0.1172552485	participated in
0.1172414224	ci 0
0.1172242734	with high affinity
0.1171857038	two independent
0.1171478190	vulnerability to
0.1170114280	β d
0.1170005259	significantly more
0.1169826175	critical for
0.1169318145	the aromatase inhibitor
0.1168317282	o methyltransferase
0.1166517752	competitive inhibitor of
0.1165569483	results show
0.1164463537	than placebo
0.1164214134	an apparent
0.1163984818	compound c
0.1163867963	upregulation of
0.1163218784	addition of
0.1162791792	tools for
0.1162605071	added to
0.1162103965	3 weeks
0.1161818798	in turn
0.1160420589	the metabolic syndrome
0.1160164188	4 days
0.1160017675	or = 10
0.1159857086	major role in
0.1158665162	the treatment of
0.1158378951	marked increase in
0.1158257443	provide evidence for
0.1155173980	amino acids in
0.1155014402	2 +
0.1154101157	increase in
0.1154020876	candidate for
0.1153909467	safety profile of
0.1153592874	coexpression of
0.1153471265	values for
0.1150655134	mrna and protein expression of
0.1150633086	during development
0.1150378659	dependent effects
0.1149997815	the treatment of parkinson
0.1149655271	reported here
0.1148404611	plasma concentration of
0.1147834738	cytotoxic effects of
0.1147171063	differ between
0.1146503181	for 7 days
0.1145704154	8 week
0.1144452416	comparable to
0.1144088543	an inhibitor of
0.1142121501	this compound
0.1141980533	expression level of
0.1141858004	highly selective for
0.1139940429	molecule 1
0.1138620370	characterisation of
0.1138191528	8 microm
0.1137071923	mechanisms involved in
0.1136963162	a powerful
0.1133278703	a positive correlation
0.1132710106	growth inhibition of
0.1132209023	after 24 h
0.1131901048	contribution to
0.1131881566	coexpressed with
0.1131164222	non specific
0.1130629254	approved for
0.1130201454	the ligand binding
0.1129653150	into three groups
0.1129389525	in vivo studies
0.1128160124	the peroxisome proliferator activated receptor
0.1127765523	seems to
0.1127674808	controlled by
0.1126583235	4 methyl
0.1125640170	extracts from
0.1125532887	combined with
0.1125239397	not yet
0.1124941728	to stabilize
0.1124446717	a significant
0.1123348442	a marked increase
0.1123171933	suppressed by
0.1122827183	day 1
0.1121926823	the sodium channel
0.1121741234	portion of
0.1121356746	after intravenous
0.1120702352	kinase activity of
0.1120465989	insulin resistance in
0.1120411463	starting at
0.1119637403	mediators of
0.1118543045	evaluation of
0.1117616404	the mechanisms underlying
0.1117427326	the oxytocin receptor
0.1117329323	to induce apoptosis
0.1117312712	does not inhibit
0.1117118292	dependent upon
0.1115736400	the main
0.1115733515	the antitussive
0.1115042372	activity in
0.1114640273	+ +
0.1114257646	4 phenyl 1
0.1114231759	necessary for
0.1113546675	role for
0.1111913306	significant reduction of
0.1111097059	diet containing
0.1110256552	individuals with
0.1110239292	2 methyl
0.1110167935	to gp330
0.1109793055	determination of
0.1109187875	three doses
0.1108214497	inhibition by
0.1107610350	a competitive inhibitor
0.1106358675	each other
0.1105667970	a patient with
0.1104485672	more sensitive
0.1103321377	downregulation of
0.1102421876	a combination of
0.1102098691	binding domain of
0.1101948847	the low affinity
0.1101106817	coding for
0.1100619225	restricted to
0.1100330509	antioxidant activity of
0.1100121487	levels of
0.1100089114	binding sites in
0.1099409655	protein kinase a
0.1099407266	candidates for
0.1098611578	with ic50 values
0.1098292436	data indicated
0.1098233268	all compounds
0.1098113717	the rat
0.1098103445	activity relationships of
0.1097375578	observed in
0.1097022706	analysis of
0.1095441298	the transcriptional level
0.1094837560	binding pocket of
0.1093539526	the cell surface
0.1092557235	tyrosine phosphorylation of
0.1090691765	loss of
0.1090561779	dependent activation of
0.1089752135	+ 5
0.1089383350	add on
0.1088868479	a broad range of
0.1088359119	selective inhibitors of
0.1088210474	n = 10
0.1086821693	mrna levels of
0.1086426562	this enzyme
0.1085336224	10 nmol
0.1084584528	protective effect of
0.1084458065	n = 6
0.1083971348	in type 2 diabetic patients
0.1083841545	caused by mutations in
0.1083394916	expression levels of
0.1083278561	the alpha 1b
0.1082690707	6 mg kg
0.1082685326	also inhibited
0.1081852581	by altering
0.1081435886	in rat
0.1081108277	an endogenous
0.1080914559	cells treated with
0.1079704924	sulfation of
0.1078256374	inflammatory response in
0.1077417128	12 h
0.1077327575	all cases
0.1075377721	attached to
0.1074219450	used to evaluate
0.1073864334	abundance of
0.1072434816	evidenced by
0.1072162162	a single agent
0.1070909438	potency against
0.1070574694	achieved by
0.1068505367	50 nm
0.1067345469	this interaction
0.1067336542	much more
0.1066757663	over expression
0.1066666904	this approach
0.1066541871	the cell membrane
0.1064216378	monitored by
0.1064154383	a novel
0.1063884515	replacement of
0.1063499726	7 ±
0.1063141252	against oxidative
0.1062102404	or placebo
0.1061309758	contrary to
0.1060827983	results indicated
0.1060645122	this purpose
0.1060550353	the mineralocorticoid receptor
0.1059476977	important role in
0.1058215019	to induce
0.1057816363	characterised by
0.1057308039	to discover
0.1057244399	very similar
0.1056678566	treatment resulted in
0.1056495177	this study examined
0.1056158468	found to
0.1055336230	key role in
0.1051407524	in vitro study
0.1048409269	assessed by
0.1047732351	these models
0.1047600301	+ 20
0.1045976435	fatty acids in
0.1045387979	undertaken to
0.1044924396	blockage of
0.1042481679	3 hydroxy 3
0.1041410214	binding site for
0.1040890335	surface expression of
0.1040222355	fold higher in
0.1039679397	dose of 0
0.1039425782	reactivation of
0.1038268802	circulating levels
0.1037133503	unlikely to
0.1035205781	breakdown of
0.1034758809	the histamine h1
0.1034689724	a crucial role
0.1033592215	resistant to
0.1033377593	by means of
0.1033182286	separated by
0.1033086133	secreted by
0.1032707082	a potent
0.1032459950	15 days
0.1031815142	a significant effect
0.1031503527	predictors of
0.1031337924	toxic effects of
0.1030817229	benefit from
0.1030245469	a resolution
0.1029809736	the crystal structure
0.1026722763	overall response
0.1026416093	an anti inflammatory
0.1025649712	the first report
0.1025093030	percentage of
0.1024708335	three patients
0.1024137832	18 h
0.1023669532	n 3
0.1022350895	these diseases
0.1021543626	did not increase
0.1020781742	generated by
0.1020145547	release of
0.1019395081	a key role in
0.1019342035	used to identify
0.1019144013	assessment of
0.1018684848	a time dependent
0.1018356089	to elicit
0.1018010685	not statistically
0.1017956329	the steady state
0.1017955925	not completely
0.1017847156	a non competitive
0.1017471230	collected from
0.1017329034	a mouse model
0.1016433163	like receptors
0.1015055411	association with
0.1015008091	blood pressure in
0.1014623497	and insulin levels
0.1014518923	the treatment of advanced
0.1012508751	alteration of
0.1012393457	approved by
0.1012041636	previously shown to
0.1011765924	for treating
0.1011447367	tcdd on
0.1011139593	the first evidence
0.1011010960	insulin sensitivity in
0.1010974842	a promising
0.1010078541	gene expression of
0.1010041046	widely used as
0.1009841361	4 + 1
0.1009476580	analogous to
0.1009382504	present in
0.1008836012	= 6
0.1008768241	n = 5
0.1008116736	neuroprotective effects of
0.1007364631	the treatment of breast cancer
0.1007341466	5 days
0.1006563138	significantly increased in
0.1005502134	6 microm
0.1004471145	adverse effects on
0.1004204688	the development of
0.1003451788	challenged with
0.1002706583	identified as
0.1002615578	in human embryonic kidney
0.1001978763	also observed
0.1001967386	sequence analysis of
0.1001356966	of inflammatory cells
0.1001133414	min after
0.1000277263	a potential mechanism
0.0999734188	of hypoxia inducible factor
0.0999200709	over time
0.0998714369	these ligands
0.0998043040	8 + 0
0.0997812256	the beta 2 adrenoceptor
0.0997253873	these genes
0.0997195323	therapeutic potential for
0.0996418698	society for
0.0996177520	a potential
0.0994883096	option for
0.0994706304	of rat aorta
0.0993026991	2 toxin
0.0992732025	opioid receptors in
0.0992008914	6 mm
0.0990755141	requirements for
0.0989856969	= 24
0.0989028462	binding affinity of
0.0986947027	not affected by
0.0986914078	times more
0.0986110084	to confirm
0.0985846215	a pivotal role in
0.0985330995	in human cells
0.0984718133	ic50 values of
0.0984345572	values of 1
0.0983814286	8 oh
0.0982599152	in preventing
0.0981975503	identical to
0.0981953352	dependent increase in
0.0981918344	a single dose
0.0981899662	her 2
0.0981241074	mediated induction
0.0980980036	an additive
0.0980448695	to gain
0.0979725388	no significant effect on
0.0979600849	an efficient
0.0979364576	this disease
0.0978885956	90 mg
0.0977938781	a major
0.0976794994	most sensitive
0.0976596317	a potential target
0.0975587031	a consequence
0.0975255787	of vitamin b6
0.0974910040	adjustment for
0.0974454154	an initial
0.0974373738	induce apoptosis in
0.0974009239	a high
0.0973532447	decrease in
0.0973338192	phase i
0.0971693649	used to examine
0.0971374730	poisoning with
0.0971280009	4 amino
0.0970907429	related genes in
0.0970752216	in man
0.0970083832	mrna levels in
0.0968805680	major cause of
0.0968782759	alpha expression
0.0968639135	interference with
0.0967990499	cancer cells by
0.0967916553	ci 1
0.0966738428	the effect of
0.0966709039	treatment of
0.0965882723	reduced expression of
0.0965762841	measurement of
0.0965110283	protein expression of
0.0964680111	specific inhibitor of
0.0963843518	prepared by
0.0963405124	3 o
0.0962706199	low dose of
0.0962400722	less sensitive to
0.0962028538	by suppressing
0.0961962635	biological evaluation of
0.0961906020	present studies
0.0961470580	the anti inflammatory effects of
0.0960756866	did not show
0.0960670734	a low
0.0960646244	defined as
0.0960286158	the at1 receptor
0.0960218650	n = 7
0.0959830853	action of
0.0959748340	propensity to
0.0959575136	these actions
0.0959390189	from rat liver
0.0958081713	by modulating
0.0957951809	cd4 +
0.0956987933	potentiated by
0.0956727443	mean plasma
0.0955963912	predictor of
0.0955213620	in rat liver
0.0954204688	the role of
0.0953908028	by inducing
0.0953584293	the gene encoding
0.0953582992	at week
0.0953445363	comparison of
0.0952928586	an increased risk of
0.0952850690	this drug
0.0951546695	presence of
0.0951194214	metabolized by
0.0950100068	activity against
0.0949787337	= 15
0.0949074458	information on
0.0945963912	details of
0.0945270004	in rat kidney
0.0945159738	the pathophysiology of
0.0944020231	improvements in
0.0943334773	animal models of
0.0941091514	molecular mechanism of
0.0940509295	proposed as
0.0940448246	inhibitory activity of
0.0940071761	the effects of
0.0940042372	inhibitors of
0.0939012980	levels in
0.0938949431	the mammalian target of rapamycin
0.0938737404	these results show
0.0937514471	coupled to
0.0937379201	lack of
0.0936569761	i r
0.0936506517	compete with
0.0936434787	a transcription factor
0.0936422257	preference for
0.0936397388	induced apoptosis of
0.0936216754	beta d
0.0935193350	molecular weight of
0.0934691618	the alpha 1a
0.0934615585	a proton
0.0934597005	used to study
0.0933781072	determinants of
0.0933776415	selective inhibitor of
0.0933383966	modes of
0.0933056858	the liver
0.0933021042	affinity binding
0.0932993615	administration of
0.0932669982	+ 12
0.0932596404	starting from
0.0932262205	the mechanism underlying
0.0932003080	10 20
0.0931883138	by adding
0.0931499717	binding sites of
0.0930577293	the possibility
0.0930234781	result in
0.0930036408	self assembly of
0.0928809108	screened for
0.0928096437	binding properties of
0.0928093993	the selective beta
0.0927646986	1 μm
0.0927294695	to suppress
0.0926960548	transported by
0.0926436126	clinical trials for
0.0926347626	the beta cell
0.0926330771	development of new
0.0925687140	neuroprotective effect of
0.0925125830	a single oral
0.0925123701	determinants for
0.0924956250	the pro inflammatory
0.0924616389	these molecules
0.0924457148	transport system
0.0924245287	alpha production
0.0923420452	to analyze
0.0922945281	old mice
0.0922379116	phosphorylation of
0.0922366766	strategy for
0.0922019293	did not significantly
0.0921093873	this observation
0.0920954224	probably due to
0.0920800657	a low affinity
0.0920532964	in rodents
0.0920513015	variations in
0.0920270376	shifts in
0.0919628215	damage induced by
0.0919443023	basis for
0.0919085313	changes in
0.0919062256	the alpha 1 adrenoceptor
0.0918602665	glutathione s
0.0918591402	this study investigated
0.0918421118	data from
0.0918412004	cells resulted in
0.0918179638	found to inhibit
0.0917175863	functions as
0.0917057194	phosphoinositide 3
0.0915117211	increases in
0.0914946151	mixtures of
0.0914813665	n methyl d
0.0914801582	an inhibitory effect
0.0914267614	able to inhibit
0.0913801892	subjects with
0.0913686673	5 nmol
0.0913675836	1 31
0.0913637219	the inflammatory response
0.0913088154	h after
0.0912866572	decreased levels of
0.0912691557	difficult to
0.0911847494	insulin secretion in
0.0911634822	co treatment
0.0911188091	amounts of
0.0909945015	contribution of
0.0909609185	the molecular basis of
0.0908877684	activated by
0.0908685159	understanding of
0.0908514394	those obtained
0.0908193750	gene expression by
0.0908105478	a first line
0.0907957315	better understanding
0.0904786395	various types of
0.0903736068	to inhibit
0.0902988575	inhibitory action of
0.0902375263	enzymatic activity of
0.0899656568	the crystal structures
0.0898947356	a strong
0.0898946986	referred to
0.0898551589	the extracellular matrix
0.0897019821	the present results
0.0896974531	transcriptional activity of
0.0896551995	anticancer activity of
0.0895745963	treatment of cancer
0.0895143009	essential role in
0.0894791803	these studies
0.0894615452	also prevented
0.0893898424	functional changes
0.0893646043	fold less
0.0893270436	several genes
0.0891434573	more selective
0.0890173074	further confirmed
0.0890146300	during early
0.0888947356	a unique
0.0888820198	a novel mechanism
0.0888373754	insensitive to
0.0888073402	attenuation of
0.0887960397	7 macrophages
0.0887957565	group i
0.0887838527	quantified by
0.0887056778	located on
0.0885787570	a trend
0.0885573733	induced activation of
0.0883617288	protection from
0.0883157499	after adjusting
0.0883072580	new therapeutic
0.0882097503	to maintain
0.0881856302	with sitagliptin
0.0881510550	evaluation of novel
0.0881201364	overexpression of
0.0881099808	significantly reduced by
0.0879863061	tumor growth in
0.0879809546	a significant increase in
0.0878403567	inactivation by
0.0875881987	samples from
0.0875686995	5 hours
0.0875545810	findings show
0.0875141733	less sensitive
0.0874727768	acid receptor
0.0874534663	the major
0.0873878042	associated with greater
0.0873852189	coenzyme a
0.0871910186	in mice lacking
0.0871487617	the p gp
0.0870673117	property of
0.0870203736	point to
0.0870195020	05 vs
0.0870099925	activity relationship
0.0869295213	c type
0.0869258805	this combination
0.0869201105	5 nm
0.0869064882	management of
0.0868025062	possible mechanism
0.0867671518	n = 4
0.0867572376	a therapeutic agent
0.0867206654	transferred to
0.0867120324	used as
0.0865719292	6 fold
0.0865390805	the treatment of type 2 diabetes
0.0865382633	tolerance to
0.0865225566	cells with
0.0864826386	not only
0.0864339040	used to determine
0.0863371717	search for
0.0863370493	10 microg
0.0863283068	a dual
0.0863169135	mutations in
0.0862735058	mediation of
0.0862550980	protein expression in
0.0862516068	phosphatase 1
0.0862392437	animal model of
0.0862137270	potential role of
0.0861539758	history of
0.0860911812	a central role
0.0860863820	this investigation
0.0860594787	interactions with
0.0859773882	strategies for
0.0859533137	protein 2
0.0859288618	the catalytic
0.0859024983	the combined treatment
0.0858975316	potential target for
0.0858463297	the rate limiting
0.0857925876	defined by
0.0857838132	the male rat
0.0857827700	the outer
0.0857818846	no change
0.0857370633	at concentrations up to
0.0855946232	rationale for
0.0855906022	by increasing
0.0855203641	properties of
0.0855101275	signaling through
0.0855053022	in vitro model
0.0854912760	two genes
0.0854770062	more sensitive to
0.0854456378	formed by
0.0854280807	crucial for
0.0853752590	8 ±
0.0853229190	of endothelin 1
0.0853218908	suppression of
0.0853092499	cell death in
0.0852785659	active metabolite of
0.0851586913	the expression of
0.0850190255	receptor antagonists in
0.0848407792	driven by
0.0848378875	catalytic activity of
0.0846945198	these pathways
0.0846700306	an excellent
0.0846607132	investigate whether
0.0846606456	2 amino
0.0846100884	a specific inhibitor of
0.0843437879	or =
0.0843183239	evidence for
0.0841856400	by reducing
0.0841798287	also discussed
0.0841514769	10 days
0.0840951769	also increased
0.0840788848	1 34
0.0840592555	the final
0.0840096120	the rat brain
0.0839722606	obtained using
0.0839104614	a marked increase in
0.0838665351	protein levels in
0.0838357429	the protein level
0.0838123527	optimization of
0.0837528965	data show
0.0837342353	mouse model of
0.0837199106	the dopamine d2
0.0836778658	treatment of patients
0.0836733696	detected by
0.0836392269	a new
0.0836165914	these proteins
0.0835389974	a large
0.0834865601	effects induced by
0.0834713320	a critical role
0.0834098327	better than
0.0834063103	in patients with
0.0833996027	applied to
0.0833812507	molecular mechanisms of
0.0833765444	cells from
0.0833163377	with increasing
0.0833092542	responsiveness to
0.0832764769	known compounds
0.0832022622	in vivo anti
0.0831443702	an oral
0.0831253222	number of
0.0831171858	in relation to
0.0831073459	protein levels of
0.0831066668	activation by
0.0830508279	antibody against
0.0830373769	both wild type
0.0830205639	these mutations
0.0830163661	down regulated by
0.0828571435	antitumor activity in
0.0828461425	dependent on
0.0826751909	reduction in
0.0826639834	knockdown of
0.0825574718	roles in
0.0825529685	stimulated by
0.0825187942	decreases in
0.0824828939	to discriminate
0.0824674125	reduced by
0.0824039922	accumulation of
0.0822387577	a dramatic
0.0821403636	potent inhibitor
0.0821298569	sensitive to
0.0821173329	no differences
0.0819509460	pharmacological properties of
0.0818675222	participation of
0.0818066541	cell proliferation in
0.0815025668	binding activity of
0.0814627684	evaluated by
0.0814470990	for cancer therapy
0.0814276311	augmentation of
0.0814036595	this difference
0.0813902714	less active
0.0813593129	5 min
0.0813373322	expression of pro
0.0813125622	to study
0.0812785347	coadministration of
0.0812485921	obtained by
0.0812026251	binding site in
0.0811968164	10 ng
0.0811933263	the structure activity
0.0811870625	cell receptor
0.0811765408	also examined
0.0811563462	a novel approach
0.0811345892	involvement of
0.0811344507	related gene
0.0811110459	mechanism of
0.0810776434	death induced by
0.0810703581	a better understanding
0.0810642888	equivalent to
0.0808788216	influence on
0.0808179352	2 + 0
0.0806854421	series of
0.0806624236	cell viability in
0.0805777646	vehicle or
0.0805601826	detected in
0.0805235960	significantly decreased in
0.0805175259	kg m
0.0804699262	the mitogen activated protein
0.0804422882	in parallel with
0.0804201517	receptor expression in
0.0803853770	sufficient for
0.0803518116	5 + 0
0.0802159407	an active
0.0801740231	method for
0.0801672962	the majority
0.0801360143	assessments of
0.0801065999	study indicates
0.0798645516	significant changes
0.0798518276	dysregulation of
0.0798227701	significantly inhibited by
0.0797178084	variation in
0.0797176751	6 h
0.0796942978	analyzed by
0.0796843957	occurrence of
0.0796741085	the pathogenesis of
0.0796021172	the central nervous system
0.0794896578	amount of
0.0794118010	attenuated by
0.0793778653	spectra of
0.0793609660	analyzed using
0.0791508888	an independent
0.0791457052	mg m
0.0791392161	6 + 0
0.0791311934	for 8 weeks
0.0790556505	blockade of
0.0790406969	also studied
0.0790337076	high level of
0.0790229958	no change in
0.0790098458	this disorder
0.0788122760	acting on
0.0787497251	actions of
0.0787290897	3 x 10
0.0787168386	rat model of
0.0787041561	to select
0.0786981043	derivatives as
0.0786840123	l 2
0.0785648548	other drugs
0.0785164936	a critical role in
0.0785148378	to test
0.0784012214	16 mg
0.0783678084	cell death by
0.0783484507	an index
0.0783442971	the cerebellum
0.0781593998	antitumor activity of
0.0780062944	cytotoxic effect of
0.0779939718	more active
0.0779888221	10 weeks
0.0779672073	studies indicated
0.0778705972	exploration of
0.0777094547	a potential therapeutic
0.0776749943	1 nm
0.0776620944	about 10
0.0775900991	the pi3k akt
0.0775598642	to increase
0.0774713293	on chromosome
0.0774489532	assayed by
0.0774257808	level of
0.0774194186	present work
0.0773454143	a specific inhibitor
0.0772946680	for 4 weeks
0.0772345830	did not cause
0.0772277156	a selective
0.0772242074	a ring
0.0771788477	modification of
0.0771772280	by examining
0.0771286124	more susceptible
0.0771207711	dependent manner in
0.0771171054	developed as
0.0771023251	the generation of reactive oxygen species
0.0770085040	the high dose
0.0768833450	in vitro binding
0.0768535490	enantiomer of
0.0767767045	activities against
0.0766984004	an irreversible
0.0765579960	after injection
0.0765005682	sensitization to
0.0764956689	active form of
0.0763905129	the results of
0.0763745205	biological activities of
0.0763302159	four new
0.0762956256	up regulated by
0.0762820672	consequence of
0.0762644024	also demonstrated
0.0762514653	for 3 days
0.0762243139	observed with
0.0762014781	drugs such as
0.0761830486	ablation of
0.0761384296	+ 10
0.0760326680	studies indicate
0.0759937665	the curve
0.0759601822	enhancement of
0.0759441432	a deficiency
0.0758891206	a number of
0.0758795925	the relative
0.0756060224	degree of
0.0755384151	s 1
0.0754930826	significantly associated with
0.0754877049	sought to
0.0754204688	the absence of
0.0752314594	no significant changes
0.0750914001	a specific
0.0750832782	1 + 0
0.0748773612	beneficial effects of
0.0748754155	together with
0.0748674197	factor receptor
0.0748177507	the nucleus
0.0748159929	examined using
0.0748128438	apoptosis through
0.0747664405	different classes of
0.0747478607	1 nmol
0.0746856656	signaling pathway in
0.0746799398	0 mg
0.0746679647	concentration of
0.0746444047	m phase
0.0745390752	all subjects
0.0744799887	= 17
0.0744712878	actions on
0.0743993093	the inhibitory effect
0.0743857998	classes of
0.0743565440	apoptosis via
0.0742519129	this mechanism
0.0742372020	an increase
0.0742094426	after incubation
0.0742007987	3 + 0
0.0739287739	the potential
0.0738662912	more important
0.0738235484	to investigate whether
0.0737543010	action on
0.0737243994	the first study
0.0737238463	a decrease in
0.0736586119	the x ray
0.0735996332	2 adrenoceptor agonist
0.0735910642	comparison with
0.0735751671	an effect
0.0735715837	doses of
0.0735369270	in brain tissue
0.0735241661	signs of
0.0734978886	a key
0.0734648828	on days
0.0734431502	performed on
0.0733891641	significantly reduced in
0.0733733696	a novel class of
0.0733733596	a simple
0.0733396922	= 11
0.0732727276	mol of
0.0732442192	the striatum
0.0732251027	degradation by
0.0731845876	the patent
0.0731845115	increased by
0.0730999144	therapy for
0.0730984580	biological activity of
0.0730404151	contributions of
0.0729581365	development of
0.0729570942	copies of
0.0728483076	a similar
0.0727936062	the genes encoding
0.0727587309	pharmacodynamics of
0.0726964126	induced changes in
0.0726889373	three new
0.0726856768	further evidence
0.0726630538	signaling pathways in
0.0725968183	identified by
0.0725569984	in patients treated
0.0725227905	the cytosol
0.0725107941	markers of
0.0724635660	central role in
0.0723845448	extent than
0.0723014226	diversity of
0.0722879905	for 5 days
0.0722365598	three different
0.0721823224	absent in
0.0721751075	inhibitor of
0.0721144664	adjusting for
0.0720789865	located in
0.0720727872	the cytoplasm
0.0720022593	homozygous for
0.0719895193	cloned from
0.0719615284	coupled with
0.0719311301	an aqueous
0.0719122612	for studying
0.0718713083	novel approach
0.0717804006	effective than
0.0717803943	better understanding of
0.0717622962	adsorption of
0.0716968287	to enhance
0.0716800231	the side chain
0.0716739907	1 year
0.0716320708	to confer
0.0716250853	this class
0.0715676462	an antibody
0.0714784124	dose of
0.0714423547	a marked
0.0713651288	the estrogen receptor
0.0712509787	the existence of
0.0712292312	the full length
0.0711897649	by radioimmunoassay
0.0711742654	also showed
0.0711056885	at least two
0.0710681500	overexpressed in
0.0710578255	the formation of
0.0710485055	infusions of
0.0709678771	ingestion of
0.0709463165	processing of
0.0709208424	known to
0.0708906281	set of
0.0708406697	day 5
0.0708346499	regulator of
0.0707520165	many studies
0.0707325891	the plasma concentration
0.0707097711	k +
0.0707072730	the selective alpha
0.0706751294	5 x 10
0.0706173202	men with
0.0706108362	reduction of
0.0705864741	observed after
0.0705743580	useful for
0.0705371976	fall in
0.0705309746	a rat model
0.0704847340	a rare
0.0704587761	new drugs
0.0704298650	occurs at
0.0704095626	consumption of
0.0703578027	at 37
0.0702970963	sensitivity of
0.0702923121	studies on
0.0702610142	the market
0.0702604509	incorporation of
0.0702081365	activities of
0.0701250711	for 30 min
0.0701178959	dissociation of
0.0701142868	stimulation of
0.0700511723	biology of
0.0700144497	cell lines with
0.0699972436	no association
0.0699243336	amplitude of
0.0698346313	structure of
0.0698017767	by activating
0.0697792204	of activated t cells
0.0697458452	the anti inflammatory effect
0.0697430605	3 day
0.0697370966	phosphorylation at
0.0697324256	elevation in
0.0696830598	treatment of various
0.0696715823	disorders such as
0.0696438057	results from
0.0696268001	effective at
0.0696219052	risk of
0.0695098106	kg b
0.0694797995	in patients with acute
0.0694163951	very high
0.0693116478	approach to
0.0693077671	a small
0.0693014226	manipulation of
0.0692522002	assay using
0.0692508886	important for
0.0691771608	inflammatory activity
0.0690954787	a minimum
0.0690178501	treatment for
0.0690066367	a critical
0.0689251105	at doses
0.0688889229	injected with
0.0688635750	a potential target for
0.0687752440	segment of
0.0687171176	= 25
0.0686546942	diseases such as
0.0686516989	used to investigate
0.0685271366	delivery of
0.0684976437	also determined
0.0684027727	and time dependent manner
0.0683726571	7 nm
0.0683108971	treatment of patients with
0.0681806485	proposed to
0.0681228805	an inhibitory
0.0681206252	the activity of
0.0681120017	this case
0.0680155919	1 mg
0.0679945109	a non selective
0.0679147560	verified by
0.0679053908	study indicated
0.0678969830	investigated using
0.0678303612	the present
0.0678139802	a valuable
0.0676693615	the uterus
0.0676491521	the fact
0.0676460426	upregulated by
0.0675351650	combinations of
0.0674858498	targets for
0.0674408151	a weak
0.0674281193	associated with increased
0.0674146755	any effect on
0.0673860391	+ t cells
0.0673538036	version of
0.0672489267	2 selective inhibitors
0.0671995407	increased in
0.0671781203	this model
0.0671072190	the literature
0.0670734249	a new target
0.0670578255	in response to
0.0670386625	the molecular
0.0669926135	none of
0.0669460811	at 250
0.0668765755	2 months
0.0668461060	the inhibition of
0.0668425790	act on
0.0668346313	domain of
0.0668034971	aspect of
0.0667132406	in vitro activity
0.0666351027	region of
0.0666177284	relevance to
0.0663455040	to reduce
0.0662441067	significant role in
0.0661244797	cell proliferation by
0.0661206252	the levels of
0.0661183948	source of
0.0661104260	a common
0.0660924422	liver injury in
0.0660231136	2 nm
0.0660010921	in mammals
0.0659854985	to regulate
0.0659562818	safety and efficacy of
0.0659498146	generated from
0.0659026542	expressed at
0.0658715173	a novel mechanism of action
0.0658209351	3 mm
0.0658198506	at 300
0.0657977140	alterations in
0.0657067496	= 5
0.0656935827	detoxification of
0.0656377684	prevention of
0.0656095236	designed to
0.0655712696	detection of
0.0655594050	or = 1
0.0655474600	deletion of
0.0655462073	curves for
0.0655181830	6 mg
0.0655173457	n 2
0.0655015776	the production of
0.0654892917	the parent
0.0654119535	by combining
0.0653894391	4 microm
0.0653549924	in patients with advanced
0.0653367319	also investigated
0.0653132310	but did not affect
0.0652796499	modifications of
0.0652565524	the circadian
0.0652505876	the importance of
0.0652409938	preincubation with
0.0651683478	quantification of
0.0651568258	independent of
0.0650856024	two additional
0.0650832967	a truncated
0.0650805659	potentiation of
0.0649687608	accuracy of
0.0648622527	determinant of
0.0648078302	at least one
0.0648029466	model of
0.0647511278	3 nm
0.0647348553	a suitable
0.0647089209	a role in
0.0646527661	over expression of
0.0646217080	three compounds
0.0646023894	also suppressed
0.0645982716	advances in
0.0645943088	and well tolerated
0.0645072218	dependent inhibition of
0.0645036094	different mechanisms
0.0644025809	concentrations of
0.0643932870	measured as
0.0643872690	modulation by
0.0643561741	as shown by
0.0642418103	binds to
0.0642094492	by blocking
0.0641934388	0 + 0
0.0641650603	regulators of
0.0640476571	all tissues
0.0640012980	formation of
0.0639243714	site at
0.0639219406	several mechanisms
0.0638954657	complexes with
0.0638811941	the stimulatory effect
0.0638688441	either alone or
0.0638562151	prediction of
0.0638461060	the activation of
0.0638334828	not significantly
0.0638073787	h before
0.0637738841	expression and activity of
0.0636493849	high affinity to
0.0635891646	agonists at
0.0635610464	the dose response
0.0635420150	the results
0.0635283385	n = 3
0.0635228030	an anti
0.0634811426	facilitated by
0.0633001562	this method
0.0632858273	potential for
0.0632469522	to deliver
0.0631821916	an antidepressant
0.0631206252	the regulation of
0.0631113004	expected to
0.0631048620	2 years
0.0631000120	needs to
0.0630925758	activity by
0.0630696132	uptake of
0.0629783386	more likely to
0.0629696918	to disrupt
0.0628872565	profile of
0.0628868994	the stomach
0.0628276320	for 12 weeks
0.0627996830	form of
0.0627364536	to provide
0.0627211252	affinity than
0.0627157381	application of
0.0627107268	or in combination with other
0.0627004299	enhanced by
0.0625810385	4 hours
0.0625351340	to yield
0.0625228030	an enzyme
0.0625223114	agreement with
0.0624769127	a broad spectrum of
0.0624526016	both types of
0.0624192810	risk for
0.0624135078	a range of
0.0624029676	development of novel
0.0623699145	also known as
0.0623325085	death through
0.0623318591	delay in
0.0622885719	distribution of
0.0622809551	human t
0.0622671161	the latter
0.0622443358	an essential role in
0.0622147332	agent for
0.0621984957	a result of
0.0621735509	the alpha
0.0621732518	1 methyl
0.0621625439	potency than
0.0621476522	the binding of
0.0621353251	reported to
0.0620879024	the use of
0.0620759747	a complete
0.0620271863	acting as
0.0619916588	sensitive k
0.0619526339	the c terminus of
0.0619083263	efficacy of
0.0619020834	classification of
0.0618960102	considered to
0.0618795526	analysed by
0.0617211399	spectrum of
0.0616214547	atherosclerosis in
0.0616027713	abrogated by
0.0615610624	the exact
0.0615544109	a major role in
0.0614126247	mechanism for
0.0614074682	stages of
0.0613420850	overview of
0.0612637638	approach for
0.0612364536	to block
0.0612195562	predicted to
0.0611595833	new target
0.0611124306	the hypothalamus
0.0611102414	selective for
0.0610222828	drugs used
0.0610148903	cleavage of
0.0609346285	in addition to
0.0608796344	location of
0.0608633226	a direct
0.0608241553	appearance of
0.0605959867	regions of
0.0605871448	independently of
0.0605573167	promise for
0.0605372962	observed during
0.0605288239	defective in
0.0605096620	a significant decrease in
0.0605028860	downregulated by
0.0605015776	the amount of
0.0604976571	other tissues
0.0604923675	h +
0.0604636548	effects via
0.0604460522	without effect
0.0604410883	remains to
0.0604234722	among patients
0.0604185747	decreased by
0.0603946672	absence of
0.0603639694	expression and function of
0.0603501298	the cytotoxic effects
0.0602926786	factor 2
0.0602217628	5 ±
0.0602134037	an activator of
0.0601998619	target for
0.0601633097	knowledge of
0.0601419817	mechanisms of
0.0600883410	a novel series of
0.0600876632	on days 1
0.0600403102	novel mechanism of action
0.0599991181	marker for
0.0599608454	a crucial role in
0.0599081740	played by
0.0598795897	antagonism of
0.0598663816	showed only
0.0598349109	a reduction in
0.0597907063	after adjustment
0.0597872919	the mechanism of
0.0597632767	the alpha 2
0.0597291368	injection of
0.0596786352	the duodenum
0.0596139114	also reduced
0.0596014737	a prospective
0.0594897123	initiated by
0.0594671514	the goal of
0.0594562264	state of
0.0594554974	after oral
0.0594537896	non small
0.0594114645	biotransformation of
0.0593890649	elevation of
0.0593082271	an overview of
0.0592998318	two different
0.0592323468	the number of
0.0591828655	these interactions
0.0591801106	novel drug
0.0591250622	the cytotoxic effect of
0.0591200966	displacement of
0.0591155416	clinical use of
0.0590853560	measured in
0.0590184727	this study aimed to
0.0590108207	concentration time
0.0589847156	evaluated as
0.0589321609	after incubation with
0.0589112558	flux of
0.0588857176	these factors
0.0588783849	feature of
0.0588401284	new compounds
0.0587838559	the first
0.0587090034	did not result in
0.0586674243	not observed
0.0586420628	desensitization of
0.0585779761	this molecule
0.0585754918	forms of
0.0585560835	alone or in combination with
0.0585036245	12 mg
0.0585015776	the influence of
0.0584495298	regulation by
0.0584238395	reversal of
0.0583164540	tumors with
0.0582948012	member of
0.0582785692	a pyrene
0.0582166928	autophagy in
0.0582024765	both drugs
0.0580879024	the level of
0.0580826385	proportion of
0.0580013845	the beginning of
0.0579686385	impact of
0.0579567262	increased after
0.0579527341	variety of
0.0578954448	measured at
0.0578761087	concentrations up to
0.0578545526	assayed for
0.0578341679	subject to
0.0578109962	decline in
0.0577431950	these results indicated
0.0576752883	at concentrations
0.0575992618	proven to
0.0575974772	in vitro and in vivo studies
0.0575727194	homology to
0.0575438367	5 years
0.0575015776	the affinity of
0.0575015776	the interaction of
0.0574729908	the world
0.0574510931	a dose and time dependent
0.0573319191	further confirmed by
0.0572805447	configuration of
0.0572549836	expression system
0.0572465020	a potent inhibitor
0.0571154847	by immunohistochemistry
0.0571032650	to support
0.0571000447	aim of
0.0570480235	evaluated for
0.0570443345	a case
0.0570344692	moderate to
0.0569750614	mechanisms of action of
0.0569279466	production of
0.0569040396	231 cells
0.0569016441	phosphorylation on
0.0568963333	an increase of
0.0568130074	carriers of
0.0567425745	= 4
0.0565968822	antagonist at
0.0565915774	with placebo
0.0565536124	a rapid
0.0565132767	the alpha 1
0.0565026132	the data suggest
0.0564983063	the hippocampus
0.0564879166	different concentrations
0.0563569770	in contrast to
0.0563287611	a significant role in
0.0562632121	significantly different
0.0562575864	knowledge on
0.0562510025	a large number of
0.0562481838	residues in
0.0562465747	tested for
0.0562255603	rise to
0.0561165798	an open
0.0561127378	once daily for
0.0560963857	active site of
0.0560806754	the last
0.0560668646	rates of
0.0560546548	metabolized to
0.0560247740	a rational
0.0559897429	the predominant
0.0559783852	show here
0.0559540351	modified by
0.0559355060	in rats treated
0.0559315284	injections of
0.0559248485	to protect
0.0558949482	relation to
0.0557844230	to correlate
0.0557820052	rate of
0.0557290272	the distal
0.0557138020	an intact
0.0557017319	therapeutic potential of
0.0556891519	widely used to
0.0556748673	synthesized by
0.0556709025	as compared to
0.0556204006	6 mice
0.0556109770	these experiments
0.0556053625	a candidate
0.0555758026	conversion of
0.0555034009	discovery of
0.0554974405	activity than
0.0554638934	nm for
0.0554296750	not fully
0.0554072414	the upper
0.0553742304	to reverse
0.0553591679	termination of
0.0553402459	an estrogen
0.0552941695	component of
0.0552736657	effects against
0.0552706507	a role for
0.0551861521	complexity of
0.0551632728	provided by
0.0551547784	events associated with
0.0551206426	inactivation of
0.0550650499	3 h
0.0549858499	measures of
0.0549454866	respect to
0.0549381501	uptake by
0.0548472710	by preventing
0.0547159265	the treatment of diabetes
0.0546895584	regard to
0.0546728811	8 h
0.0546569428	down regulated in
0.0546431072	a subset of
0.0546139114	also decreased
0.0545579173	values of
0.0545376986	prevalence of
0.0545282605	significant changes in
0.0545247508	apoptosis in
0.0545052115	the occurrence of
0.0544660724	after administration
0.0544409957	a progressive
0.0544207335	a rat model of
0.0542152997	a central role in
0.0541765532	these parameters
0.0541534232	observed for
0.0541460923	1 h
0.0541331565	the discovery of
0.0540409082	to synthesize
0.0540372438	any effect
0.0540117669	selected for
0.0539511036	not altered
0.0539042448	4 h
0.0538489645	defect in
0.0538218179	c terminus of
0.0537954205	assay for
0.0537661621	not known
0.0537264131	some patients
0.0537226653	suppression by
0.0537019148	indicator of
0.0536620406	3 days
0.0536377873	terminus of
0.0536185720	variability in
0.0535492423	2 h
0.0535233342	less well
0.0535184261	significance of
0.0534829157	widely used in
0.0534525633	methods for
0.0533870370	toxic to
0.0533537056	effects through
0.0533211005	neurons in
0.0532911380	administered to
0.0532191701	as evidenced
0.0531876913	potential of
0.0531861521	expansion of
0.0531831069	a model
0.0531544279	progress in
0.0531305271	2 mm
0.0530417968	degradation of
0.0530273886	components of
0.0529399402	= 2
0.0529127156	change in
0.0528775755	microm for
0.0528698665	on day
0.0528431576	increased during
0.0528138158	expression through
0.0527341483	not detected
0.0527324684	receptors in
0.0526628037	the risk of
0.0526156634	does not appear
0.0525088569	for predicting
0.0524799131	choice for
0.0524664898	a dose of
0.0524044563	a wide
0.0523766425	a better understanding of
0.0523413834	effectiveness of
0.0523272024	compound for
0.0523190474	relaxation of
0.0523066354	exception of
0.0523004553	attempts to
0.0523000726	not altered by
0.0522671065	efficacy and safety of
0.0522211266	a new therapeutic
0.0522191181	prolongation of
0.0522067535	limited by
0.0521511994	improvement in
0.0521155191	other proteins
0.0520940299	the treatment of chronic
0.0520894180	transformation of
0.0520728080	this series
0.0520451144	than previously
0.0519342979	required to
0.0517934467	extract from
0.0517886713	numbers of
0.0517523185	model for
0.0517520300	or vehicle
0.0517346971	production by
0.0516463809	limited to
0.0516422513	to modify
0.0515616630	characteristics of
0.0515339945	correlated to
0.0515317186	need to
0.0515256962	activity at
0.0515042273	a member of
0.0514427494	pattern of
0.0514054103	up regulated in
0.0513856518	complex with
0.0513631148	1 phosphate
0.0513586080	a single dose of
0.0513451153	status of
0.0513326858	these responses
0.0512986166	trained to
0.0512968077	the treatment of asthma
0.0512496718	at 24 h
0.0511876913	metabolism of
0.0511786995	to stimulate
0.0511086024	both proteins
0.0510580069	only 10
0.0510540974	emergence of
0.0510540512	the absence or
0.0510098120	any other
0.0510070270	a biomarker
0.0509614635	4 nm
0.0509390872	also measured
0.0509122674	also attenuated
0.0508966842	for 24 h
0.0508446706	the current
0.0507872919	the involvement of
0.0507680192	aims to
0.0507284589	but not by
0.0506818937	function of
0.0506333263	interaction of
0.0505977751	immunoreactivity in
0.0505892661	assembly of
0.0505871834	the beta 2
0.0505367725	to modulate
0.0505178118	evolution of
0.0505082402	acetylation of
0.0504723686	the active site of
0.0504500380	not directly
0.0504333191	secretion by
0.0504311084	neurotransmission in
0.0503135082	the active
0.0503028198	two types of
0.0502865795	mechanism of action of
0.0500694169	impairment of
0.0500283691	fold for
0.0500024056	by regulating
0.0499912046	constants for
0.0499873872	even more
0.0499813987	hyperglycemia in
0.0499734084	little or
0.0499724311	characteristic of
0.0499625422	to undergo
0.0499197107	the percentage of
0.0498545095	used to
0.0498461060	the release of
0.0498212458	likely to
0.0497872919	the control of
0.0497648617	consequences of
0.0496977751	relaxation in
0.0496113754	diet for
0.0495967628	3 ±
0.0495734683	investigation of
0.0494255832	more complex
0.0493994451	by comparing
0.0493925786	a down regulation of
0.0493453076	no treatment
0.0493234440	utilized to
0.0493101163	active than
0.0492826959	both enzymes
0.0492557116	iop in
0.0492339220	potency for
0.0490136731	a natural
0.0489843696	inflammatory effect of
0.0489520038	a novel target
0.0489333191	stimulation by
0.0489292312	the design of
0.0489099695	stabilization of
0.0488510582	to activate
0.0488068026	correlation with
0.0487996248	employed to
0.0487837662	n = 1
0.0487732741	characterized as
0.0487692730	m +
0.0487461515	kinase b
0.0487322312	cells via
0.0487145125	studies using
0.0486666122	measured with
0.0486389067	the metabolism of
0.0486106294	agents such as
0.0485729817	also detected
0.0485031226	but did
0.0484509781	the emergence of
0.0483831115	alteration in
0.0483680893	potential as
0.0483323815	not significantly different from
0.0482982583	features of
0.0482613927	an experimental
0.0482414940	a hydrophobic
0.0481488917	to receive
0.0481377423	to demonstrate
0.0481331565	the impact of
0.0481258802	also evaluated
0.0481016584	effect against
0.0480907563	defects in
0.0480696664	strategy to
0.0480515532	also assessed
0.0480446072	except for
0.0480170440	as determined
0.0480011049	further investigated
0.0479822312	cells through
0.0479425851	3 mg
0.0479331176	a general
0.0479328466	act by
0.0478757333	up to
0.0478547215	the potency of
0.0478506244	mean +
0.0478274421	these conditions
0.0477505760	examination of
0.0477402778	organization of
0.0477078604	family of
0.0477039227	to protect against
0.0476048097	place in
0.0475907563	composition of
0.0475717307	parts of
0.0475036337	several studies
0.0474904177	the cytotoxicity of
0.0474760364	the precise
0.0473967322	administered at
0.0473902796	to explain
0.0473467489	monitoring of
0.0472872584	synthesis of
0.0472823812	transfected with
0.0472753204	retention of
0.0472256853	defect of
0.0472227850	maturation of
0.0471931200	the extent of
0.0471739891	promoted by
0.0471720778	function after
0.0471544279	aid in
0.0471299478	on platelets
0.0471267707	expression via
0.0471037975	n = 2
0.0470361838	people with
0.0470219011	light on
0.0469493887	protected by
0.0469345774	day 7
0.0468786601	the time course of
0.0468236859	an intravenous
0.0468169752	specificity for
0.0468041882	the combination of
0.0467872919	the addition of
0.0467744083	class of
0.0467565537	the rate of
0.0467416058	a prominent
0.0467247988	a poor
0.0467188814	= 3
0.0465695454	mutation in
0.0465321941	observed at
0.0465218028	repression of
0.0464970178	following exposure
0.0464904691	evaluated in
0.0464716145	many patients
0.0464411154	depletion of
0.0463996925	biomarker for
0.0463950381	n terminus of
0.0463846926	effective in
0.0463452873	but also
0.0463175739	healing of
0.0463175739	availability of
0.0462333263	secretion of
0.0461633033	critical role in
0.0461347158	relevant to
0.0460989572	higher in
0.0460615290	10 m
0.0460396181	subset of
0.0460316495	the concept
0.0460275286	transport of
0.0460169618	infusion of
0.0460023899	incidence of
0.0459986172	the potential to
0.0459787274	metastasis in
0.0459234695	agonist at
0.0458190788	this agent
0.0458139129	to conclude
0.0458037037	arrest in
0.0457895193	a significant reduction in
0.0457753204	occupancy of
0.0457382811	two enzymes
0.0457374045	alternative to
0.0457284589	the accumulation of
0.0457260260	recommended for
0.0457044794	the increase in
0.0456652976	exposure on
0.0455972963	obtained with
0.0455942458	the human 5
0.0455781196	inflammatory effects of
0.0455619589	not detected in
0.0455238971	with ki values of
0.0454766813	roles of
0.0454045592	the availability of
0.0454027502	fraction of
0.0453376802	new drug
0.0453273085	using in vitro
0.0453092306	compared with other
0.0452901628	influence of
0.0452881214	quality of
0.0452255727	corresponding to
0.0451862271	an early
0.0451784487	accumulation in
0.0451454278	but does
0.0450896685	an association between
0.0450863793	many other
0.0450712445	the majority of
0.0450290177	pocket of
0.0450031492	novel series of
0.0449842077	a potent inhibitor of
0.0449610493	the synthesis of
0.0449571861	the induction of apoptosis
0.0448896053	these changes
0.0448570368	relevant for
0.0448516513	kinetics of
0.0447872919	the efficacy of
0.0447695130	abundant in
0.0447496574	3 phosphate
0.0447458458	report on
0.0447436104	the action of
0.0447350768	the central
0.0446963983	incubation of
0.0446662360	activators of
0.0446411344	even at
0.0446266206	the mechanism of action of
0.0446028257	without effect on
0.0445268552	identity to
0.0445022961	found in
0.0444948981	suggested by
0.0444769117	detected at
0.0444404283	suggested to
0.0444348285	the potential role
0.0444346382	3 hours
0.0444144004	a result
0.0444068031	mode of action of
0.0443819242	reflected in
0.0443751754	remain to
0.0443674032	as determined by
0.0442318289	severity of
0.0441566363	secondary to
0.0440694013	production in
0.0440407402	the down regulation of
0.0440117077	in patients with chronic
0.0439952074	responsive to
0.0439830301	part of
0.0439053236	manifestations of
0.0438929527	both compounds
0.0438666182	vs 1
0.0437860377	to mimic
0.0437853082	attachment of
0.0437436104	the concentration of
0.0437321916	by enhancing
0.0437294146	effective as
0.0437223358	approved in
0.0436943516	= 50
0.0436831092	this polymorphism
0.0436520146	grown in
0.0436438876	a high degree of
0.0436279241	the structure of
0.0436153514	treatments for
0.0436003140	the treatment of alzheimer
0.0435595871	abundance in
0.0435526937	a remarkable
0.0434240896	dosage of
0.0433833558	a partial
0.0433623511	remodeling in
0.0432508148	substrate for
0.0432215690	addition to
0.0432141690	substitution of
0.0431768250	1 x 10
0.0431647240	3 d
0.0431578512	a useful
0.0431569455	possible role of
0.0431464466	these data show
0.0431428725	8 mg
0.0430586083	combination with
0.0430284986	using in vivo
0.0430248810	or = 0
0.0430015247	1 ng
0.0429960620	validation of
0.0429703704	hydrolysis of
0.0428952981	the control
0.0428828888	collected for
0.0428667670	to control
0.0428294805	demonstrated to
0.0428038591	affinity of
0.0427761320	the crystal structure of
0.0427548580	an animal
0.0427340432	the appearance of
0.0427126168	needed for
0.0427125568	to mediate
0.0426420294	also blocked
0.0426418683	toxicity of
0.0426313061	cultures of
0.0426055494	a substantial
0.0425900549	transport by
0.0425766368	testosterone to
0.0425441239	a broad
0.0425006344	for clinical use
0.0424615072	benefits of
0.0424389191	distributed in
0.0424349627	as measured by
0.0424082115	inhibitors such as
0.0424065631	different concentrations of
0.0423380503	metabolism in
0.0422933549	efficacy in
0.0422557258	affinity at
0.0422438426	developed by
0.0422155300	as assessed by
0.0421984683	types of
0.0421271306	with type 2 diabetes
0.0421010119	x receptors
0.0420483656	as inhibitors of
0.0420357205	3 times
0.0420196241	studied in
0.0420193604	a modest
0.0419390838	comprised of
0.0419080880	obtained at
0.0418705625	a lack of
0.0418605053	in vertebrates
0.0418345178	panel of
0.0418271759	sites on
0.0418234586	to facilitate
0.0418022355	purification of
0.0417980895	efficiency of
0.0417888158	activity via
0.0417830705	significantly associated
0.0417784583	nm at
0.0417436104	the phosphorylation of
0.0417318233	to occur
0.0417205224	the association of
0.0417152575	adults with
0.0417016513	oxidation of
0.0416700032	success of
0.0416654402	a novel therapeutic
0.0416149426	induced changes
0.0416134490	stability of
0.0416055011	pharmacology of
0.0415340818	μm for
0.0415217922	associated with decreased
0.0415040936	expressed as
0.0414166844	the inhibitory effects of
0.0413553696	established by
0.0413444173	block by
0.0413435689	the inhibitory effect of
0.0413343181	in animal models of
0.0413211005	proliferation of
0.0412955987	a double
0.0412854382	found between
0.0412413027	a selective inhibitor
0.0412296074	capacity to
0.0412242237	goal of
0.0411812037	orientation of
0.0411747876	a major cause of
0.0411522727	following exposure to
0.0411486532	after treatment with
0.0411471516	the expression of genes
0.0411378047	dependence on
0.0411279241	the potential of
0.0411211005	site of
0.0411002929	intensity of
0.0410814035	like effects
0.0410667299	comparable with
0.0410542312	after administration of
0.0410385003	to help
0.0410199504	nature of
0.0409790893	a review of
0.0409732344	compounds such as
0.0409569428	or in combination
0.0409550753	two drugs
0.0408515538	mode of
0.0408461060	the identification of
0.0408433671	both wild type and
0.0408418288	measure of
0.0408196662	livers of
0.0408038591	ratio of
0.0407937944	investigated in
0.0407376190	fibrosis in
0.0406782434	function in
0.0406770577	association of
0.0406740278	increased from
0.0405953911	all four
0.0405849489	recruitment of
0.0405805479	use of
0.0405062367	the degree of
0.0404143572	to give
0.0404021143	in mediating
0.0403904737	more than one
0.0403444085	tissue from
0.0403380503	lower in
0.0403102771	the reduction of
0.0401652904	upregulated in
0.0401311633	developed to
0.0400970858	profiles of
0.0400661735	new class
0.0400449045	mutagenesis of
0.0400317242	metabolized in
0.0400272641	stress in
0.0399790893	the exception of
0.0399511103	a decrease of
0.0398530462	possibility of
0.0398513235	the inhibitory
0.0398367408	difference in
0.0398276687	content of
0.0398099750	other than
0.0398083249	two compounds
0.0397846715	control of
0.0397565537	the activities of
0.0397016740	the expression levels
0.0396678511	utility of
0.0396645598	product of
0.0396626971	tool to
0.0396418683	toxicity in
0.0396055011	recovery of
0.0395758265	a dose
0.0395681914	the antiplatelet
0.0395394209	potency of
0.0395372492	to bind
0.0395046285	to possess
0.0394860429	the question
0.0394742240	amplification of
0.0394316876	for treatment of
0.0394125422	a representative
0.0394110020	performed in
0.0394026048	even after
0.0393849844	to screen
0.0393775231	a dose and time
0.0393722717	discussed in
0.0393478697	pairs of
0.0393395700	a model of
0.0393055733	the lack of
0.0393029563	the aim
0.0392447814	means to
0.0392238175	secretion from
0.0391028935	movement of
0.0390915783	to affect
0.0390710600	advantage of
0.0390576035	a favorable
0.0390513381	target of
0.0390350651	used for
0.0390070403	the same time
0.0390003694	decreased in
0.0389986238	conformation of
0.0389954240	also tested
0.0389505530	also enhanced
0.0389363927	the end of
0.0388705753	capacity for
0.0388612575	the induction of
0.0388049497	to restore
0.0387967746	this end
0.0387962529	ligands for
0.0387896577	several other
0.0387645075	a low dose of
0.0387515259	to take
0.0386009762	a set of
0.0385938263	the corresponding
0.0385755769	h after treatment
0.0385022719	the beneficial effects of
0.0384894421	but does not
0.0384423668	refractory to
0.0383034174	a nonselective
0.0382921561	bioavailability of
0.0382885189	magnitude of
0.0382634294	by monitoring
0.0382622742	reduced in
0.0382026700	localization of
0.0381790417	an association
0.0381684319	these values
0.0381308357	localized in
0.0381215075	therapies for
0.0380642283	associated protein
0.0380451989	bound with
0.0380448814	obtained for
0.0380173750	homologous to
0.0380100848	developed for
0.0379941799	unchanged in
0.0379620165	binding at
0.0379599252	end of
0.0379539842	importance of
0.0379345388	the catalytic site of
0.0379152981	the mechanisms
0.0379065318	a period of
0.0378879167	release by
0.0378189715	models of
0.0378063668	discontinuation of
0.0377761320	in subjects with
0.0377615767	identified in
0.0377005892	transfection of
0.0376768957	a concentration
0.0376745185	the introduction of
0.0376293413	support for
0.0376154750	deposition of
0.0375343903	the in vivo effects
0.0375265402	and activator of transcription
0.0375114242	a marker of
0.0374635366	search of
0.0374374700	improved by
0.0374275308	therapeutic use of
0.0373871967	exists in
0.0373690692	limitations of
0.0373664258	by determining
0.0373595811	7 cells
0.0373218425	the pathophysiology
0.0373118335	studied by
0.0372476878	examined in
0.0372433035	conducted to
0.0372421033	start of
0.0372239422	maintained in
0.0372210934	formed in
0.0372090314	stimulated with
0.0371906974	altered by
0.0371817438	demonstrated by
0.0371652904	diagnosis of
0.0371606752	the decrease in
0.0371008578	to find
0.0370794660	determined in
0.0370497981	investigated as
0.0370202467	r =
0.0369956389	the onset of
0.0369862812	therapy with
0.0368865765	means of
0.0368830961	= 10
0.0368801323	strength of
0.0368597188	the well known
0.0368490303	by about
0.0367734822	also significantly
0.0367132809	2 x 10
0.0366863955	formulation of
0.0366535168	markers for
0.0366269458	concept of
0.0365883563	heterogeneity of
0.0365788003	a selective inhibitor of
0.0365558265	the number
0.0365329811	selection of
0.0365295171	in comparison with
0.0365294239	supplementation with
0.0364997215	a well known
0.0364496857	with ic50 values of
0.0364440270	patterns of
0.0364100861	only one
0.0363840615	but did not
0.0363746503	but not in
0.0363556788	occurred in
0.0363444890	cohort of
0.0363133135	site on
0.0362595108	the presence
0.0362484766	duration of
0.0362463211	the two drugs
0.0362208284	new class of
0.0362082565	mechanism by
0.0361958115	shift in
0.0361802397	the mechanism
0.0361625422	a systematic
0.0361254895	detectable in
0.0360909429	an appropriate
0.0360115767	reported in
0.0359820074	a monoclonal
0.0359160226	the result of
0.0359140074	a competitive inhibitor of
0.0359090934	pathway in
0.0358643419	the induction
0.0358539323	administered by
0.0358433178	the gut
0.0357922452	genes associated with
0.0357791869	extract of
0.0357582540	important to
0.0357301838	the capacity of
0.0357141705	period of
0.0357120336	determined at
0.0356538716	after exposure to
0.0356311953	event in
0.0356083839	the clinic
0.0356041390	separation of
0.0355894668	presented with
0.0355538933	these tissues
0.0355100325	substrates for
0.0355070700	an inhibitor
0.0354929740	alone did not
0.0354167191	to respond to
0.0354058125	to decrease
0.0353656284	tissues from
0.0353475714	known as
0.0353243718	rich in
0.0352705581	performed to
0.0352532197	in patients with type 2 diabetes
0.0352415873	analyzed in
0.0352378501	decline of
0.0351639871	acquisition of
0.0351639445	order of
0.0351431313	the loss of
0.0351309327	expressions of
0.0351223633	the role
0.0350054051	array of
0.0350035348	primarily by
0.0349488735	pretreatment of
0.0348004397	secretion in
0.0347455353	a competitive
0.0347237301	conducted in
0.0347130826	modulator of
0.0346636516	a typical
0.0346165505	preparation of
0.0345888095	design of
0.0345845548	kg i
0.0345783928	demonstrated for
0.0344738542	dependence of
0.0343614295	a link between
0.0343534830	the protective
0.0343404577	capability of
0.0342869521	improvement of
0.0342056838	maintenance of
0.0342037629	evidence from
0.0341970189	novel class of
0.0341463135	first time
0.0341173966	estimated to
0.0340943604	a classical
0.0340840494	the management of
0.0340691303	a robust
0.0340635172	the possibility of
0.0340285732	occur in
0.0339349220	as demonstrated by
0.0339288754	rise in
0.0338547215	the function of
0.0338357409	proposed for
0.0337421225	no changes in
0.0337193705	balance of
0.0337081195	b inhibitor
0.0336725010	deamination of
0.0336367005	an overall
0.0335888095	cultured in
0.0335809922	at doses of
0.0335507394	the livers of
0.0335307977	enriched in
0.0334860583	a consequence of
0.0334492314	the structures of
0.0333890353	the proliferation of
0.0333766924	novel mechanism of
0.0333643490	coupling of
0.0332390141	the ability
0.0332283728	library of
0.0332237700	different from
0.0332144716	an established
0.0331766778	critical to
0.0331763253	structures of
0.0331733687	mediator of
0.0331626971	subgroup of
0.0331576792	extent of
0.0331109929	the mechanism of action
0.0330995970	a concomitant
0.0330893889	the progression of
0.0330749206	regulated in
0.0330749206	cytotoxicity of
0.0330577582	a good
0.0330227465	inflammation in
0.0330166690	via activation of
0.0330009012	the therapeutic potential of
0.0329652672	a special
0.0329443516	* 1
0.0329182586	combination of
0.0328412263	through inhibition of
0.0328197455	but only
0.0327812964	the mechanisms by
0.0327810156	transmission in
0.0327759955	the degree
0.0327387932	the mechanisms of
0.0327237301	conserved in
0.0326985355	seen in
0.0326840417	polymerization of
0.0326814413	specific for
0.0326247045	the treatment of patients
0.0326196920	the mechanism by
0.0325858938	investigated by
0.0324994011	route of
0.0324982157	steps in
0.0324175119	and in combination
0.0324128685	revealed by
0.0323391677	episodes of
0.0323296927	the mechanisms of action
0.0322895134	cells against
0.0322672511	purpose of
0.0322482711	to express
0.0322024513	the beginning
0.0321936334	inducer of
0.0321674004	the mrna levels of
0.0321362939	to alter
0.0321260038	to exert
0.0321035075	as well
0.0320944968	a mixture of
0.0320849366	modeling of
0.0320810211	increase of
0.0320781988	at least as
0.0320652672	a lesser
0.0320244058	as assessed
0.0319886591	also observed in
0.0319574658	identity of
0.0319081561	introduction of
0.0319015247	to attenuate
0.0318058288	ineffective in
0.0317729808	terms of
0.0317317806	an inhibition of
0.0317145977	used in
0.0316767671	in rats with
0.0316717515	initiation of
0.0316547375	administered with
0.0316147804	function as
0.0316028120	mainly due to
0.0315916557	the kinetics of
0.0315849038	provide further
0.0315663106	a history of
0.0315100668	an interaction
0.0315062367	the prevention of
0.0314646820	a profound
0.0314581973	orders of
0.0314476389	the absence
0.0314185013	to play
0.0313868258	range of
0.0313663103	the prevalence
0.0313393679	the modulation of
0.0313387174	day after
0.0312532985	mechanisms by
0.0312414987	in agreement with
0.0311674004	the protective effects of
0.0311386552	excretion of
0.0311374972	a major cause
0.0311115161	some other
0.0310749206	greater in
0.0310663106	the treatment of patients with
0.0310561900	the relationship between
0.0310467937	the discovery
0.0310170949	useful as
0.0310097421	observed by
0.0309743618	essential to
0.0309445067	the need for
0.0309025157	resistance in
0.0308882532	confirmed in
0.0308407609	frequency of
0.0308135172	the effectiveness of
0.0308017144	generation of
0.0307779373	a clear
0.0307759955	the pathogenesis
0.0307536094	2 hours
0.0307336024	an antagonist
0.0307188652	recognition of
0.0306760392	daily for
0.0306402724	isolation of
0.0306196920	the roles of
0.0306084664	truncated at
0.0305979555	value of
0.0305713133	pharmacokinetics of
0.0305616774	to interact
0.0305062367	the conversion of
0.0304476479	basis of
0.0304423814	clearance of
0.0304228711	to lead
0.0303902137	observed on
0.0303110247	a risk factor for
0.0302370891	other forms of
0.0301006909	marker of
0.0300905851	benefit in
0.0299935798	an intracellular
0.0299404972	the former
0.0298992515	mixture of
0.0298340243	performed with
0.0298163153	tested in
0.0298043321	necessary to
0.0296786201	the transport of
0.0296750736	obtained in
0.0296706987	a host
0.0296419329	the hydrolysis of
0.0296294152	kg day of
0.0296254230	binds with
0.0295587775	tested by
0.0295182987	occurs in
0.0294810266	the contribution of
0.0294662307	the reduction in
0.0294386198	noted in
0.0294140992	to exhibit
0.0293685091	expressed on
0.0293316876	the sensitivity of
0.0293079764	excess of
0.0292863124	a role
0.0292103373	specificity of
0.0290225127	as part of
0.0289982297	3 +
0.0289283623	modulators of
0.0289142292	elimination of
0.0288823850	in mice with
0.0288598549	not prevent
0.0288406086	a target for
0.0287743100	capacity of
0.0287526014	by mutations in
0.0287373390	the protective effect of
0.0287160517	that inhibition of
0.0286903074	exist in
0.0286858704	well tolerated in
0.0286183042	included in
0.0286011076	a second
0.0285987852	ability of
0.0285191764	randomized to
0.0284810638	assessed in
0.0284762008	need for
0.0284591189	a rise in
0.0284546646	this system
0.0284445908	the potential for
0.0283271358	relevance of
0.0282860886	this class of
0.0282183178	the vasculature
0.0281953123	the frequency of
0.0281674004	in rats treated with
0.0281606752	the administration of
0.0281290558	pathogenesis of
0.0281260038	a dominant
0.0280438191	if not
0.0279948341	a mouse model of
0.0279884451	achieved with
0.0279857615	as compared with
0.0279853015	5 +
0.0279514850	step in
0.0279450149	associated with reduced
0.0278571473	sites for
0.0278464865	as well as on
0.0278434338	the increase of
0.0278359616	alone or
0.0278251468	a high affinity for
0.0278118969	the biological activity of
0.0277751765	not associated with
0.0277526014	2 expression in
0.0276984235	also found
0.0276762202	seen with
0.0276634444	translocation of
0.0276576428	useful in
0.0276093725	performed by
0.0275670681	downstream of
0.0275139340	a potent and selective
0.0273831314	investigated for
0.0273192955	alone or in
0.0272755036	expressed by
0.0272457697	elevated in
0.0272075818	different between
0.0270452956	a *
0.0270383287	death in
0.0270259065	the order of
0.0270096577	but not to
0.0269990758	the pharmacokinetics of
0.0269593852	biosynthesis of
0.0269575146	the crystal
0.0269053894	the exception
0.0268862566	activity through
0.0266570998	metabolite of
0.0266474801	not result in
0.0265474100	abnormalities in
0.0265123228	disposition of
0.0265078518	in primary cultures of
0.0265072752	the case of
0.0264467494	= 20
0.0264457975	also shown
0.0264317536	case of
0.0264273584	the urinary excretion of
0.0264061945	for binding to
0.0262270055	activator of
0.0261897935	examined for
0.0261736539	time course of
0.0261150461	the development of new
0.0259676389	the identification
0.0259565215	no changes
0.0259459740	to make
0.0259023576	contrast to
0.0257909709	reported for
0.0256862683	of genes involved in
0.0256625120	the prevention and
0.0255670333	shown by
0.0255653074	sample of
0.0255263244	by treatment with
0.0254685013	an alpha
0.0254515009	with high affinity to
0.0253772116	but without
0.0253715907	this study provides
0.0253701763	the translocation of
0.0253513084	the clearance of
0.0253403898	no significant changes in
0.0253126506	treated for
0.0252930797	the magnitude of
0.0252785115	the relevance of
0.0251674004	the expression levels of
0.0251489893	the toxicity of
0.0251455636	system for
0.0251158981	the duration of
0.0250895824	determined for
0.0250547549	a crucial
0.0249363468	examined by
0.0249206600	a family of
0.0249094071	the liver of
0.0248796577	that treatment with
0.0248721741	day treatment
0.0248719383	the molecular mechanism of
0.0248706771	to become
0.0248340670	the conformation of
0.0247412455	the crystal structures of
0.0246807305	not induce
0.0245663106	the potential role of
0.0244989564	pronounced in
0.0244530311	the catalytic activity of
0.0244259439	and protein expression of
0.0244245470	to allow
0.0244094071	the brain of
0.0243701763	the content of
0.0243628084	the mode of action of
0.0243481288	the specificity of
0.0243470933	help to
0.0243241992	no evidence of
0.0242737132	the cardiovascular system
0.0242110641	a model for
0.0242081844	to interfere with
0.0241427412	a possible
0.0239671764	a mutation in
0.0239349068	third of
0.0238020187	this effect of
0.0237554819	in vitro by
0.0237082267	factor for
0.0236786201	the site of
0.0236176389	a review
0.0235875536	to act
0.0235501339	that treatment of
0.0235123228	limit of
0.0234094071	the inactivation of
0.0233813679	also associated with
0.0233340670	in vivo effects of
0.0233127688	1 microg
0.0232988010	to bind to
0.0232523165	also activated
0.0231974880	the dose of
0.0231777465	the proportion
0.0229349068	the need
0.0228295174	a component of
0.0227998833	a rapid and
0.0227640884	no differences in
0.0227035097	in patients treated with
0.0226617200	gain of
0.0226287670	use for
0.0225437956	available for
0.0225424998	6 ±
0.0225010279	novel target
0.0224492314	in complex with
0.0224294071	the effects on
0.0223906708	in individuals with
0.0223613787	the stability of
0.0223481288	the proportion of
0.0222668220	described as
0.0222538798	result of
0.0222427404	the analysis of
0.0222314436	changes at
0.0221124720	3 vs
0.0221077395	the occurrence
0.0221054971	the association between
0.0220809027	an antagonist of
0.0219744722	onset of
0.0219511680	the rank order of
0.0218732679	the percentage
0.0217464355	the time course
0.0216998100	in combination with other
0.0216882246	the balance between
0.0216604736	the area under
0.0215592914	these effects of
0.0215390365	two novel
0.0215119534	the mrna expression of
0.0214745249	4 x
0.0214168403	the interaction with
0.0213901763	and inflammation in
0.0213352813	cause of
0.0212427404	the changes in
0.0212206247	possible mechanism of
0.0212202464	value for
0.0211834672	that activation of
0.0210451926	the utility of
0.0210245432	the pharmacological properties of
0.0209874535	via inhibition of
0.0209668006	in rats by
0.0207751539	or absence of
0.0207322751	a brief
0.0206830328	the interaction between
0.0206786201	the secretion of
0.0206548740	not produce
0.0206521344	the cells with
0.0205811043	to cause
0.0205092772	the mode of
0.0204971796	no difference in
0.0204904270	but not for
0.0204245470	made by
0.0204094071	the rates of
0.0204094071	the blockade of
0.0203892201	both in vitro and
0.0203887025	a novel mechanism of
0.0203363392	during treatment with
0.0203232001	to interact with
0.0203049689	a few
0.0202256173	for up to
0.0202027555	and in vivo studies
0.0201455636	found with
0.0201298000	not due to
0.0201057371	used with
0.0201054956	the neuroprotective effect of
0.0201019767	progression of
0.0200015215	to respond
0.0200007337	the disposition of
0.0199847656	the top
0.0199787359	as well as by
0.0198431050	to act as
0.0198258899	the generation of
0.0197970193	a third
0.0197274763	also shown to
0.0197160859	the immune system
0.0197116023	made to
0.0196982115	known for
0.0194765648	an important role of
0.0194168403	the results from
0.0194135332	described for
0.0193701763	of cells with
0.0193479098	for determination of
0.0193205549	the quality of
0.0192988010	the delivery of
0.0192888304	the range of
0.0192760738	the elevation of
0.0192124701	way to
0.0192052716	the course of
0.0192005925	an ic50 of
0.0190942591	but not with
0.0190760738	the downregulation of
0.0190196016	the recognition of
0.0190027064	to show
0.0189968665	to describe
0.0189332166	the removal of
0.0189322897	a regulator of
0.0188340670	a change in
0.0188183884	in children with
0.0185638779	the severity of
0.0185150461	through activation of
0.0184662307	the uptake of
0.0184312547	the incidence of
0.0184168403	the characterization of
0.0183901763	and progression of
0.0183787355	made in
0.0183701763	the detection of
0.0183613787	a comparison of
0.0183613787	the maintenance of
0.0183215407	an ic50
0.0183059883	and then
0.0182185216	a function of
0.0181459488	the development of novel
0.0180456982	the antitumor activity of
0.0180384695	the participation of
0.0180357630	the results show
0.0180178180	the suppression of
0.0180007337	the isolation of
0.0179332166	the measurement of
0.0178939859	the hippocampus of
0.0178480239	not required for
0.0177998833	the investigation of
0.0177811470	by pretreatment with
0.0177005766	in association with
0.0176786201	the distribution of
0.0176218867	interest in
0.0175334672	as well as in
0.0174788969	found for
0.0174590620	of tcdd on
0.0174380214	use as
0.0174331264	or in combination with
0.0174094071	the upregulation of
0.0173671536	the response to
0.0173489564	an effect on
0.0172289457	a source of
0.0171613787	the oxidation of
0.0170760738	and secretion of
0.0170571858	all other
0.0170196016	the nature of
0.0169487870	no significant differences in
0.0169332166	and maintenance of
0.0169312431	in adults with
0.0169139859	and pharmacokinetics of
0.0168255488	possible to
0.0168090549	the degradation of
0.0167461900	both in vitro and in
0.0167415423	not required
0.0167039336	the interactions between
0.0166961417	the first report of
0.0166786201	the actions of
0.0166786201	the determination of
0.0166521344	the concentrations of
0.0165961417	an accumulation of
0.0165739999	described in
0.0164978137	the difference between
0.0164591352	or even
0.0163215407	a mixture
0.0161974880	the stimulation of
0.0161916974	indicated by
0.0161786201	a loss of
0.0161219383	at concentrations of
0.0160760738	the ability to
0.0160368430	the incorporation of
0.0160061322	the ratio of
0.0159406498	the evaluation of
0.0159332166	the application of
0.0159139859	the characteristics of
0.0158114640	the efficacy and safety of
0.0158090549	the difference in
0.0157998833	the enhancement of
0.0156912099	the consequences of
0.0156690397	a substrate for
0.0156440784	mainly by
0.0155827583	and biological evaluation of
0.0155100457	mild to
0.0155007337	the initiation of
0.0154356894	associated to
0.0154094071	the understanding of
0.0153113365	and perhaps
0.0152451861	course of
0.0152289457	in men with
0.0152185216	the expressions of
0.0152035097	a role of
0.0151811234	to near
0.0148939859	the first to
0.0148939859	and toxicity of
0.0148340670	the significance of
0.0147265648	an interaction with
0.0146912099	and duration of
0.0146912099	the prevalence of
0.0146912099	the selection of
0.0146877379	2 adrenergic
0.0146877379	an activator
0.0146521344	the assessment of
0.0146489564	the efficiency of
0.0146294298	to account for
0.0145100457	approaches to
0.0143671536	the properties of
0.0143489564	the biosynthesis of
0.0142289457	with selectivity for
0.0141532166	the form of
0.0141489564	the recruitment of
0.0139401600	by binding to
0.0138950523	more potent in
0.0137804842	made of
0.0136912099	the diagnosis of
0.0136489564	the basis for
0.0134773192	a concentration of
0.0134412099	the active metabolite of
0.0133188010	the overexpression of
0.0130179751	a reduction of
0.0129194855	indicated for
0.0127289457	the results indicated
0.0097023656	not well
0.0086162534	given to
